Processing 00000000.tx.1: Metal-catalyzed Oxidation of -Synuclein HELPING TO DEFINE THE RELATIONSHIP BETWEEN OLIGOMERS, PROTOFIBRILS, AND FILAMENTS* Nelson B. 

Phrase: "Metal-catalyzed Oxidation of -Synuclein HELPING TO"

Phrase: "DEFINE"

Phrase: "THE RELATIONSHIP BETWEEN OLIGOMERS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439849:Relationship [Qualitative Concept]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "PROTOFIBRILS,"

Phrase: "AND"

Phrase: "FILAMENTS"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "* Nelson B."
Processing 00000000.tx.2: Cole, Diane D. 

Phrase: "Cole,"

Phrase: "Diane D."
Processing 00000000.tx.3: Murphy, Jacob Lebowitz||, Luca Di Noto**, Rodney L. 

Phrase: "Murphy,"

Phrase: "Jacob Lebowitz||,"

Phrase: "Luca Di Noto"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1538482:NOTO [Gene or Genome]
   827   C3538902:DI [Gene or Genome]
   827   C3541881:DI [Idea or Concept]

Phrase: "*"

Phrase: "*,"

Phrase: "Rodney L."
Processing 00000000.tx.4: Levine**, and Robert L. 

Phrase: "Levine"

Phrase: "*"

Phrase: "*,"

Phrase: "and"

Phrase: "Robert L."
Processing 00000000.tx.5: Nussbaum From the Genetic Diseases Research Branch, National Human Genome Research Institute, National Institutes of Health, the Division of Extramural Activities, NINDS, National Institutes of Health, the ||Division of Bioengineering and Physical Science, Office of Research Services, National Institutes of Health, and the **Laboratory of Biochemistry, NHLBI, National Institutes of Health, Bethesda, Maryland 20892 Received for publication, August 30, 2004 , and in revised form, December 16, 2004.  

Phrase: "Nussbaum From the Genetic Diseases"

Phrase: "Research"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035168:research [Research Activity]
  1000   C0242481:Research [Research Activity]

Phrase: "Branch,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1253959:Branch [Body Part, Organ, or Organ Component]
  1000   C1881507:Branch [Chemical Viewed Structurally]
  1000   C2700383:Branch [Plant]
  1000   C2826234:BRANCH [Intellectual Product]

Phrase: "National Human Genome Research Institute,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1955973:National Human Genome Research Institute [Health Care Related Organization]
   840   C0017429:Genome, Human [Gene or Genome]
   840   C0035172:Research Institute [Organization]
   804   C0017428:Genome [Gene or Genome]
   804   C0021622:institute [Organization]
   804   C0035168:research [Research Activity]
   804   C0086418:Human [Human]
   804   C0242481:Research [Research Activity]
   804   C1272753:Institute [Idea or Concept]
   804   C2338314:Genome [Conceptual Entity]
   804   C3245503:national [Intellectual Product]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "the Division of Extramural Activities,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   926   C1512006:Division of Extramural Activities [Health Care Related Organization]
   760   C1293097:Division [Therapeutic or Preventive Procedure]
   760   C2919030:Division [Organization]
   760   C2919031:Division [Activity]

Phrase: "NINDS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2350584:NINDS [Health Care Related Organization]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "the ||Division of Bioengineering"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1293097:Division [Therapeutic or Preventive Procedure]
   770   C2919030:Division [Organization]
   770   C2919031:Division [Activity]

Phrase: "and"

Phrase: "Physical Science,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0031816:physical science [Occupation or Discipline]
   861   C0031809:Physical [Health Care Activity]
   861   C0036397:Science [Occupation or Discipline]
   861   C0205485:Physical [Functional Concept]
   861   C1509143:Physical [Finding]

Phrase: "Office of Research Services,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2826339:Office of Research Services [Health Care Related Organization]
   770   C0442603:Office [Manufactured Object]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "and"

Phrase: "the **Laboratory of Biochemistry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "NHLBI,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1955970:NHLBI [Health Care Related Organization]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "Maryland 20892"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0024858:Maryland [Geographic Area]

Phrase: "Received for publication,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0034036:Publication [Intellectual Product,Manufactured Object]
   790   C0034037:Publication [Occupational Activity]
   790   C1514756:Received [Qualitative Concept]
   790   C1704324:Publication [Intellectual Product]

Phrase: "August 30,"

Phrase: "2004 ,"

Phrase: "and in revised form,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1515981:And [Idea or Concept]
   770   C1522492:Form [Functional Concept]
   770   C1527075:Revised [Therapeutic or Preventive Procedure]

Phrase: "December 16,"

Phrase: "2004."
Processing 00000000.tx.6: ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Oxidative stress is implicated in a number of neuro-degenerative diseases and is associated with the selective loss of dopaminergic neurons of the substantia nigra in Parkinson's disease. 

Phrase: "ABSTRACT TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Oxidative stress"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]
   861   C0038435:Stress [Finding]
   861   C0311404:Oxidative [Functional Concept]
   789 E C0231297:Stressful [Functional Concept]

Phrase: "is"

Phrase: "implicated in a number of neuro-degenerative diseases"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0011164:Degenerative [Pathologic Function]
   744   C0012634:Diseases [Disease or Syndrome]
   744   C0237753:*Number [Quantitative Concept]
   744   C0449788:Number [Quantitative Concept]
   744   C1880269:Degenerative [Functional Concept]
   737   C1285162:Degenerative Disease [Disease or Syndrome]

Phrase: "and"

Phrase: "is"

Phrase: "associated with the selective loss of dopaminergic neurons of the substantia nigra"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   790   C3550005:Loss of dopaminergic neurons [Finding]
   767   C0598940:Loss of neurons [Finding]
           neuron loss
   753   C0038590:Substantia Nigra [Body Part, Organ, or Organ Component]
   753   C0332281:Associated with [Qualitative Concept]
           Associated
   753   C1269578:Substantia nigra [Body Part, Organ, or Organ Component]
   753   C1512035:Dopaminergic Neurons [Cell]
   736   C0027882:Neurons [Cell]
   736   C0282151:Dopaminergic [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   736   C1517945:Loss [Quantitative Concept]
   709 E C1850496:Neuronal loss [Finding]
   703 E C0750490:Associate [Idea or Concept]
   703 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in Parkinson's disease."
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]
Processing 00000000.tx.7: The role of -synuclein as a potential target of intracellular oxidants has been demonstrated by the identification of posttranslational modifications of synuclein within intracellular aggregates that accumulate in Parkinson's disease brains, as well as the ability of a number of oxidative insults to induce synuclein oligomerization. 

Phrase: "The role of -synuclein as a potential target of intracellular oxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated by the identification of posttranslational modifications of synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C0033666:Post-Translational Modifications [Molecular Function]
   742   C0020792:Identification [Mental Process]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205396:Identification [Qualitative Concept]
   708   C0392747:Modification [Functional Concept]
   708   C1554963:modification [Qualitative Concept]

Phrase: "within intracellular aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "that"

Phrase: "accumulate in Parkinson's disease brains,"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   806   C0030567:Parkinson Disease [Disease or Syndrome]
   806   C1521736:Parkinson's Disease [Functional Concept]
   806   C2681933:PARKINSON DISEASE [Gene or Genome]
   781   C0006111:Brain Disease [Disease or Syndrome]
   760   C0006104:Brains [Body Part, Organ, or Organ Component]
   760   C0012634:Disease [Disease or Syndrome]
   726 E C1269537:Brain [Body Part, Organ, or Organ Component]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "as well as"

Phrase: "the ability of a number of oxidative insults to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085732:Ability [Organism Attribute]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "synuclein oligomerization."
Processing 00000000.tx.8: The relationship between these relatively small soluble oligomers, potentially neurotoxic synuclein protofibrils, and synuclein filaments remains unclear. 

Phrase: "The relationship between these relatively small soluble oligomers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "potentially neurotoxic synuclein protofibrils,"

Phrase: "and"

Phrase: "synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.9: We have found that metal-catalyzed oxidation of -synuclein inhibited formation of synuclein filaments with a concomitant accumulation of sheet-rich oligomers that may represent synuclein protofibrils. 

Phrase: "We"

Phrase: "have"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that metal-catalyzed oxidation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "formation of synuclein filaments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "with a concomitant accumulation"

Phrase: "of sheet-rich oligomers"

Phrase: "that"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "synuclein protofibrils."
Processing 00000000.tx.10: Similar results with a number of oxidative and enzymatic treatments suggest that the covalent association of synuclein into higher molecular mass oligomers/protofibrils represents an alternate pathway from filament formation and renders synuclein less prone to proteasomal degradation.  

Phrase: "Similar results with a number of oxidative"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "and"

Phrase: "enzymatic treatments"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the covalent association of synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "into higher molecular mass oligomers/protofibrils"

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an alternate pathway from filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C3534339:alternate pathway [Molecular Function]
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]

Phrase: "and"

Phrase: "renders"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "less prone to proteasomal degradation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033422:Prone [Spatial Concept]
Processing 00000000.tx.11: INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The role of oxidative stress in the etiology of Parkinson's disease (PD)1 has received extensive attention, yet little is understood regarding the primacy of damaging events that ultimately lead to cell loss and brain dysfunction. 

Phrase: "INTRODUCTION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: "(PD)1"

Phrase: "has"

Phrase: "received extensive attention,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0004268:Attention [Mental Process]

Phrase: "yet little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   861   C0700321:Little [Quantitative Concept]
   861   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "understood"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0162340:Understand [Mental Process]

Phrase: "regarding"

Phrase: "the primacy of damaging events"

Phrase: "that ultimately"

Phrase: "lead to cell loss"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   770   C0007634:Cell [Cell]
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C1269647:Cell [Cell]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1517945:Loss [Quantitative Concept]
   770   C1522538:Lead [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1948049:Cell [Spatial Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "brain dysfunction."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0262405:brain dysfunction [Disease or Syndrome]
   861   C0031847:dysfunction [Functional Concept]
   861   C0277785:Dysfunction, NOS [Qualitative Concept]
   805 E C0231174:Malfunction [Functional Concept]
   805 E C1881681:MALFUNCTION [Phenomenon or Process]
Processing 00000000.tx.12: The detection of biochemical landmarks of oxidative stress in post-mortem tissues yields clues as to the initiating event(s) (1, 2), although it is difficult to distinguish a causative role for oxidative stress in disease initiation and progression versus damage as a product of general metabolic failure (3). 

Phrase: "The detection of biochemical landmarks of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C2754096:detection of oxidative stress [Cell Function]
   744   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "in post-mortem tissues"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   983   C0444184:Postmortem tissue [Tissue]
   827   C0040300:Tissues [Tissue]
   793 E C1547928:Tissue [Intellectual Product]
   734   C0004398:postmortem [Diagnostic Procedure]
   734   C0580205:Postmortem [Temporal Concept]
   734   C0848632:post mortem [Finding]

Phrase: "yields"

Phrase: "clues as to the initiating event"

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "(1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "it"

Phrase: "is"

Phrase: "difficult to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0332218:Difficult [Qualitative Concept]
   789 E C1299586:Difficulty [Finding]

Phrase: "distinguish"

Phrase: "a causative role for oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in disease initiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0589507:Initiation [Mental Process]
   861   C1158830:Initiation [Genetic Function]
   861   C1704686:Initiation [Functional Concept]

Phrase: "and"

Phrase: "progression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0242656:progression [Pathologic Function]
  1000   C0449258:Progression [Functional Concept]

Phrase: "versus"

Phrase: "damage as a product of general metabolic failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0010957:Damage [Injury or Poisoning]
   744   C1883709:Damage [Functional Concept]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")."
Processing 00000000.tx.13: The major pathological findings in PD, which involve the selective demise of neurons of the substantia nigra pars compacta, have been attributed largely to the unique sensitivity of these dopamine-containing neurons to impairments in mitochondrial complex I activity (4). 

Phrase: "The major pathological findings in PD,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   753   C2607943:findings [Functional Concept]
   753   C2926606:Findings [Clinical Attribute]
   753   C3539655:Findings [Intellectual Product]
   740   C1317598:Pathologic findings [Finding]
   719 E C0037088:Finding [Sign or Symptom]
   719 E C0243095:Finding [Finding]
   719 E C2825141:Finding [Finding]

Phrase: "which"

Phrase: "involve"

Phrase: "the selective demise of neurons of the substantia nigra pars compacta,"

Phrase: "have"

Phrase: "been"

Phrase: "attributed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0449234:Attribute [Idea or Concept]
   966   C1704772:Attribute [Conceptual Entity]
   966   C1882133:Attribute [Qualitative Concept]

Phrase: "largely to the unique sensitivity of these dopamine-containing neurons"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   757   C1512035:dopamine neurons [Cell]
   739   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   739   C0027882:Neurons [Cell]
   739   C0036667:Sensitivity [Quantitative Concept]
   739   C0312418:Sensitivity [Mental Process]
   739   C0332256:Containing [Functional Concept]
   739   C0427965:Sensitivity [Finding]
   739   C1511883:Sensitivity [Quantitative Concept]
   739   C1522640:Sensitivity [Qualitative Concept]
   739   C1710548:Unique [Qualitative Concept]
   739   C2346484:SENSITIVITY [Phenomenon or Process]
   739   C2349185:Sensitivity [Qualitative Concept]
   739   C2700400:Containing [Activity]
   722   C0332324:Sensitive to [Functional Concept]

Phrase: "to impairments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0684336:Impairments [Pathologic Function]
  1000   C2598156:Impairments [Clinical Attribute]

Phrase: "in mitochondrial complex I activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0205177:Activity [Functional Concept]
   812   C0439167:% activity [Quantitative Concept]
   812   C0441655:Activity [Activity]
   812   C1561536:*Activity [Idea or Concept]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.14: Pesticides and other environmental toxins that affect complex I, such as 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (5, 6), paraquat (7, 8), and rotenone (9, 10), replicate many of the features of sporadic PD including the selective degeneration of dopamine neurons and formation of intracellular aggregates containing alpha-synuclein. 

Phrase: "Pesticides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031253:Pesticides [Hazardous or Poisonous Substance]

Phrase: "and"

Phrase: "other environmental toxins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0040549:Toxins [Biologically Active Substance,Hazardous or Poisonous Substance]

Phrase: "that"

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "complex I,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2245017:Complex I [Cell Component]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "such as 1-methyl-4-phenyl-1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C2827734:1+ [Quantitative Concept]
   804   C2945751:phenyl [Chemical Viewed Structurally]
   804   C2981698:1+ [Classification]

Phrase: "2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "6-tetrahydropyridine"

Phrase: "(5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "6"

Phrase: ")"

Phrase: ","

Phrase: "paraquat"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030493:Paraquat [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(7,"

Phrase: "8"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "rotenone"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0035871:Rotenone [Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(9,"

Phrase: "10"

Phrase: ")"

Phrase: ","

Phrase: "replicate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205173:Replicate [Functional Concept]
  1000   C0205341:Replicate [Functional Concept]
  1000   C1883725:Replicate [Qualitative Concept]

Phrase: "many of the features of sporadic PD"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0205422:Sporadic [Temporal Concept]
   748   C0439064:Many [Quantitative Concept]
   748   C0747726:many [Conceptual Entity]
   714   C1521970:Feature [Qualitative Concept]
   714   C1706388:Feature [Conceptual Entity]
   714   C2346469:Feature [Qualitative Concept]
   714   C2348519:Feature [Qualitative Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the selective degeneration of dopamine neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0027746:degeneration neurons [Cell or Molecular Dysfunction]
   753   C0011164:Degeneration [Pathologic Function]
   753   C1880269:Degeneration [Functional Concept]

Phrase: "and"

Phrase: "formation of intracellular aggregates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "alpha-synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0285890:alpha-Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1420276:SYNUCLEIN, ALPHA [Gene or Genome]
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439095:Alpha [Intellectual Product]
   861   C2003941:Alpha [Intellectual Product]
   861   C2350010:Alpha [Qualitative Concept]
Processing 00000000.tx.15: One common feature of these toxins is their ability to induce oxidative damage via the generation of reactive oxygen species (ROS) produced by mitochondrial respiratory chain dysfunction (4). 

Phrase: "One common feature of these toxins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1521970:Feature [Qualitative Concept]
   753   C1706388:Feature [Conceptual Entity]
   753   C2346469:Feature [Qualitative Concept]
   753   C2348519:Feature [Qualitative Concept]

Phrase: "is"

Phrase: "their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "oxidative damage via the generation of reactive oxygen species (ROS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0010957:Damage [Injury or Poisoning]
   742   C1883709:Damage [Functional Concept]

Phrase: "produced by mitochondrial respiratory chain dysfunction"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C1325653:mitochondrial respiratory chain [Cell Component]
           respiratory chain
   790   C0162362:Respiratory Chain [Molecular Function]
   783   C1260922:RESPIRATORY DYSFUNCTION NOS [Sign or Symptom]
   753   C0026237:Mitochondrial [Cell Component]
   753   C0031847:dysfunction [Functional Concept]
   753   C0277785:Dysfunction, NOS [Qualitative Concept]
   753   C0337112:Chain [Manufactured Object]
   753   C0521346:respiratory [Functional Concept]
   753   C0521451:Mitochondrial [Functional Concept]
   753   C1524075:Chain [Idea or Concept]
   753   C1546767:Respiratory [Intellectual Product]

Phrase: "(4"

Phrase: ")."
Processing 00000000.tx.16: Inherent in the toxicity due to the generation of ROS is the fundamental role of transition metals, principally iron and copper, in catalyzing ROS formation via their ability to undergo interconversion between oxidized and reduced states (1116). 

Phrase: "Inherent in the toxicity"

Phrase: "due to the generation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0079411:Generation [Temporal Concept]
  1000   C3146294:Generation [Activity]
   907 E C1414672:Genesis [Gene or Genome]
   907 E C2984892:Genesis [Gene or Genome]

Phrase: "of ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "the fundamental role of transition metals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "principally iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "copper,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "in catalyzing ROS formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]
   717   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "via their ability to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0085732:Ability [Organism Attribute]
   789 E C1299581:Able [Finding]

Phrase: "undergo"

Phrase: "interconversion between oxidized"

Phrase: "and"

Phrase: "reduced states"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1301808:states [Geographic Area]
   827 E C1442792:State [Functional Concept]
   827 E C3148680:State [Geographic Area]

Phrase: "(1116"

Phrase: ")."
Processing 00000000.tx.17: In fact, considerable evidence suggests that much of the toxicity of the enzymatically generated superoxide radical anion and hydrogen peroxide is because of their reaction with reduced iron or copper ions to generate the highly reactive hydroxyl radical via iron-catalyzed Haber-Weiss and Fenton reactions (15, 16). 

Phrase: "In fact,"

Phrase: "considerable evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that much of the toxicity of the enzymatically generated superoxide radical anion"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0038836:Superoxide Radical [Element, Ion, or Isotope]
           Superoxide Anion
           Superoxide
   736   C0003075:Anion [Element, Ion, or Isotope]
   736   C0040539:toxicity [Qualitative Concept]
   736   C0302912:Radical [Chemical Viewed Structurally]
   736   C0439807:Radical [Qualitative Concept]
   736   C0600688:Toxicity [Injury or Poisoning]
   736   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "is because of their reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0443286:Reaction [Functional Concept]
   760   C1114821:Reaction [Clinical Attribute]

Phrase: "with reduced iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "or"

Phrase: "copper ions to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0022023:Ions [Element, Ion, or Isotope]
   793 E C1700702:ION [Functional Concept]

Phrase: "generate"

Phrase: "the highly reactive hydroxyl radical via iron-catalyzed Haber-Weiss"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0063146:Hydroxyl Radical [Inorganic Chemical]
           Hydroxyl
   739   C0302912:Radical [Chemical Viewed Structurally]
   739   C0439807:Radical [Qualitative Concept]
   739   C0700307:Hydroxyl [Inorganic Chemical]

Phrase: "and"

Phrase: "Fenton reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "(15,"

Phrase: "16"

Phrase: ")."
Processing 00000000.tx.18: Similarly, transition metals stimulate the formation of alkoxyl and peroxyl radicals from the decomposition of polyunsaturated fatty acids (17, 18) and semiquinones derived from oxidized catecholamines (19). 

Phrase: "Similarly,"

Phrase: "transition metals"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0682906:transition metal [Element, Ion, or Isotope]
   861   C0025552:Metals [Inorganic Chemical]
   861   C0599156:Transition [Cell or Molecular Dysfunction]
   861   C2700061:Transition [Activity]
   789 E C1182674:Transitional [Spatial Concept]
   789 E C1548597:Transitional [Idea or Concept]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "stimulate"

Phrase: "the formation of alkoxyl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "peroxyl radicals from the decomposition of polyunsaturated fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0070417:peroxyl radical [Inorganic Chemical]
   742   C0302912:radicals [Chemical Viewed Structurally]
   728   C0302913:Acid radical [Inorganic Chemical]
   708 E C0439807:Radical [Qualitative Concept]

Phrase: "(17,"

Phrase: "18"

Phrase: ")"

Phrase: "and"

Phrase: "semiquinones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0597433:semiquinone [Organic Chemical]

Phrase: "derived from oxidized catecholamines"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0007412:Catecholamines [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   770   C1441547:Derived [Qualitative Concept]
   770   C3245521:derived [Idea or Concept]
   737   C0030011:oxidize [Molecular Function]
   737 E C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "(19"

Phrase: ")."
Processing 00000000.tx.19: -Synuclein is a 140-amino acid, principally unstructured cytosolic protein, an unknown fraction of which reversibly associates with membranes via a series of amphipathic helices, located in its N-terminal region (20). 

Phrase: "-Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "a 140-amino acid,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C2917660:Amino Acid [Pharmacologic Substance]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "principally unstructured cytosolic protein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "an unknown fraction of which reversibly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1264633:Fraction of [Quantitative Concept]
           Fraction
   753   C1554103:Fraction [Idea or Concept]

Phrase: "associates with membranes"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   790   C0025255:Membranes [Tissue]
   790   C0750490:Associate [Idea or Concept]
   790   C1706221:Associate [Professional or Occupational Group]
   756 E C0596901:Membrane [Cell Component]
   756 E C1706182:Membrane [Manufactured Object]
   706 E C0205287:Membranous [Qualitative Concept]

Phrase: "via a series"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205549:Series [Quantitative Concept]
  1000   C2348044:Series [Intellectual Product]

Phrase: "of amphipathic helices,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0018882:Helix [Eukaryote]
   861   C0229304:Helix [Body Part, Organ, or Organ Component]
   861   C1017315:helices [Eukaryote]
   861   C1704821:Helix [Spatial Concept]
   861   C1705682:Helix [Anatomical Structure]

Phrase: "located in its N-terminal region"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0017446:Region [Geographic Area]
   753   C0205088:Terminal [Temporal Concept]
   753   C0205147:Region [Spatial Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]

Phrase: "(20"

Phrase: ")."
Processing 00000000.tx.20: A central, relatively hydrophobic domain (NAC) is responsible for the capacity of -synuclein to form sheet-rich amyloid filaments (21), which is followed by an acidic tail region that blocks rapid synuclein filament assembly (22) and allows synuclein to function as a molecular chaperone (23, 24). 

Phrase: "A central, relatively hydrophobic domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "(NAC)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3538756:NAC [Gene or Genome]

Phrase: "is"

Phrase: "responsible for the capacity of -synuclein to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1273518:Responsible to [Finding]
           Responsible

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "sheet-rich amyloid filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   779   C0010851:Filament [Cell Component]
   729 E C1979891:Filamentous [Qualitative Concept]

Phrase: "(21"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "followed by an acidic tail region"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332283:Followed by [Temporal Concept]
           followed
   783   C1515860:Acidic Region [Amino Acid Sequence]
   753   C0001128:Acidic [Chemical]
   753   C0017446:Region [Geographic Area]
   753   C0039259:Tail [Body Part, Organ, or Organ Component]
   753   C0205147:Region [Spatial Concept]
   719 E C1719822:Follow [Intellectual Product]

Phrase: "that"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "rapid synuclein filament assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1706853:Assembly [Activity]
   812   C1879748:Assembly [Manufactured Object]

Phrase: "(22"

Phrase: ")"

Phrase: "and"

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "synuclein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "function as a molecular chaperone"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   806   C0243041:Molecular Chaperone [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           Chaperone
   797   C1148560:molecular function [Molecular Function]
   760   C0031843:function [Physiologic Function]
   760   C0542341:Function [Functional Concept]
   760   C0700205:FUNCTION [Classification]
   760   C1521991:Molecular [Qualitative Concept]
   760   C1705273:Function [Intellectual Product]

Phrase: "(23,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450348:23 [Quantitative Concept]

Phrase: "24"

Phrase: ")."
Processing 00000000.tx.21: Both wild type and mutant forms of -synuclein have been linked genetically to PD (2528). 

Phrase: "Both wild type"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1883559:Wild Type [Organism Attribute]
   861   C0332307:Type [Qualitative Concept]
   861   C0445392:Wild [Intellectual Product]
   861   C1547052:*Type [Quantitative Concept]

Phrase: "and"

Phrase: "mutant forms of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "have"

Phrase: "been"

Phrase: "linked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1517892:Link [Intellectual Product]
   966   C1704666:Link [Intellectual Product]

Phrase: "genetically to PD (2528"

Phrase: ")."
Processing 00000000.tx.22: In addition, biochemical and histological analyses have identified -synuclein as a major component of the intraneuronal inclusions known as Lewy bodies and Lewy neurites associated with a number of diseases, including PD, collectively termed synucleinopathies (2931). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "biochemical"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205474:Biochemical [Functional Concept]

Phrase: "and"

Phrase: "histological analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "have"

Phrase: "identified -"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205396:Identified [Qualitative Concept]
  1000   C1550043:Identified [Finding]
  1000   C1551388:Identified [Functional Concept]

Phrase: "synuclein as a major component of the intraneuronal inclusions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "known as Lewy bodies"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0085200:Lewy Bodies [Cell Component]
   770   C0205309:Known [Qualitative Concept]
   770   C0242821:bodies [Human]
   770   C1995017:Bodies [Cell Component]
   737 E C0460148:Body [Anatomical Structure]
   737 E C1268086:Body [Anatomical Structure]

Phrase: "and"

Phrase: "Lewy neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C3548404:Lewy neurite [Cell Component]
   861   C0085103:Neurites [Cell Component]

Phrase: "associated with a number of diseases,"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   790   C0332281:Associated with [Qualitative Concept]
           Associated
   767   C0243083:associated disease [Pathologic Function]
   753   C0012634:Diseases [Disease or Syndrome]
   753   C0237753:*Number [Quantitative Concept]
   753   C0449788:Number [Quantitative Concept]
   719 E C0750490:Associate [Idea or Concept]
   719 E C1706221:Associate [Professional or Occupational Group]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "PD,"

Phrase: "collectively termed synucleinopathies"

Phrase: "(2931"

Phrase: ")."
Processing 00000000.tx.23: Although the filamentous nature of these inclusions can be mimicked structurally by the in vitro polymerization of recombinant -synuclein (3234), the identification of both SDS-soluble and -insoluble oligomers from synucleinopathy brains (31, 3538) indicates that changes in the solubility of synuclein and/or the formation of covalently associated synuclein oligomers, rather than the exclusive non-covalent association of synuclein into filaments, may underlie its role in pathogenesis. 

Phrase: "Although"

Phrase: "the filamentous nature of these inclusions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "can"

Phrase: "be"

Phrase: "mimicked"

Phrase: "structurally by the in vitro polymerization of recombinant -synuclein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0021135:In Vitro [Intellectual Product]
   764   C1533691:in vitro [Qualitative Concept]
           vitro
   764   C2827718:In Vitro [Functional Concept]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0314672:Polymerisation [Phenomenon or Process]
   742   C1514798:recombinant [Organism]

Phrase: "(3234"

Phrase: ")"

Phrase: ","

Phrase: "the identification of both SDS-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1749467:soluble [Cell Component]
  1000   C1948047:Soluble [Qualitative Concept]

Phrase: "and -"

Phrase: "insoluble oligomers from synucleinopathy brains"

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "3538"

Phrase: ")"

Phrase: "indicates"

Phrase: "that changes in the solubility of synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0392747:changes [Functional Concept]
   748   C0443172:changes [Quantitative Concept]
   714 E C1705241:Change [Quantitative Concept]

Phrase: "and/or"

Phrase: "the formation of covalently associated synuclein oligomers,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "rather than"

Phrase: "the exclusive non-covalent association of synuclein"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004083:Association [Mental Process]
   748   C0439849:Association [Qualitative Concept]
   748   C0596306:Association [Phenomenon or Process]
   748   C0699792:association [Social Behavior]

Phrase: "into filaments,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "may"

Phrase: "underlie"

Phrase: "its role in pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]
Processing 00000000.tx.24: Indeed, a number of treatments induce the formation of SDS-resistant synuclein oligomers in vitro, many of which require oxidizing conditions. 

Phrase: "Indeed,"

Phrase: "a number of treatments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the formation of SDS-resistant synuclein oligomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "many of which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0439064:Many [Quantitative Concept]
   790   C0747726:many [Conceptual Entity]

Phrase: "require"

Phrase: "oxidizing conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.25: These include cross-linking in the presence of transition metals (3942), peroxynitrite (43, 44), polyunsaturated fatty acids (45, 46), and tissue transglutaminase (tTGase) (47, 48). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "cross-linking in the presence of transition metals"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   770   C0332220:Cross-linking [Functional Concept]
   754 E C0178576:Cross link [Natural Phenomenon or Process]
   744   C0025552:Metals [Inorganic Chemical]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0599156:Transition [Cell or Molecular Dysfunction]
   744   C2700061:Transition [Activity]
   744   C2828360:Cross [Conceptual Entity]
   737   C0682906:transition metal [Element, Ion, or Isotope]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "(3942"

Phrase: ")"

Phrase: ","

Phrase: "peroxynitrite"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]

Phrase: "(43,"

Phrase: "44"

Phrase: ")"

Phrase: ","

Phrase: "polyunsaturated fatty acids"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0032615:Polyunsaturated Fatty Acids [Biologically Active Substance,Lipid]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "(45,"

Phrase: "46"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "tissue transglutaminase (tTGase)"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(47,"

Phrase: "48"

Phrase: ")."
Processing 00000000.tx.26: Larger oligomerized forms of synuclein termed "protofibrils,"2 operationally defined from gel filtration experiments, have also been described that may function as intermediates in the pathway leading to filament formation and have been proposed to play a role as toxic intermediates in the etiology of PD (4951). 

Phrase: "Larger oligomerized forms of synuclein termed ""protofibrils,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: """2 operationally"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0740116:+2 [Quantitative Concept]
   861   C2827735:2+ [Quantitative Concept]
   861   C2981700:2+ [Classification]

Phrase: "defined from gel filtration experiments,"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0008559:Gel Filtration [Laboratory Procedure]
   760   C0016107:filtration [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C0681814:Experiments [Research Activity]
   760   C1382104:Gel [Substance]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726 E C1706386:Experiment [Conceptual Entity]

Phrase: "have"

Phrase: "also"

Phrase: "been"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "that"

Phrase: "may"

Phrase: "function as intermediates"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0031843:function [Physiologic Function]
   790   C0542341:Function [Functional Concept]
   790   C0700205:FUNCTION [Classification]
   790   C1705273:Function [Intellectual Product]
   756   C0205103:Intermediate [Spatial Concept]
   756   C1550465:intermediate [Idea or Concept]
   756   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "in the pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704259:Pathway [Molecular Function]
  1000   C1705987:Pathway [Conceptual Entity]

Phrase: "leading to filament formation"
Meta Candidates (Total=10; Excluded=4; Pruned=0; Remaining=6)
   770   C0010851:Filament [Cell Component]
   770   C0220781:formation [Biologic Function]
   770   C0332152:Leading [Temporal Concept]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
   770   C1522538:Leading [Functional Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role as toxic intermediates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of PD (4951"

Phrase: ")."
Processing 00000000.tx.27: Although the relationship between the formation of smaller soluble SDS-resistant oligomers, larger soluble synuclein protofibrils, and insoluble synuclein filaments in pathogenesis remains unclear (51), abnormally accumulated or modified synuclein may compromise the ability of the proteasome to efficiently degrade cellular proteins (5255), resulting in proteolytic stress that leads to neuronal dysfunction and degeneration (56). 

Phrase: "Although"

Phrase: "the relationship between the formation of smaller soluble SDS-resistant oligomers,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   738   C0439849:Relationship [Qualitative Concept]
   738   C1705630:Relationship [Idea or Concept]
   738   C1706279:Relationship [Idea or Concept]
   738   C3540605:Relationship [Intellectual Product]

Phrase: "larger soluble synuclein protofibrils,"

Phrase: "and"

Phrase: "insoluble synuclein filaments in pathogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C0010851:Filament [Cell Component]

Phrase: "remains"

Phrase: "unclear"

Phrase: "(51"

Phrase: ")"

Phrase: ","

Phrase: "abnormally"

Phrase: "accumulated"

Phrase: "or"

Phrase: "modified synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "may"

Phrase: "compromise"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945640:compromise [Finding]

Phrase: "the ability of the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0085732:Ability [Organism Attribute]

Phrase: "to efficiently"

Phrase: "degrade"

Phrase: "cellular proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(5255"

Phrase: ")"

Phrase: ","

Phrase: "resulting in proteolytic stress"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
   833   C0332294:Resulting in [Functional Concept]
   770   C0038435:Stress [Finding]
   770   C0597304:Proteolytic [Molecular Function]
   770   C0678226:resulting [Functional Concept]
   770   C1947941:proteolytic [Enzyme]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2825142:Result [Finding]

Phrase: "that"

Phrase: "leads to neuronal dysfunction"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0031847:dysfunction [Functional Concept]
   770   C0181586:leads [Medical Device]
   770   C0277785:Dysfunction, NOS [Qualitative Concept]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522538:Lead [Functional Concept]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
   715 E C0231174:Malfunction [Functional Concept]
   715 E C1881681:MALFUNCTION [Phenomenon or Process]

Phrase: "and"

Phrase: "degeneration"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0011164:Degeneration [Pathologic Function]
  1000   C1880269:Degeneration [Functional Concept]

Phrase: "(56"

Phrase: ")."
Processing 00000000.tx.28: Whether metalcatalyzed oxidative processes are causative in Lewy body formation or accumulate subsequent to defects in protein and lipid turnover remains unknown. 

Phrase: "Whether"

Phrase: "metalcatalyzed oxidative processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1184743:Process [Body Part, Organ, or Organ Component]
   793   C1522240:Process [Phenomenon or Process]

Phrase: "are"

Phrase: "causative in Lewy body formation"

Phrase: "or"

Phrase: "accumulate subsequent to defects"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C0243067:defects [Functional Concept]
   770   C0332282:Subsequent [Temporal Concept]
   737 E C1457869:Defect [Functional Concept]
   737 E C1861101:DEFECT [Disease or Syndrome]

Phrase: "in protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "lipid turnover remains"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.29: Given the potential role of oxidative stress in the etiology of PD, we sought to investigate the role that oxidation plays in the relationship between synuclein oligomers, protofibrils, and filaments. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the potential role of oxidative stress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0035820:Role [Social Behavior]
   753   C1705810:Role [Conceptual Entity]

Phrase: "in the etiology"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:aetiology [Functional Concept]
  1000   C1314792:Aetiology [Functional Concept]
  1000   C1524003:Etiology [Conceptual Entity]

Phrase: "of PD,"

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "investigate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292732:investigate [Functional Concept]

Phrase: "the role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0035820:Role [Social Behavior]
  1000   C1705810:Role [Conceptual Entity]

Phrase: "that oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "plays in the relationship"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0032214:Play [Daily or Recreational Activity]
   770   C0439849:Relationship [Qualitative Concept]
   770   C0600138:Plays [Finding]
   770   C1705630:Relationship [Idea or Concept]
   770   C1706279:Relationship [Idea or Concept]
   770   C3540605:Relationship [Intellectual Product]

Phrase: "between synuclein oligomers,"

Phrase: "protofibrils,"

Phrase: "and"

Phrase: "filaments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.30: We found that a model metal-catalyzed oxidation (MCO) system consisting of a redox active metal (iron or copper), oxygen, and a reducing agent to recycle the oxidized metal (57), enhanced the oxidation of -synuclein over previously used MCO systems. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "a model metal-catalyzed oxidation (MCO) system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   897   C0026339:Model System [Intellectual Product,Research Device]
   897   C3161035:Model System [Intellectual Product]
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "consisting of a redox active metal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025552:Metal [Inorganic Chemical]
   753   C0030012:Redox [Molecular Function]
   753   C0205177:Active [Functional Concept]
   719   C0332529:CONSIST [Qualitative Concept]

Phrase: "(iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "or"

Phrase: "copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "oxygen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "and"

Phrase: "a reducing agent to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0376446:reducing agent [Indicator, Reagent, or Diagnostic Aid]
   827   C0392756:Reducing [Qualitative Concept]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "recycle"

Phrase: "the oxidized metal"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025552:Metal [Inorganic Chemical]
   789 E C2986473:Metallic [Qualitative Concept]

Phrase: "(57"

Phrase: ")"

Phrase: ","

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the oxidation of -synuclein over previously used MCO systems."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   813   C0026339:Model System [Intellectual Product,Research Device]
   813   C3161035:Model System [Intellectual Product]
   755   C0449913:System [Functional Concept]
   755   C1553451:System [Manufactured Object]
   755   C1704459:System [Medical Device]
   705 E C0205373:Systemic [Functional Concept]
Processing 00000000.tx.31: Under these conditions, production of synuclein oligomers and protofibrils was enhanced, whereas synuclein filaments were not produced. 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "production of synuclein oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "protofibrils"

Phrase: "was"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: ","

Phrase: "whereas"

Phrase: "synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "produced."
Processing 00000000.tx.32: Rather, altering oxidative stress levels could modulate the conversion between synuclein protofibrils and filaments. 

Phrase: "Rather,"

Phrase: "altering"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   907   C0392747:Altered [Functional Concept]

Phrase: "oxidative stress levels"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   884   C1319127:Stress level [Finding]
   827   C0441889:Levels [Qualitative Concept]
   793 E C0456079:Level [Classification]
   793 E C1547707:Level [Geographic Area]
   793 E C2946261:Level [Pharmacologic Substance]
   734   C0242606:Oxidative Stress [Cell or Molecular Dysfunction]

Phrase: "could"

Phrase: "modulate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "the conversion between synuclein protofibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439836:Conversion [Functional Concept]

Phrase: "and"

Phrase: "filaments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.33: This raises the possibility that synuclein oxidation/oligomerization/protofibril formation represents a divergent pathway from fibril assembly. 

Phrase: "This"

Phrase: "raises"

Phrase: "the possibility"

Phrase: "that synuclein oxidation/oligomerization/protofibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0220781:formation [Biologic Function]
   804   C0439634:formation [Spatial Concept]
   804   C1522492:Formation [Functional Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a divergent pathway from fibril assembly."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1704259:Pathway [Molecular Function]
   753   C1705987:Pathway [Conceptual Entity]
Processing 00000000.tx.34: Failure to efficiently degrade oxidized synuclein by the proteasome underlies the potential pathological consequences of these structural modifications.  

Phrase: "Failure to efficiently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231174:Failure [Functional Concept]
   790   C0680095:failure [Individual Behavior]

Phrase: "degrade"

Phrase: "oxidized synuclein by the proteasome"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "underlies"

Phrase: "the potential pathological consequences of these structural modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0686907:Consequence of [Functional Concept]
           consequences
Processing 00000000.tx.35: EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  ReagentsHuman wild type -synuclein was expressed in bacteria and purified as described (58, 59). 

Phrase: "EXPERIMENTAL PROCEDURES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   791   C0557061:Discussion [Therapeutic or Preventive Procedure]
   791   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "ReagentsHuman wild type -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "expressed in bacteria"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0004611:Bacteria [Bacterium]
   790   C1510439:bacteria [Functional Concept]
   790   C2347473:% Bacteria [Quantitative Concept]
   718 E C0521009:Bacterial [Qualitative Concept]

Phrase: "and"

Phrase: "purified as described"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1552738:described [Idea or Concept]
   790   C1998793:Purified [Functional Concept]

Phrase: "(58,"

Phrase: "59"

Phrase: ")."
Processing 00000000.tx.36: The purity was judged to be greater than 97% by high pressure liquid chromatography. 

Phrase: "The purity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1882508:Purity [Quantitative Concept]
   928 E C2247561:PurE [Molecular Function]

Phrase: "was"

Phrase: "judged"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0221191:Judge [Professional or Occupational Group]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "greater than 97%"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C0439093:Greater Than [Quantitative Concept]
   790   C0443228:greater [Quantitative Concept]
   790   C1704243:Greater [Quantitative Concept]
   756 E C0549177:Great [Quantitative Concept]

Phrase: "by high pressure liquid chromatography."
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0008562:Chromatography, High Pressure Liquid [Laboratory Procedure]
   861   C0008565:Liquid Chromatography [Laboratory Procedure]
   812   C0008550:Chromatography [Laboratory Procedure]
   812   C0033095:Pressure [Phenomenon or Process]
   812   C0205250:High [Qualitative Concept]
   812   C0302908:Liquid [Substance]
   812   C0460139:Pressure [Finding]
   812   C1299351:High [Qualitative Concept]
   812   C1304698:Liquid [Finding]
   812   C1306345:Pressure [Functional Concept]
   812   C1546699:Liquid NOS [Intellectual Product]
   812   C1561501:Liquid NOS [Substance]
   812   C2700149:HIGH [Intellectual Product]
   712 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.37: Antibodies to synuclein included (with indicated epitopes): mouse monoclonal 202 (extreme C terminus, (60)), a kind gift from V. 

Phrase: "Antibodies to synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "included"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]

Phrase: "("

Phrase: "with indicated epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]

Phrase: ")"

Phrase: ":"

Phrase: "mouse monoclonal 202"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]
   827   C0746619:monoclonal [Finding]

Phrase: "(extreme C terminus,"

Phrase: "(60"

Phrase: ")"

Phrase: ")"

Phrase: ","

Phrase: "a kind gift from V."
Processing 00000000.tx.38: Lee, University of Pennsylvania, and LB509 (115122, Zymed Laboratories Inc.). 

Phrase: "Lee,"

Phrase: "University of Pennsylvania,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0030853:Pennsylvania [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "and"

Phrase: "LB509"

Phrase: "(115122,"

Phrase: "Zymed Laboratories"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.39: Anti-oligomer polyclonal serum was a kind gift from C. 

Phrase: "Anti-oligomer polyclonal serum"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0229671:Serum [Body Substance]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "was"

Phrase: "a kind gift from C."
Processing 00000000.tx.40: Glabe (61). 

Phrase: "Glabe"

Phrase: "(61"

Phrase: ")."
Processing 00000000.tx.41: Dithiothreitol (DTT) was from ICN Biomedicals, Inc (Aurora, OH). 

Phrase: "Dithiothreitol (DTT)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "was from ICN Biomedicals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "Inc (Aurora,"

Phrase: "OH"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220853:OH- [Element, Ion, or Isotope]

Phrase: ")."
Processing 00000000.tx.42: Clioquinol was from Calbiochem. 

Phrase: "Clioquinol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021978:Clioquinol [Organic Chemical,Pharmacologic Substance]

Phrase: "was from Calbiochem."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.43: Chelex 100 resin was from Bio-Rad Laboratories. 

Phrase: "Chelex 100 resin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0035191:Resin [Biomedical or Dental Material]
   734   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was from Bio-Rad Laboratories."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0022877:Laboratories [Manufactured Object,Organization]
   760   C0043194:WAS [Disease or Syndrome]
   760   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1421478:WAS [Gene or Genome]
   760   C1619828:Laboratories [Intellectual Product]
   726 E C3244292:laboratory [Functional Concept]
Processing 00000000.tx.44: DSP (dithiobis(succinimidyl propionate)) (59) was from Pierce. 

Phrase: "DSP (dithiobis(succinimidyl propionate)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   923   C0058494:dithiobis((succinimidyl)propionate) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0033474:propionate [Organic Chemical]
   812   C0392214:Propionate [Lipid]

Phrase: ")"

Phrase: "(59"

Phrase: ")"

Phrase: "was from Pierce."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0043194:WAS [Disease or Syndrome]
   790   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C1421478:WAS [Gene or Genome]
Processing 00000000.tx.45: Copper(II) sulfate, iron(III) chloride, deferoxamine mesylate salt (deferoxamine), diethylenetriaminepentaacetic acid, bathocuproinedisulfonic acid, guinea pig tissue transglutaminase (EC 2.3.2.13 [EC] ), cis-4,7,10,13,16,19-docosahexaenoic acid sodium salt, catalog number D-8768), 5,8,11,14-eicosatetraenoic acid (arachidonic acid sodium salt, catalog number A-8798), soybean lipoxidase (EC 1.13.11.12 [EC] ), 3-hydroxytyramine hydrochloride (dopamine), thioflavin T and 44'-dianilino-11'-binaphthyl-55'-disulfonic acid (bis-ANS), Ala-Ala-Phe-7-amido-4-methylcoumarin, 7-amino-4-methylcoumarin, 8-anilino-1-naphthalenesulfonic acid, boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin, Z-Leu-Leu-Glu-7-amido-4-methylcoumarin, and all other reagents were from Sigma. 

Phrase: "Copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "(II"

Phrase: ")"

Phrase: "sulfate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038720:Sulfate [Inorganic Chemical]
  1000   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
  1000   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "chloride,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008203:Chloride, NOS [Inorganic Chemical]
  1000   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "deferoxamine mesylate salt"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   827   C0036140:Salt [Chemical Viewed Structurally]
   827   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C0206136:Salt [Food,Inorganic Chemical]
   755 E C1537053:salty [Qualitative Concept]
   734   C0011148:Deferoxamine Mesilate [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   727 E C0678584:saltiness [Qualitative Concept]

Phrase: "(deferoxamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: ","

Phrase: "diethylenetriaminepentaacetic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013254:(Diethylenetriamine)pentaacetic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "bathocuproinedisulfonic acid,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "guinea pig tissue transglutaminase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   861   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
   861   C2256568:tissue transglutaminase [Molecular Function]
   812   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0040300:Tissue [Tissue]
   812   C1547928:Tissue [Intellectual Product]

Phrase: "(EC 2.3.2.13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0020289:EC 3 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0040676:EC 2 [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "[EC]"

Phrase: ")"

Phrase: ","

Phrase: "cis-4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1504308:Cis [Eukaryote]

Phrase: "7,"

Phrase: "10,"

Phrase: "13,"

Phrase: "16,"

Phrase: "19-docosahexaenoic acid sodium salt,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   840   C0351302:sodium salt [Inorganic Chemical,Pharmacologic Substance]
   804   C0036140:Salt [Chemical Viewed Structurally]
   804   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   804   C0206136:Salt [Food,Inorganic Chemical]
   733 E C1537053:salty [Qualitative Concept]
   704 E C0678584:saltiness [Qualitative Concept]

Phrase: "catalog number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C3274660:Catalog Number [Intellectual Product]
   861   C0237753:*Number [Quantitative Concept]
   861   C0449788:Number [Quantitative Concept]

Phrase: "D-"

Phrase: "8768"

Phrase: ")"

Phrase: ","

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "8,"

Phrase: "11,"

Phrase: "14-eicosatetraenoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0003695:Eicosatetraenoic acid [Eicosanoid]
   901   C0376150:Eicosatetraenoic Acid [Eicosanoid]
   827   C0001128:Acid [Chemical]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "(arachidonic acid sodium salt,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0351302:sodium salt [Inorganic Chemical,Pharmacologic Substance]
   812   C0036140:Salt [Chemical Viewed Structurally]
   812   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   812   C0206136:Salt [Food,Inorganic Chemical]
   741 E C1537053:salty [Qualitative Concept]
   712 E C0678584:saltiness [Qualitative Concept]

Phrase: "catalog number A-8798"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C3274660:Catalog Number [Intellectual Product]
   812   C0237753:*Number [Quantitative Concept]
   812   C0376658:Catalog [Intellectual Product]
   812   C0449788:Number [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "soybean lipoxidase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0023837:Lipoxidase [Amino Acid, Peptide, or Protein,Enzyme]
   805 E C2936592:Lipoxygenases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(EC 1.13.11.12"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0030016:EC 1 [Amino Acid, Peptide, or Protein,Enzyme]
   840   C1417734:EC-1 [Gene or Genome]

Phrase: "[EC]"

Phrase: ")"

Phrase: ","

Phrase: "3-hydroxytyramine hydrochloride"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1512523:hydrochloride [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: ","

Phrase: "thioflavin T"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "44'-dianilino-11'-binaphthyl-55'-disulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]

Phrase: "(bis-ANS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0048876:bis-ANS [Organic Chemical,Pharmacologic Substance]
   861   C0004388:ANS [Body System]

Phrase: ")"

Phrase: ","

Phrase: "Ala-Ala-Phe-7-amido-4-methylcoumarin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0763892:Ala-Ala-Phe 7-amido-4-methylcoumarin [Amino Acid, Peptide, or Protein]

Phrase: "7-amino-4-methylcoumarin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0049828:7-amino-4-methylcoumarin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   902   C3659528:7-methylcoumarin [Organic Chemical]

Phrase: "8-anilino-1-naphthalenesulfonic acid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1872594:8-anilino-1-naphthalenesulfonic acid [Organic Chemical]
   804   C0001128:Acid [Chemical]
   804   C0202406:Acid [Laboratory Procedure]

Phrase: "boc-Leu-Ser-Thr-Arg-7-amido-4-methylcoumarin,"

Phrase: "Z-Leu-Leu-Glu-7-amido-4-methylcoumarin,"

Phrase: "and"

Phrase: "all other reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "were from Sigma."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1719918:Sigma [Intellectual Product]
Processing 00000000.tx.46: 1020% Tris-tricine gels were from Invitrogen. 

Phrase: "1020% Tris-tricine gels"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0017243:Gels [Biomedical or Dental Material]
   779 E C1382104:Gel [Substance]

Phrase: "were from Invitrogen."
Processing 00000000.tx.47: MCO of -SynucleinRecombinant -synuclein was incubated at the indicated concentrations in 20 mM sodium phosphate buffer, pH 7.4, for 1618 h at 37 C, unless otherwise indicated. 

Phrase: "MCO of -SynucleinRecombinant -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   795   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated at the indicated concentrations"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0086045:Concentrations [Mental Process]
   760   C1439852:Incubated [Laboratory Procedure]
   760   C1444656:Indicated [Finding]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "in 20 mM sodium phosphate buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "for 1618 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C,"

Phrase: "unless"

Phrase: "otherwise"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.48: Where indicated, incubations included iron(III) chloride or copper(II) sulfate, hydrogen peroxide, DTT, and metal chelators at the indicated concentrations. 

Phrase: "Where"

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: ","

Phrase: "incubations"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439070:III [Intellectual Product]
  1000   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "chloride"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0008203:Chloride, NOS [Inorganic Chemical]
  1000   C0596019:Chloride [Element, Ion, or Isotope]

Phrase: "or"

Phrase: "copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "(II"

Phrase: ")"

Phrase: "sulfate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0038720:Sulfate [Inorganic Chemical]
  1000   C0475337:sulfate [Element, Ion, or Isotope,Inorganic Chemical]
  1000   C3536965:SULFATE [Element, Ion, or Isotope]

Phrase: "hydrogen peroxide,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "and"

Phrase: "metal chelators at the indicated concentrations."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   773   C1881795:Metal Chelator [Pharmacologic Substance]
   773   C3537172:Metal Chelator [Pharmacologic Substance]
   753   C0007974:Chelators [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   719 E C1664784:Chelator [Eukaryote]
Processing 00000000.tx.49: Variability was observed in the effectiveness of different lots of DTT to result in synuclein oxidation/oligomerization, which was likely because of the presence of contaminating metals present in the various solutions. 

Phrase: "Variability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2827666:Variability [Conceptual Entity]
   928 E C0439828:Variable [Qualitative Concept]

Phrase: "was"

Phrase: "observed in the effectiveness of different lots of DTT to"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   739   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   739   C1280519:Effectiveness [Qualitative Concept]
   739   C1441672:Observed [Functional Concept]
   739   C1705242:Different [Qualitative Concept]
   706   C1115660:LOT [Intellectual Product]
   706   C1518000:Lot [Qualitative Concept]
   706   C1710198:Lot [Idea or Concept]

Phrase: "result in synuclein oxidation/oligomerization,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0030011:Oxidation [Molecular Function]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1274040:Result [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2825142:Result [Finding]

Phrase: "which"

Phrase: "was"

Phrase: "likely because of the presence of contaminating metals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0025552:Metals [Inorganic Chemical]
   744   C0332148:Likely [Qualitative Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0750492:Likely [Idea or Concept]
   711   C0205279:contaminate [Functional Concept]

Phrase: "present in the various solutions."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0037633:Solutions [Substance]
   760   C0150312:Present [Quantitative Concept]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C0449450:Present [Idea or Concept]
   726 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.50: The addition of neutralized solutions derived from a low pH elution of Chelex 100-treated DTT stock solutions demonstrated that the likely primary source of contaminating trace metal was the DTT itself. 

Phrase: "The addition of neutralized solutions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "derived from a low pH elution of Chelex 100-treated DTT stock solutions"
Meta Candidates (Total=20; Excluded=2; Pruned=0; Remaining=18)
   750   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   750   C0728725:Low pH [Finding]
   735   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   735   C0020283:[pH] [Quantitative Concept]
   735   C0037633:Solutions [Substance]
   735   C0055279:chelex [Organic Chemical,Pharmacologic Substance]
   735   C0205251:low [Qualitative Concept]
   735   C0332293:treated [Therapeutic or Preventive Procedure]
   735   C0450407:ph+ [Finding]
   735   C0450408:ph++ [Finding]
   735   C0450409:ph+++ [Finding]
   735   C1299352:Low [Qualitative Concept]
   735   C1441547:Derived [Qualitative Concept]
   735   C1441565:Elution [Laboratory Procedure]
   735   C1522326:Treated [Functional Concept]
   735   C1550472:low [Idea or Concept]
   735   C1710198:Stock [Idea or Concept]
   735   C3245521:derived [Idea or Concept]
   702 E C0525069:Solution [Biomedical or Dental Material]
   702 E C1292734:TREAT [Functional Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the likely primary source of contaminating trace metal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0449416:Source [Finding]
   744   C1705919:Source [Idea or Concept]

Phrase: "was"

Phrase: "the DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "itself."
Processing 00000000.tx.51: Anaerobic conditions were created by exposing all solutions to an anoxic atmosphere containing 95% N2, 5% H2 for 3 h at room temperature prior to incubation. 

Phrase: "Anaerobic conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "were"

Phrase: "created by exposing"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   882   C1707531:Created By [Qualitative Concept]
   790   C0332157:exposing [Clinical Attribute]
   790   C1706214:Created [Activity]
   756 E C3244320:create [Functional Concept]

Phrase: "all solutions to an anoxic atmosphere"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0037633:Solutions [Substance]
   719 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "95% N2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0441960:N2 [Finding]

Phrase: "5% H2 for 3 h"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0919509:H2 [Gene or Genome]
   760   C1419394:H2 [Gene or Genome]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "prior to incubation."
Processing 00000000.tx.52: Dr. 

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.53: Tracey Rouault (Cell Biology and Metabolism Branch, NICHD, National Institutes of Health) generously provided the anoxic chamber. 

Phrase: "Tracey Rouault"

Phrase: "(Cell Biology"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Metabolism Branch,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1253959:Branch [Body Part, Organ, or Organ Component]
   861   C1881507:Branch [Chemical Viewed Structurally]
   861   C2700383:Branch [Plant]
   861   C2826234:BRANCH [Intellectual Product]

Phrase: "NICHD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513896:NICHD [Health Care Related Organization]
  1000   C2982885:NICHD [Intellectual Product]

Phrase: "National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: ")"

Phrase: "generously"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "the anoxic chamber."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0935616:Chamber [Body Part, Organ, or Organ Component]
Processing 00000000.tx.54: After the reactions, SDS sample buffer was added to the samples, which were then boiled for 5 min then loaded onto precast 1020% Tris-tricine gels for SDS-PAGE. 

Phrase: "After the reactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0443286:Reaction [Functional Concept]
   966   C1114821:Reaction [Clinical Attribute]

Phrase: "SDS sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to the samples,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C1524062:Added [Functional Concept]
   737   C0370003:Sample [Substance]
   737 E C1883712:Add [Functional Concept]
   737   C2347026:Sample [Conceptual Entity]

Phrase: "which"

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "boiled for 5 min then"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0702093:/min [Temporal Concept]
   760   C1883708:Then [Temporal Concept]
   726   C0242301:Boil [Disease or Syndrome]
   726   C1546559:Boil [Intellectual Product]

Phrase: "loaded onto precast 1020% Tris-tricine gels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   748   C0017243:Gels [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]
   748   C1708715:Loaded [Activity]
   714 E C1382104:Gel [Substance]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]

Phrase: "for SDS-PAGE."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]
Processing 00000000.tx.55: No differences were detected whether the synuclein samples were boiled or not, or whether the SDS sample buffer contained 100 mM DTT or not (except when using the thiol-reducible cross-linker DSP, where DTT was omitted). 

Phrase: "No differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "whether"

Phrase: "the synuclein samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0370003:Sample [Substance]
   827   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "boiled"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0242301:Boil [Disease or Syndrome]
   966   C1546559:Boil [Intellectual Product]

Phrase: "or"

Phrase: "not,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "or"

Phrase: "whether"

Phrase: "the SDS sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "100 mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "not (except"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1518422:Not [Functional Concept]

Phrase: "when"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the thiol-reducible cross-linker DSP,"

Phrase: "where DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "was"

Phrase: "omitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.56: Synuclein was detected by immunoblotting after transfer to nitrocellulose membranes (Protran, 0.2 m, Schleicher & Schuell), or by silver staining, according to the manufacturer's instruction (Silver Stain Plus, Bio-Rad). 

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected by immunoblotting"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C0442726:Detected [Finding]
   790   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "after"

Phrase: "transfer to nitrocellulose membranes"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   812   C0025255:Membranes [Tissue]
   779 E C0596901:Membrane [Cell Component]
   779 E C1706182:Membrane [Manufactured Object]
   729 E C0205287:Membranous [Qualitative Concept]

Phrase: "(Protran,"

Phrase: "0.2 m,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]

Phrase: "Schleicher & Schuell"

Phrase: ")"

Phrase: ","

Phrase: "or by silver staining,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   833   C1293950:Silver Staining [Laboratory Procedure]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   770   C1704680:Staining [Finding]

Phrase: "according to the manufacturer's instruction"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039401:Instruction [Educational Activity]
   861   C0302828:Instruction [Intellectual Product]
   861   C1442085:instruction [Idea or Concept]

Phrase: "(Silver Stain Plus, Bio-Rad"

Phrase: ")."
Processing 00000000.tx.57: In Vitro Assembly of Synuclein Filaments, Ultrastructural and Biochemical AnalysisPurified recombinant synuclein was concentrated to 10 mg/ml (Centriprep 10,000 MWCO), dialyzed overnight against phosphate-buffered saline (PBS (Invitrogen), 1 mM K2HPO4, 155 mM NaCl, 3 mM Na2HPO4, pH 7.4), and incubated at a concentration of 3 mg/ml (200 M) for up to 72 h at 37 C with shaking (1400 rpm; Eppendorf Thermomixer R). 

Phrase: "In Vitro Assembly of Synuclein Filaments,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1706853:Assembly [Activity]
   753   C1879748:Assembly [Manufactured Object]

Phrase: "Ultrastructural"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0041623:Ultrastructure [Idea or Concept]

Phrase: "and"

Phrase: "Biochemical AnalysisPurified recombinant synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "concentrated to 10 mg/ml (Centriprep 10,000 MWCO"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   764   C0439294:mg ml [Quantitative Concept]
   742   C0439269:mg% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1880165:Concentrated [Biomedical or Dental Material]
   742   C1960952:mg % [Quantitative Concept]
   742   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   708 E C1880310:Concentrate [Manufactured Object]
   708 E C2003864:Concentrate [Substance]

Phrase: ")"

Phrase: ","

Phrase: "dialyzed"

Phrase: "overnight against phosphate-buffered saline"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   797   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0031701:phosphate [Organophosphorus Compound]
   760   C0036082:Saline [Substance]
   760   C0439583:Overnight [Temporal Concept]
   760   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "(PBS (Invitrogen"

Phrase: ")"

Phrase: ","

Phrase: "1 mM K2HPO4,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0138037:K2HPO4 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "155 mM NaCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   827   C1959973:% NaCl [Quantitative Concept]

Phrase: "3 mM Na2HPO4,"

Phrase: "pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "incubated at a concentration of 3 mg/ml (200"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   764   C0439294:mg ml [Quantitative Concept]
   742   C0086045:Concentration [Mental Process]
   742   C0439269:mg% [Quantitative Concept]
   742   C0439526:/mL [Quantitative Concept]
   742   C1439852:Incubated [Laboratory Procedure]
   742   C1446561:Concentration [Quantitative Concept]
   742   C1960952:mg % [Quantitative Concept]
   742   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "M) for"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   833   C0441923:M+ [Intellectual Product]

Phrase: "up to 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C"

Phrase: "with shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040822:Shaking [Sign or Symptom]
   966 E C1883023:Shake [Activity]

Phrase: "(1400 rpm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0582523:rpm [Quantitative Concept]

Phrase: "; Eppendorf Thermomixer R"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.58: 100 M Fe(III)/10 mM DTT or 10 mM deferoxamine were included where indicated. 

Phrase: "100 M Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "/10 mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "10 mM deferoxamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "were"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "where"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.59: For incubations using preformed synuclein "seeds", synuclein filaments generated from 72 h incubations were briefly sonicated (5 s) and added to incubations at a 1:100 dilution (based on total synuclein concentration). 

Phrase: "For incubations"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "preformed synuclein ""seeds"","
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0036563:Seed [Plant]
   827   C1705192:Seed [Laboratory Procedure]
   827   C1882540:{Seed} [Quantitative Concept]
   827   C2346495:Seed [Conceptual Entity]
   771 E C1519232:Seminal [Clinical Attribute]

Phrase: "synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "generated from 72 h incubations"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
   760   C3146294:Generated [Activity]

Phrase: "were"

Phrase: "briefly"

Phrase: "sonicated"

Phrase: "(5 s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "and"

Phrase: "added to incubations"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1524062:Added [Functional Concept]
   756 E C1883712:Add [Functional Concept]

Phrase: "at a 1"

Phrase: ":"

Phrase: "100 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "("

Phrase: "based on total synuclein concentration"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0086045:Concentration [Mental Process]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.60: We found that sonication dramatically reduced the lag time required to generate new synuclein filaments over unsonicated preformed filament seeds (62), and under these conditions incubations were routinely performed for 1620 h. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that sonication dramatically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037680:Sonication [Research Activity]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the lag time"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0040223:Time [Temporal Concept]
   861   C1416797:Lag [Gene or Genome]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "new synuclein filaments over unsonicated preformed filament seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C0036563:Seed [Plant]
   793   C1705192:Seed [Laboratory Procedure]
   793   C1882540:{Seed} [Quantitative Concept]
   793   C2346495:Seed [Conceptual Entity]
   737 E C1519232:Seminal [Clinical Attribute]

Phrase: "(62"

Phrase: ")"

Phrase: ","

Phrase: "and under these conditions incubations"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1515981:And [Idea or Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "were"

Phrase: "routinely"

Phrase: "performed for 1620 h."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.61: For electron microscopy, aliquots (1 l) were taken, diluted 2-fold in water, placed on 1% pioloform and copper-coated grids, and negatively stained with 1% uranyl acetate. 

Phrase: "For electron microscopy,"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0026019:Electron Microscopy [Laboratory Procedure]
  1000   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   861   C0013852:Electron [Quantitative Concept]
   861   C0026018:Microscopy [Laboratory Procedure]
   861   C3463986:Electron [Bird]
   789 E C0013850:Electronic [Manufactured Object]
   789 E C0205288:Microscopic [Qualitative Concept]
   789 E C1547561:Electronic [Idea or Concept]

Phrase: "aliquots"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1510844:Aliquot [Quantitative Concept]

Phrase: "(1 l)"

Phrase: "were"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: ","

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "2-fold in water,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332462:Fold [Spatial Concept]
   770   C1880834:FOLD [Phenomenon or Process]

Phrase: "placed on 1% pioloform"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0617575:pioloform [Organic Chemical]
   737   C0442504:Place [Spatial Concept]
   737   C1704765:Place [Functional Concept]
   737   C1882509:Place [Activity]
   737   C3496241:place [Disease or Syndrome]

Phrase: "and"

Phrase: "copper-coated grids,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1415284:GRID [Gene or Genome]
   793   C2348395:Grid [Medical Device]
   793   C2825313:Grid [Manufactured Object]

Phrase: "and"

Phrase: "negatively"

Phrase: "stained with 1% uranyl acetate."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C2984971:URANYL ACETATE STAIN [Laboratory Procedure]
   806   C0077854:uranyl acetate [Organic Chemical,Pharmacologic Substance]
   760   C0000975:Acetate [Organic Chemical,Pharmacologic Substance]
   760   C2986582:Stained [Qualitative Concept]
   726 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]
Processing 00000000.tx.62: Filaments and other non-filamentous structures were observed on a JEOL-100 transmission electron microscope at an accelerating voltage of 80 keV. 

Phrase: "Filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "and"

Phrase: "other non-filamentous structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "observed on a JEOL-100 transmission electron microscope"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   800   C0262880:Transmission Electron Microscope [Medical Device]
   770   C0181845:Electron Microscope [Medical Device]
   744   C0013852:Electron [Quantitative Concept]
   744   C0040722:transmission [Idea or Concept]
   744   C0181839:Microscope [Medical Device]
   744   C0242781:Transmission [Pathologic Function]
   744   C1441672:Observed [Functional Concept]
   744   C1521797:Transmission [Natural Phenomenon or Process]
   744   C1706379:Microscope [Medical Device]
   744   C3463986:Electron [Bird]

Phrase: "at an accelerating voltage"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0598352:Voltage [Quantitative Concept]

Phrase: "of 80 keV."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1881333:KeV [Quantitative Concept]
Processing 00000000.tx.63: For thioflavin T fluorescence measurements, 5-l aliquots from the synuclein incubations were added to 1 ml of a solution containing 10 M thioflavin T (prepared from a 100 M filtered stock solution in water) in 90 mM glycine-NaOH, pH 8.5 (the resulting synuclein concentration was 1 M, and under oxidizing conditions, the final Fe(III) concentration was 0.5 M). 

Phrase: "For thioflavin T fluorescence measurements,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0242485:measurements [Functional Concept]

Phrase: "5-l aliquots from the synuclein incubations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1510844:Aliquot [Quantitative Concept]

Phrase: "were"

Phrase: "added to 1 ml of a solution"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   757   C0945818:Add 1 [Quantitative Concept]
   748   C0037633:Solution [Substance]
   748   C0439526:/mL [Quantitative Concept]
   748   C0525069:Solution [Biomedical or Dental Material]
   748   C1524062:Added [Functional Concept]
   714 E C1883712:Add [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 M thioflavin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "T ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "prepared from a 100 M"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   726   C1521827:Prepare [Functional Concept]

Phrase: "filtered"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]

Phrase: "stock solution in water"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0597683:water solution [Clinical Drug]
   770   C0037633:Solution [Substance]
   770   C0525069:Solution [Biomedical or Dental Material]

Phrase: ")"

Phrase: "in 90 mM glycine-NaOH,"

Phrase: "pH 8.5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "("

Phrase: "the resulting synuclein concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "1 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "and under oxidizing conditions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1515981:And [Idea or Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "the final Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439070:III [Intellectual Product]
   827   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0086045:Concentration [Mental Process]
  1000   C1446561:Concentration [Quantitative Concept]
   928 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "was"

Phrase: "0.5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0444499:0/5 [Quantitative Concept]

Phrase: "M)."
Processing 00000000.tx.64: Fluorescence measurements were performed in a 1-cm cuvette (Uvette, 2201600 nm, Eppendorf) with the excitation at 440 nm (slit width 4 nm) and emission scan 450600 nm (slit width 4 nm) and analyzed with Felix fluorescence analysis software (Photon Technology International), courtesy of Paul Smith and Alec Eidsath, Instrumentation Research and Development Resource (OD), National Institutes of Health. 

Phrase: "Fluorescence measurements"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0242485:measurements [Functional Concept]

Phrase: "were"

Phrase: "performed in a 1-cm cuvette"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0180266:cuvette [Medical Device]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "(Uvette,"

Phrase: "2201600 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "Eppendorf"

Phrase: ")"

Phrase: "with the excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "at 440 nm (slit width 4 nm)"

Phrase: "and"

Phrase: "emission scan 450600 nm (slit width 4 nm)"

Phrase: "and"

Phrase: "analyzed with Felix fluorescence analysis software"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0002778:Analysis [Laboratory Procedure]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0037585:Software [Intellectual Product,Manufactured Object]
   753   C0936012:Analysis [Research Activity]
           Analyzed
   753   C1524024:analysis [Functional Concept]

Phrase: "(Photon Technology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0039421:Technology [Occupation or Discipline]

Phrase: "International"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512888:International [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "courtesy of Paul Smith"

Phrase: "and"

Phrase: "Alec Eidsath,"

Phrase: "Instrumentation Research and Development Resource"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0035201:Research Resource [Idea or Concept]
           Resource
   717   C0035170:Research and Development [Research Activity]

Phrase: "(OD"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0029421:OD [Disease or Syndrome]
  1000   C0439164:OD [Quantitative Concept]
  1000   C1512019:OD [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "National Institutes of Health."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]
Processing 00000000.tx.65: The graphs are representative of at least three independent experiments from at least two separate synuclein preparations. 

Phrase: "The graphs"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0681493:graphs [Intellectual Product]
   966 E C2698021:Graph [Conceptual Entity]

Phrase: "are"

Phrase: "representative of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1882932:Representative [Activity]

Phrase: "at least three independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0681814:Experiments [Research Activity]
   779 E C1706386:Experiment [Conceptual Entity]
   729 E C1517586:Experimental [Qualitative Concept]

Phrase: "from"

Phrase: "at least two separate synuclein preparations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0455052:Preparation [Health Care Activity]
   771   C1521827:Preparation [Functional Concept]
Processing 00000000.tx.66: For analysis of synuclein protofibrils, insoluble fibrils were removed by centrifugation (16,000 x g for 10 min), and the supernatants (200-l volume) were subjected to size exclusion chromatography using a Superdex HR200 column (Amersham Biosciences) with PBS containing 0.02% sodium azide as the mobile phase and a flow rate of 0.4 ml/min. 

Phrase: "For analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002778:Analysis [Laboratory Procedure]
  1000   C0936012:Analysis [Research Activity]
  1000   C1524024:analysis [Functional Concept]

Phrase: "of synuclein protofibrils,"

Phrase: "insoluble fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0225328:fibrils [Cell Component]
   827 E C1948066:Fibril [Physical Object]

Phrase: "were"

Phrase: "removed by centrifugation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "(16,000 x g for 10 min),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C0560021:g/min [Quantitative Concept]
   748   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "(200-l volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0449468:*Volume [Quantitative Concept]
   827   C1690016:% volume [Qualitative Concept]
   827   C1705102:Volume [Intellectual Product]
   827   C2700258:Volume [Laboratory Procedure]

Phrase: ")"

Phrase: "were"

Phrase: "subjected to size exclusion chromatography"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   862   C0008559:Size Exclusion Chromatography [Laboratory Procedure]
           Chromatography, Exclusion
   862   C1148476:Chromatography, Size Exclusion [Laboratory Procedure]
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0456389:size [Spatial Concept]
   760   C0680251:EXCLUSION [Functional Concept]
   760   C2828389:Exclusion [Activity]
   726   C0681850:Subject [Group]
   726   C1550501:{Subject} [Idea or Concept]
   726   C1706203:Subject [Idea or Concept]
   726   C2349001:Subject [Human]
   726   C2697811:Subject [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a Superdex HR200 column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1185738:Column [Body Part, Organ, or Organ Component]
   827   C1706132:Column [Idea or Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "with PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.02% sodium azide as the mobile phase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0074721:Sodium Azide [Hazardous or Poisonous Substance,Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid]
   744   C0004492:azide [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "a flow rate of 0.4 ml/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2826285:Flow Rate [Quantitative Concept]
   744   C0806140:Flow [Natural Phenomenon or Process]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.67: The column eluate was monitored at 280 nm (Waters 2487). 

Phrase: "The column eluate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0301870:Eluate [Body Substance]
   861   C1272724:Eluate [Substance]

Phrase: "was"

Phrase: "monitored at 280 nm (Waters 2487"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   753   C0043047:Waters [Inorganic Chemical,Pharmacologic Substance]
   753   C0312860:NM [Cell Function]
   750   C0327277:Water monitor [Reptile]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719 E C0599638:WATER [Substance]
   719   C1521743:Monitor [Professional or Occupational Group]
   719 E C1550678:Water [Inorganic Chemical]
   719   C1704646:Monitor [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.68: An on-line multi-angle light scattering detection system (Wyatt Technology Dawn EOS) was used to determine the masses of the eluting species. 

Phrase: "An on-line multi-angle light scattering detection system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   897   C0029038:On-Line System [Intellectual Product,Manufactured Object]
   793   C0449913:System [Functional Concept]
   793   C1553451:System [Manufactured Object]
   793   C1704459:System [Medical Device]
   721 E C0205373:Systemic [Functional Concept]

Phrase: "(Wyatt Technology Dawn EOS)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0211273:EOS [Biomedical or Dental Material]
   812   C1623465:Eos [Bird]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the masses of the eluting species."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0577559:Mass [Finding]
   719   C1306372:*Mass [Quantitative Concept]
   719   C3152252:Mass [Quantitative Concept]
Processing 00000000.tx.69: Wyatt Technology Astra software was used for the data analysis. 

Phrase: "Wyatt Technology Astra software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "was"

Phrase: "used for the data analysis."
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   806   C0010992:Data Analysis [Occupational Activity]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1273517:used [Finding]
   760   C1511726:Data [Idea or Concept]
   760   C1524024:analysis [Functional Concept]
   760   C3245479:data [Medical Device]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.70: Purification of Synuclein OligomersSynuclein oligomers generated by treating 3 mg/ml synuclein at 37 C overnight with 100 M Fe(III)/10 mM DTT were loaded (0.2 ml) onto a Superose 6 HR 10/30 gel filtration column (Amersham Biosciences) using 50 mM potassium phosphate, pH 7.0, 100 mM KCl as the mobile phase and a flow rate of 0.5 ml/min. 

Phrase: "Purification of Synuclein OligomersSynuclein oligomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0243114:purification [Functional Concept]
   760   C1998793:Purification [Functional Concept]

Phrase: "generated by treating 3 mg/ml synuclein"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   778   C0439294:mg ml [Quantitative Concept]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0332293:treating [Therapeutic or Preventive Procedure]
   748   C0439269:mg% [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1522326:Treating [Functional Concept]
   748   C1960952:mg % [Quantitative Concept]
   748   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]
   748   C3146294:Generated [Activity]
   714 E C1292734:TREAT [Functional Concept]

Phrase: "at 37 C overnight"

Phrase: "with 100 M Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "/10 mM DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "were"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "(0.2 ml)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439526:/mL [Quantitative Concept]

Phrase: "onto a Superose 6 HR 10/30 gel filtration column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C1185738:Column [Body Part, Organ, or Organ Component]
   793   C1706132:Column [Idea or Concept]

Phrase: "(Amersham Biosciences"

Phrase: ")"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "50 mM potassium phosphate,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0071778:potassium phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   812   C0031701:phosphate [Organophosphorus Compound]
   812   C0032821:Potassium [Element, Ion, or Isotope]
   812   C0597277:Potassium+ [Element, Ion, or Isotope,Pharmacologic Substance]
   812   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "pH 7.0,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "100 mM KCl as the mobile phase"

Phrase: "and"

Phrase: "a flow rate of 0.5 ml/min."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C2826285:Flow Rate [Quantitative Concept]
   744   C0806140:Flow [Natural Phenomenon or Process]
   744   C0871208:Rate [Activity]
   744   C1521828:Rate [Quantitative Concept]
Processing 00000000.tx.71: We found this column gave a slightly better separation of oligomeric from monomeric synuclein compared with Superdex 200. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "this column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1185738:Column [Body Part, Organ, or Organ Component]
  1000   C1706132:Column [Idea or Concept]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "a slightly better separation of oligomeric"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0036679:Separation [Pathologic Function]
   753   C0237868:Separation [Social Behavior]
   753   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "from monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "compared with Superdex 200."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1707455:Compared [Activity]
Processing 00000000.tx.72: Fractions containing synuclein oligomers were concentrated by Centricon (Amicon) centrifugal filter devices or by reverse osmosis with Slide-A-Lyzer dialysis cassettes (10,000 MWCO) and concentrating solution (Pierce), which resulted in less loss of material presumably because of binding of oligomers to the filters. 

Phrase: "Fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1264633:Fractions [Quantitative Concept]
   966 E C1554103:Fraction [Idea or Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "synuclein oligomers"

Phrase: "were"

Phrase: "concentrated by Centricon"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C1880165:Concentrated [Biomedical or Dental Material]
   756 E C1880310:Concentrate [Manufactured Object]
   756 E C2003864:Concentrate [Substance]

Phrase: "(Amicon"

Phrase: ")"

Phrase: "centrifugal filter devices"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025080:DEVICES [Medical Device]
   827   C0220819:devices [Manufactured Object]
   827   C0699733:Devices [Manufactured Object]

Phrase: "or by reverse osmosis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0678629:reverse osmosis [Laboratory Procedure]
   770   C0029391:Osmosis [Natural Phenomenon or Process]
   770   C1555029:Reverse [Idea or Concept]

Phrase: "with Slide-A-Lyzer dialysis cassettes"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   804   C0450240:cassettes [Medical Device]
   771 E C1706210:Cassette [Manufactured Object]

Phrase: "(10,000 MWCO"

Phrase: ")"

Phrase: "and"

Phrase: "concentrating solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   983   C1707468:SOLUTION, CONCENTRATE [Biomedical or Dental Material]
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "(Pierce"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "resulted in less loss of material presumably"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0520510:Material [Substance]
   748   C1517945:Loss [Quantitative Concept]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "because of binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0243122:binding [Functional Concept]
  1000   C1145667:Binding [Activity]
  1000   C1167622:Binding [Molecular Function]

Phrase: "of oligomers"

Phrase: "to the filters."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0180860:Filters [Manufactured Object]
   966 E C0581406:Filter [Medical Device]
   966 E C1522664:Filter [Intellectual Product]
   966 E C1704449:Filter [Conceptual Entity]
   966 E C1704684:Filter [Medical Device]
   966 E C1875155:FILTER [Medical Device]
Processing 00000000.tx.73: CD SpectroscopyFar-UV CD spectra of purified monomeric (70 M) and oligomeric synuclein (20 M) were collected at 20 C on a Jasco J-720 spectropolarimeter equipped with a temperature controller using a 0.02-cm path length cell. 

Phrase: "CD SpectroscopyFar-UV CD spectra of purified monomeric"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1883073:Spectrum [Quantitative Concept]
   711   C2827424:Spectrum [Conceptual Entity]

Phrase: "(70"

Phrase: "M)"

Phrase: "and"

Phrase: "oligomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(20"

Phrase: "M)"

Phrase: "were"

Phrase: "collected at 20 C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1516695:Collected [Idea or Concept]
   770   C1516698:Collected [Functional Concept]

Phrase: "on a Jasco J-720 spectropolarimeter"

Phrase: "equipped with a temperature controller"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0005903:temperature [Organism Attribute]
   760   C0039476:*Temperature [Quantitative Concept]
   760   C0180112:Controller [Medical Device]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a 0.02-cm path length cell."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   799   C0007634:Cell [Cell]
   799   C1269647:Cell [Cell]
   799   C1704653:Cell [Medical Device]
   799   C1948049:Cell [Spatial Concept]
Processing 00000000.tx.74: Data were collected at 1 nm intervals with a response time of 1 s/measurement at a scan speed of 1020 nm/min. 

Phrase: "Data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: "at 1 nm intervals with a response time of 1 s/measurement"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   736   C1272706:intervals [Temporal Concept]
   734   C0872291:Time Interval [Temporal Concept]
   703 E C1552654:Interval [Idea or Concept]
   703 E C1552713:Interval [Intellectual Product]

Phrase: "at a scan speed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678536:Speed [Quantitative Concept]

Phrase: "of 1020 nm/min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]
Processing 00000000.tx.75: The final spectrum was obtained by subtracting the background from the mean of four individual scans. 

Phrase: "The final spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883073:Spectrum [Quantitative Concept]
   861   C2827424:Spectrum [Conceptual Entity]

Phrase: "was"

Phrase: "obtained by subtracting"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C1301820:Obtained [Functional Concept]
   756 E C1706701:Obtain [Activity]
   756   C1719767:Subtract [Intellectual Product]
   756   C2348589:Subtract [Phenomenon or Process]
   718 E C1517378:Gain [Quantitative Concept]

Phrase: "the background from the mean of four individual scans."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1706907:Background [Conceptual Entity]
Processing 00000000.tx.76: Analysis of Synuclein Fibrillization by Centrifugal Sedimentation Untreated synuclein or seeded assembly reactions were centrifuged at 16,000 x g for 10 min. 

Phrase: "Analysis of Synuclein Fibrillization"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "by Centrifugal Sedimentation Untreated synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "seeded assembly reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0443286:Reaction [Functional Concept]
   793   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "centrifuged at 16,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0456692:/10 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.77: Supernatants and pellets were separated, pellets were washed with 0.5 ml of PBS, repelleted, and diluted to the same volume as the supernatants. 

Phrase: "Supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "and"

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "separated"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086972:Separated [Finding]
  1000   C0443299:separated [Spatial Concept]
  1000   C0687118:Separated [Functional Concept]

Phrase: ","

Phrase: "pellets"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0993610:pellets [Biomedical or Dental Material]
   966 E C0441436:Pellet [Manufactured Object]
   966 E C1998480:Pellet [Quantitative Concept]

Phrase: "were"

Phrase: "washed with 0.5 ml of PBS,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0439526:/mL [Quantitative Concept]
   748   C1548982:Washed [Idea or Concept]
   748   C1720830:PBS [Disease or Syndrome]
   748   C1823521:PBS [Gene or Genome]
   714 E C0441648:Wash [Activity]

Phrase: "repelleted,"

Phrase: "and"

Phrase: "diluted to the same volume"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0445247:Same [Qualitative Concept]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]
   726   C1720119:Dilute [Functional Concept]
   726   C1948037:Dilute [Functional Concept]

Phrase: "as the supernatants."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]
Processing 00000000.tx.78: SDS sample buffer was added to equal sample volumes, and the samples were heated to 100 C for 5 min. 

Phrase: "SDS sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added to equal sample volumes,"
Meta Candidates (Total=11; Excluded=4; Pruned=0; Remaining=7)
   797   C0205163:Equal To [Qualitative Concept]
           Equal
   760   C0370003:Sample [Substance]
   760   C0449468:volumes [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1549782:Equal [Idea or Concept]
   760   C2347026:Sample [Conceptual Entity]
   726 E C1690016:% volume [Qualitative Concept]
   726 E C1705102:Volume [Intellectual Product]
   726 E C1883712:Add [Functional Concept]
   726 E C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "heated to 100 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0018837:Heat [Natural Phenomenon or Process]

Phrase: "for 5 min."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.79: Synuclein proteins were resolved by SDS-PAGE and immunoblotted with anti-synuclein antibodies. 

Phrase: "Synuclein proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "resolved by SDS-PAGE"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1514893:Resolved [Idea or Concept]
   770   C1704732:Page [Intellectual Product]
   770   C2699488:Resolved [Conceptual Entity]

Phrase: "and"

Phrase: "immunoblotted with anti-synuclein antibodies."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   726   C0020985:Immunoblot [Laboratory Procedure]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.80: For seeded reactions, up to 10 g of total protein was loaded/lane to visualize the seed, which was added at a 1:100 dilution (100 ng). 

Phrase: "For seeded reactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "up to 10 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of total protein"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0555903:Total protein [Laboratory Procedure]
  1000   C1261360:total protein [Laboratory or Test Result]
   861   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0439175:% total [Quantitative Concept]
   861   C0439810:Total [Qualitative Concept]

Phrase: "was"

Phrase: "loaded"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708715:Loaded [Activity]
   966 E C1550025:Load [Idea or Concept]
   966 E C1704782:Load [Manufactured Object]

Phrase: "/lane to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: "visualize"

Phrase: "the seed,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0036563:Seed [Plant]
  1000   C1705192:Seed [Laboratory Procedure]
  1000   C1882540:{Seed} [Quantitative Concept]
  1000   C2346495:Seed [Conceptual Entity]
   944 E C1519232:Seminal [Clinical Attribute]

Phrase: "which"

Phrase: "was"

Phrase: "added at a 1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   802   C0945818:Add 1 [Quantitative Concept]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: ":"

Phrase: "100 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "(100 ng"

Phrase: ")."
Processing 00000000.tx.81: 20 S Proteasome Degradation AssayThe 20 S catalytic core was purified from rat liver, as described (63). 

Phrase: "20 S Proteasome Degradation AssayThe 20 S catalytic core"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   807   C0600499:Catalytic Core [Amino Acid Sequence]
   791   C0444669:Core [Spatial Concept]
   791   C1167518:core [Cell Component]
   791   C1706352:Core [Medical Device]
   791   C1882467:Core [Manufactured Object]
   791   C3274653:Core [Body Substance]

Phrase: "was"

Phrase: "purified from rat liver,"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(63"

Phrase: ")."
Processing 00000000.tx.82: To assay for synuclein degradation, 1 M synuclein, either control or oxidized by DTT/iron, was incubated at 37 C for 1 h with 50 nM purified 20 S proteasomes in 50 mM HEPES buffer, pH 7.8, in the absence or presence of 50 M MG132. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "assay for synuclein degradation,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0005507:Assay [Laboratory Procedure]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243073:assay [Qualitative Concept]
   770   C0243125:degradation [Functional Concept]
   770   C0699900:Degradation [Organism Function]
   770   C1510438:Assay [Laboratory Procedure]

Phrase: "1 M synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "either control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "oxidized by DTT/iron,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]
   737   C0030011:oxidize [Molecular Function]

Phrase: "was"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with 50 nM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "20 S proteasomes in 50 mM HEPES buffer,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   744   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   711 E C1325620:proteasome [Cell Component]
   711 E C1752727:Proteasome [Molecular Function]

Phrase: "pH 7.8,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "or"

Phrase: "presence of 50 M MG132."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
Processing 00000000.tx.83: The reaction was stopped after 1 h by addition of 0.05% trifluoroacetic acid. 

Phrase: "The reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "stopped after 1 h"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   819   C0700308:h 1 [Element, Ion, or Isotope]
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1272691:stopped [Qualitative Concept]
   737 E C1947925:Stop [Activity]
   737 E C2746065:Stop [Temporal Concept]

Phrase: "by addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "of 0.05% trifluoroacetic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040982:Trifluoroacetic Acid [Organic Chemical]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.84: SDS sample buffer was added followed by SDS-PAGE and immunoblotting with anti-synuclein antibodies. 

Phrase: "SDS sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "followed by SDS-PAGE"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332283:Followed by [Temporal Concept]
           followed
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C1704732:Page [Intellectual Product]
   737 E C1719822:Follow [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting with anti-synuclein antibodies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.85: Chymotrypsin-like, trypsinlike, and peptidyl-glutamyl-peptide hydrolase (glutamyl-like) activities of the 20 S proteasome were assayed with fluorogenic peptides AAF-MCA, LSTR-MCA, and LLE-MCA, respectively, according to Ref. 

Phrase: "Chymotrypsin-like, trypsinlike,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   734   C1413809:chymotrypsin-like [Gene or Genome]

Phrase: "and"

Phrase: "peptidyl-glutamyl-peptide hydrolase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0030940:Peptide hydrolase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1947941:Peptide Hydrolase [Enzyme]
   812   C0020289:Hydrolase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0030956:Peptide [Amino Acid, Peptide, or Protein]

Phrase: "(glutamyl-"

Phrase: "like"

Phrase: ")"

Phrase: "activities of the 20 S proteasome"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   767   C1622946:proteasome activity [Molecular Function]
   753   C0441655:Activities [Activity]
   719 E C0205177:Activity [Functional Concept]
   719 E C0439167:% activity [Quantitative Concept]
   719 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "assayed with fluorogenic peptides AAF-MCA,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0001034:AAF [Hazardous or Poisonous Substance,Organic Chemical]
   753   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   753   C0149566:MCA [Body Part, Organ, or Organ Component]
   719   C0005507:Assay [Laboratory Procedure]
   719   C0243073:assay [Qualitative Concept]
   719   C1510438:Assay [Laboratory Procedure]

Phrase: "LSTR-MCA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "LLE-MCA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0149566:MCA [Body Part, Organ, or Organ Component]

Phrase: "respectively,"

Phrase: "according to Ref."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425988:REF [Gene or Genome]
Processing 00000000.tx.86: 64. 

Phrase: "64."
Processing 00000000.tx.87: A typical assay was carried out with 50 nM (final concentration) 20 S in a total volume of 0.2 ml in 50 mM Hepes, pH 7.8, supplemented with the appropriate peptide substrate (100 M, final concentration) in a 96-well plate. 

Phrase: "A typical assay"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]

Phrase: "was"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out with 50 nM (final concentration"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0086045:Concentration [Mental Process]
   753   C0205088:Final [Temporal Concept]
   753   C0312860:NM [Cell Function]
   753   C0439787:Out [Spatial Concept]
   753   C0849355:Out [Qualitative Concept]
   753   C1446561:Concentration [Quantitative Concept]
   753   C1546485:Final [Idea or Concept]

Phrase: ")"

Phrase: "20 S in a total volume of 0.2 ml"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   757   C0439390:mL/s [Quantitative Concept]

Phrase: "in 50 mM Hepes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "pH 7.8,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "supplemented with the appropriate peptide substrate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030956:Peptide [Amino Acid, Peptide, or Protein]
   753   C1548787:Appropriate [Qualitative Concept]
   753   C1710236:Substrate [Manufactured Object]
   719   C0242295:Supplement [Food]
   719   C1947943:Supplement [Intellectual Product]
   719   C2348609:Supplement [Functional Concept]

Phrase: "(100 M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "in a 96-well plate."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0005971:Plate [Medical Device]
   827   C1139930:plate [Medical Device]
   827   C3537155:Plate [Manufactured Object]
Processing 00000000.tx.88: Following incubation at 37 C for 60 min, the reaction was quenched by addition of acid. 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "incubation at 37 C"

Phrase: "for 60 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "the reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "quenched by addition of acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0001128:Acid [Chemical]
   760   C0202406:Acid [Laboratory Procedure]
   760   C1883712:Addition [Functional Concept]
Processing 00000000.tx.89: The samples in each well of the plate were read using either a SpectraMax Gemini EM (Molecular Devices) or a CytoFluor series 4000 (PerSeptive Biosystems) multi-well plate reader. 

Phrase: "The samples in each well of the plate"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C0370003:Sample [Substance]
   711   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "read"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Read [Daily or Recreational Activity]
  1000   C1705179:read [Finding]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "either"

Phrase: "a SpectraMax Gemini EM (Molecular Devices"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0025080:DEVICES [Medical Device]
   804   C0220819:devices [Manufactured Object]
   804   C0699733:Devices [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "a CytoFluor series 4000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205549:Series [Quantitative Concept]
   827   C2348044:Series [Intellectual Product]

Phrase: "(PerSeptive Biosystems"

Phrase: ")"

Phrase: "multi-well plate reader."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1514743:Reader [Professional or Occupational Group]
   812   C1706461:Reader [Manufactured Object]
Processing 00000000.tx.90: The excitation and emission wavelength were 360 and 460 nm, respectively. 

Phrase: "The excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "emission wavelength"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449819:Wavelength [Quantitative Concept]

Phrase: "were"

Phrase: "360"

Phrase: "and"

Phrase: "460 nm,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "respectively."
Processing 00000000.tx.91: A standard curve of the fluorescence for the pure product was used to calculate the concentration of liberated aminomethylcoumarin product in the assays. 

Phrase: "A standard curve of the fluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205134:Curve [Spatial Concept]

Phrase: "for the pure product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1514468:product [Entity]
   861   C1704444:Product [Quantitative Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "calculate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441506:Calculate [Activity]

Phrase: "the concentration of liberated aminomethylcoumarin product"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "in the assays."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.92: Statistical analyses used the non-parametric Wilcoxon rank sum test for significance that makes no assumption about whether the data are normally distributed. 

Phrase: "Statistical analyses"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   983   C0871424:statistical analysis [Research Activity]
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the non-parametric Wilcoxon rank sum test for significance"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0242928:Test, Rank-Sum [Quantitative Concept]
   784   C0242931:Wilcoxon Rank Test [Quantitative Concept]
   784   C1709255:Non-Parametric Test [Intellectual Product]
   762   C0871608:Wilcoxon Test [Intellectual Product]
   762   C1711157:Parametric Test [Intellectual Product]
   742   C0022885:Test [Laboratory Procedure]
   742   C0039593:Test [Functional Concept]
   742   C0392366:test [Intellectual Product]
   742   C0699794:Rank [Intellectual Product]
   742   C1515051:Sum [Quantitative Concept]

Phrase: "that"

Phrase: "makes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1881534:Make [Functional Concept]

Phrase: "no assumption about"

Phrase: "whether"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "normally"

Phrase: "distributed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]
Processing 00000000.tx.93: Synuclein Cross-linking in the Presence of tTGase, Lipid Hydroperoxides, DSP, and DopaminetTGase catalyzes the formation of an -(-glutamyl)lysine isopeptide bond between glutamine and lysine residues and requires calcium for maximal activity (65, 66). 

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Cross-linking in the Presence of tTGase,"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   770   C0332220:Cross-linking [Functional Concept]
   770   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   770   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
   770   C2256568:tissue transglutaminase [Molecular Function]
   754 E C0178576:Cross link [Natural Phenomenon or Process]
   744   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0040300:Tissue [Tissue]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1547928:Tissue [Intellectual Product]
   744   C2828360:Cross [Conceptual Entity]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "Lipid Hydroperoxides,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0023776:Lipid Hydroperoxide [Lipid]
   827   C0020281:Hydroperoxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "DSP,"

Phrase: "and"

Phrase: "DopaminetTGase"

Phrase: "catalyzes"

Phrase: "the formation of an -(-glutamyl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: ")"

Phrase: "lysine isopeptide bond between glutamine"

Phrase: "and"

Phrase: "lysine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "and"

Phrase: "requires"

Phrase: "calcium for maximal activity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0006726:Calcium [Inorganic Chemical]
   770   C2936886:Calcium [Pharmacologic Substance]

Phrase: "(65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")."
Processing 00000000.tx.94: Synuclein incubations in the presence of tTGase (50 nM) were performed in PBS supplemented with 5 mM CaCl2. 

Phrase: "Synuclein incubations in the presence of tTGase"

Phrase: "(50 nM)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "were"

Phrase: "performed in PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0884358:Performed [Functional Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "supplemented with 5 mM CaCl2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   726   C0242295:Supplement [Food]
   726   C1947943:Supplement [Intellectual Product]
   726   C2348609:Supplement [Functional Concept]
Processing 00000000.tx.95: Under control conditions in the absence of tTGase, we found that calcium alone dramatically enhanced synuclein filament formation in PBS (see Fig. 7A; data not shown). 

Phrase: "Under control conditions"
Meta Candidates (Total=17; Excluded=9; Pruned=0; Remaining=8)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of tTGase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that calcium alone dramatically enhanced synuclein filament formation in PBS ("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.96: This was likely because of a seeding effect of calcium phosphate crystals, because the addition of 15% (by volume) of preformed and washed calcium phosphate crystals significantly reduced the lag time for synuclein filament formation. 

Phrase: "This"

Phrase: "was"

Phrase: "likely because of a seeding effect of calcium phosphate crystals,"
Meta Candidates (Total=27; Excluded=4; Pruned=0; Remaining=23)
   782   C0368819:Calcium phosphate crystals [Pharmacologic Substance]
   782   C2698962:Calcium Phosphate Crystals [Laboratory Procedure]
   760   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   760   C0427910:Phosphate crystals [Laboratory or Test Result]
   760   C1161320:calcium phosphate [Pharmacologic Substance]
   757   C1979660:Calcium crystals [Organic Chemical]
   739   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   739   C0006726:Calcium [Inorganic Chemical]
   739   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   739   C0031701:phosphate [Organophosphorus Compound]
   739   C0332148:Likely [Qualitative Concept]
   739   C0427896:Crystals [Body Substance]
   739   C0444626:Crystals [Chemical Viewed Structurally]
   739   C0750492:Likely [Idea or Concept]
   739   C1280500:Effect [Qualitative Concept]
   739   C1378554:Crystals [Biomedical or Dental Material]
   739   C1533132:Crystals [Body Substance]
   739   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   739   C1705192:Seeding [Laboratory Procedure]
   739   C2348382:Effect [Qualitative Concept]
   739   C2699477:Crystals [Laboratory Procedure]
   739   C2936886:Calcium [Pharmacologic Substance]
   706 E C0036563:Seed [Plant]
   706 E C1704641:Crystal [Manufactured Object]
   706 E C1882540:{Seed} [Quantitative Concept]
   706 E C2346495:Seed [Conceptual Entity]

Phrase: "because"

Phrase: "the addition of 15%"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1883712:Addition [Functional Concept]

Phrase: "("

Phrase: "by volume"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0449468:*Volume [Quantitative Concept]
  1000   C1690016:% volume [Qualitative Concept]
  1000   C1705102:Volume [Intellectual Product]
  1000   C2700258:Volume [Laboratory Procedure]

Phrase: ")"

Phrase: "of preformed"

Phrase: "and"

Phrase: "washed calcium phosphate crystals significantly"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   884   C0368819:Calcium phosphate crystals [Pharmacologic Substance]
   884   C2698962:Calcium Phosphate Crystals [Laboratory Procedure]
   853   C1979660:Calcium crystals [Organic Chemical]
   840   C0427910:Phosphate crystals [Laboratory or Test Result]
   804   C0427896:Crystals [Body Substance]
   804   C0444626:Crystals [Chemical Viewed Structurally]
   804   C1378554:Crystals [Biomedical or Dental Material]
   804   C1533132:Crystals [Body Substance]
   804   C2699477:Crystals [Laboratory Procedure]
   771 E C1704641:Crystal [Manufactured Object]

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "the lag time for synuclein filament formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0040223:Time [Temporal Concept]
   748   C1416797:Lag [Gene or Genome]
   748   C3541383:Time [Temporal Concept]
Processing 00000000.tx.97: However, we found that the oligomerization of synuclein in the presence of tTGase was enhanced in PBS versus buffers such as Tris or HEPES. 

Phrase: "However,"

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "the oligomerization of synuclein"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of tTGase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "was"

Phrase: "enhanced in PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   790   C2349975:Enhanced [Activity]

Phrase: "versus"

Phrase: "buffers such as Tris"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   819   C0041175:Tris Buffer [Organic Chemical,Pharmacologic Substance]
           TRIS
   770   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   770   C0814229:TRI [Intellectual Product]

Phrase: "or"

Phrase: "HEPES."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.98: DTT did not appear to enhance tTGase activity and so was omitted to prevent reduction of contaminating endogenous metals. 

Phrase: "DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "tTGase activity"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C2256568:tissue transglutaminase activity [Molecular Function]
           tissue transglutaminase
   901   C2256566:transglutaminase activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
   734   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
   734   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]

Phrase: "and"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "was"

Phrase: "omitted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750563:omitted [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "reduction of contaminating endogenous metals."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0301630:Reduction [Natural Phenomenon or Process]
   760   C0392756:Reduction [Qualitative Concept]
   760   C0441610:Reduction [Therapeutic or Preventive Procedure]
Processing 00000000.tx.99: View larger version (35K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(35K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.100: 7. 

Phrase: "7."
Processing 00000000.tx.101: Oxidation of synuclein prevents its degradation by purified 20 S proteasomes. 

Phrase: "Oxidation of synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0030011:Oxidation [Molecular Function]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "its degradation by purified 20 S proteasomes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0243125:degradation [Functional Concept]
   748   C0699900:Degradation [Organism Function]
Processing 00000000.tx.102: Control (untreated) or DTT/iron-treated synuclein was incubated with purified 20 S proteasomal particles at 37 C for 1 h, in the presence or absence of MG132, as indicated. 

Phrase: "Control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(untreated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332155:untreated [Finding]

Phrase: ")"

Phrase: "or"

Phrase: "DTT/iron-treated synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated with purified 20 S proteasomal particles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0597177:particles [Chemical Viewed Structurally]
   748   C1439852:Incubated [Laboratory Procedure]
   748   C1998793:Purified [Functional Concept]

Phrase: "at 37 C"

Phrase: "for 1 h,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "or"

Phrase: "absence of MG132,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0332197:absence [Quantitative Concept]
   790   C1689985:Absence [Anatomical Abnormality]
   718 E C2699517:ABSENT [Finding]

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.103: Synuclein was detected with the monoclonal anti-synuclein antibody, LB 509. 

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "detected with the monoclonal anti-synuclein antibody,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   774   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   774   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   748   C0442726:Detected [Finding]
   748   C0746619:monoclonal [Finding]
   748   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "LB 509."
Processing 00000000.tx.104: Note the relative resistance of oxidized synuclein (monomer as well as oligomers) to proteasomal degradation.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the relative resistance of oxidized synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0237834:Resistance [Mental Process]
   753   C1514892:Resistance [Physiologic Function]

Phrase: "(monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "as well as"

Phrase: "oligomers"

Phrase: ")"

Phrase: "to proteasomal degradation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0243125:degradation [Functional Concept]
   861   C0699900:Degradation [Organism Function]
Processing 00000000.tx.105: The peroxides of arachidonic acid (C20:4) and docosahexaenoic acid (C22:6) were prepared according to Armstrong et al. 

Phrase: "The peroxides of arachidonic acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031180:Peroxides [Inorganic Chemical]

Phrase: "(C20"

Phrase: ":"

Phrase: "4"

Phrase: ")"

Phrase: "and"

Phrase: "docosahexaenoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012968:docosahexaenoic acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0556150:docosahexaenoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(C22"

Phrase: ":"

Phrase: "6"

Phrase: ")"

Phrase: "were"

Phrase: "prepared according to Armstrong et al."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0680240:according [Social Behavior]
   719   C1521827:Prepare [Functional Concept]
Processing 00000000.tx.106: (67). 

Phrase: "(67"

Phrase: ")."
Processing 00000000.tx.107: Briefly, 10 mM fatty acid (final concentration) was incubated in 1 ml of 0.1 M sodium borate, pH 9.0, in the presence of 0.1 mg of lipoxygenase for 2 h at 4 C. 

Phrase: "Briefly,"

Phrase: "10 mM fatty acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0015684:Fatty acid [Lipid]
   812   C0001128:Acid [Chemical]
   812   C0202406:Acid [Laboratory Procedure]

Phrase: "(final concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")"

Phrase: "was"

Phrase: "incubated in 1 ml of 0.1 M sodium borate,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   760   C0053942:Sodium Borate [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0074727:sodium borate [Inorganic Chemical,Pharmacologic Substance]
   757   C0597484:Sodium 1+ [Element, Ion, or Isotope,Pharmacologic Substance]
           Sodium+
   739   C0006007:Borate [Chemical Viewed Structurally]
   739   C0037473:Sodium [Biologically Active Substance,Element, Ion, or Isotope]
   739   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   739   C0439526:/mL [Quantitative Concept]
   739   C0441923:M+ [Intellectual Product]
   739   C1439852:Incubated [Laboratory Procedure]

Phrase: "pH 9.0,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 0.1 mg"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0439269:mg% [Quantitative Concept]
   827   C1960952:mg % [Quantitative Concept]
   827   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "of lipoxygenase"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0023837:Lipoxygenase [Amino Acid, Peptide, or Protein,Enzyme]
   916 E C2936592:Lipoxygenases [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "for 2 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0011744:2 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 4 C."
Processing 00000000.tx.108: Samples were extracted three times with an equal volume of diethyl ether, and the collected upper phases were evaporated with nitrogen. 

Phrase: "Samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "extracted"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]

Phrase: "three times with an equal volume of diethyl ether,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   742   C0040223:times [Temporal Concept]
   742   C1632851:Times [Quantitative Concept]
   708 E C3541383:Time [Temporal Concept]

Phrase: "and"

Phrase: "the collected upper phases"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0585064:Phases [Temporal Concept]
   827   C1067936:Phasis [Eukaryote]
   793 E C0205390:Phase [Temporal Concept]

Phrase: "were"

Phrase: "evaporated with nitrogen."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0028158:Nitrogen [Element, Ion, or Isotope]
   790   C1550581:nitrogen [Human-caused Phenomenon or Process]
Processing 00000000.tx.109: 0.1 ml of 0.1 M sodium borate, pH 9.0 was added, and samples were vortexed and evaporated for 5 min, to remove the residual ether, and sonicated briefly (5 s) in an ice bath. 

Phrase: "0.1 ml of 0.1 M sodium borate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0439526:/mL [Quantitative Concept]

Phrase: "pH 9.0"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "vortexed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439648:vortexed [Spatial Concept]
  1000   C0724378:vortexed [Organic Chemical,Pharmacologic Substance]
   966 E C2719416:Vortex [Pharmacologic Substance]

Phrase: "and"

Phrase: "evaporated for 5 min,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "the residual ether,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0014994:Ether [Organic Chemical,Pharmacologic Substance]
   861   C0014996:Ether, NOS [Organic Chemical,Pharmacologic Substance]
   861   C1161324:ether [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "sonicated"

Phrase: "briefly"

Phrase: "(5 s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "in an ice bath."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0150141:Bath [Therapeutic or Preventive Procedure]
Processing 00000000.tx.110: Lipid peroxide concentrations were calculated from the absorbance at 234 nm using a molar extinction coefficient of 27,000 M-1 cm-1. 

Phrase: "Lipid peroxide concentrations"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]
   734   C0023776:lipid peroxide [Lipid]

Phrase: "were"

Phrase: "calculated from the absorbance"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0444686:Calculated [Functional Concept]
   770   C1268822:Absorbance [Clinical Attribute]
   770   C1441506:Calculated [Activity]
   770   C1443182:Calculated [Laboratory Procedure]
   770   C2825050:Absorbance [Phenomenon or Process]

Phrase: "at 234 nm"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a molar extinction coefficient of 27,000"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0015347:extinction [Mental Process]
   748   C1707429:*Coefficient [Quantitative Concept]

Phrase: "M-"

Phrase: "1 cm-1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C2827734:1+ [Quantitative Concept]
   827   C2981698:1+ [Classification]
Processing 00000000.tx.111: Docosahexaenoic acid and arachidonic acid and their respective peroxides were used at 200 M. 

Phrase: "Docosahexaenoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012968:docosahexaenoic acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0556150:docosahexaenoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "and"

Phrase: "their respective peroxides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0031180:Peroxides [Inorganic Chemical]

Phrase: "were"

Phrase: "used at 200 M."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.112: The lysine-specific cross-linker DSP was used at 500 M, and dopamine was used at 200 M. 

Phrase: "The lysine-specific cross-linker DSP"

Phrase: "was"

Phrase: "used at 500 M,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "and"

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "used at 200 M."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]
   770   C1273517:used [Finding]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.113: The concentrations of these reagents were chosen to reflect the optimal production of oligomers, as assessed by immunoblotting with anti-synuclein antibodies, when synuclein was used at a concentration of 200 M. 

Phrase: "The concentrations of these reagents"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "chosen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707391:Chosen [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "the optimal production of oligomers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "as"

Phrase: "assessed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: "with anti-synuclein antibodies,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "when"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "used at a concentration of 200 M."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   757   C1524063:Use of [Functional Concept]
   748   C0086045:Concentration [Mental Process]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1273517:used [Finding]
   748   C1446561:Concentration [Quantitative Concept]
   714 E C0042153:use [Functional Concept]
   714 E C0457083:Use [Functional Concept]
   714 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.114: Proportionally less of the cross-linking reagents were necessary at lower synuclein concentrations.  

Phrase: "Proportionally less of the cross-linking reagents"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   814   C0010360:Cross-Linking Reagents [Indicator, Reagent, or Diagnostic Aid]
   778   C0332220:Cross-linking [Functional Concept]
   762 E C0178576:Cross link [Natural Phenomenon or Process]
   748   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   748   C2828360:Cross [Conceptual Entity]
   714   C1517892:Link [Intellectual Product]
   714   C1704666:Link [Intellectual Product]

Phrase: "were"

Phrase: "necessary at lower synuclein concentrations."
Processing 00000000.tx.115: RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Enhanced Metal-catalyzed Oxidation of Synuclein in the Presence of DTTAlthough traditionally used as antioxidants in biochemical systems, reducing agents, such as ascorbate and DTT, are extremely effective in generating ROS in the presence of trace amounts of transition metals, principally iron and copper (6870). 

Phrase: "RESULTS TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0557061:Discussion [Therapeutic or Preventive Procedure]
   793   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Enhanced Metal-catalyzed Oxidation of Synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025552:Metal [Inorganic Chemical]
   753   C0030011:Oxidation [Molecular Function]

Phrase: "in the Presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DTTAlthough traditionally"

Phrase: "used as antioxidants"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0003402:Antioxidants [Pharmacologic Substance]
   790   C1273517:used [Finding]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]

Phrase: "in biochemical systems,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0449913:System [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   777 E C0205373:Systemic [Functional Concept]

Phrase: "reducing agents,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0376446:Reducing Agents [Indicator, Reagent, or Diagnostic Aid]
   861   C0392756:Reducing [Qualitative Concept]
   827   C0450442:Agent [Chemical Viewed Functionally]
   827   C1254351:Agent [Pharmacologic Substance]
   827   C1521826:Agent [Intellectual Product]

Phrase: "such as ascorbate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178487:Ascorbate [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "and"

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "are"

Phrase: "extremely effective in generating ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280519:effective [Qualitative Concept]
   748   C1704419:Effective [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of trace amounts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   983   C0442822:trace amount [Quantitative Concept]
   861   C1265611:amounts [Quantitative Concept]

Phrase: "of transition metals,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   966   C0682906:transition metal [Element, Ion, or Isotope]
   861   C0025552:Metals [Inorganic Chemical]
   861   C0599156:Transition [Cell or Molecular Dysfunction]
   861   C2700061:Transition [Activity]
   789 E C1182674:Transitional [Spatial Concept]
   789 E C1548597:Transitional [Idea or Concept]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "principally iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "(6870"

Phrase: ")."
Processing 00000000.tx.116: We wished to compare the effectiveness of supplying reducing equivalents in the form of DTT with reagents used previously to study the metal-catalyzed oxidation of -synuclein (3942). 

Phrase: "We"

Phrase: "wished"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1423524:WISH [Gene or Genome]
   966   C3273411:WISH [Gene or Genome]
   966   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the effectiveness of supplying reducing equivalents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1280519:Effectiveness [Qualitative Concept]

Phrase: "in the form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "of DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "with reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "previously to"

Phrase: "study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "the metal-catalyzed oxidation of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(3942"

Phrase: ")."
Processing 00000000.tx.117: Purified recombinant synuclein was incubated overnight at 37 C with 10 M of exogenous Cu(II) or Fe(III) in the presence of 300 M hydrogen peroxide. 

Phrase: "Purified recombinant synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "overnight at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]

Phrase: "with 10 M"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "of exogenous Cu(II"

Phrase: ")"

Phrase: "or"

Phrase: "Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 300 M hydrogen peroxide."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   812   C0020275:Hydrogen [Element, Ion, or Isotope]
   812   C0031180:Peroxide [Inorganic Chemical]
   812   C0523702:HYDROGEN [Laboratory Procedure]
   812   C0885426:hydrogen [Inorganic Chemical]
Processing 00000000.tx.118: Lower concentrations of metals were used compared with other reports (3942) to test the sensitivity of synuclein to the different MCO systems, and because these levels are likely to be more physiologically relevant. 

Phrase: "Lower concentrations of metals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0086045:Concentrations [Mental Process]
   737 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "compared with other reports"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0684224:Reports [Intellectual Product]
   770   C0700287:reports [Health Care Activity]
   770   C1707455:Compared [Activity]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(3942"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "test"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0022885:Test [Laboratory Procedure]
  1000   C0039593:Test [Functional Concept]
  1000   C0392366:test [Intellectual Product]

Phrase: "the sensitivity of synuclein"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0036667:Sensitivity [Quantitative Concept]
   770   C0312418:Sensitivity [Mental Process]
   770   C0427965:Sensitivity [Finding]
   770   C1511883:Sensitivity [Quantitative Concept]
   770   C1522640:Sensitivity [Qualitative Concept]
   770   C2346484:SENSITIVITY [Phenomenon or Process]
   770   C2349185:Sensitivity [Qualitative Concept]

Phrase: "to the different MCO systems,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   859   C0026339:Model System [Intellectual Product,Research Device]
   859   C3161035:Model System [Intellectual Product]
   766   C0449913:System [Functional Concept]
   766   C1553451:System [Manufactured Object]
   766   C1704459:System [Medical Device]
   716 E C0205373:Systemic [Functional Concept]

Phrase: "and"

Phrase: "because"

Phrase: "these levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0441889:Levels [Qualitative Concept]
   966 E C0456079:Level [Classification]
   966 E C1547707:Level [Geographic Area]
   966 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "more physiologically relevant."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347946:Relevant [Qualitative Concept]
Processing 00000000.tx.119: Under these conditions, minimal oxidation of synuclein was observed, as reflected by the formation of low levels of synuclein oligomers (dimers, trimers, etc) (Fig. 1A, lanes 3 and 4). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "minimal oxidation of synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "as"

Phrase: "reflected by the formation of low levels of synuclein oligomers"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0205251:low [Qualitative Concept]
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C0441889:Levels [Qualitative Concept]
   739   C0558058:reflected [Mental Process]
   739   C1299352:Low [Qualitative Concept]
   739   C1522492:Formation [Functional Concept]
   739   C1550472:low [Idea or Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "(dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "trimers,"

Phrase: "etc) (Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0450344:1A [Intellectual Product]
   827   C1553633:1a [Medical Device]

Phrase: "lanes 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.120: No enhancement of oligomerization was observed if the incubations contained a reduced form of the metals (Cu(I) or Fe(II)) nor was there a significant increase in the production of synuclein oligomers observed up to 50 M metal, the maximum level tested (data not shown, although see below). 

Phrase: "No enhancement of oligomerization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   770   C2349975:Enhancement [Activity]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "if"

Phrase: "the incubations"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a reduced form of the metals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "(Cu(I)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "or"

Phrase: "Fe(II"

Phrase: ")"

Phrase: ")"

Phrase: "nor"

Phrase: "was"

Phrase: "there"

Phrase: "a significant increase in the production of synuclein oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "observed up to 50 M metal,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0025552:Metal [Inorganic Chemical]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1441672:Observed [Functional Concept]

Phrase: "the maximum level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "although"

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.121: In the presence of DTT, however, a substantial increase of synuclein oligomers was generated in the presence of copper (Fig. 1A, lane 7) and especially iron (lane 8). 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "however,"

Phrase: "a substantial increase of synuclein oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "generated in the presence of copper"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C2347872:Copper+ [Element, Ion, or Isotope]
   753   C2348263:Copper [Element, Ion, or Isotope]
   753   C3146294:Generated [Activity]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lane 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "and"

Phrase: "especially iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "(lane 8"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.122: The oligomers were resistant to dissociation with 6 M urea, as well as SDS, thus demonstrating their covalent association (data not shown). 

Phrase: "The oligomers"

Phrase: "were"

Phrase: "resistant to dissociation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "with 6 M urea,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0041942:Urea [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   771 E C0728794:Ureaphil [Organic Chemical,Pharmacologic Substance]

Phrase: "as well as"

Phrase: "SDS,"

Phrase: "thus"

Phrase: "demonstrating"

Phrase: "their covalent association"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0004083:Association [Mental Process]
   861   C0439849:Association [Qualitative Concept]
   861   C0596306:Association [Phenomenon or Process]
   861   C0699792:association [Social Behavior]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.123: Fe(II) and Fe(III) enhanced synuclein oligomerization equally in the presence of DTT but were without effect alone (data not shown). 

Phrase: "Fe(II"

Phrase: ")"

Phrase: "and"

Phrase: "Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "enhanced synuclein oligomerization equally in the presence of DTT"

Phrase: "but"

Phrase: "were without effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1280500:Effect [Qualitative Concept]
   790   C2348382:Effect [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: This demonstrates that DTT effectively recycled oxidized iron to its reactive ferrous form, and at similar metal concentrations, was more effective in enhancing the MCO of synuclein when compared with other systems (3942). 

Phrase: "This"

Phrase: "demonstrates"

Phrase: "that DTT effectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "recycled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282114:recycled [Human-caused Phenomenon or Process]

Phrase: "oxidized iron to its reactive ferrous form,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0376520:Iron [Inorganic Chemical]
   748   C1166521:iron [Pharmacologic Substance]

Phrase: "and at similar metal concentrations,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0025552:Metal [Inorganic Chemical]
   760   C0086045:Concentrations [Mental Process]
   760   C1515981:And [Idea or Concept]
   760   C2348205:Similar [Qualitative Concept]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "was"

Phrase: "more effective in enhancing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "the MCO of synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025552:Metal [Inorganic Chemical]
   748   C0030011:Oxidation [Molecular Function]

Phrase: "when"

Phrase: "compared with other systems"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1707455:Compared [Activity]
   737   C0449913:System [Functional Concept]
   737   C1553451:System [Manufactured Object]
   737   C1704459:System [Medical Device]

Phrase: "(3942"

Phrase: ")."
Processing 00000000.tx.125: Oligomerization was largely inhibited by the iron chelators deferoxamine and diethylenetriaminepentaacetic acid (Fig. 1A, lanes 9 and 10) and clioquinol (not shown) but less so by the copper chelator bathocuproinedisulfonic acid (Fig. 1A, lane 11). 

Phrase: "Oligomerization"

Phrase: "was"

Phrase: "largely"

Phrase: "inhibited by the iron chelators deferoxamine"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   773   C2266987:Iron Chelator [Pharmacologic Substance]
   753   C0007974:Chelators [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0311403:Inhibited [Qualitative Concept]
   753   C0376520:Iron [Inorganic Chemical]
   753   C1166521:iron [Pharmacologic Substance]
   719 E C1664784:Chelator [Eukaryote]

Phrase: "and"

Phrase: "diethylenetriaminepentaacetic acid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0013254:(Diethylenetriamine)pentaacetic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lanes 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "10"

Phrase: ")"

Phrase: "and"

Phrase: "clioquinol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0021978:Clioquinol [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: "but"

Phrase: "less so by the copper chelator bathocuproinedisulfonic acid"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0001128:Acid [Chemical]
   744   C0007974:chelator [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0439092:less [Intellectual Product]
   744   C0547044:Less [Qualitative Concept]
   744   C1664784:Chelator [Eukaryote]
   744   C2347872:Copper+ [Element, Ion, or Isotope]
   744   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lane 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")."
Processing 00000000.tx.126: Even with DTT alone, a substantial increase in the generation of synuclein oligomers was observed (Fig. 1A, lanes 5 and 6). 

Phrase: "Even with DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "a substantial increase in the generation of synuclein oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lanes 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.127: The effect of adding DTT alone raises the likelihood that the redox cycling of trace metals present in the buffered solutions was sufficient to induce the formation of synuclein oligomers. 

Phrase: "The effect of adding DTT"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "raises"

Phrase: "the likelihood"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0033204:Likelihood [Quantitative Concept]
   928 E C0332148:Likely [Qualitative Concept]
   928 E C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the redox cycling of trace metals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1511572:Cycle [Temporal Concept]

Phrase: "present in the buffered solutions"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   760   C0037633:Solutions [Substance]
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]
   726 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "sufficient to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205410:Sufficient [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the formation of synuclein oligomers."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.128: Consistent with this is the lack of oligomerization in the presence of DTT when trace iron in the solution was complexed by deferoxamine (Fig. 1A, lane 12) or when divalent metals were depleted by prior treatment with Chelex 100 beads (data not shown). 

Phrase: "Consistent with this"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "is"

Phrase: "the lack of oligomerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332268:lack [Qualitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "when"

Phrase: "trace iron in the solution"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]

Phrase: "was"

Phrase: "complexed by deferoxamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756   C0439855:Complex [Qualitative Concept]
   756   C1704241:Complex [Chemical Viewed Structurally]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "lane 12"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1708639:Lane [Spatial Concept]

Phrase: ")"

Phrase: "or"

Phrase: "when"

Phrase: "divalent metals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0596455:divalent metal [Element, Ion, or Isotope]
   861   C0025552:Metals [Inorganic Chemical]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "were"

Phrase: "depleted by prior treatment"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C1514463:Prior Treatment [Clinical Attribute]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0332152:Prior [Temporal Concept]
   770   C0333668:Depleted [Functional Concept]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C2826257:PRIOR [Event]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with Chelex 100 beads"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0991566:Beads [Biomedical or Dental Material]
   793 E C2346972:Bead [Spatial Concept]
   734   C0055280:Chelex 100 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.129: A requirement for oxygen under these conditions was addressed by incubating synuclein solutions anaerobically. 

Phrase: "A requirement for oxygen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Requirement [Functional Concept]

Phrase: "under these conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "was"

Phrase: "addressed by incubating synuclein solutions anaerobically."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   753   C0037633:Solutions [Substance]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1439852:incubating [Laboratory Procedure]
   719   C0376649:Address [Intellectual Product]
   719 E C0525069:Solution [Biomedical or Dental Material]
   719   C1442065:Address [Spatial Concept]
Processing 00000000.tx.130: As can be seen in Fig. 

Phrase: "As"

Phrase: "can"

Phrase: "be"

Phrase: "seen in Fig."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0205397:Seen [Qualitative Concept]
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756 E C0042789:see [Organism Function]
   756 E C1947903:See [Activity]
Processing 00000000.tx.131: 1B, oligomerization of synuclein in the presence of DTT alone, as well as with DTT and added iron, was virtually eliminated in the absence of oxygen. 

Phrase: "1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450345:1B [Intellectual Product]

Phrase: "oligomerization of synuclein"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "alone,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "as well as with DTT"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   760   C0205170:Well [Qualitative Concept]
   760   C3146287:Well [Manufactured Object]

Phrase: "and"

Phrase: "added iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "was"

Phrase: "virtually"

Phrase: "eliminated in the absence of oxygen."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   783   C0003130:Oxygen, absence [Pathologic Function]
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0332197:absence [Quantitative Concept]
   753   C0849355:Eliminated [Qualitative Concept]
   753   C1689985:Absence [Anatomical Abnormality]
Processing 00000000.tx.132: These results demonstrate a critical role for oxygen in synuclein oligomerization and provide evidence that the continued regeneration of reduced forms of transition metals, especially iron, can significantly enhance the metal-catalyzed oxidation of synuclein. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "a critical role for oxygen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in synuclein oligomerization"

Phrase: "and"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "the continued regeneration of reduced forms of transition metals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0034963:Regeneration [Organ or Tissue Function]

Phrase: "especially iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "can"

Phrase: "significantly"

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the metal-catalyzed oxidation of synuclein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0025552:Metal [Inorganic Chemical]
   753   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.133: Because of the complex nature of iron chemistry (15, 18, 71) and the observation that the site-specific "caged" generation of ROS may be unavailable to general free radical scavengers (15, 69), we have not yet attempted to identify the actual oxidizing species generated under these conditions. 

Phrase: "Because of the complex nature"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "of iron chemistry"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007996:Chemistry [Occupation or Discipline]
   861   C0079107:chemistry [Classification]
   861   C0201682:Chemistry [Laboratory Procedure]

Phrase: "(15,"

Phrase: "18,"

Phrase: "71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the site-specific """
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0449604:site specific [Spatial Concept]
   861   C0205145:Site [Spatial Concept]
   861   C0205369:Specific [Qualitative Concept]
   861   C1515974:Site [Body Location or Region]
   861   C1552740:specific [Intellectual Product]
   861   C2825164:Site [Spatial Concept]

Phrase: "caged"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0337189:Cage [Manufactured Object]
   966   C0441239:Cage [Medical Device]

Phrase: """ generation of ROS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "may"

Phrase: "be"

Phrase: "unavailable to general free radical scavengers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0686905:Unavailable [Functional Concept]

Phrase: "(15,"

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "have"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "attempted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1516084:Attempt [Event]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "identify"

Phrase: "the actual oxidizing species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "generated under these conditions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3146294:Generated [Activity]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.134: View larger version (20K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(20K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.135: 1. 

Phrase: "1."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]
Processing 00000000.tx.136: DTT enhances MCO of human -synuclein. 

Phrase: "DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "MCO of human -synuclein."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0025552:Metal [Inorganic Chemical]
   748   C0030011:Oxidation [Molecular Function]
Processing 00000000.tx.137: A, 0.1 mg/ml purified recombinant human -synuclein was treated under different oxidizing conditions in 20 mM sodium phosphate buffer, pH 7.4, at 37 C for 16 h. 

Phrase: "A,"

Phrase: "0.1 mg/ml"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439294:mg ml [Quantitative Concept]
   812   C0439526:/mL [Quantitative Concept]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "recombinant human -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "treated under different oxidizing conditions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0332293:treated [Therapeutic or Preventive Procedure]
   760   C1522326:Treated [Functional Concept]
   760   C1705242:Different [Qualitative Concept]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726 E C1292734:TREAT [Functional Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "in 20 mM sodium phosphate buffer,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C3256935:sodium phosphate buffer [Pharmacologic Substance]
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "pH 7.4,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: "at 37 C"

Phrase: "for 16 h."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.138: SDS sample buffer was added, the samples were boiled for 5 min, and 500 ng of synuclein was loaded on a 1020% Tris-tricine gel. 

Phrase: "SDS sample buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "was"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: ","

Phrase: "the samples"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "were"

Phrase: "boiled for 5 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0702093:/min [Temporal Concept]
   737   C0242301:Boil [Disease or Syndrome]
   737   C1546559:Boil [Intellectual Product]

Phrase: "and"

Phrase: "500 ng of synuclein"

Phrase: "was"

Phrase: "loaded on a 1020% Tris-tricine gel."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0041175:TRIS [Organic Chemical,Pharmacologic Substance]
   748   C0077068:tricine [Organic Chemical]
   748   C0077281:Tris [Hazardous or Poisonous Substance,Organophosphorus Compound]
   748   C0814229:TRI [Intellectual Product]
   748   C1382104:Gel [Substance]
   748   C1708715:Loaded [Activity]
   714 E C1550025:Load [Idea or Concept]
   714 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.139: Detection was with an antibody (202) that recognizes the extreme C terminus of synuclein. 

Phrase: "Detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "was with an antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1421478:WAS [Gene or Genome]

Phrase: "(202"

Phrase: ")"

Phrase: "that"

Phrase: "recognizes"

Phrase: "the extreme C terminus of synuclein."
Processing 00000000.tx.140: Molecular mass markers are on the left. 

Phrase: "Molecular mass markers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0005516:molecular markers [Clinical Attribute]
           Marker
   734   C3152252:Molecular Mass [Quantitative Concept]

Phrase: "are on the left."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205091:Left [Spatial Concept]
   770   C1551058:Are [Quantitative Concept]
   770   C1552822:left [Functional Concept]
Processing 00000000.tx.141: Unit synuclein oligomers are designated n = 1 (monomer), n = 2 (dimer), n = 3 (trimer), etc. 

Phrase: "Unit synuclein oligomers"

Phrase: "are"

Phrase: "designated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1524084:Designated [Functional Concept]

Phrase: "n = 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: ")"

Phrase: ","

Phrase: "n = 2 (dimer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimer [Chemical Viewed Structurally]

Phrase: ")"

Phrase: ","

Phrase: "n = 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: "(trimer"

Phrase: ")"

Phrase: ","

Phrase: "etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]
Processing 00000000.tx.142: Df, deferoxamine; 

Phrase: "Df,"

Phrase: "deferoxamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ";"
Processing 00000000.tx.143: BCS, bathocuproine disulfonic acid. 

Phrase: "BCS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1412777:BCS [Gene or Genome]

Phrase: "bathocuproine disulfonic acid."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0001128:Acid [Chemical]
   827   C0052999:bathocuproine [Organic Chemical,Pharmacologic Substance]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.144: B, stock solutions (synuclein, DTT, iron, buffer) were exposed separately to an anoxic atmosphere for 3 h at room temperature before being diluted and incubated as in A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "stock solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0037633:Solutions [Substance]
   827 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "(synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "buffer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: ")"

Phrase: "were"

Phrase: "exposed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332157:Exposed [Clinical Attribute]

Phrase: "separately to an anoxic atmosphere"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0004178:Atmosphere [Natural Phenomenon or Process]
   760   C0678214:atmosphere [Quantitative Concept]

Phrase: "for 3 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0041119:3 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at room temperature"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]

Phrase: "before"

Phrase: "being"

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "and"

Phrase: "incubated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1439852:Incubated [Laboratory Procedure]

Phrase: "as in A."
Processing 00000000.tx.145: Incubations were in the presence (left panel) or absence (right panel) of oxygen. 

Phrase: "Incubations"

Phrase: "were in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "(left panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "or"

Phrase: "absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "(right panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "of oxygen."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
Processing 00000000.tx.146: The apparent increase in the amount of synuclein (monomeric and oligomeric) under oxidizing conditions (i.e. with DTT/iron) in A and B may be because of conformational changes that accompany synuclein oxidation and result in an increase in detection with anti-synuclein antibodies. 

Phrase: "The apparent increase in the amount of synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "oligomeric"

Phrase: ")"

Phrase: "under oxidizing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "with DTT/iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: ")"

Phrase: "in A"

Phrase: "and"

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "may"

Phrase: "be because of conformational"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2987476:Be [Conceptual Entity]

Phrase: "changes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0392747:Change [Functional Concept]
  1000   C0443172:change [Quantitative Concept]
  1000   C1705241:Change [Quantitative Concept]

Phrase: "that"

Phrase: "accompany"

Phrase: "synuclein oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "and"

Phrase: "result in an increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in detection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "with anti-synuclein antibodies."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   913   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   896 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.147: These effects were also observed by silver staining (not shown). 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "observed by silver staining"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C1293950:Silver Staining [Laboratory Procedure]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   770   C1441672:Observed [Functional Concept]
   770   C1704680:Staining [Finding]

Phrase: "("

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.148: With higher levels of iron, increased oligomerization does result in progressive loss of monomeric synuclein into higher molecular mass oligomers (see Fig. 5).  

Phrase: "With higher levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "increased oligomerization"

Phrase: "does"

Phrase: "result in progressive loss of monomeric synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1274040:Result [Functional Concept]
   748   C1546471:Result [Idea or Concept]
   748   C2825142:Result [Finding]

Phrase: "into higher molecular mass oligomers"

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.149: MCO Prevents Synuclein Filament FormationBecause the role of synuclein oxidation during fibrillization has not been clearly defined (39, 4244, 72, 73), the effect of MCO on the formation of synuclein filaments in vitro was examined. 

Phrase: "MCO"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0025552:Metal [Inorganic Chemical]
   812   C0030011:Oxidation [Molecular Function]
   741 E C2986473:Metallic [Qualitative Concept]

Phrase: "Prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "Synuclein Filament FormationBecause"

Phrase: "the role of synuclein oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "during fibrillization"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "clearly"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "(39,"

Phrase: "4244,"

Phrase: "72,"

Phrase: "73"

Phrase: ")"

Phrase: ","

Phrase: "the effect of MCO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "was"

Phrase: "examined."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]
Processing 00000000.tx.150: Treatment of 200 M synuclein at 37 C for 72 h with shaking under control conditions (i.e. in the absence of DTT or iron) resulted in the production of relatively uniform mostly unbranched, but often twisted, 610-nm wide filaments up to several micrometers long (Fig. 2A). 

Phrase: "Treatment of 200 M synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "at 37 C"

Phrase: "for 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040822:Shaking [Sign or Symptom]
   966 E C1883023:Shake [Activity]

Phrase: "under control conditions"
Meta Candidates (Total=17; Excluded=9; Pruned=0; Remaining=8)
   861   C0243148:control [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "or"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: ")"

Phrase: "resulted in the production of relatively uniform mostly unbranched,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0033268:production [Occupational Activity]
   742   C0205375:Uniform [Qualitative Concept]
   742   C0750554:mostly [Idea or Concept]
   742   C1608508:uniform [Quantitative Concept]
   708   C1274040:Result [Functional Concept]
   708   C1546471:Result [Idea or Concept]
   708   C2825142:Result [Finding]

Phrase: "but"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "twisted"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
  1000   C0231467:Twisted [Spatial Concept]
   966 E C0040480:twist [Physiologic Function]
   928 E C0231458:Rotated [Spatial Concept]
   907 E C1265748:Twisting [Pathologic Function]
   907 E C1881716:TWISTING [Phenomenon or Process]

Phrase: ","

Phrase: "610-nm wide filaments up to several micrometers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0010851:Filament [Cell Component]

Phrase: "long"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205166:Long [Qualitative Concept]
  1000   C1706317:Long [Qualitative Concept]

Phrase: "(Fig. 2A"

Phrase: ")."
Processing 00000000.tx.151: Little in the way of non-filamentous background was observed or was the background increased when DTT/iron were added to monomeric synuclein or preformed synuclein filaments just prior to their deposition onto EM grids (data not shown). 

Phrase: "Little in the way of non-filamentous background"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   744   C0700321:Little [Quantitative Concept]
   744   C2700395:Little [Quantitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "or"

Phrase: "was"

Phrase: "the background"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706907:Background [Conceptual Entity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "when"

Phrase: "DTT/iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "were"

Phrase: "added to monomeric synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]

Phrase: "or"

Phrase: "preformed synuclein filaments just prior to their deposition"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C0010851:Filament [Cell Component]

Phrase: "onto EM grids"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1415284:GRID [Gene or Genome]
   827   C2348395:Grid [Medical Device]
   827   C2825313:Grid [Manufactured Object]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.152: When DTT/iron were present during the incubation, however, a large number of primarily small 50100 nm short curvilinear structures were generated, as well as a number of apparently anastomosing 100250-nm networks (Fig. 2B) that may be derived from coalescence of the smaller structures and that occasionally contained loops within the networks (see Fig. 2C, arrowhead). 

Phrase: "When"

Phrase: "DTT/iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "were"

Phrase: "present during the incubation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "however,"

Phrase: "a large number of primarily small 50100 nm short curvilinear structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0237753:*Number [Quantitative Concept]
   738   C0449788:Number [Quantitative Concept]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "as well as"

Phrase: "a number of apparently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "anastomosing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0332853:anastomose [Acquired Abnormality]

Phrase: "100250-nm networks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1882071:networks [Conceptual Entity]
   793 E C1513822:Network [Professional or Occupational Group]
   793 E C1705739:Network [Manufactured Object]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "derived from coalescence of the smaller structures"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0547044:Smaller [Qualitative Concept]
   748   C0678594:structures [Spatial Concept]
   748   C0700321:Smaller [Quantitative Concept]
   748   C1441547:Derived [Qualitative Concept]
   748   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "that occasionally contained loops within the networks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   748   C0181687:loops [Medical Device]
   714 E C0419518:Loop [Medical Device]
   714 E C0445022:Loop [Spatial Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 2C,"

Phrase: "arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")."
Processing 00000000.tx.153: Although rare, 20-nm diameter annular structures were also observed (Fig. 2D, arrow). 

Phrase: "Although"

Phrase: "rare, 20-nm diameter annular structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Fig. 2D, arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.154: These results demonstrate that in the presence of an enhanced MCO system, synuclein filaments fail to be generated and are replaced by an assortment of structures of varying morphologies. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that in the presence of an enhanced MCO system,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   751   C0026339:Model System [Intellectual Product,Research Device]
   751   C3161035:Model System [Intellectual Product]
           Model
   736   C0025552:Metal [Inorganic Chemical]
   736   C0030011:Oxidation [Molecular Function]
   736   C0392148:Presence [Therapeutic or Preventive Procedure]
   736   C0449913:System [Functional Concept]
   736   C1553451:System [Manufactured Object]
   736   C1704459:System [Medical Device]
   736   C2349975:Enhanced [Activity]

Phrase: "synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "and"

Phrase: "are"

Phrase: "replaced by an assortment of structures of varying morphologies."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C1299987:Replaced by [Functional Concept]
           replaced
   742   C0559956:Replaced [Functional Concept]
   742   C0678594:structures [Spatial Concept]
   742   C2346866:Assortment [Conceptual Entity]
   708   C0332437:Morphology [Qualitative Concept]
   708   C0543482:morphology [Spatial Concept]
   708   C0700329:Morphology, NOS [Finding]
   708   C0700619:Morphology [Biomedical Occupation or Discipline]
   708 E C1554078:Replace [Idea or Concept]
Processing 00000000.tx.155: View larger version (84K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(84K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.156: 2. 

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.157: Oxidation with DTT/iron inhibits synuclein filament formation and generates curvilinear and branched networks. 

Phrase: "Oxidation with DTT/iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "synuclein filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "generates"

Phrase: "curvilinear"

Phrase: "and"

Phrase: "branched networks."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C1882071:networks [Conceptual Entity]
   827 E C1513822:Network [Professional or Occupational Group]
   827 E C1705739:Network [Manufactured Object]
Processing 00000000.tx.158: Negative stain electron microscopy, under control (A) or oxidizing (BD) conditions. 

Phrase: "Negative stain electron microscopy,"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C1441647:Electron microscopy, negative stain [Laboratory Procedure]
   861   C0026019:Electron Microscopy [Laboratory Procedure]
   861   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   812   C0013852:Electron [Quantitative Concept]
   812   C0026018:Microscopy [Laboratory Procedure]
   812   C3463986:Electron [Bird]
   741 E C0013850:Electronic [Manufactured Object]
   741 E C0205288:Microscopic [Qualitative Concept]
   741 E C1547561:Electronic [Idea or Concept]

Phrase: "under control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "(A)"

Phrase: "or"

Phrase: "oxidizing"

Phrase: "(BD) conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.159: 200 M synuclein was incubated at 37 C for 72 h with shaking in PBS, without (A) or with (BD) 10 mM DTT/100 M Fe(III). 

Phrase: "200 M synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated at 37 C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "with shaking"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0040822:Shaking [Sign or Symptom]
   966 E C1883023:Shake [Activity]

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "without"

Phrase: "(A)"

Phrase: "or with"

Phrase: "(BD) 10 mM DTT/100 M Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0439070:III [Intellectual Product]
   793   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.160: Scale bar = 100 nm (AC) and 20 nm (D). 

Phrase: "Scale bar = 100 nm ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0312860:NM [Cell Function]

Phrase: "AC)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1412573:AC [Gene or Genome]
  1000   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3539770:AC [Gene or Genome]

Phrase: "and"

Phrase: "20 nm ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0312860:NM [Cell Function]

Phrase: "D)."
Processing 00000000.tx.161: The oxidized assemblies in B often contained loop-like (C, arrowhead) and occasional annular (D, arrow) structures.  

Phrase: "The oxidized assemblies in B often contained loop-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1706853:Assembly [Activity]
   711   C1879748:Assembly [Manufactured Object]

Phrase: "like"

Phrase: "(C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: ")"

Phrase: "and"

Phrase: "occasional annular"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0521164:Annular [Spatial Concept]
   789 E C2262860:annulus [Cell Component]

Phrase: "(D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.162: To examine whether these oxidized assemblies contained a crossed sheet structure common to amyloid fibrils, the thioflavin T dye binding characteristics of control and iron-treated synuclein solutions was compared. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "these oxidized assemblies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "a crossed sheet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2349187:Sheet [Quantitative Concept]

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "common to amyloid fibrils,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205214:Common [Quantitative Concept]
   770   C1522138:Common [Functional Concept]
   770   C3245511:common [Intellectual Product]

Phrase: "the thioflavin T dye binding characteristics of control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1521970:Characteristics [Qualitative Concept]

Phrase: "and"

Phrase: "iron-treated synuclein solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0037633:Solutions [Substance]
   779 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "was"

Phrase: "compared."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compared [Activity]
Processing 00000000.tx.163: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.164: 3A, the non-incubated synuclein monomer did not bind dye, as expected from its natively unfolded conformation. 

Phrase: "3A,"

Phrase: "the non-incubated synuclein monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "dye,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013343:Dye [Indicator, Reagent, or Diagnostic Aid]

Phrase: "as"

Phrase: "expected from its natively unfolded conformation."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0026377:Conformation [Spatial Concept]
   753   C1517001:Expected [Idea or Concept]
Processing 00000000.tx.165: Synuclein incubated under control conditions (i.e. no additions) resulted in production of filaments, reflected by an increase in thioflavin T fluorescence. 

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "incubated under control conditions"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   770   C0243148:control [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "(i.e."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0683454:I-E [Diagnostic Procedure,Intellectual Product]
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "no additions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1883712:Addition [Functional Concept]
   916 E C1524062:Additional [Functional Concept]

Phrase: ")"

Phrase: "resulted in production of filaments,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0033268:production [Occupational Activity]
   726   C0010851:Filament [Cell Component]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "reflected by an increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0442805:Increase [Functional Concept]
   770   C0558058:reflected [Mental Process]

Phrase: "in thioflavin T fluorescence."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0016315:Fluorescence [Natural Phenomenon or Process]
   755 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.166: Synuclein incubated in the presence of DTT alone generally prevented filament formation, although this effect was variable and could be prevented by treating the DTT solutions with Chelex-100 beads to remove contaminating metals (see "Experimental Procedures"). 

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "incubated in the presence of DTT alone generally prevented filament formation,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   738   C0010851:Filament [Cell Component]
   738   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   738   C0205171:Alone [Quantitative Concept]
   738   C0220781:formation [Biologic Function]
   738   C0392148:Presence [Therapeutic or Preventive Procedure]
   738   C0439044:alone [Finding]
   738   C0439634:formation [Spatial Concept]
   738   C0679994:alone [Group Attribute]
   738   C1439852:Incubated [Laboratory Procedure]
   738   C1522492:Formation [Functional Concept]
   704   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "although"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "variable"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439828:Variable [Qualitative Concept]

Phrase: "and"

Phrase: "could"

Phrase: "be"

Phrase: "prevented by treating"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0332293:treating [Therapeutic or Preventive Procedure]
   790   C1522326:Treating [Functional Concept]
   756   C0309872:PREVENT [Pharmacologic Substance]
   756 E C1292734:TREAT [Functional Concept]

Phrase: "the DTT solutions with Chelex-100"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0037633:Solutions [Substance]
   719 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "beads"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0991566:Beads [Biomedical or Dental Material]
  1000   C2346972:Bead [Spatial Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "contaminating metals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025552:Metals [Inorganic Chemical]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.167: The addition of exogenous iron in the presence of DTT (whether Chelex-treated or not) completely inhibited the formation of sheet-containing structures, as shown by a lack of thioflavin T binding. 

Phrase: "The addition of exogenous iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883712:Addition [Functional Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "("

Phrase: "whether"

Phrase: "Chelex-treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332293:treated [Therapeutic or Preventive Procedure]
   861   C1522326:Treated [Functional Concept]
   827 E C1292734:TREAT [Functional Concept]

Phrase: "or"

Phrase: "not) completely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205197:Completely [Qualitative Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the formation of sheet-containing structures,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "shown by a lack of thioflavin T binding."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C0243122:binding [Functional Concept]
   744   C0332268:lack [Qualitative Concept]
   744   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   711   C1547282:Show [Intellectual Product]
Processing 00000000.tx.168: This was not because of a quenching of the thioflavin T signal by iron, because the addition of a 100-fold excess of exogenous iron (to 50 M Fe(III), see "Experimental Procedures") to preformed synuclein filaments had no effect on fluorescence emission (data not shown). 

Phrase: "This"

Phrase: "was"

Phrase: "not because of a quenching of the thioflavin T signal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   739   C1518422:Not [Functional Concept]
   739   C1710082:Signal [Phenomenon or Process]

Phrase: "by iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "because"

Phrase: "the addition of a 100-fold excess of exogenous iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C1883712:Addition [Functional Concept]

Phrase: "("

Phrase: "to 50 M Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")"

Phrase: "to preformed synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "had"

Phrase: "no effect on fluorescence emission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.169: The thioflavin T signal was quenched, however, by 50% at 250 M Fe(III), and no signal was detected at 500 M Fe(III) (data not shown). 

Phrase: "The thioflavin T signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1710082:Signal [Phenomenon or Process]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "quenched"

Phrase: ","

Phrase: "however,"

Phrase: "by 50%"

Phrase: "at 250 M Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439070:III [Intellectual Product]
   812   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "no signal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710082:Signal [Phenomenon or Process]

Phrase: "was"

Phrase: "detected at 500 M Fe(III"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0439070:III [Intellectual Product]
   753   C0441923:M+ [Intellectual Product]
   753   C0442726:Detected [Finding]
   753   C1511790:Detected [Therapeutic or Preventive Procedure]
   753   C1705160:III [Qualitative Concept]
   753   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.170: Conversely, an addition of the iron chelator deferoxamine to the DTT/iron-containing solution restored filament formation to control levels and enhanced filament formation when added to control incubations (Fig. 3A). 

Phrase: "Conversely,"

Phrase: "an addition of the iron chelator deferoxamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1883712:Addition [Functional Concept]

Phrase: "to the DTT/iron-containing solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0037633:Solution [Substance]
   812   C0525069:Solution [Biomedical or Dental Material]

Phrase: "restored"

Phrase: "filament formation to control levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   804   C0243148:control [Qualitative Concept]
   804   C0441889:Levels [Qualitative Concept]
   804   C1550141:Control [Substance]
   804   C1882979:Control [Conceptual Entity]
   804   C2587213:Control [Functional Concept]
   804   C3274648:Control [Qualitative Concept]
   771 E C0456079:Level [Classification]
   771 E C1547707:Level [Geographic Area]
   771 E C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "enhanced filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "when"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "incubations"

Phrase: "(Fig. 3A"

Phrase: ")."
Processing 00000000.tx.171: No difference in the morphology of the synuclein filaments was observed in the presence of deferoxamine; 

Phrase: "No difference in the morphology of the synuclein filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1705241:*Difference [Quantitative Concept]
   742   C1705242:Difference [Qualitative Concept]

Phrase: "was"

Phrase: "observed in the presence of deferoxamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1441672:Observed [Functional Concept]

Phrase: ";"
Processing 00000000.tx.172: however, filaments began forming more rapidly, often appearing in less than 24 h (data not shown). 

Phrase: "however,"

Phrase: "filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "began"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0439659:Begin [Temporal Concept]

Phrase: "forming"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0205431:Forming [Functional Concept]
  1000   C1522492:Forming [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]

Phrase: "more rapidly,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C1637379:Rapidly [Qualitative Concept]

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "appearing in less"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C0700364:APPEAR [Qualitative Concept]

Phrase: "than 24 h (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1511726:Data [Idea or Concept]
   827   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.173: These results suggest that synuclein oxidation/oligomerization, at least under the conditions described here, and synuclein filament formation, are divergent processes. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that synuclein oxidation/oligomerization,"

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "under the conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here,"

Phrase: "and"

Phrase: "synuclein filament formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "are"

Phrase: "divergent processes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1184743:Process [Body Part, Organ, or Organ Component]
   827   C1522240:Process [Phenomenon or Process]
Processing 00000000.tx.174: This is supported by experiments examining filament formation under anaerobic conditions (Fig. 3B), where oxygen depletion significantly enhanced filament formation over control incubations performed in the presence of oxygen and, even in the presence of DTT/iron, restored filament formation to control levels. 

Phrase: "This"

Phrase: "is"

Phrase: "supported by experiments"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0681814:Experiments [Research Activity]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1706386:Experiment [Conceptual Entity]
   706 E C1517586:Experimental [Qualitative Concept]

Phrase: "examining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332128:examining [Finding]
  1000   C2004054:Examining [Activity]

Phrase: "filament formation under anaerobic conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 3B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450365:3b [Intellectual Product]
   861   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "where oxygen depletion significantly enhanced filament formation over control incubations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C0220781:formation [Biologic Function]
   739   C0439634:formation [Spatial Concept]
   739   C1522492:Formation [Functional Concept]

Phrase: "performed in the presence of oxygen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C0884358:Performed [Functional Concept]
   719 E C2947996:Perform [Pharmacologic Substance]

Phrase: "and"

Phrase: ","

Phrase: "even in the presence of DTT/iron,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   748   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   748   C0376520:Iron [Inorganic Chemical]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1166521:iron [Pharmacologic Substance]

Phrase: "restored filament formation to control levels."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   799   C0243148:control [Qualitative Concept]
   799   C0441889:Levels [Qualitative Concept]
   799   C1550141:Control [Substance]
   799   C1882979:Control [Conceptual Entity]
   799   C2587213:Control [Functional Concept]
   799   C3274648:Control [Qualitative Concept]
   766 E C0456079:Level [Classification]
   766 E C1547707:Level [Geographic Area]
   766 E C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.175: View larger version (16K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(16K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.176: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.177: Oxidation inhibits sheet/filament formation. 

Phrase: "Oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "sheet/filament formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.178: 200 M synuclein was incubated under control conditions (no additions) or supplemented with DTT (10 mM), Fe(III) (100 M), or deferoxamine (Df, 10 mM), as indicated. 

Phrase: "200 M synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated under control conditions"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   770   C0243148:control [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "("

Phrase: "no additions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1883712:Addition [Functional Concept]
   916 E C1524062:Additional [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "supplemented with DTT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   756   C0242295:Supplement [Food]
   756   C1947943:Supplement [Intellectual Product]
   756   C2348609:Supplement [Functional Concept]

Phrase: "(10 mM"

Phrase: ")"

Phrase: ","

Phrase: "Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "(100"

Phrase: "M)"

Phrase: ","

Phrase: "or"

Phrase: "deferoxamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011145:Deferoxamine [Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Df,"

Phrase: "10 mM"

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.179: After incubation in PBS for 72 h at 37 C, synuclein was added to 1 ml of solution containing 10 M thioflavin T (1 M, final synuclein concentration). 

Phrase: "After incubation"

Phrase: "in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "for 72 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C,"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "added to 1 ml of solution"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   767   C0945818:Add 1 [Quantitative Concept]
   753   C0037633:Solution [Substance]
   753   C0439526:/mL [Quantitative Concept]
   753   C0525069:Solution [Biomedical or Dental Material]
   753   C1524062:Added [Functional Concept]
   719 E C1883712:Add [Functional Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 M thioflavin T (1 M,"

Phrase: "final synuclein concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0086045:Concentration [Mental Process]
   827   C1446561:Concentration [Quantitative Concept]
   755 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: ")."
Processing 00000000.tx.180: Excitation was at 440 nm, and emission scans were at 450600 nm. 

Phrase: "Excitation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0549255:Excitation [Activity]

Phrase: "was at 440 nm,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0043194:WAS [Disease or Syndrome]
   770   C0258432:WAS [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0312860:NM [Cell Function]
   770   C1421478:WAS [Gene or Genome]

Phrase: "and"

Phrase: "emission scans"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2986746:Emission scan [Diagnostic Procedure]
   861   C0034606:Scan [Diagnostic Procedure]
   861   C0441633:Scan [Diagnostic Procedure]
   861   C2826292:SCAN [Finding]

Phrase: "were at 450600 nm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0312860:NM [Cell Function]
Processing 00000000.tx.181: A shows the effects of iron treatment and iron chelation on synuclein filament formation under oxygen containing conditions, whereas the B compares the effect of oxygen containing (-ox) or oxygen depleted (-anoxic) solutions on filament formation. 

Phrase: "A"

Phrase: "shows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the effects of iron treatment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   781   C1518681:Treatment Effect [Finding]
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "iron chelation on synuclein filament formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1517598:Iron Chelation [Molecular Function]
   753   C3537131:Chelation [Molecular Function]

Phrase: "under oxygen containing conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "whereas"

Phrase: "the B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "compares"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the effect of oxygen"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280500:Effect [Qualitative Concept]
   770   C2348382:Effect [Qualitative Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "(-ox)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0300971:Ox [Mammal]

Phrase: "or"

Phrase: "oxygen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "depleted"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0333668:Depleted [Functional Concept]
   928 E C1550032:Unload [Idea or Concept]
   928 E C1880497:Empty [Qualitative Concept]
   928 E C1996907:Emptying [Activity]

Phrase: "(-anoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0003130:Anoxia [Pathologic Function]

Phrase: ")"

Phrase: "solutions on filament formation."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C0037633:Solutions [Substance]
   737 E C0525069:Solution [Biomedical or Dental Material]
Processing 00000000.tx.182: Monomeric synuclein (non-incubated) and synuclein incubated under control conditions in the absence of oxidants (no additions) are indicated.  

Phrase: "Monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(non-incubated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1439852:Incubated [Laboratory Procedure]
   861   C1518422:Non [Functional Concept]

Phrase: ")"

Phrase: "and"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "incubated under control conditions"
Meta Candidates (Total=14; Excluded=5; Pruned=0; Remaining=9)
   770   C0243148:control [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]
   715 E C0040607:Training [Educational Activity]
   715 E C0220931:Training [Educational Activity]
   715 E C0336809:Train [Manufactured Object]
   715 E C1552514:Train [Manufactured Object]
   715 E C2673163:training [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of oxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085403:Oxidants [Chemical Viewed Functionally]

Phrase: "("

Phrase: "no additions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1883712:Addition [Functional Concept]
   916 E C1524062:Additional [Functional Concept]

Phrase: ")"

Phrase: "are"

Phrase: "indicated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]
Processing 00000000.tx.183: The Role of Synuclein Oxidation in Protofibril Formation The soluble forms of oligomeric synuclein that elute in the void volume from Superdex 200 gel filtration columns after synuclein filaments have been removed by centrifugation have been defined as representing synuclein protofibrils, the possible toxic intermediates in the etiology of PD (4951). 

Phrase: "The Role of Synuclein Oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in Protofibril Formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "The soluble forms of oligomeric synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   753   C0348078:forms [Qualitative Concept]
   753   C0376315:Forms [Manufactured Object]
   719 E C1522492:Form [Functional Concept]

Phrase: "that"

Phrase: "elute in the void volume"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0042034:void [Organism Function]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1552835:void [Idea or Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "from Superdex 200 gel filtration columns"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1185738:Column [Body Part, Organ, or Organ Component]
   771   C1706132:Column [Idea or Concept]

Phrase: "after synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "have"

Phrase: "been"

Phrase: "removed by centrifugation"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "have"

Phrase: "been"

Phrase: "defined as representing synuclein protofibrils,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]
   726   C1882932:Represent [Activity]

Phrase: "the possible toxic intermediates in the etiology of PD (4951"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   706   C0205103:Intermediate [Spatial Concept]
   706   C1550465:intermediate [Idea or Concept]
   706   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: ")."
Processing 00000000.tx.184: Because the MCO system described here prevented the assembly of synuclein into filaments, we wished to address whether formation of synuclein protofibrils was similarly affected. 

Phrase: "Because"

Phrase: "the MCO system"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   897   C0026339:Model System [Intellectual Product,Research Device]
   897   C3161035:Model System [Intellectual Product]
   804   C0449913:System [Functional Concept]
   804   C1553451:System [Manufactured Object]
   804   C1704459:System [Medical Device]
   733 E C0205373:Systemic [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "here"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the assembly of synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1706853:Assembly [Activity]
   770   C1879748:Assembly [Manufactured Object]

Phrase: "into filaments,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "we"

Phrase: "wished"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1423524:WISH [Gene or Genome]
   966   C3273411:WISH [Gene or Genome]
   966   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "whether"

Phrase: "formation of synuclein protofibrils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "similarly"

Phrase: "affected."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]
Processing 00000000.tx.185: Synuclein was incubated under control or oxidizing conditions as described above, insoluble material (including filaments) was removed by centrifugation, and the resulting supernatants were loaded onto a Superdex 200 column (Fig. 4). 

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "incubated under control"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0243148:control [Qualitative Concept]
   790   C1439852:Incubated [Laboratory Procedure]
   790   C1550141:Control [Substance]
   790   C1882979:Control [Conceptual Entity]
   790   C2587213:Control [Functional Concept]
   790   C3274648:Control [Qualitative Concept]

Phrase: "or"

Phrase: "oxidizing conditions as described above, insoluble material"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C0012634:condition [Disease or Syndrome]
   714   C0348080:Condition [Qualitative Concept]
   714   C1705253:Condition [Conceptual Entity]

Phrase: "("

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: ")"

Phrase: "was"

Phrase: "removed by centrifugation,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0007703:Centrifugation [Laboratory Procedure]
   790   C0849355:Removed [Qualitative Concept]
   756 E C1883720:Remove [Activity]
   756 E C3244314:remove [Functional Concept]

Phrase: "and"

Phrase: "the resulting supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "loaded onto a Superdex 200 column"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   753   C1185738:Column [Body Part, Organ, or Organ Component]
   753   C1706132:Column [Idea or Concept]
   753   C1708715:Loaded [Activity]
   719 E C1550025:Load [Idea or Concept]
   719 E C1704782:Load [Manufactured Object]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.186: On-line light scattering detection, together with SDS-PAGE of isolated fractions, indicated that the untreated synuclein monomer eluted at 19 min with little or no material eluting in the void volume (Fig. 4A). 

Phrase: "On-line light scattering detection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "together with SDS-PAGE"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "of isolated fractions,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "indicated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444656:Indicated [Finding]

Phrase: "that"

Phrase: "the untreated synuclein monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "eluted at 19 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0702093:/min [Temporal Concept]

Phrase: "with little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "or"

Phrase: "no material eluting in the void volume"

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")."
Processing 00000000.tx.187: Supernatants from control incubations without DTT/iron contained monomeric synuclein, as well as larger synuclein species that eluted in the void volume peak (Fig. 4B), as described previously (50). 

Phrase: "Supernatants from control incubations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1550101:Supernatant [Body Substance]

Phrase: "without DTT/iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "monomeric synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "as well as"

Phrase: "larger synuclein species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "that"

Phrase: "eluted in the void volume peak"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0042034:void [Organism Function]
   753   C0444505:Peak [Quantitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1552835:void [Idea or Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C2700258:Volume [Laboratory Procedure]

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "as"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "previously"

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.188: These larger synuclein species routinely represented less than 3% of the amount of monomeric synuclein. 

Phrase: "These larger synuclein species routinely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1705920:Species [Conceptual Entity]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "less than 3% of the amount of monomeric synuclein."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0439092:Less Than [Intellectual Product]
           less
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0547044:Less [Qualitative Concept]
   742   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.189: Smaller synuclein fragments were also generated that could be detected by silver staining and by immunoblot analysis using antibodies directed toward the N terminus, but not the extreme C terminus (data not shown), suggesting that C-terminal cleavage of synuclein was occurring during the incubations. 

Phrase: "Smaller synuclein fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0332255:fragments [Functional Concept]
   827   C0486805:Fragments [Body Substance]
   793 E C1708096:Fragment [Qualitative Concept]

Phrase: "were"

Phrase: "also"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "that"

Phrase: "could"

Phrase: "be"

Phrase: "detected by silver staining"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1293950:Silver Staining [Laboratory Procedure]
   770   C0037125:Silver [Element, Ion, or Isotope]
   770   C0442726:Detected [Finding]
   770   C0487602:Staining [Laboratory Procedure]
   770   C0947651:SILVER [Biomedical or Dental Material,Pharmacologic Substance]
   770   C1305285:Silver [Qualitative Concept]
   770   C1318876:Silver [Indicator, Reagent, or Diagnostic Aid]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1704680:Staining [Finding]

Phrase: "and by immunoblot analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0020985:Immunoblot Analysis [Laboratory Procedure]
           Immunoblot
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1515981:And [Idea or Concept]
   770   C1524024:analysis [Functional Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "directed toward the N terminus,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the extreme C terminus"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that C-terminal cleavage of synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0010813:cleavage [Cell Function]
   753   C0596311:Cleavage [Phenomenon or Process]
   753   C1330957:cleavage [Cell Function]

Phrase: "was"

Phrase: "occurring during the incubations."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1709305:Occur [Activity]
   737   C2745955:OCCUR [Temporal Concept]
Processing 00000000.tx.190: The mechanism by which these synuclein fragments are generated is currently under investigation. 

Phrase: "The mechanism by which"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "these synuclein fragments"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0332255:fragments [Functional Concept]
   861   C0486805:Fragments [Body Substance]
   827 E C1708096:Fragment [Qualitative Concept]

Phrase: "are"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "is"

Phrase: "currently under investigation."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0521116:Currently [Temporal Concept]
   790   C1261322:Investigation [Health Care Activity]
   790   C1552578:investigation [Idea or Concept]
   718 E C1517586:Investigational [Qualitative Concept]
   718 E C3245491:investigational [Intellectual Product]
Processing 00000000.tx.191: The molecular mass of the void volume oligomers was 5.4 x 105 kDa, as determined by on-line light scattering, representing 37 synuclein subunits, similar to what has been previously reported using gel filtration and scanning transmission electron microscopy (74). 

Phrase: "The molecular mass of the void volume oligomers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   744   C0577559:Mass [Finding]
   744   C1306372:*Mass [Quantitative Concept]

Phrase: "was"

Phrase: "5.4 x 105 kDa,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1532717:kDa [Quantitative Concept]

Phrase: "as"

Phrase: "determined by on-line light scattering,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C0596837:Light Scattering [Phenomenon or Process]
   753   C0023693:Light [Natural Phenomenon or Process]
   753   C0205132:Line [Spatial Concept]
   753   C0439742:Scattering [Spatial Concept]
   753   C1306462:Light [Functional Concept]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]
   753   C1881376:Light [Qualitative Concept]

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "37 synuclein subunits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1711351:Subunit [Quantitative Concept]

Phrase: "similar to what"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "has"

Phrase: "been"

Phrase: "previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "gel filtration"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0008559:Gel Filtration [Laboratory Procedure]
   861   C0016107:filtration [Laboratory Procedure]
   861   C0017243:Gel [Biomedical or Dental Material]
   861   C1382104:Gel [Substance]

Phrase: "and"

Phrase: "scanning transmission electron microscopy"
Meta Candidates (Total=17; Excluded=4; Pruned=0; Remaining=13)
  1000   C0162731:Microscopy, Electron, Scanning Transmission [Laboratory Procedure]
   923   C0026020:Scanning Electron Microscopy [Laboratory Procedure]
   923   C0678118:Transmission Electron Microscopy [Laboratory Procedure]
   861   C0026019:Electron Microscopy [Laboratory Procedure]
   861   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   812   C0013852:Electron [Quantitative Concept]
   812   C0026018:Microscopy [Laboratory Procedure]
   812   C0034606:Scanning [Diagnostic Procedure]
   812   C0040722:transmission [Idea or Concept]
   812   C0242781:Transmission [Pathologic Function]
   812   C0441633:Scanning [Diagnostic Procedure]
   812   C1521797:Transmission [Natural Phenomenon or Process]
   812   C3463986:Electron [Bird]
   779 E C2826292:SCAN [Finding]
   741 E C0013850:Electronic [Manufactured Object]
   741 E C0205288:Microscopic [Qualitative Concept]
   741 E C1547561:Electronic [Idea or Concept]

Phrase: "(74"

Phrase: ")."
Processing 00000000.tx.192: View larger version (28K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.193: 4. 

Phrase: "4."
Processing 00000000.tx.194: Oxidation with DTT/iron stimulates synuclein protofibril formation. 

Phrase: "Oxidation with DTT/iron"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "stimulates"

Phrase: "synuclein protofibril formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.195: 200 M synuclein solutions were incubated for 72 h as in Fig. 

Phrase: "200 M synuclein solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0037633:Solutions [Substance]
   779 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "incubated for 72 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.196: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.197: After incubation, the solutions were centrifuged at 16,000 x g for 10 min to remove filaments and other large aggregates, and the supernatants were loaded onto a Superdex HR200 gel filtration column. 

Phrase: "After incubation,"

Phrase: "the solutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0037633:Solutions [Substance]
   966 E C0525069:Solution [Biomedical or Dental Material]

Phrase: "were"

Phrase: "centrifuged at 16,000 x g"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439267:g% [Quantitative Concept]
   719   C0179834:centrifuge [Medical Device]

Phrase: "for 10 min to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0456692:/10 min [Temporal Concept]
   827   C0702093:/min [Temporal Concept]

Phrase: "remove"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0849355:remove [Qualitative Concept]
  1000   C1883720:Remove [Activity]
  1000   C3244314:remove [Functional Concept]

Phrase: "filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "and"

Phrase: "other large aggregates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "and"

Phrase: "the supernatants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1550101:Supernatant [Body Substance]

Phrase: "were"

Phrase: "loaded onto a Superdex HR200 gel filtration column."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0008559:Gel Filtration [Laboratory Procedure]
   744   C0016107:filtration [Laboratory Procedure]
   744   C0017243:Gel [Biomedical or Dental Material]
   744   C1185738:Column [Body Part, Organ, or Organ Component]
   744   C1382104:Gel [Substance]
   744   C1706132:Column [Idea or Concept]
   744   C1708715:Loaded [Activity]
   711 E C1550025:Load [Idea or Concept]
   711 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.198: Detection of the eluates was monitored at 280 nm (UV, solid line) and by on-line light scattering to determine the masses of the eluting species (LS, dotted line). 

Phrase: "Detection of the eluates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "was"

Phrase: "monitored at 280 nm (UV,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0041625:UV [Natural Phenomenon or Process]
   760   C0312860:NM [Cell Function]
   760   C1961129:uV [Quantitative Concept]
   726   C0030695:monitor [Health Care Activity]
   726   C0150369:monitor [Health Care Activity]
   726   C0181904:Monitor [Medical Device]
   726   C0596972:Monitor [Medical Device]
   726   C1521743:Monitor [Professional or Occupational Group]
   726   C1704646:Monitor [Manufactured Object]

Phrase: "solid line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: "and by on-line light scattering to"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   778   C0596837:Light Scattering [Phenomenon or Process]
   748   C0023693:Light [Natural Phenomenon or Process]
   748   C0205132:Line [Spatial Concept]
   748   C0439742:Scattering [Spatial Concept]
   748   C1306462:Light [Functional Concept]
   748   C1515981:And [Idea or Concept]
   748   C1550648:Line [Substance]
   748   C1552960:Line [Quantitative Concept]
   748   C1881376:Light [Qualitative Concept]

Phrase: "determine"

Phrase: "the masses of the eluting species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C0577559:Mass [Finding]
   719   C1306372:*Mass [Quantitative Concept]
   719   C3152252:Mass [Quantitative Concept]

Phrase: "(LS,"

Phrase: "dotted line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205132:Line [Spatial Concept]
   861   C1550648:Line [Substance]
   861   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.199: At 1214 min for all samples, the sensitivity of the UV detector was decreased from 0.1 mV/absorbance unit to 0.5 mV/absorbance unit to prevent saturation from the monomer signal. 

Phrase: "At 1214 min"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0702093:/min [Temporal Concept]

Phrase: "for all samples,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0370003:Sample [Substance]
   966   C2347026:Sample [Conceptual Entity]

Phrase: "the sensitivity of the UV detector"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0036667:Sensitivity [Quantitative Concept]
   753   C0312418:Sensitivity [Mental Process]
   753   C0427965:Sensitivity [Finding]
   753   C1511883:Sensitivity [Quantitative Concept]
   753   C1522640:Sensitivity [Qualitative Concept]
   753   C2346484:SENSITIVITY [Phenomenon or Process]
   753   C2349185:Sensitivity [Qualitative Concept]

Phrase: "was"

Phrase: "decreased from 0.1 mV/absorbance unit"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   778   C2346712:Absorbance Unit [Quantitative Concept]
   748   C0205216:Decreased [Quantitative Concept]
   748   C0392756:Decreased [Qualitative Concept]
   748   C0439148:Unit [Quantitative Concept]
   748   C0442797:decreased [Qualitative Concept]
   748   C1268822:Absorbance [Clinical Attribute]
   748   C1519795:Unit [Quantitative Concept]
   748   C1704753:Unit [Manufactured Object]
   748   C1880519:Unit [Quantitative Concept]
   748   C2825050:Absorbance [Phenomenon or Process]
   714 E C0547047:Decrease [Quantitative Concept]

Phrase: "to 0.5 mV/absorbance unit to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C2346712:Absorbance Unit [Quantitative Concept]
   799   C0439148:Unit [Quantitative Concept]
   799   C1519795:Unit [Quantitative Concept]
   799   C1704753:Unit [Manufactured Object]
   799   C1880519:Unit [Quantitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "saturation from the monomer signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0522534:Saturation [Phenomenon or Process]
Processing 00000000.tx.200: A, untreated synuclein monomer, 350 ug; 

Phrase: "A,"

Phrase: "untreated synuclein monomer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "350 ug"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0041573:UG [Geographic Area]
   861   C0439211:ug [Quantitative Concept]

Phrase: ";"
Processing 00000000.tx.201: B, control incubation; 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "control incubation"

Phrase: ";"
Processing 00000000.tx.202: C, incubation with DTT/iron; 

Phrase: "C,"

Phrase: "incubation with DTT/iron"

Phrase: ";"
Processing 00000000.tx.203: and D, control incubation with deferoxamine. 

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "control incubation with deferoxamine."
Processing 00000000.tx.204: Note the scale differences in the ordinates under the different conditions.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "the scale differences in the ordinates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]

Phrase: "under the different conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.205: Incubation with DTT/iron resulted in an 520-fold enhancement in the production of synuclein protofibrils, as well as the generation of a range of species that vary from small oligomers (dimers, etc.) up to larger oligomers that elute just after the void volume (Fig. 4C, see below). 

Phrase: "Incubation with DTT/iron"

Phrase: "resulted in an 520-fold enhancement"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0332462:Fold [Spatial Concept]
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C1880834:FOLD [Phenomenon or Process]
   753   C2349975:Enhancement [Activity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "in the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of synuclein protofibrils,"

Phrase: "as well as"

Phrase: "the generation of a range of species"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0079411:Generation [Temporal Concept]
   748   C3146294:Generation [Activity]

Phrase: "that"

Phrase: "vary from small oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0700321:Small [Quantitative Concept]

Phrase: "(dimers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "etc.) up to larger oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1548556:etc. [Idea or Concept]

Phrase: "that"

Phrase: "elute"

Phrase: "just after the void volume"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0042034:void [Organism Function]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1552835:void [Idea or Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "(Fig. 4C,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450376:4c [Intellectual Product]

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.206: Conversely, incubation in the presence of deferoxamine almost completely prevented protofibril formation, as well as generation of smaller synuclein oligomers (Fig. 4D). 

Phrase: "Conversely,"

Phrase: "incubation in the presence of deferoxamine almost completely prevented protofibril formation,"

Phrase: "as well as"

Phrase: "generation of smaller synuclein oligomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "(Fig. 4D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450377:4d [Intellectual Product]
   861   C2986754:4D [Temporal Concept]

Phrase: ")."
Processing 00000000.tx.207: The amount of monomeric synuclein remaining in the supernatant was reduced 2-fold in the presence of deferoxamine when compared with control incubations, although the production of truncated synuclein fragments appeared not to be affected (Fig. 4, compare D with C). 

Phrase: "The amount of monomeric synuclein remaining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1265611:Amount [Quantitative Concept]

Phrase: "in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: "was"

Phrase: "reduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392756:Reduced [Qualitative Concept]

Phrase: "2-fold in the presence of deferoxamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0332462:Fold [Spatial Concept]
   748   C1880834:FOLD [Phenomenon or Process]

Phrase: "when"

Phrase: "compared with control incubations,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "although"

Phrase: "the production of truncated synuclein fragments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "appeared"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0700364:APPEAR [Qualitative Concept]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "D with C)."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   858   C0012358:D & C [Therapeutic or Preventive Procedure]
   858   C0012764:D.C. [Geographic Area]
   858   C1444662:D/C [Finding]
   858   C1512015:D.C. [Intellectual Product]
   790   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.208: This is consistent with the results from Fig. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with the results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "from Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.209: 3, in which filament assembly was enhanced when oxidation was prevented. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "in which filament assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "was"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "when"

Phrase: "oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "prevented."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.210: These results demonstrate that synuclein oxidation enhances the production of synuclein protofibrils and raise the possibility that oxidation/covalent cross-linking of synuclein may actually be required for their accumulation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "demonstrate"

Phrase: "that synuclein oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the production of synuclein protofibrils"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0033268:production [Occupational Activity]

Phrase: "and"

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that oxidation/covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1511539:Covalent [Molecular Function]
   789 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking of synuclein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332220:Cross-linking [Functional Concept]
   816 E C0178576:Cross link [Natural Phenomenon or Process]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "may"

Phrase: "actually"

Phrase: "be"

Phrase: "required for their accumulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Required [Functional Concept]
Processing 00000000.tx.211: The demonstration that the in vitro treatment of synuclein with dopamine and other catecholamines result in enhanced protofibril formation that was inhibited when oxidation was prevented (72), is consistent with this view (see below). 

Phrase: "The demonstration"

Phrase: "that"

Phrase: "the in vitro treatment of synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0039798:treatment [Functional Concept]
   753   C0087111:Treatment [Therapeutic or Preventive Procedure]
   753   C1522326:Treatment [Functional Concept]
   753   C1533734:Treatment [Therapeutic or Preventive Procedure]
   753   C1705169:Treatment [Conceptual Entity]
   753   C3538994:TREATMENT [Research Activity]

Phrase: "with dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "other catecholamines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0007412:Catecholamines [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   966 E C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "result in enhanced protofibril formation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1274040:Result [Functional Concept]
   760   C1522492:Formation [Functional Concept]
   760   C1546471:Result [Idea or Concept]
   760   C2349975:Enhanced [Activity]
   760   C2825142:Result [Finding]

Phrase: "that"

Phrase: "was"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "when"

Phrase: "oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "was"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "(72"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "consistent with this view"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.212: Characterization of Synuclein OligomersTo further characterize the oligomers generated by DTT/iron treatment, oligomers were separated from the oxidized synuclein monomer by Superose 6 gel filtration chromatography (Fig. 5A). 

Phrase: "Characterization of Synuclein OligomersTo further"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1880022:Characterization [Activity]

Phrase: "characterize"

Phrase: "the oligomers"

Phrase: "generated by DTT/iron treatment,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   760   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3146294:Generated [Activity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "oligomers"

Phrase: "were"

Phrase: "separated from the oxidized synuclein monomer"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086972:Separated [Finding]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0443299:separated [Spatial Concept]
   753   C0596973:Monomer [Chemical Viewed Structurally]
   753   C0687118:Separated [Functional Concept]
   719   C0030011:oxidize [Molecular Function]

Phrase: "by Superose 6 gel filtration chromatography"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   884   C0008559:Gel Filtration Chromatography [Laboratory Procedure]
           Gel Chromatography
           Gel Filtration
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0016107:filtration [Laboratory Procedure]
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C1382104:Gel [Substance]
   704 E C0302647:chromatograph [Medical Device]

Phrase: "(Fig. 5A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: ")."
Processing 00000000.tx.213: Although some of the monomeric synuclein eluted with the higher molecular mass oligomers (fractions 2028), most of the monomeric synuclein eluted later from the column (fractions 3638). 

Phrase: "Although"

Phrase: "some of the monomeric synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205392:Some [Quantitative Concept]
   760   C3540770:Some [Intellectual Product]

Phrase: "eluted with the higher molecular mass oligomers"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   778   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   748   C0577559:Mass [Finding]
   748   C1306372:*Mass [Quantitative Concept]
   748   C1521991:Molecular [Qualitative Concept]
   714   C0205250:High [Qualitative Concept]
   714   C1299351:High [Qualitative Concept]
   714   C2700149:HIGH [Intellectual Product]

Phrase: "(fractions 2028"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "most of the monomeric synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0205393:Most [Quantitative Concept]

Phrase: "eluted"

Phrase: "later from the column"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C0205087:Late [Temporal Concept]

Phrase: "(fractions 3638"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.214: Given the effectiveness of the separation, it is likely that the low levels of monomeric synuclein observed in fractions 2026 represents molecules dissociated from higher molecular mass oligomers by SDS rather than the failure of the column to separate unincorporated monomer from the oligomers. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the effectiveness of the separation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1280519:Effectiveness [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "the low levels of monomeric synuclein"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "observed in fractions 2026"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C1264633:Fractions [Quantitative Concept]
   770   C1441672:Observed [Functional Concept]
   737 E C1554103:Fraction [Idea or Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "molecules"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0567416:molecules [Substance]
   916 E C1521991:Molecular [Qualitative Concept]

Phrase: "dissociated from higher molecular mass oligomers"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1521991:Molecular [Qualitative Concept]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "by SDS"

Phrase: "rather than"

Phrase: "the failure of the column to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]

Phrase: "separate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443299:Separate [Spatial Concept]

Phrase: "unincorporated monomer from the oligomers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.215: Similar results were observed when purified synuclein protofibrils were isolated by Superdex 200 gel filtration chromatography (from Fig. 3C) and analyzed by SDS-PAGE/immunoblotting (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "when"

Phrase: "purified synuclein protofibrils"

Phrase: "were"

Phrase: "isolated by Superdex 200 gel filtration chromatography"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   814   C0008559:Gel Filtration Chromatography [Laboratory Procedure]
           Gel Filtration
           Gel Chromatography
   748   C0008550:Chromatography [Laboratory Procedure]
   748   C0016107:filtration [Laboratory Procedure]
   748   C0017243:Gel [Biomedical or Dental Material]
   748   C0205409:Isolated [Functional Concept]
   748   C1382104:Gel [Substance]
   748   C1548221:Isolated [Idea or Concept]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "("

Phrase: "from Fig. 3C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450366:3c [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "analyzed by SDS-PAGE/"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "immunoblotting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.216: Thus, higher molecular mass oligomers likely consist of both SDS-sensitive and SDS-resistant synuclein (54). 

Phrase: "Thus,"

Phrase: "higher molecular mass oligomers likely"

Phrase: "consist of both SDS-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332529:CONSIST [Qualitative Concept]

Phrase: "sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: "and"

Phrase: "SDS-resistant synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(54"

Phrase: ")."
Processing 00000000.tx.217: A secondary structure analysis of purified oligomers by far-UV CD showed a transition from the unfolded conformation of native -synuclein, characterized by a maximum negative ellipticity at 200 nm (75), to a likely sheet structure with a minimum 218 nm (Fig. 5B). 

Phrase: "A secondary structure analysis of purified oligomers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0002778:Analysis [Laboratory Procedure]
   748   C0936012:Analysis [Research Activity]
   748   C1524024:analysis [Functional Concept]
   743   C0204514:Structural analysis [Therapeutic or Preventive Procedure]

Phrase: "by far-UV CD"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "a transition from the unfolded conformation of native -synuclein,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0599156:Transition [Cell or Molecular Dysfunction]
   742   C2700061:Transition [Activity]

Phrase: "characterized by a maximum negative ellipticity"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0205160:Negative [Qualitative Concept]
   753   C0806909:Maximum [Quantitative Concept]
   753   C1513916:Negative [Finding]
   753   C1552615:maximum [Quantitative Concept]
   753   C1880022:Characterized [Activity]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]
   753   C2826546:MAXIMUM [Quantitative Concept]

Phrase: "at 200 nm (75"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0312860:NM [Cell Function]

Phrase: ")"

Phrase: ","

Phrase: "to a likely sheet structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:Structure [Spatial Concept]

Phrase: "with a minimum 218 nm (Fig. 5B"

Phrase: ")."
Processing 00000000.tx.218: This spectrum is similar to that previously reported for purified protofibrils (50). 

Phrase: "This spectrum"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1883073:Spectrum [Quantitative Concept]
  1000   C2827424:Spectrum [Conceptual Entity]

Phrase: "is"

Phrase: "similar to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C2348205:Similar [Qualitative Concept]

Phrase: "that previously"

Phrase: "reported for purified protofibrils"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0684224:Reported [Intellectual Product]
   770   C0700287:Reported [Health Care Activity]
   770   C1998793:Purified [Functional Concept]
   770   C3496591:Reported [Clinical Attribute]
   737 E C3273238:Report [Intellectual Product]

Phrase: "(50"

Phrase: ")."
Processing 00000000.tx.219: Significant light scattering prevented us from more accurately determining the percentage sheet content within these structures (76). 

Phrase: "Significant light scattering"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0596837:Light Scattering [Phenomenon or Process]
   827   C0023693:Light [Natural Phenomenon or Process]
   827   C0439742:Scattering [Spatial Concept]
   827   C1306462:Light [Functional Concept]
   827   C1881376:Light [Qualitative Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "us from more accurately"

Phrase: "determining"

Phrase: "the percentage sheet content within these structures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0423896:Content [Mental Process]
   748   C0456205:Content [Conceptual Entity]

Phrase: "(76"

Phrase: ")."
Processing 00000000.tx.220: These CD changes were not associated with the binding of thioflavin T (as expected from Fig. 3) or with binding to the hydrophobic dye bis-ANS (or ANS), nor did oligomerization result from the formation of appreciable dityrosine cross-links as monitored by changes in intrinsic fluorescence (data not shown). 

Phrase: "These CD changes"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392747:changes [Functional Concept]
   861   C0443172:changes [Quantitative Concept]
   827 E C1705241:Change [Quantitative Concept]

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "associated with the binding of thioflavin T (as"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0332281:Associated with [Qualitative Concept]
           Associated
   744   C0243122:binding [Functional Concept]
   744   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   744   C1145667:Binding [Activity]
   744   C1167622:Binding [Molecular Function]
   711 E C0750490:Associate [Idea or Concept]
   711 E C1706221:Associate [Professional or Occupational Group]

Phrase: "expected from Fig. 3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   770   C1517001:Expected [Idea or Concept]

Phrase: ")"

Phrase: "or with binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0243122:binding [Functional Concept]
   790   C1145667:Binding [Activity]
   790   C1167622:Binding [Molecular Function]

Phrase: "to the hydrophobic dye bis-ANS ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0048876:bis-ANS [Organic Chemical,Pharmacologic Substance]
   812   C0004388:ANS [Body System]

Phrase: "or"

Phrase: "ANS"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004388:ANS [Body System]

Phrase: ")"

Phrase: ","

Phrase: "nor"

Phrase: "did"

Phrase: "oligomerization result from the formation of appreciable dityrosine cross-links"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1274040:Result [Functional Concept]
   739   C1546471:Result [Idea or Concept]
   739   C2825142:Result [Finding]

Phrase: "as"

Phrase: "monitored by changes"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0392747:changes [Functional Concept]
   790   C0443172:changes [Quantitative Concept]
   756   C0030695:monitor [Health Care Activity]
   756   C0150369:monitor [Health Care Activity]
   756   C0181904:Monitor [Medical Device]
   756   C0596972:Monitor [Medical Device]
   756   C1521743:Monitor [Professional or Occupational Group]
   756   C1704646:Monitor [Manufactured Object]
   756 E C1705241:Change [Quantitative Concept]

Phrase: "in intrinsic fluorescence"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0016315:Fluorescence [Natural Phenomenon or Process]
   789 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.221: Thus, although the synuclein oligomers generated by oxidative cross-linking contain a sheet, they lack the amyloid structure characteristic of synuclein filaments (77). 

Phrase: "Thus,"

Phrase: "although"

Phrase: "the synuclein oligomers"

Phrase: "generated by oxidative"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0311404:Oxidative [Functional Concept]
   790   C3146294:Generated [Activity]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "a sheet,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349187:Sheet [Quantitative Concept]

Phrase: "they"

Phrase: "lack"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "characteristic of synuclein filaments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1521970:Characteristic [Qualitative Concept]

Phrase: "(77"

Phrase: ")."
Processing 00000000.tx.222: It has not yet been determined the minimal synuclein species that contributes to the sheet conformation (small oligomers or larger synuclein oligomers/protofibrils). 

Phrase: "It"

Phrase: "has"

Phrase: "not yet"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined"

Phrase: "the minimal synuclein species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "that"

Phrase: "contributes to the sheet conformation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0026377:Conformation [Spatial Concept]
   760   C1880177:Contribute [Activity]
   760   C2349187:Sheet [Quantitative Concept]

Phrase: "(small oligomers"

Phrase: "or"

Phrase: "larger synuclein oligomers/protofibrils"

Phrase: ")."
Processing 00000000.tx.223: View larger version (47K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(47K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.224: 5. 

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.225: Purification and structural analysis of synuclein oligomers. 

Phrase: "Purification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0243114:purification [Functional Concept]
  1000   C1998793:Purification [Functional Concept]

Phrase: "and"

Phrase: "structural analysis of synuclein oligomers."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0204514:Structural analysis [Therapeutic or Preventive Procedure]
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
Processing 00000000.tx.226: 200 M synuclein was oxidized in PBS containing 10 mM DTT/100 M Fe(III) overnight at 37 C. 

Phrase: "200 M synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "oxidized in PBS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756   C0030011:oxidize [Molecular Function]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10 mM DTT/100 M Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0439070:III [Intellectual Product]
   795   C1705160:III [Qualitative Concept]

Phrase: ")"

Phrase: "overnight at 37 C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439583:Overnight [Temporal Concept]
Processing 00000000.tx.227: A, oligomers were separated from the monomer by Superose 6 gel filtration chromatography. 

Phrase: "A,"

Phrase: "oligomers"

Phrase: "were"

Phrase: "separated from the monomer"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0086972:Separated [Finding]
   770   C0443299:separated [Spatial Concept]
   770   C0596973:Monomer [Chemical Viewed Structurally]
   770   C0687118:Separated [Functional Concept]

Phrase: "by Superose 6 gel filtration chromatography."
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   884   C0008559:Gel Filtration Chromatography [Laboratory Procedure]
           Gel Chromatography
           Gel Filtration
   804   C0008550:Chromatography [Laboratory Procedure]
   804   C0016107:filtration [Laboratory Procedure]
   804   C0017243:Gel [Biomedical or Dental Material]
   804   C1382104:Gel [Substance]
   704 E C0302647:chromatograph [Medical Device]
Processing 00000000.tx.228: 1-ml fractions were collected, and oxidized oligomers (fractions 2028) and monomers (fractions 3638) were concentrated and dialyzed against PBS overnight. 

Phrase: "1-ml fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1264633:Fractions [Quantitative Concept]
   793 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "collected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1516695:Collected [Idea or Concept]
  1000   C1516698:Collected [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "oxidized oligomers"

Phrase: "(fractions 2028"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "and"

Phrase: "monomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596973:monomers [Chemical Viewed Structurally]

Phrase: "(fractions 3638"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "were"

Phrase: "concentrated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1880165:Concentrated [Biomedical or Dental Material]
   966 E C1880310:Concentrate [Manufactured Object]
   966 E C2003864:Concentrate [Substance]

Phrase: "and"

Phrase: "dialyzed against PBS overnight."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439583:Overnight [Temporal Concept]
   770   C1720830:PBS [Disease or Syndrome]
   770   C1823521:PBS [Gene or Genome]
Processing 00000000.tx.229: B, far-UV CD spectroscopy of purified oligomers and untreated synuclein monomer. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "far-UV CD spectroscopy of purified oligomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0037812:spectroscopy [Laboratory Procedure]
   748   C2713504:Spectroscopy [Occupation or Discipline]
   748   C2984732:SPECTROSCOPY [Functional Concept]

Phrase: "and"

Phrase: "untreated synuclein monomer."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596973:Monomer [Chemical Viewed Structurally]
Processing 00000000.tx.230: C, thioflavin T assay. 

Phrase: "C,"

Phrase: "thioflavin T assay."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005507:Assay [Laboratory Procedure]
   827   C0243073:assay [Qualitative Concept]
   827   C1510438:Assay [Laboratory Procedure]
   734   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
Processing 00000000.tx.231: 18- or 48-h incubations with 200 M unseeded (control) synuclein or synuclein containing 1% preformed filament seeds or 1% purified oligomer seeds. 

Phrase: "18-"

Phrase: "or"

Phrase: "48-h incubations with 200 M"

Phrase: "unseeded"

Phrase: "(control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: ")"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "or"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "1% preformed filament seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0036563:Seed [Plant]
   812   C1705192:Seed [Laboratory Procedure]
   812   C1882540:{Seed} [Quantitative Concept]
   812   C2346495:Seed [Conceptual Entity]
   756 E C1519232:Seminal [Clinical Attribute]

Phrase: "or"

Phrase: "1% purified oligomer seeds."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0036563:Seed [Plant]
   812   C1705192:Seed [Laboratory Procedure]
   812   C1882540:{Seed} [Quantitative Concept]
   812   C2346495:Seed [Conceptual Entity]
   756 E C1519232:Seminal [Clinical Attribute]
Processing 00000000.tx.232: At 18 h synuclein filaments were generated in the presence of filament seeds (dark blue broken line), but not in their absence (solid red line). 

Phrase: "At 18 h synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   779   C0010851:Filament [Cell Component]
   729 E C1979891:Filamentous [Qualitative Concept]

Phrase: "were"

Phrase: "generated in the presence of filament seeds"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0010851:Filament [Cell Component]
   748   C0036563:Seed [Plant]
   748   C0392148:Presence [Therapeutic or Preventive Procedure]
   748   C1705192:Seed [Laboratory Procedure]
   748   C1882540:{Seed} [Quantitative Concept]
   748   C2346495:Seed [Conceptual Entity]
   748   C3146294:Generated [Activity]

Phrase: "(dark blue broken line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205132:Line [Spatial Concept]
   812   C1550648:Line [Substance]
   812   C1552960:Line [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not in their absence"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332197:absence [Quantitative Concept]
   770   C1518422:Not [Functional Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "(solid red line"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205132:Line [Spatial Concept]
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]
   827   C1550648:Line [Substance]
   827   C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.233: Oligomer seeds have no enhancing effect at 18 h (green broken line) but by 48 h have reached control levels (compare red and black dotted lines). 

Phrase: "Oligomer seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0036563:Seed [Plant]
   861   C1705192:Seed [Laboratory Procedure]
   861   C1882540:{Seed} [Quantitative Concept]
   861   C2346495:Seed [Conceptual Entity]
   805 E C1519232:Seminal [Clinical Attribute]

Phrase: "have"

Phrase: "no enhancing effect at 18 h (green broken line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   762   C1301751:No effect [Qualitative Concept]
   742   C1280500:Effect [Qualitative Concept]
   742   C2348382:Effect [Qualitative Concept]

Phrase: ")"

Phrase: "but by 48 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "have"

Phrase: "reached"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2584321:Reach [Organism Function]

Phrase: "control levels"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   861   C0243148:control [Qualitative Concept]
   861   C0441889:Levels [Qualitative Concept]
   861   C1550141:Control [Substance]
   861   C1882979:Control [Conceptual Entity]
   861   C2587213:Control [Functional Concept]
   861   C3274648:Control [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "("

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "black dotted lines"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0205132:lines [Spatial Concept]
   793 E C1550648:Line [Substance]
   793 E C1552960:Line [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.234: Also note that the oxidized monomer fails to generate fibrils. 

Phrase: "Also"

Phrase: "note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the oxidized monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "fails"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.235: D, sedimentation assay. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "sedimentation assay."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0005507:Assay [Laboratory Procedure]
   861   C0243073:assay [Qualitative Concept]
   861   C1510438:Assay [Laboratory Procedure]
Processing 00000000.tx.236: Incubations from 48-h treatments in C were pelleted, and equal volumes of supernatant (s) and pellet (p) fractions were analyzed by SDS-PAGE and immunoblotting with the anti-synuclein antibody 202. 

Phrase: "Incubations from 48-h treatments"

Phrase: "in C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "were"

Phrase: "pelleted"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0441436:Pellet [Manufactured Object]
   966   C0993610:Pellet [Biomedical or Dental Material]
   966   C1998480:Pellet [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "equal volumes of supernatant (s)"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0449468:volumes [Quantitative Concept]
   737 E C1690016:% volume [Qualitative Concept]
   737 E C1705102:Volume [Intellectual Product]
   737 E C2700258:Volume [Laboratory Procedure]

Phrase: "and"

Phrase: "pellet (p) fractions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: "were"

Phrase: "analyzed by SDS-PAGE"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   833   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   770   C0936012:Analyzed [Research Activity]
   770   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "immunoblotting with the anti-synuclein antibody 202."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0020985:Immunoblotting [Laboratory Procedure]
Processing 00000000.tx.237: Untreated synuclein is shown in lanes 1 and 2. 

Phrase: "Untreated synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "shown in lanes 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547282:Show [Intellectual Product]
   737   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]
Processing 00000000.tx.238: To detect the distribution of the seeds, which were added at 1% of monomeric synuclein, up to 10 g of total synuclein was loaded in each lane. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "the distribution of the seeds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "which"

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "at 1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "of monomeric synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "up to 10 g"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "of total synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "loaded in each lane."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   770   C1708715:Loaded [Activity]
   737 E C1550025:Load [Idea or Concept]
   737 E C1704782:Load [Manufactured Object]
Processing 00000000.tx.239: Purified oligomeric synuclein used at the same ratio (1%) in the seeded reactions (100 ng) is shown in lane 9. 

Phrase: "Purified oligomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "used at the same ratio"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0445247:Same [Qualitative Concept]
   760   C0456603:Ratio [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1547037:Ratio [Intellectual Product]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "(1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "in the seeded reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "(100 ng)"

Phrase: "is"

Phrase: "shown in lane 9."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1708639:Lane [Spatial Concept]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.240: A 3-fold excess of purified oligomers (300 ng) are shown in lane 10 to illustrate that low levels of synuclein monomer dissociate from the oligomers in the presence of SDS. 

Phrase: "A 3-fold excess of purified oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1979886:Excess [Qualitative Concept]

Phrase: "(300 ng)"

Phrase: "are"

Phrase: "shown in lane 10 to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1708639:Lane [Spatial Concept]
   726   C1547282:Show [Intellectual Product]

Phrase: "illustrate"

Phrase: "that low levels of synuclein monomer"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "dissociate from the oligomers"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of SDS."
Processing 00000000.tx.241: A mixture of monomeric synuclein and oligomeric seeds maintained at 4 C is shown in lanes 7 and 8. 

Phrase: "A mixture of monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0439962:Mixture [Substance]

Phrase: "and"

Phrase: "oligomeric seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0036563:Seed [Plant]
   861   C1705192:Seed [Laboratory Procedure]
   861   C1882540:{Seed} [Quantitative Concept]
   861   C2346495:Seed [Conceptual Entity]
   805 E C1519232:Seminal [Clinical Attribute]

Phrase: "maintained at 4 C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1314677:Maintained [Functional Concept]
   737 E C0024501:Maintain [Activity]

Phrase: "is"

Phrase: "shown in lanes 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1547282:Show [Intellectual Product]
   737   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "8."
Processing 00000000.tx.242: Note that the oligomers remain in the supernatant after centrifugation under these conditions.  

Phrase: "Note"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1316572:Note [Clinical Attribute]
  1000   C1317574:Note [Intellectual Product]
  1000   C1369612:Note [Clinical Attribute]

Phrase: "that"

Phrase: "the oligomers"

Phrase: "remain in the supernatant"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550101:Supernatant [Body Substance]

Phrase: "after centrifugation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0007703:Centrifugation [Laboratory Procedure]

Phrase: "under these conditions."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]
Processing 00000000.tx.243: Given that treatment of synuclein with DTT/iron inhibited filament formation, it is unlikely that the oligomers that produced this treatment would function as seeds to promote synuclein fibrillization, as is the case with seeds from preformed filaments (62). 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "that treatment of synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with DTT/iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "filament formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unlikely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0750558:Unlikely [Conceptual Entity]
  1000   C1710571:Unlikely [Qualitative Concept]

Phrase: "that"

Phrase: "the oligomers"

Phrase: "that"

Phrase: "produced"

Phrase: "this treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0039798:treatment [Functional Concept]
  1000   C0087111:Treatment [Therapeutic or Preventive Procedure]
  1000   C1522326:Treatment [Functional Concept]
  1000   C1533734:Treatment [Therapeutic or Preventive Procedure]
  1000   C1705169:Treatment [Conceptual Entity]
  1000   C3538994:TREATMENT [Research Activity]

Phrase: "would"

Phrase: "function as seeds to"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   770   C0031843:function [Physiologic Function]
   770   C0036563:Seed [Plant]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1705192:Seed [Laboratory Procedure]
   770   C1705273:Function [Intellectual Product]
   770   C1882540:{Seed} [Quantitative Concept]
   770   C2346495:Seed [Conceptual Entity]
   715 E C1519232:Seminal [Clinical Attribute]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "synuclein fibrillization,"

Phrase: "as is"

Phrase: "the case with seeds"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0868928:Case [Functional Concept]
   770   C1706255:CASE [Medical Device]
   770   C1706256:Case [Conceptual Entity]

Phrase: "from preformed filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "(62"

Phrase: ")."
Processing 00000000.tx.244: Indeed, inclusion of 1% purified oligomers (based on total synuclein concentration) to 200 M untreated monomeric synuclein failed to stimulate filament formation after an 18-h incubation, compared with significant fibril formation when 1% sonicated control seeds were added (Fig. 5C). 

Phrase: "Indeed,"

Phrase: "inclusion of 1% purified oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1512693:Inclusion [Qualitative Concept]

Phrase: "("

Phrase: "based on total synuclein concentration"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   760   C0086045:Concentration [Mental Process]
   760   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0439175:% total [Quantitative Concept]
   760   C0439810:Total [Qualitative Concept]
   760   C1446561:Concentration [Quantitative Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: ")"

Phrase: "to 200 M untreated monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stimulate"

Phrase: "filament formation after an 18-h incubation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "compared with significant fibril formation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0220781:formation [Biologic Function]
   760   C0225328:Fibril [Cell Component]
   760   C0237881:significant [Quantitative Concept]
   760   C0439634:formation [Spatial Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1522492:Formation [Functional Concept]
   760   C1546944:Significant [Qualitative Concept]
   760   C1707455:Compared [Activity]
   760   C1948066:Fibril [Physical Object]

Phrase: "when"

Phrase: "1% sonicated control seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0036563:Seed [Plant]
   812   C1705192:Seed [Laboratory Procedure]
   812   C1882540:{Seed} [Quantitative Concept]
   812   C2346495:Seed [Conceptual Entity]
   756 E C1519232:Seminal [Clinical Attribute]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "(Fig. 5C"

Phrase: ")."
Processing 00000000.tx.245: However, the oligomeric seeds did not inhibit subsequent filament formation during more extended incubations (Fig. 5C, 48 h). 

Phrase: "However,"

Phrase: "the oligomeric seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   861   C0036563:Seed [Plant]
   861   C1705192:Seed [Laboratory Procedure]
   861   C1882540:{Seed} [Quantitative Concept]
   861   C2346495:Seed [Conceptual Entity]
   805 E C1519232:Seminal [Clinical Attribute]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "subsequent filament formation during more extended incubations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 5C,"

Phrase: "48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.246: Sedimentation analysis (Fig. 5D) demonstrated that the soluble oligomer seeds became incorporated into pelletable material after 48 h at 37 C (Fig. 5C, compare lanes 5 and 6 with 7 and 8). 

Phrase: "Sedimentation analysis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]

Phrase: "(Fig. 5D"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the soluble oligomer seeds"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   827   C0036563:Seed [Plant]
   827   C1705192:Seed [Laboratory Procedure]
   827   C1882540:{Seed} [Quantitative Concept]
   827   C2346495:Seed [Conceptual Entity]
   771 E C1519232:Seminal [Clinical Attribute]

Phrase: "became"

Phrase: "incorporated into pelletable material"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0520510:Material [Substance]

Phrase: "after 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "at 37 C (Fig. 5C,"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 5"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "6 with 7"

Phrase: "and"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.247: Thus, at these low concentrations, synuclein oligomers do not function as crystal poisons that inhibit nucleation-dependent fibrillization (78) but can assemble with an unmodified monomeric synuclein into fibrils. 

Phrase: "Thus,"

Phrase: "at these low concentrations,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "synuclein oligomers"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "function as crystal poisons"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   770   C0031843:function [Physiologic Function]
   770   C0032346:Poisons [Hazardous or Poisonous Substance]
   770   C0427896:Crystal [Body Substance]
   770   C0444626:Crystal [Chemical Viewed Structurally]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1533132:Crystal [Body Substance]
   770   C1704641:Crystal [Manufactured Object]
   770   C1705273:Function [Intellectual Product]
   737 E C1548769:Poison [Intellectual Product]
   737 E C1550590:poison [Idea or Concept]

Phrase: "that"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "nucleation-dependent fibrillization"

Phrase: "(78"

Phrase: ")"

Phrase: "but"

Phrase: "can"

Phrase: "assemble with an unmodified monomeric synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1706853:Assemble [Activity]

Phrase: "into fibrils."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.248: Whether higher proportions (>1%) of purified synuclein oligomers would inhibit fibrillization of unmodified synuclein, similar to results with hydrogen peroxide-treated (73) or nitrated synuclein (79), has not been tested. 

Phrase: "Whether"

Phrase: "higher proportions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1709707:Proportion [Quantitative Concept]
   777 E C0205351:Proportional [Qualitative Concept]

Phrase: "("

Phrase: ">1%"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "of purified synuclein oligomers"

Phrase: "would"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "fibrillization of unmodified synuclein,"

Phrase: "similar to results"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "with hydrogen peroxide-treated"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0332293:treated [Therapeutic or Preventive Procedure]
   827   C1522326:Treated [Functional Concept]
   793 E C1292734:TREAT [Functional Concept]
   734   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]

Phrase: "(73"

Phrase: ")"

Phrase: "or"

Phrase: "nitrated synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(79"

Phrase: ")"

Phrase: ","

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "tested."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]
Processing 00000000.tx.249: Also shown in Fig. 

Phrase: "Also"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.250: 5C is the observation that the oxidized synuclein monomer that had been purified by gel filtration (Fig. 5A, fractions 3638) was incapable of assembling into fibrils after 48 h, or even after more extended incubations (up to 5 days tested; data not shown). 

Phrase: "5C"

Phrase: "is"

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that"

Phrase: "the oxidized synuclein monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "had"

Phrase: "been"

Phrase: "purified by gel filtration"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0008559:Gel Filtration [Laboratory Procedure]
   770   C0016107:filtration [Laboratory Procedure]
   770   C0017243:Gel [Biomedical or Dental Material]
   770   C1382104:Gel [Substance]
   770   C1998793:Purified [Functional Concept]

Phrase: "(Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "fractions 3638"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1264633:Fractions [Quantitative Concept]
   827 E C1554103:Fraction [Idea or Concept]

Phrase: ")"

Phrase: "was"

Phrase: "incapable of assembling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1550518:incapable [Idea or Concept]

Phrase: "into fibrils"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0225328:fibrils [Cell Component]
   966 E C1948066:Fibril [Physical Object]

Phrase: "after 48 h,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "or"

Phrase: "even"

Phrase: "after"

Phrase: "more extended incubations"

Phrase: "("

Phrase: "up to 5 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442466:5 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "tested"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392366:tested [Intellectual Product]
   966 E C0022885:Test [Laboratory Procedure]
   966 E C0039593:Test [Functional Concept]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.251: These results are similar to those of Fink and colleagues (73), who demonstrated that progressive oxidation of the four methionines of synuclein to methionine sulfoxide by hydrogen peroxide prevented fibril formation in the absence of oligomer formation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "similar to those of Fink"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2348205:Similar [Qualitative Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(73"

Phrase: ")"

Phrase: ","

Phrase: "who"

Phrase: "demonstrated"

Phrase: "that progressive oxidation of the four methionines of synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0030011:Oxidation [Molecular Function]

Phrase: "to methionine sulfoxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0066124:methionine sulfoxide [Amino Acid, Peptide, or Protein]
   861   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "by hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "fibril formation in the absence of oligomer formation."
Processing 00000000.tx.252: The nature of the modification(s) to monomeric synuclein under our oxidizing conditions has not been determined. 

Phrase: "The nature of the modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0349590:Nature [Idea or Concept]
   760   C1262865:Nature [Functional Concept]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "to monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "under our oxidizing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined."
Processing 00000000.tx.253: Inhibition of Synuclein Filament Formation by Cross-linked Synuclein OligomersGiven the above results, we wished to address the general issue of whether treatments previously shown to generate SDS-resistant synuclein cross-links would also inhibit synuclein filament formation. 

Phrase: "Inhibition of Synuclein Filament Formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "by"

Phrase: "Cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "Synuclein OligomersGiven"

Phrase: "the above results,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "we"

Phrase: "wished"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1423524:WISH [Gene or Genome]
   966   C3273411:WISH [Gene or Genome]
   966   C3273412:WISH [Amino Acid, Peptide, or Protein]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "the general issue of"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033213:Issue [Finding]
   770   C0205246:General [Spatial Concept]
   770   C1553889:General [Idea or Concept]
   770   C1706387:Issue [Intellectual Product]

Phrase: "whether"

Phrase: "treatments previously"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0087111:Treatments [Therapeutic or Preventive Procedure]
   827 E C0039798:treatment [Functional Concept]
   827 E C1522326:Treatment [Functional Concept]
   827 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   827 E C1705169:Treatment [Conceptual Entity]
   827 E C3538994:TREATMENT [Research Activity]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "generate"

Phrase: "SDS-resistant synuclein cross-links"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   840   C0332220:cross links [Functional Concept]
   823 E C0178576:Cross link [Natural Phenomenon or Process]
   804   C2828360:Cross [Conceptual Entity]
   771   C1517892:Link [Intellectual Product]
   771   C1704666:Link [Intellectual Product]

Phrase: "would"

Phrase: "also"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "synuclein filament formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]
Processing 00000000.tx.254: These include: DTT/iron,asdescribedabove,tTGase(48),whichcatalyzesthecalcium-dependent formation of an -(-glutamyl)lysine isopeptide bond between glutamine and lysine residues, polyunsaturated fatty acids, such as arachidonic acid (45) and docosahexaenoic acid (46) and their respective lipid peroxides, synthetic cross-linkers, such as DSP (59), and the pro-oxidant dopamine (72). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: ":"

Phrase: "DTT/iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "asdescribedabove,"

Phrase: "tTGase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(48"

Phrase: ")"

Phrase: ","

Phrase: "whichcatalyzesthecalcium-dependent formation of an -(-glutamyl"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: ")"

Phrase: "lysine isopeptide bond between glutamine"

Phrase: "and"

Phrase: "lysine residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "polyunsaturated fatty acids,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0032615:Polyunsaturated Fatty Acids [Biologically Active Substance,Lipid]
   901   C0015684:Fatty Acids [Lipid]
   827   C0001128:Acids [Chemical]
   793 E C0202406:Acid [Laboratory Procedure]

Phrase: "such as arachidonic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003695:Arachidonic Acid [Eicosanoid]
  1000   C2316832:Arachidonic Acid [Laboratory Procedure]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(45"

Phrase: ")"

Phrase: "and"

Phrase: "docosahexaenoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0012968:docosahexaenoic acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
  1000   C0556150:docosahexaenoic acid [Lipid,Pharmacologic Substance]
   861   C0001128:Acid [Chemical]
   861   C0202406:Acid [Laboratory Procedure]

Phrase: "(46"

Phrase: ")"

Phrase: "and"

Phrase: "their respective lipid peroxides,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0023776:Lipid Peroxides [Lipid]
   827   C0023779:Lipid [Lipid]
   827   C0031180:Peroxides [Inorganic Chemical]

Phrase: "synthetic cross-linkers,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2828360:Cross [Conceptual Entity]

Phrase: "such as DSP (59"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the pro-oxidant dopamine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]
   734   C0162772:Pro-oxidant [Biologically Active Substance,Element, Ion, or Isotope]

Phrase: "(72"

Phrase: ")."
Processing 00000000.tx.255: Filament formation was monitored by both thioflavin T fluorescence and by sedimentation analysis. 

Phrase: "Filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "monitored by both thioflavin T fluorescence"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0016315:Fluorescence [Natural Phenomenon or Process]
   753   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   719   C0030695:monitor [Health Care Activity]
   719   C0150369:monitor [Health Care Activity]
   719   C0181904:Monitor [Medical Device]
   719   C0596972:Monitor [Medical Device]
   719   C1521743:Monitor [Professional or Occupational Group]
   719   C1704646:Monitor [Manufactured Object]

Phrase: "and by sedimentation analysis."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0597428:Sedimentation [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1384604:Sedimentation [Natural Phenomenon or Process]
   770   C1515981:And [Idea or Concept]
   770   C1524024:analysis [Functional Concept]
Processing 00000000.tx.256: To eliminate the effects of nonspecific synuclein oxidation during long term (72 h) incubations, seeded reactions were used, which resulted in efficient filament formation in as little as 12 h. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "eliminate"

Phrase: "the effects of nonspecific synuclein oxidation"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "during long term"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0443252:Long-term [Temporal Concept]
   861   C0205166:Long [Qualitative Concept]
   861   C1515273:Term [Temporal Concept]
   861   C1705313:Term [Idea or Concept]
   861   C1706317:Long [Qualitative Concept]
   861   C2826302:TERM [Intellectual Product]

Phrase: "(72 h) incubations,"

Phrase: "seeded reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "which"

Phrase: "resulted in efficient filament formation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   760   C0010851:Filament [Cell Component]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C0442799:Efficient [Qualitative Concept]
   760   C1522492:Formation [Functional Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in"

Phrase: "as"

Phrase: "little as 12 h."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
   770   C0700321:Little [Quantitative Concept]
   770   C2700395:Little [Quantitative Concept]
Processing 00000000.tx.257: Compared with control reactions (Fig. 6, A and B, lanes 1 and 2), treatment with DTT/iron inhibited the formation of synuclein filaments (as previously shown in Fig. 3A), even when incubated with control seeds, and resulted in the production of oligomers that remained soluble during centrifugation (Fig. 6B, lanes 3 and 4). 

Phrase: "Compared with control reactions"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "treatment with DTT/iron"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the formation of synuclein filaments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "previously"

Phrase: "shown in Fig. 3A"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "even"

Phrase: "when"

Phrase: "incubated with control seeds,"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   770   C0036563:Seed [Plant]
   770   C0243148:control [Qualitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]
   770   C1550141:Control [Substance]
   770   C1705192:Seed [Laboratory Procedure]
   770   C1882540:{Seed} [Quantitative Concept]
   770   C1882979:Control [Conceptual Entity]
   770   C2346495:Seed [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]
   715 E C1519232:Seminal [Clinical Attribute]

Phrase: "and"

Phrase: "resulted in the production of oligomers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0033268:production [Occupational Activity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "that"

Phrase: "remained"

Phrase: "soluble during centrifugation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1749467:soluble [Cell Component]
   790   C1948047:Soluble [Qualitative Concept]

Phrase: "(Fig. 6B,"

Phrase: "lanes 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "4"

Phrase: ")."
Processing 00000000.tx.258: In the absence of Ca2+, tTGase had no effect on filament assembly or on the amount of synuclein pelleted by centrifugation, with only minor amounts of dimeric synuclein generated during the incubation, similar to control conditions (Fig. 6B, compare lanes 1 and 2 with 5 and 6). 

Phrase: "In the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "tTGase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "had"

Phrase: "no effect on filament assembly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "or on the amount of synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1265611:Amount [Quantitative Concept]

Phrase: "pelleted by centrifugation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0007703:Centrifugation [Laboratory Procedure]
   756   C0441436:Pellet [Manufactured Object]
   756   C0993610:Pellet [Biomedical or Dental Material]
   756   C1998480:Pellet [Quantitative Concept]

Phrase: "with only minor amounts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1265611:amounts [Quantitative Concept]

Phrase: "of dimeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "generated during the incubation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3146294:Generated [Activity]

Phrase: "similar to control conditions"
Meta Candidates (Total=17; Excluded=9; Pruned=0; Remaining=8)
   812   C0243148:control [Qualitative Concept]
   812   C1550141:Control [Substance]
   812   C1882979:Control [Conceptual Entity]
   812   C2587213:Control [Functional Concept]
   812   C3274648:Control [Qualitative Concept]
   779   C0012634:condition [Disease or Syndrome]
   779   C0348080:Condition [Qualitative Concept]
   779   C1705253:Condition [Conceptual Entity]
   756 E C0040607:Training [Educational Activity]
   756 E C0220931:Training [Educational Activity]
   756 E C0336809:Train [Manufactured Object]
   756 E C1552514:Train [Manufactured Object]
   756 E C2673163:training [Qualitative Concept]
   729 E C0009647:Conditioned [Mental Process]
   729 E C1701901:Conditional [Qualitative Concept]
   729 E C1963686:Conditional [Functional Concept]
   706 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(Fig. 6B,"

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "lanes 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "2 with 5"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   858   C0450346:2 5 [Quantitative Concept]
   790   C0740116:+2 [Quantitative Concept]
   790   C2827735:2+ [Quantitative Concept]
   790   C2981700:2+ [Classification]

Phrase: "and"

Phrase: "6"

Phrase: ")."
Processing 00000000.tx.259: However, in the presence of 5 mM Ca2+, fibril formation was blocked, and oligomeric forms of synuclein were generated, but remained soluble (Fig. 6B, lanes 7 and 8). 

Phrase: "However,"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of 5 mM Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "was"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: ","

Phrase: "and"

Phrase: "oligomeric forms of synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: ","

Phrase: "but"

Phrase: "remained soluble"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1749467:soluble [Cell Component]
   861   C1948047:Soluble [Qualitative Concept]

Phrase: "(Fig. 6B,"

Phrase: "lanes 7"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "8"

Phrase: ")."
Processing 00000000.tx.260: Interestingly, Ca2+ alone stimulated fibril formation over control conditions (Fig. 6A), presumably because of an enhanced seeding effect of calcium phosphate crystals (see "Experimental Procedures"). 

Phrase: "Interestingly,"

Phrase: "Ca2+ alone stimulated fibril formation over control conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "presumably because of an enhanced seeding effect of calcium phosphate crystals"
Meta Candidates (Total=26; Excluded=4; Pruned=0; Remaining=22)
   775   C0368819:Calcium phosphate crystals [Pharmacologic Substance]
   775   C2698962:Calcium Phosphate Crystals [Laboratory Procedure]
   756   C0006711:calcium phosphate [Inorganic Chemical,Pharmacologic Substance]
   756   C0006712:Calcium/Phosphate [Inorganic Chemical,Pharmacologic Substance]
   756   C0427910:Phosphate crystals [Laboratory or Test Result]
   756   C1161320:calcium phosphate [Pharmacologic Substance]
   754   C1979660:Calcium crystals [Organic Chemical]
   738   C0006675:Calcium [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   738   C0006726:Calcium [Inorganic Chemical]
   738   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   738   C0031701:phosphate [Organophosphorus Compound]
   738   C0427896:Crystals [Body Substance]
   738   C0444626:Crystals [Chemical Viewed Structurally]
   738   C1280500:Effect [Qualitative Concept]
   738   C1378554:Crystals [Biomedical or Dental Material]
   738   C1533132:Crystals [Body Substance]
   738   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
   738   C1705192:Seeding [Laboratory Procedure]
   738   C2348382:Effect [Qualitative Concept]
   738   C2349975:Enhanced [Activity]
   738   C2699477:Crystals [Laboratory Procedure]
   738   C2936886:Calcium [Pharmacologic Substance]
   704 E C0036563:Seed [Plant]
   704 E C1704641:Crystal [Manufactured Object]
   704 E C1882540:{Seed} [Quantitative Concept]
   704 E C2346495:Seed [Conceptual Entity]

Phrase: "(see ""Experimental Procedures"""
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0025664:procedures [Intellectual Product]
   827   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   827   C2700391:procedures [Activity]
   793 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   793 E C3274430:PROCEDURE [Health Care Activity]
   793 E C3538935:Procedure [Idea or Concept]
   793 E C3539779:Procedure [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.261: Incubation in the presence of docosahexaenoic acid resulted in a moderate decrease in fibril assembly and a concomitant increase in formation of soluble oligomers (Fig. 6B, lanes 9 and 10). 

Phrase: "Incubation in the presence of docosahexaenoic acid"

Phrase: "resulted in a moderate decrease"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0205081:Moderate [Qualitative Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C1881878:Moderate [Qualitative Concept]
   726   C1274040:Result [Functional Concept]
   726   C1546471:Result [Idea or Concept]
   726   C2825142:Result [Finding]

Phrase: "in fibril assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "and"

Phrase: "a concomitant increase in formation of soluble oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0442805:Increase [Functional Concept]

Phrase: "(Fig. 6B,"

Phrase: "lanes 9"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "10"

Phrase: ")."
Processing 00000000.tx.262: Enzymatically generated docosahexaenoic acid lipid peroxides enhanced this effect, completely disrupting filament formation (Fig. 6A) while inducing formation of almost exclusively soluble oligomers (Fig. 6B, lanes 11 and 12). 

Phrase: "Enzymatically"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "docosahexaenoic acid lipid peroxides"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   906   C0058621:docosahexaenoic acid peroxide [Lipid]
   861   C0023776:Lipid Peroxides [Lipid]
   812   C0023779:Lipid [Lipid]
   812   C0031180:Peroxides [Inorganic Chemical]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "this effect,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "disrupting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332454:disrupting [Qualitative Concept]

Phrase: "filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 6A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553638:6a [Medical Device]

Phrase: ")"

Phrase: "while"

Phrase: "inducing formation of almost exclusively soluble oligomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 6B,"

Phrase: "lanes 11"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "12"

Phrase: ")."
Processing 00000000.tx.263: Similar results were observed with arachidonic acid, although higher concentrations of lipid peroxide were required (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "observed with arachidonic acid,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0003695:Arachidonic Acid [Eicosanoid]
   833   C2316832:Arachidonic Acid [Laboratory Procedure]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1441672:Observed [Functional Concept]

Phrase: "although"

Phrase: "higher concentrations of lipid peroxide"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "were"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.264: Thus, the oxidation of polyunsaturated fatty acids dramatically enhance synuclein cross-linking, which is likely because of the formation of reactive aldehydes derived from lipid peroxide decomposition (80) (see "Discussion"). 

Phrase: "Thus,"

Phrase: "the oxidation of polyunsaturated fatty acids dramatically"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   886   C2984156:Oxidation of Polyunsaturated Fatty Acid [Functional Concept]
   800   C1158366:acids fatty oxidation [Molecular Function]
   748   C0030011:Oxidation [Molecular Function]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: ","

Phrase: "which"

Phrase: "is"

Phrase: "likely because of the formation of reactive aldehydes"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   750   C1156548:aldehyde formation [Molecular Function]
   744   C0001992:Aldehydes [Organic Chemical]
   744   C0205332:Reactive [Qualitative Concept]
   744   C0220781:formation [Biologic Function]
   744   C0332148:Likely [Qualitative Concept]
   744   C0439634:formation [Spatial Concept]
   744   C0750492:Likely [Idea or Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "derived from lipid peroxide decomposition"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0023776:lipid peroxide [Lipid]
   760   C0023779:Lipid [Lipid]
   760   C0031180:Peroxide [Inorganic Chemical]
   760   C1441547:Derived [Qualitative Concept]
   760   C3245521:derived [Idea or Concept]

Phrase: "(80"

Phrase: ")"

Phrase: "(see ""Discussion"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: ")."
Processing 00000000.tx.265: The lysine-directed cross-linking agent DSP and the oxidant dopamine both inhibited fibril formation and resulted in the formation of mostly soluble oligomers (Fig. 6B, lanes 13 and 14 and 15 and 16, respectively). 

Phrase: "The lysine-directed cross-linking agent DSP"

Phrase: "and"

Phrase: "the oxidant dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "both"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "resulted in the formation of mostly soluble oligomers"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C0750554:mostly [Idea or Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1749467:soluble [Cell Component]
   744   C1948047:Soluble [Qualitative Concept]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "(Fig. 6B,"

Phrase: "lanes 13"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1708639:Lane [Spatial Concept]

Phrase: "and"

Phrase: "14"

Phrase: "and"

Phrase: "15"

Phrase: "and"

Phrase: "16,"

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.266: Thus, both enzymatic (e.g. tTGase) and oxidative (DTT/iron, lipid peroxidation, dopamine) processes, as well as synthetic cross-linking reagents (e.g. DSP) inhibit synuclein filament formation by forming covalently associated soluble synuclein oligomers. 

Phrase: "Thus,"

Phrase: "both enzymatic"

Phrase: "("

Phrase: "e.g. tTGase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "oxidative"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0311404:Oxidative [Functional Concept]

Phrase: "(DTT/iron,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   861   C0376520:Iron [Inorganic Chemical]
   861   C1166521:iron [Pharmacologic Substance]

Phrase: "lipid peroxidation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "processes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1184743:Process [Body Part, Organ, or Organ Component]
   966   C1522240:Process [Phenomenon or Process]

Phrase: "as well as"

Phrase: "synthetic cross-linking reagents"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   923   C0010360:Cross-Linking Reagents [Indicator, Reagent, or Diagnostic Aid]
   861   C0332220:Cross-linking [Functional Concept]
   844 E C0178576:Cross link [Natural Phenomenon or Process]
   812   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]
   812   C2828360:Cross [Conceptual Entity]
   779   C1517892:Link [Intellectual Product]
   779   C1704666:Link [Intellectual Product]

Phrase: "("

Phrase: "e.g. DSP)"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "synuclein filament formation by forming covalently"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "soluble synuclein oligomers."
Processing 00000000.tx.267: View larger version (42K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.268: 6. 

Phrase: "6."
Processing 00000000.tx.269: Synuclein cross-linking under various conditions. 

Phrase: "Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cross-linking under various conditions."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   806   C0332220:Cross-linking [Functional Concept]
   790 E C0178576:Cross link [Natural Phenomenon or Process]
   760   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   760   C2828360:Cross [Conceptual Entity]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]
   726   C1705253:Condition [Conceptual Entity]
Processing 00000000.tx.270: A and B, seeded reactions were incubated for 18 h at 37 C in PBS with no additions or in the presence of 10 mM DTT/50 M Fe(III), tTGase (50 nM) without or with 5 mM Ca2+, 5 mM Ca2+ alone, docosahexaenoic acid (DHA, 200 M), docosahexaenoic acid peroxide (DHA perox, 200 M), DSP (500 M), and dopamine (200 M). 

Phrase: "A"

Phrase: "and"

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "seeded reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "incubated for 18 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1720830:PBS [Disease or Syndrome]
   812   C1823521:PBS [Gene or Genome]

Phrase: "with no additions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1883712:Addition [Functional Concept]
   916 E C1524062:Additional [Functional Concept]

Phrase: "or in the presence of 10 mM DTT/50 M Fe(III"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   751   C3501774:III-10 [Organic Chemical,Pharmacologic Substance]
   736   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   736   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   736   C0392148:Presence [Therapeutic or Preventive Procedure]
   736   C0439070:III [Intellectual Product]
   736   C0441923:M+ [Intellectual Product]
   736   C1705160:III [Qualitative Concept]
   736   C2346593:Fe+++ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: ","

Phrase: "tTGase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(50 nM) without"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0312860:NM [Cell Function]

Phrase: "or with 5 mM Ca2+,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596235:Ca2+ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "5 mM Ca2+ alone, docosahexaenoic acid"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0012968:docosahexaenoic acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   827   C0556150:docosahexaenoic acid [Lipid,Pharmacologic Substance]
   799   C0001128:Acid [Chemical]
   799   C0202406:Acid [Laboratory Procedure]

Phrase: "(DHA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0142831:dha's [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
  1000   C2348308:DHA [Lipid,Pharmacologic Substance]

Phrase: "200"

Phrase: "M)"

Phrase: ","

Phrase: "docosahexaenoic acid peroxide"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0058621:docosahexaenoic acid peroxide [Lipid]
   827   C0031180:Peroxide [Inorganic Chemical]
   734   C0012968:docosahexaenoic acid [Biologically Active Substance,Lipid,Pharmacologic Substance]
   734   C0556150:docosahexaenoic acid [Lipid,Pharmacologic Substance]

Phrase: "(DHA perox,"

Phrase: "200"

Phrase: "M)"

Phrase: ","

Phrase: "DSP (500"

Phrase: "M)"

Phrase: ","

Phrase: "and"

Phrase: "dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "(200"

Phrase: "M)."
Processing 00000000.tx.271: A, filament formation as detected by thioflavin T fluorescence as in Fig. 

Phrase: "A,"

Phrase: "filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "detected by thioflavin T fluorescence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.272: 3. 

Phrase: "3."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]
Processing 00000000.tx.273: B, sedimentation analysis from samples in A. 

Phrase: "B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "sedimentation analysis from samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1303103:Sample analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in A."
Processing 00000000.tx.274: C and D, seeded reactions were incubated for 18 h at 37 C in PBS with no additions or in the presence of 300 M H2O2 alone or with 500 M exogenous Cu(II) or Fe(III). 

Phrase: "C"

Phrase: "and"

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "seeded reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "were"

Phrase: "incubated for 18 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C1439852:Incubated [Laboratory Procedure]

Phrase: "at 37 C in PBS"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C1720830:PBS [Disease or Syndrome]
   812   C1823521:PBS [Gene or Genome]

Phrase: "with no additions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C1883712:Addition [Functional Concept]
   916 E C1524062:Additional [Functional Concept]

Phrase: "or in the presence of 300 M H2O2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   744   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C0441923:M+ [Intellectual Product]

Phrase: "alone"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205171:Alone [Quantitative Concept]
  1000   C0439044:alone [Finding]
  1000   C0679994:alone [Group Attribute]

Phrase: "or with 500 M exogenous Cu(II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0205101:Exogenous [Spatial Concept]
   748   C0205228:Exogenous [Functional Concept]
   748   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0441923:M+ [Intellectual Product]
   748   C1177210:Cu++ [Inorganic Chemical,Pharmacologic Substance]
   748   C2347872:Cu+ [Element, Ion, or Isotope]

Phrase: ")"

Phrase: "or"

Phrase: "Fe(III"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439070:III [Intellectual Product]
   861   C1705160:III [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.275: C, filament formation as detected by thioflavin T fluorescence. 

Phrase: "C,"

Phrase: "filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "detected by thioflavin T fluorescence."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C0016315:Fluorescence [Natural Phenomenon or Process]
   760   C0442726:Detected [Finding]
   760   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
Processing 00000000.tx.276: D, sedimentation analysis from samples in C. 

Phrase: "D,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0073187:D NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "sedimentation analysis from samples"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   802   C1303103:Sample analysis [Laboratory Procedure]
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]

Phrase: "in C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]
Processing 00000000.tx.277: Incubations were fractionated and processed as in Fig. 

Phrase: "Incubations"

Phrase: "were"

Phrase: "fractionated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979893:Fractionated [Qualitative Concept]

Phrase: "and"

Phrase: "processed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1522240:Processed [Phenomenon or Process]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]

Phrase: "as in Fig."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
Processing 00000000.tx.278: 5.  

Phrase: "5."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]
Processing 00000000.tx.279: Finally, it has been reported that although both nitrative and oxidative stresses resulted in the production of synuclein oligomers, only nitrative stress induced by peroxynitrite treatment prevented filament formation (42). 

Phrase: "Finally,"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "although"

Phrase: "both nitrative"

Phrase: "and"

Phrase: "oxidative stresses"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0242606:Stresses, Oxidative [Cell or Molecular Dysfunction]
   861   C0311404:Oxidative [Functional Concept]
   827   C0038435:Stress [Finding]
   777 E C0231297:Stressful [Functional Concept]

Phrase: "resulted in the production of synuclein oligomers,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0033268:production [Occupational Activity]
   748   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   714   C1274040:Result [Functional Concept]
   714   C1546471:Result [Idea or Concept]
   714   C2825142:Result [Finding]

Phrase: "only nitrative"

Phrase: "stress induced by peroxynitrite treatment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0038435:Stress [Finding]
   760   C0205263:Induced [Functional Concept]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.280: Consistent with this, we also observed that peroxynitrite treatment induced the formation of soluble synuclein oligomers and prevented filament formation (data not shown). 

Phrase: "Consistent with this,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "we also"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that peroxynitrite treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]

Phrase: "induced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induced [Functional Concept]

Phrase: "the formation of soluble synuclein oligomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "prevented filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.281: However, in contrast to previous results (42), we found that treatment with 0.5 mM Cu(II) and 0.3 mM hydrogen peroxide prevented formation of synuclein filaments (Fig. 6C) and resulted in generation of soluble oligomers (Fig. 6D). 

Phrase: "However,"

Phrase: "in contrast to previous results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that treatment with 0.5 mM Cu(II"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "0.3 mM hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0020275:Hydrogen [Element, Ion, or Isotope]
   804   C0031180:Peroxide [Inorganic Chemical]
   804   C0523702:HYDROGEN [Laboratory Procedure]
   804   C0885426:hydrogen [Inorganic Chemical]

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "formation of synuclein filaments"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 6C"

Phrase: ")"

Phrase: "and"

Phrase: "resulted in generation of soluble oligomers"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0079411:Generation [Temporal Concept]
   753   C1749467:soluble [Cell Component]
   753   C1948047:Soluble [Qualitative Concept]
   753   C3146294:Generation [Activity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "(Fig. 6D"

Phrase: ")."
Processing 00000000.tx.282: However, treatment with the same concentrations of Fe(III) and hydrogen peroxide failed to prevent filaments from forming and did not result in synuclein oligomerization (Fig. 6, C and D). 

Phrase: "However,"

Phrase: "treatment with the same concentrations of Fe(III"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0039798:treatment [Functional Concept]
   744   C0087111:Treatment [Therapeutic or Preventive Procedure]
   744   C1522326:Treatment [Functional Concept]
   744   C1533734:Treatment [Therapeutic or Preventive Procedure]
   744   C1705169:Treatment [Conceptual Entity]
   744   C3538994:TREATMENT [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "filaments from forming"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   756   C0010851:Filament [Cell Component]
   706 E C1979891:Filamentous [Qualitative Concept]

Phrase: "and"

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in synuclein oligomerization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.283: Effects of Oxidized Synuclein on the 20 S ProteasomeIt has previously been demonstrated that non-ubiquitinylated monomeric synuclein is effectively degraded by purified 20 S proteasomal particles (81). 

Phrase: "Effects of Oxidized Synuclein"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "on the 20 S ProteasomeIt"

Phrase: "has"

Phrase: "previously"

Phrase: "been"

Phrase: "demonstrated"

Phrase: "that non-ubiquitinylated monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "effectively"

Phrase: "degraded by purified 20 S proteasomal particles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0597177:particles [Chemical Viewed Structurally]
   748   C1881707:DEGRADED [Phenomenon or Process]
   748   C1998793:Purified [Functional Concept]

Phrase: "(81"

Phrase: ")."
Processing 00000000.tx.284: The lack of a requirement for the unfolding activity of the 19 S cap is likely a consequence of the already natively unfolded structure of synuclein (75). 

Phrase: "The lack of a requirement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332268:lack [Qualitative Concept]

Phrase: "for the unfolding activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "of the 19 S cap"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0179586:Cap [Manufactured Object]
   827   C1657858:CAP [Medical Device]
   827   C1706092:Cap [Medical Device]

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "a consequence of the already natively unfolded structure of synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "(75"

Phrase: ")."
Processing 00000000.tx.285: More recently, using fluorogenic peptides as substrates, it has been reported that high concentrations of monomeric as well as significantly lower concentration of amyloid-containing synuclein filaments and oligomers inhibit purified 20 S proteasomes in vitro (54, 55). 

Phrase: "More recently,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205172:More [Functional Concept]
   861   C0332185:Recently [Temporal Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorogenic peptides as substrates,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that high concentrations of monomeric"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0086045:Concentrations [Mental Process]
   726 E C1446561:Concentration [Quantitative Concept]

Phrase: "as well as"

Phrase: "significantly lower concentration of amyloid-containing synuclein filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0086045:Concentration [Mental Process]
   744   C1446561:Concentration [Quantitative Concept]

Phrase: "and"

Phrase: "oligomers"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "20 S proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C1325620:proteasome [Cell Component]
   793 E C1752727:Proteasome [Molecular Function]

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.286: Given the role of DTT/iron in enhancing the oligomerization of synuclein, we asked if these oxidized synuclein species would be efficiently degraded by the proteasome. 

Phrase: "Given"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1442162:GIVEN [Conceptual Entity]
  1000   C1550718:given [Idea or Concept]
  1000   C3244317:given [Intellectual Product]
   966 E C1947971:Give [Functional Concept]

Phrase: "the role of DTT/iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "the oligomerization of synuclein,"

Phrase: "we"

Phrase: "asked"

Phrase: "if"

Phrase: "these oxidized synuclein species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "would"

Phrase: "be"

Phrase: "efficiently"

Phrase: "degraded by the proteasome."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   770   C1325620:proteasome [Cell Component]
   770   C1752727:Proteasome [Molecular Function]
   770   C1881707:DEGRADED [Phenomenon or Process]
Processing 00000000.tx.287: As shown in Fig. 

Phrase: "As"

Phrase: "shown in Fig."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0349966:Fig [Food]
   790   C1337208:FIG [Food]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.288: 7, monomeric synuclein was effectively degraded in a proteasome-dependent manner, as reported (81), which could be blocked in the presence of the inhibitor MG132. 

Phrase: "7,"

Phrase: "monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "was"

Phrase: "effectively"

Phrase: "degraded in a proteasome-dependent manner,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1325620:proteasome [Cell Component]
   753   C1701901:Dependent [Qualitative Concept]
   753   C1752727:Proteasome [Molecular Function]
   753   C1881707:DEGRADED [Phenomenon or Process]
   753   C3244310:dependent [Functional Concept]

Phrase: "as"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "(81"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "could"

Phrase: "be"

Phrase: "blocked in the presence of the inhibitor MG132."
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   744   C0028778:Blocked [Pathologic Function]
   744   C0246694:MG132 [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0332206:Blocked [Functional Concept]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1999216:Inhibitor [Qualitative Concept]
   744   C2983591:BLOCKED [Research Activity]
   711 E C1533157:Block [Substance]
   711 E C1706084:Block [Geographic Area]
   711 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.289: In contrast, the degradation of oxidized oligomeric synuclein was almost completely prevented. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "the degradation of oxidized oligomeric synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0243125:degradation [Functional Concept]
   753   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "almost completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205197:Completely [Qualitative Concept]

Phrase: "prevented."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]
Processing 00000000.tx.290: Interestingly, degradation of the monomeric component of this oxidized mixture was also blocked (Fig. 7). 

Phrase: "Interestingly,"

Phrase: "degradation of the monomeric component of this oxidized mixture"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]

Phrase: "was"

Phrase: "also"

Phrase: "blocked"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0028778:Blocked [Pathologic Function]
  1000   C0332206:Blocked [Functional Concept]
  1000   C2983591:BLOCKED [Research Activity]
   966 E C1533157:Block [Substance]
   966 E C1706084:Block [Geographic Area]
   966 E C2828370:Block [Quantitative Concept]

Phrase: "(Fig. 7"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.291: These results are consistent with previous reports that oligomeric synuclein inhibits the activity of the proteasome (54, 55). 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are"

Phrase: "consistent with previous"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "reports"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0684224:Report [Intellectual Product]
  1000   C0700287:Report [Health Care Activity]
  1000   C3273238:Report [Intellectual Product]

Phrase: "that oligomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the activity of the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   797   C1622946:proteasome activity [Molecular Function]
   760   C0205177:Activity [Functional Concept]
   760   C0439167:% activity [Quantitative Concept]
   760   C0441655:Activity [Activity]
   760   C1561536:*Activity [Idea or Concept]

Phrase: "(54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.292: However, when the activities of the 20 S proteasome were assayed by the hydrolysis of fluorogenic peptides, no significant differences were observed between untreated and oxidized synuclein, except for a minor, increase in the trypsin-like activity in the presence of oxidized synuclein (Table I). 

Phrase: "However,"

Phrase: "when"

Phrase: "the activities of the 20 S proteasome"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   757   C1622946:proteasome activity [Molecular Function]
   748   C0441655:Activities [Activity]
   714 E C0205177:Activity [Functional Concept]
   714 E C0439167:% activity [Quantitative Concept]
   714 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "assayed by the hydrolysis of fluorogenic peptides,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0020291:Hydrolysis [Natural Phenomenon or Process]
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "no significant differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1705241:*Difference [Quantitative Concept]
   827   C1705242:Difference [Qualitative Concept]
   777 E C0443199:Differential [Qualitative Concept]

Phrase: "were"

Phrase: "observed between untreated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0332155:untreated [Finding]
   790   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "oxidized synuclein,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "except for a minor, increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0442805:Increase [Functional Concept]

Phrase: "in the trypsin-like activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1150284:trypsin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of oxidized synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.293: We did find, however, that both monomeric and oxidized synuclein inhibited the glutamyl-peptidase-hydrolyzing activity by 45%. 

Phrase: "We"

Phrase: "did"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: ","

Phrase: "however,"

Phrase: "that"

Phrase: "both monomeric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "and"

Phrase: "oxidized synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "the glutamyl-peptidase-hydrolyzing activity by 45%."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   774   C1150095:peptidase activity [Molecular Function]
   748   C0205177:Activity [Functional Concept]
   748   C0439167:% activity [Quantitative Concept]
   748   C0441655:Activity [Activity]
   748   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.294: Therefore, the failure to specifically degrade oxidized synuclein is not likely a result of active site inhibition but may reflect structural alterations that render oxidized/oligomerized synuclein inaccessible to the 20 S catalytic subunits (see "Discussion"). 

Phrase: "Therefore,"

Phrase: "the failure to specifically"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231174:Failure [Functional Concept]
   770   C0680095:failure [Individual Behavior]

Phrase: "degrade"

Phrase: "oxidized synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "not likely"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]
   861   C1518422:Not [Functional Concept]

Phrase: "a result of active site inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C2825142:Result [Finding]

Phrase: "but"

Phrase: "may"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "structural alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "that"

Phrase: "render"

Phrase: "oxidized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0030011:oxidize [Molecular Function]

Phrase: "/oligomerized synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inaccessible to the 20 S catalytic subunits"

Phrase: "(see ""Discussion"""
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557061:Discussion [Therapeutic or Preventive Procedure]
   861   C2584313:Discussion [Social Behavior]

Phrase: ")."
Processing 00000000.tx.295: View this table: [in this window] [in a new window]  TABLE I Effects of monomeric and oligomeric synuclein on 20 S proteasome activities Chymotrypsin-like, glutamyl-like, and trypsin-like activities of the 20 S proteasome were determined in the presence or absence of untreated synuclein or synuclein oxidized with DTT/iron. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  TABLE I Effects of monomeric"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "oligomeric synuclein on 20 S proteasome activities Chymotrypsin-like, glutamyl-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "like,"

Phrase: "and"

Phrase: "trypsin-like activities of the 20 S proteasome"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   750   C1150284:trypsin activity [Molecular Function]
   750   C1622946:proteasome activity [Molecular Function]
   744   C0441655:Activities [Activity]
   711 E C0205177:Activity [Functional Concept]
   711 E C0439167:% activity [Quantitative Concept]
   711 E C1561536:*Activity [Idea or Concept]

Phrase: "were"

Phrase: "determined in the presence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "absence of untreated synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "or"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "oxidized with DTT/iron."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]
   737   C0030011:oxidize [Molecular Function]
Processing 00000000.tx.296: Assays were carried out as described under "Experimental Procedures." 

Phrase: "Assays"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "were"

Phrase: "carried"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:carried [Activity]
  1000   C0699809:carried [Finding]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "as"

Phrase: "described under ""Experimental Procedures."""
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   770   C0025664:procedures [Intellectual Product]
   770   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   770   C1517586:Experimental [Qualitative Concept]
   770   C1552738:described [Idea or Concept]
   770   C2700391:procedures [Activity]
   737 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   737 E C3274430:PROCEDURE [Health Care Activity]
   737 E C3538935:Procedure [Idea or Concept]
   737 E C3539779:Procedure [Intellectual Product]
Processing 00000000.tx.297: The data show the percent inhibition of the indicated proteasomal activities in the presence of synuclein and represent the average  S.E. of two independent experiments repeated in quadruplicate.   

Phrase: "The data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "the percent inhibition of the indicated proteasomal activities"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C1628982:Percent inhibition [Quantitative Concept]
           % inhibition
   744   C0021467:Inhibition [Mental Process]
   744   C0021469:Inhibition [Molecular Function]
   744   C3463820:Inhibition [Activity]
   731   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "and"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the average"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1510992:Average [Quantitative Concept]
  1000   C2825518:AVERAGE [Quantitative Concept]

Phrase: "S."

Phrase: "E."

Phrase: "of two independent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "repeated in quadruplicate."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0205175:Quadruplicate [Quantitative Concept]
   790   C0205341:Repeated [Functional Concept]
   756 E C1547730:Repeat [Temporal Concept]
   756 E C1705914:Repeat [Conceptual Entity]
Processing 00000000.tx.298: DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  The role of oxidation in the pathogenesis of PD and more specifically in the relationship of -synuclein oxidation to pathology remains unclear. 

Phrase: "DISCUSSION TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "The role of oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0035820:Role [Social Behavior]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in the pathogenesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0543483:pathogenesis [Functional Concept]
  1000   C0699748:Pathogenesis [Pathologic Function]

Phrase: "of PD"

Phrase: "and"

Phrase: "more specifically in the relationship of -synuclein oxidation"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0030011:Oxidation [Molecular Function]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205172:More [Functional Concept]
   744   C0439849:Relationship [Qualitative Concept]
   744   C1705630:Relationship [Idea or Concept]
   744   C1706279:Relationship [Idea or Concept]
   744   C3540605:Relationship [Intellectual Product]

Phrase: "to pathology"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0030664:Pathology [Biomedical Occupation or Discipline]
  1000   C0205469:pathology [Functional Concept]
  1000   C0677042:pathology [Pathologic Function]
   928 E C1521733:Pathologic [Functional Concept]

Phrase: "remains"

Phrase: "unclear."
Processing 00000000.tx.299: In this paper, we sought to improve our understanding of the biochemical transitions of -synuclein under oxidizing conditions, so that a more defined role for synuclein oxidation in neuronal degeneration may be developed. 

Phrase: "In this paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "we"

Phrase: "sought"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "improve"

Phrase: "our understanding of the biochemical transitions of -synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0162340:Understanding [Mental Process]

Phrase: "under oxidizing conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "that"

Phrase: "a more defined role for synuclein oxidation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "in neuronal degeneration"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   964   C0027746:Neuron Degeneration [Cell or Molecular Dysfunction]
   861   C0011164:Degeneration [Pathologic Function]
   861   C1880269:Degeneration [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "developed."
Processing 00000000.tx.300: We find that in the presence of the reducing agent DTT, the MCO and oligomerization of synuclein is dramatically stimulated when compared with previously used MCO systems. 

Phrase: "We"

Phrase: "find"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0243095:Find [Finding]

Phrase: "that in the presence of the reducing agent DTT,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   764   C0376446:reducing agent [Indicator, Reagent, or Diagnostic Aid]
   742   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]
   742   C0392148:Presence [Therapeutic or Preventive Procedure]
   742   C0392756:Reducing [Qualitative Concept]
   742   C0450442:Agent [Chemical Viewed Functionally]
   742   C1254351:Agent [Pharmacologic Substance]
   742   C1521826:Agent [Intellectual Product]

Phrase: "the MCO"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0025552:Metal [Inorganic Chemical]
   812   C0030011:Oxidation [Molecular Function]
   741 E C2986473:Metallic [Qualitative Concept]

Phrase: "and"

Phrase: "oligomerization of synuclein"

Phrase: "is"

Phrase: "dramatically"

Phrase: "stimulated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1948023:Stimulated [Natural Phenomenon or Process]

Phrase: "when"

Phrase: "compared with previously used MCO systems."
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   745   C0026339:Model System [Intellectual Product,Research Device]
   745   C3161035:Model System [Intellectual Product]
           Model
   742   C0025552:Metal [Inorganic Chemical]
   742   C0030011:Oxidation [Molecular Function]
   742   C1273517:used [Finding]
   742   C1707455:Compared [Activity]
   708   C0449913:System [Functional Concept]
   708   C1553451:System [Manufactured Object]
   708   C1704459:System [Medical Device]
Processing 00000000.tx.301: This is thought to occur by recycling of oxidized metal ions into their redox active forms with subsequent catalytic activation of molecular oxygen (57). 

Phrase: "This"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur by recycling of oxidized metal ions"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0022023:Ions [Element, Ion, or Isotope]
   748   C0025552:Metal [Inorganic Chemical]
   748   C0282114:Recycling [Human-caused Phenomenon or Process]
   748   C1709305:Occur [Activity]
   748   C2745955:OCCUR [Temporal Concept]
   714   C0030011:oxidize [Molecular Function]
   714 E C1700702:ION [Functional Concept]

Phrase: "into their redox active forms"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0348078:forms [Qualitative Concept]
   827   C0376315:Forms [Manufactured Object]
   793 E C1522492:Form [Functional Concept]

Phrase: "with subsequent catalytic activation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1879547:Activation [Activity]

Phrase: "of molecular oxygen"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302920:Molecular oxygen [Element, Ion, or Isotope]
   861   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1521991:Molecular [Qualitative Concept]
   789 E C0567416:Molecule [Substance]

Phrase: "(57"

Phrase: ")."
Processing 00000000.tx.302: Although DTT itself is not physiologically relevant, abundant intracellular reductants (e.g. ascorbate, reduced flavin and pyridine nucleotides, and low molecular weight thiol-containing compounds, including metabolites of glutathione) have the capacity to reduce iron to its ferrous form under control and pathological conditions (8286). 

Phrase: "Although"

Phrase: "DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "itself"

Phrase: "is"

Phrase: "not physiologically relevant, abundant intracellular reductants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   799   C0376446:Reductants [Indicator, Reagent, or Diagnostic Aid]

Phrase: "("

Phrase: "e.g. ascorbate,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0178487:Ascorbate [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "reduced flavin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016213:flavin [Organic Chemical]
   861   C0062166:flavin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   861   C1572731:FLAVINE [Organic Chemical]

Phrase: "and"

Phrase: "pyridine nucleotides,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0597331:pyridine nucleotide [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0028630:Nucleotides [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0034251:pyridine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0034255:Pyridine [Organic Chemical]

Phrase: "and"

Phrase: "low molecular weight thiol-containing compounds,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C0205198:Compound [Qualitative Concept]
   766   C1706082:Compound [Chemical]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "metabolites of glutathione"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0870883:Metabolites [Biologically Active Substance]
   790   C2698672:METABOLITES [Regulation or Law]

Phrase: ")"

Phrase: "have"

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "reduce"

Phrase: "iron to its ferrous form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   760   C0376520:Iron [Inorganic Chemical]
   760   C1166521:iron [Pharmacologic Substance]

Phrase: "under control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "and"

Phrase: "pathological conditions"
Meta Candidates (Total=16; Excluded=11; Pruned=0; Remaining=5)
   861   C0030664:Pathological [Biomedical Occupation or Discipline]
   861   C1521733:Pathological [Functional Concept]
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   805 E C0040607:Training [Educational Activity]
   805 E C0220931:Training [Educational Activity]
   805 E C0336809:Train [Manufactured Object]
   805 E C1552514:Train [Manufactured Object]
   805 E C2673163:training [Qualitative Concept]
   789 E C0205469:pathology [Functional Concept]
   789 E C0677042:pathology [Pathologic Function]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "(8286"

Phrase: ")."
Processing 00000000.tx.303: As such, reduced forms of transition metals play an integral role in the generation of highly reactive "oxyradicals" capable of oxidizing biomolecules such as proteins, lipids, and DNA (69, 71). 

Phrase: "As"

Phrase: "such,"

Phrase: "reduced forms of transition metals"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "an integral role in the generation of highly reactive ""oxyradicals"" capable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C0035820:Role [Social Behavior]
   738   C1705810:Role [Conceptual Entity]

Phrase: "of oxidizing biomolecules"

Phrase: "such as proteins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "lipids,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023779:Lipids [Lipid]

Phrase: "and"

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "(69,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: "71"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450389:71 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.304: In the presence of iron and DTT synuclein filaments are not generated. 

Phrase: "In the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "and"

Phrase: "DTT synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0010851:Filament [Cell Component]
   743 E C1979891:Filamentous [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "generated."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]
Processing 00000000.tx.305: Instead, small, curvilinear as well as larger interconnected networks are formed, with occasional annular structures observed, similar to those described by Lansbury and colleagues (74). 

Phrase: "Instead,"

Phrase: "small,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "curvilinear"

Phrase: "as well as"

Phrase: "larger interconnected networks"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1882071:networks [Conceptual Entity]
   793 E C1513822:Network [Professional or Occupational Group]
   793 E C1705739:Network [Manufactured Object]

Phrase: "are"

Phrase: "formed"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0205431:Formed [Functional Concept]
   966 E C0348078:Form [Qualitative Concept]
   966 E C0376315:Form [Manufactured Object]
   966 E C1522492:Form [Functional Concept]

Phrase: ","

Phrase: "with occasional annular structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "similar to those"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "described by Lansbury"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(74"

Phrase: ")."
Processing 00000000.tx.306: These oxidized structures do not effectively bind thioflavin T (Fig. 3) and, as such, are not amyloid yet likely contain the sheet structure, as determined by far-UV CD spectroscopy. 

Phrase: "These oxidized structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "do"

Phrase: "not effectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "bind"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1145667:Bind [Activity]
  1000   C1167622:bind [Molecular Function]

Phrase: "thioflavin T (Fig. 3"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C0349966:Fig [Food]
   812   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   812   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: ","

Phrase: "as"

Phrase: "such,"

Phrase: "are"

Phrase: "not amyloid yet likely"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   812   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0011560:Amyloid [Pathologic Function]
   812   C0332148:Likely [Qualitative Concept]
   812   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0750492:Likely [Idea or Concept]
   812   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "the sheet structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "as"

Phrase: "determined by far-UV CD spectroscopy."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0037812:spectroscopy [Laboratory Procedure]
   753   C0041625:UV [Natural Phenomenon or Process]
   753   C0205108:far [Spatial Concept]
   753   C1961129:uV [Quantitative Concept]
   753   C2713504:Spectroscopy [Occupation or Discipline]
   753   C2984732:SPECTROSCOPY [Functional Concept]
Processing 00000000.tx.307: Bis-ANS (or ANS) binding is also not observed, demonstrating that extensive hydrophobic patches are not exposed during oxidation/oligomerization. 

Phrase: "Bis-ANS ("
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0048876:bis-ANS [Organic Chemical,Pharmacologic Substance]
   861   C0004388:ANS [Body System]

Phrase: "or"

Phrase: "ANS) binding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0243122:binding [Functional Concept]
   861   C1145667:Binding [Activity]
   861   C1167622:Binding [Molecular Function]

Phrase: "is"

Phrase: "also"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: ","

Phrase: "demonstrating"

Phrase: "that extensive hydrophobic patches"
Meta Candidates (Total=9; Excluded=8; Pruned=0; Remaining=1)
   827   C0994894:Patches [Medical Device]
   793 E C0332461:Patch [Finding]
   793 E C0445403:Patch [Biomedical or Dental Material]
   793 E C0991556:Patch [Medical Device]
   793 E C1305400:Patch [Medical Device]
   793 E C1533128:Patch [Biomedical or Dental Material]
   793 E C1706366:{Patch} [Quantitative Concept]
   793 E C1707974:Patch [Biomedical or Dental Material]
   743 E C0205413:Patchy [Qualitative Concept]

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "exposed during oxidation/oligomerization."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0030011:Oxidation [Molecular Function]
   770   C0332157:Exposed [Clinical Attribute]
Processing 00000000.tx.308: This is consistent with previous results in which only a weak binding of ANS to synuclein aggregates could be detected at neutral pH (87), although see Ref. 

Phrase: "This"

Phrase: "is"

Phrase: "consistent with previous results"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent

Phrase: "in which only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a weak binding of ANS"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0243122:binding [Functional Concept]
   760   C1145667:Binding [Activity]
   760   C1167622:Binding [Molecular Function]

Phrase: "to synuclein aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205418:aggregates [Qualitative Concept]

Phrase: "could"

Phrase: "be"

Phrase: "detected at neutral pH (87"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C1882074:Neutral pH [Qualitative Concept]
           Neutral
   760   C0020283:[pH] [Quantitative Concept]
   760   C0442726:Detected [Finding]
   760   C0450407:ph+ [Finding]
   760   C0450408:ph++ [Finding]
   760   C0450409:ph+++ [Finding]
   760   C1511790:Detected [Therapeutic or Preventive Procedure]
   760   C2825492:Neutral [Phenomenon or Process]

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Ref."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1425988:REF [Gene or Genome]
Processing 00000000.tx.309: 88. 

Phrase: "88."
Processing 00000000.tx.310: Although synuclein filaments fail to be generated under oxidizing conditions, the formation of both SDS-resistant synuclein oligomers (as assessed by immunoblotting after SDS-PAGE) and synuclein protofibrils (as defined by gel filtration chromatography) are enhanced (Fig. 4). 

Phrase: "Although"

Phrase: "synuclein filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "generated under oxidizing conditions,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C3146294:Generated [Activity]
   737   C0012634:condition [Disease or Syndrome]
   737   C0348080:Condition [Qualitative Concept]
   737   C1705253:Condition [Conceptual Entity]

Phrase: "the formation of both SDS-resistant synuclein oligomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0220781:formation [Biologic Function]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]

Phrase: "("

Phrase: "as"

Phrase: "assessed by immunoblotting"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020985:Immunoblotting [Laboratory Procedure]
   790   C1516048:Assessed [Activity]

Phrase: "after SDS-PAGE)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0600209:SDS-PAGE [Laboratory Procedure,Research Activity]
   861   C1704732:Page [Intellectual Product]

Phrase: "and"

Phrase: "synuclein protofibrils"

Phrase: "("

Phrase: "as"

Phrase: "defined by gel filtration chromatography"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   862   C0008559:Gel Filtration Chromatography [Laboratory Procedure]
           Gel Filtration
           Gel Chromatography
   760   C0008550:Chromatography [Laboratory Procedure]
   760   C0016107:filtration [Laboratory Procedure]
   760   C0017243:Gel [Biomedical or Dental Material]
   760   C1382104:Gel [Substance]
   760   C1704788:Defined [Conceptual Entity]
   760   C3539106:Defined [Intellectual Product]

Phrase: ")"

Phrase: "are"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "(Fig. 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.311: Conversely, iron chelation or oxygen depletion prevents the generation of both oligomers and protofibrils while enhancing the formation of synuclein fibrils. 

Phrase: "Conversely,"

Phrase: "iron chelation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1517598:Iron Chelation [Molecular Function]
   861   C3537131:Chelation [Molecular Function]

Phrase: "or"

Phrase: "oxygen depletion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "prevents"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0309872:PREVENT [Pharmacologic Substance]
  1000   C1292733:Prevents [Functional Concept]

Phrase: "the generation of both oligomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "and"

Phrase: "protofibrils"

Phrase: "while"

Phrase: "enhancing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2349975:Enhance [Activity]

Phrase: "the formation of synuclein fibrils."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]
Processing 00000000.tx.312: These results raise the possibility that rather than functioning as a precursor in synuclein filament formation, as has been suggested (89), extensive formation of synuclein protofibrils represents an off pathway, with synuclein oxidation/oligomerization actually required for protofibril accumulation. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "raise"

Phrase: "the possibility"

Phrase: "that"

Phrase: "rather than"

Phrase: "functioning as a precursor"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   770   C0542341:functioning [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "in synuclein filament formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0220781:formation [Biologic Function]
   827   C0439634:formation [Spatial Concept]
   827   C1522492:Formation [Functional Concept]

Phrase: "as"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "(89"

Phrase: ")"

Phrase: ","

Phrase: "extensive formation of synuclein protofibrils"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C1522492:Formation [Functional Concept]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "an off pathway,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1704259:Pathway [Molecular Function]
   790   C1705987:Pathway [Conceptual Entity]

Phrase: "with synuclein oxidation/oligomerization actually"

Phrase: "required for protofibril accumulation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Required [Functional Concept]
Processing 00000000.tx.313: Indeed, the results of Conway et al. 

Phrase: "Indeed,"

Phrase: "the results of Conway et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]
Processing 00000000.tx.314: (72) are consistent with this view. 

Phrase: "(72"

Phrase: ")"

Phrase: "are"

Phrase: "consistent with this view."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0332290:Consistent with [Idea or Concept]
           Consistent
Processing 00000000.tx.315: The treatment of synuclein with dopamine or other catecholamines enhanced protofibril formation, including the formation of low levels of dopamine-synuclein adducts, and led to a reduction in the production of synuclein filaments. 

Phrase: "The treatment of synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with dopamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013030:Dopamine [Neuroreactive Substance or Biogenic Amine,Organic Chemical,Pharmacologic Substance]

Phrase: "or"

Phrase: "other catecholamines"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0007412:Catecholamines [Neuroreactive Substance or Biogenic Amine,Pharmacologic Substance]
   966 E C3536742:Catecholamine [Pharmacologic Substance]

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "protofibril formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the formation of low levels of dopamine-synuclein adducts,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   762   C1154438:dopamine formation [Molecular Function]
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "led to a reduction"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   770   C0301630:Reduction [Natural Phenomenon or Process]
   770   C0392756:Reduction [Qualitative Concept]
   770   C0441610:Reduction [Therapeutic or Preventive Procedure]
   770   C1708698:LED [Manufactured Object]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in the production"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033268:production [Occupational Activity]

Phrase: "of synuclein filaments."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]
Processing 00000000.tx.316: These effects required oxidizing conditions and could be inhibited by iron chelators and antioxidants (72). 

Phrase: "These effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "oxidizing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "and"

Phrase: "could"

Phrase: "be"

Phrase: "inhibited by iron chelators"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   816   C2266987:Iron Chelator [Pharmacologic Substance]
   770   C0007974:Chelators [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   770   C0311403:Inhibited [Qualitative Concept]
   770   C0376520:Iron [Inorganic Chemical]
   770   C1166521:iron [Pharmacologic Substance]
   737 E C1664784:Chelator [Eukaryote]

Phrase: "and"

Phrase: "antioxidants"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003402:Antioxidants [Pharmacologic Substance]

Phrase: "(72"

Phrase: ")."
Processing 00000000.tx.317: Thus, synuclein protofibrils may simply represent soluble non-amyloid oligomeric forms of synuclein, in which a significant proportion is covalently associated (see below). 

Phrase: "Thus,"

Phrase: "synuclein protofibrils"

Phrase: "may"

Phrase: "simply"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "soluble non-amyloid oligomeric forms of synuclein,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   748   C0348078:forms [Qualitative Concept]
   748   C0376315:Forms [Manufactured Object]
   714 E C1522492:Form [Functional Concept]

Phrase: "in which"

Phrase: "a significant proportion"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1709707:Proportion [Quantitative Concept]
   789 E C0205351:Proportional [Qualitative Concept]

Phrase: "is"

Phrase: "covalently"

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.318: The relationship between synuclein oxidation/oligomerization as it relates to filament formation is unclear. 

Phrase: "The relationship between synuclein oxidation/oligomerization"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "as"

Phrase: "it"

Phrase: "relates to filament formation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010851:Filament [Cell Component]
   770   C0163712:Relate [Organic Chemical]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.319: Our results indicate that there is an inverse relationship between the formation of soluble SDS-resistant synuclein oligomers and filament formation. 

Phrase: "Our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "indicate"

Phrase: "that there"

Phrase: "is"

Phrase: "an inverse relationship between the formation of soluble SDS-resistant synuclein oligomers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0439849:Relationship [Qualitative Concept]
   736   C1705630:Relationship [Idea or Concept]
   736   C1706279:Relationship [Idea or Concept]
   736   C3540605:Relationship [Intellectual Product]

Phrase: "and"

Phrase: "filament formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.320: It is not clear, however, whether the inhibition of filament formation we observe requires covalent cross-linking per se or rather results from specific modification(s) of amino acid side chains of the synuclein monomer, with oligomerization serving only as a consequence of these modification(s). 

Phrase: "It"

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: ","

Phrase: "however,"

Phrase: "whether"

Phrase: "the inhibition of filament formation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]
   760   C3463820:Inhibition [Activity]

Phrase: "we"

Phrase: "observe"

Phrase: "requires"

Phrase: "covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "per se"

Phrase: "or"

Phrase: "rather"

Phrase: "results from specific modification"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205369:Specific [Qualitative Concept]
   770   C0392747:Modification [Functional Concept]
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C1552740:specific [Intellectual Product]
   770   C1554963:modification [Qualitative Concept]
   770   C2825142:Result [Finding]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "of amino acid side chains"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0337112:chains [Manufactured Object]
   812   C0441987:Side [Spatial Concept]
   812   C1524075:Chains [Idea or Concept]

Phrase: "of the synuclein monomer,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "with oligomerization"

Phrase: "serving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1519269:Serving [Quantitative Concept]

Phrase: "only as a consequence of these modification"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C0686907:Consequence of [Functional Concept]
           Consequence
   748   C0205171:Only [Quantitative Concept]
   748   C0392747:Modification [Functional Concept]
   748   C1554963:modification [Qualitative Concept]
   748   C1720467:Only [Intellectual Product]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")."
Processing 00000000.tx.321: It is reasonable to assume that covalent cross-linking of synuclein is not required to inhibit fibrillogenesis. 

Phrase: "It"

Phrase: "is"

Phrase: "reasonable to"

Phrase: "assume"

Phrase: "that covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking of synuclein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332220:Cross-linking [Functional Concept]
   816 E C0178576:Cross link [Natural Phenomenon or Process]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "fibrillogenesis."
Processing 00000000.tx.322: For example, oxidation of methionine residues with hydrogen peroxide (73) or nitration of tyrosine residues with tetranitromethane (79) inhibit synuclein fibril formation in the absence of covalent association and proportionally inhibit filament formation when added to unmodified synuclein. 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "oxidation of methionine residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "with hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "(73"

Phrase: ")"

Phrase: "or"

Phrase: "nitration of tyrosine residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1328815:nitration [Phenomenon or Process]

Phrase: "with tetranitromethane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039694:Tetranitromethane [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(79"

Phrase: ")"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "synuclein fibril formation in the absence of covalent association"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "proportionally"

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "when"

Phrase: "added to unmodified synuclein."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1524062:Added [Functional Concept]
   737 E C1883712:Add [Functional Concept]
Processing 00000000.tx.323: This is thought to occur via formation of hetero-oligomers between modified and unmodified synucleins, in the absence of covalent cross-linking (73, 79). 

Phrase: "This"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur via formation of hetero-oligomers"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "between modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "and"

Phrase: "unmodified synucleins,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synucleins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "(73,"

Phrase: "79"

Phrase: ")."
Processing 00000000.tx.324: Thus, the effects of synuclein oligomerization on filament assembly may be related not only to the types of modifications generated but also to the extent to which the synuclein monomer population is modified. 

Phrase: "Thus,"

Phrase: "the effects of synuclein oligomerization"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C1280500:effects [Qualitative Concept]
   726 E C2348382:Effect [Qualitative Concept]

Phrase: "on filament assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "may"

Phrase: "be"

Phrase: "related"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0439849:Related [Qualitative Concept]
  1000   C0445223:Related [Finding]
   966 E C0163712:Relate [Organic Chemical]

Phrase: "not only to the types of modifications"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   748   C0205171:Only [Quantitative Concept]
   748   C0332307:Types [Qualitative Concept]
   748   C1518422:Not [Functional Concept]
   748   C1720467:Only [Intellectual Product]
   714   C0392747:Modification [Functional Concept]
   714 E C1547052:*Type [Quantitative Concept]
   714   C1554963:modification [Qualitative Concept]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "but"

Phrase: "also to the extent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0439792:Extent [Spatial Concept]

Phrase: "to which"

Phrase: "the synuclein monomer population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0032659:Population [Quantitative Concept]
   827   C1257890:Population [Population Group]

Phrase: "is"

Phrase: "modified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]
Processing 00000000.tx.325: On the other hand, it has been suggested that covalent cross-linking of synuclein may actually promote fibril formation (44). 

Phrase: "On the"

Phrase: "other hand,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0018563:Hand [Body Part, Organ, or Organ Component]
  1000   C1281583:Hand [Body Part, Organ, or Organ Component]
  1000   C1552914:hand [Quantitative Concept]
   944 E C0024763:Manual [Intellectual Product,Manufactured Object]
   944 E C0175674:Manual [Functional Concept]

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that covalent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1511539:Covalent [Molecular Function]
   928 E C0678601:covalence [Natural Phenomenon or Process]

Phrase: "cross-linking of synuclein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332220:Cross-linking [Functional Concept]
   816 E C0178576:Cross link [Natural Phenomenon or Process]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "may"

Phrase: "actually"

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.326: This hypothesis is based primarily on an observed increase in lag time for fibril formation when synuclein is incubated for extended periods of time (1520 days) in the presence of EDTA and the anti-oxidant methionine. 

Phrase: "This hypothesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1512571:Hypothesis [Idea or Concept]

Phrase: "is"

Phrase: "based"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C1527178:Based [Functional Concept]
  1000   C1705938:Based [Idea or Concept]
   966 E C0002055:base [Inorganic Chemical]
   966 E C0178499:Base [Chemical Viewed Functionally]
   966 E C1880279:Base [Biomedical or Dental Material]

Phrase: "primarily on an observed increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0442805:Increase [Functional Concept]
   760   C1441672:Observed [Functional Concept]

Phrase: "in lag time"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   861   C0040223:Time [Temporal Concept]
   861   C1416797:Lag [Gene or Genome]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "for fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "when"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "incubated for extended periods of time"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   783   C0439582:Time periods [Temporal Concept]
   756 E C0585019:Temporal periods [Temporal Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0231448:Extended [Functional Concept]
   753   C0231449:Extended [Spatial Concept]
   753   C0439792:extended [Spatial Concept]
   753   C1439852:Incubated [Laboratory Procedure]
   753   C3541383:Time [Temporal Concept]
   719   C0439531:/period [Temporal Concept]
   719   C1948053:Period [Temporal Concept]

Phrase: "(1520 days"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of EDTA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0013618:EDTA [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "the anti-oxidant methionine."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
Processing 00000000.tx.327: This delay in fibril formation was proposed to be because of the failure to form dityrosine-linked dimers that served to nucleate fibril assembly (44). 

Phrase: "This delay in fibril formation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205421:Delay [Temporal Concept]

Phrase: "was"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be because of the failure to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]
   753   C2987476:Be [Conceptual Entity]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "dityrosine-linked dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0596448:dimers [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "served"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "nucleate"

Phrase: "fibril assembly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1706853:Assembly [Activity]
   861   C1879748:Assembly [Manufactured Object]

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.328: Our observations, however, that filament formation is accelerated and enhanced, not delayed (44), under anti-oxidant conditions (chelating endogenous metals or oxygen depletion, see Fig. 3) are inconsistent with this view, unless undetectable levels of dityrosine-linked synuclein are generated under chelation and anoxic conditions that lead to the enhanced filament assembly. 

Phrase: "Our observations,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0302523:observations [Research Activity]
  1000   C0700325:observations [Health Care Activity]
  1000   C3244290:observations [Functional Concept]
   966 E C1964257:Observation [Diagnostic Procedure]
   916 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "however,"

Phrase: "that filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "accelerated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521110:Accelerated [Functional Concept]

Phrase: "and"

Phrase: "enhanced,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]
   928 E C1627358:Enhancement [Therapeutic or Preventive Procedure]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "delayed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205421:Delayed [Temporal Concept]
  1000   C3272602:Delayed [Qualitative Concept]

Phrase: "(44"

Phrase: ")"

Phrase: ","

Phrase: "under anti-oxidant conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "("

Phrase: "chelating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3537131:Chelating [Molecular Function]

Phrase: "endogenous metals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025552:Metals [Inorganic Chemical]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "or"

Phrase: "oxygen depletion,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333668:Depletion [Functional Concept]

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "are"

Phrase: "inconsistent with this view,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0442809:Inconsistent [Qualitative Concept]

Phrase: "unless"

Phrase: "undetectable levels of dityrosine-linked synuclein"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   753   C0441889:Levels [Qualitative Concept]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "are"

Phrase: "generated under chelation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C3146294:Generated [Activity]
   790   C3537131:Chelation [Molecular Function]

Phrase: "and"

Phrase: "anoxic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0003130:Anoxia [Pathologic Function]

Phrase: "conditions"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
  1000   C0012634:condition [Disease or Syndrome]
  1000   C0348080:Condition [Qualitative Concept]
  1000   C1705253:Condition [Conceptual Entity]
   944 E C0040607:Training [Educational Activity]
   944 E C0220931:Training [Educational Activity]
   944 E C0336809:Train [Manufactured Object]
   944 E C1552514:Train [Manufactured Object]
   944 E C2673163:training [Qualitative Concept]
   916 E C0009647:Conditioned [Mental Process]

Phrase: "that lead to the enhanced filament assembly."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   748   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   748   C1522538:Lead [Functional Concept]
   748   C2348269:Lead [Element, Ion, or Isotope]
   748   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.329: It has been reported that addition of relatively high levels of exogenous copper (0.5 mM) to hydrogen peroxide (0.3 mM) resulted in formation of SDS-resistant synuclein oligomers, yet no effect on fibril assembly was observed (42). 

Phrase: "It"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that addition of relatively high levels of exogenous copper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1883712:Addition [Functional Concept]

Phrase: "(0.5 mM) to hydrogen peroxide"

Phrase: "(0.3 mM)"

Phrase: "resulted in formation of SDS-resistant synuclein oligomers,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0220781:formation [Biologic Function]
   744   C0332325:Resistant [Functional Concept]
   744   C0439634:formation [Spatial Concept]
   744   C1522492:Formation [Functional Concept]
   744   C2827757:RESISTANT [Laboratory or Test Result]
   711   C1274040:Result [Functional Concept]
   711   C1546471:Result [Idea or Concept]
   711   C2825142:Result [Finding]

Phrase: "yet"

Phrase: "no effect on fibril assembly"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   806   C1301751:No effect [Qualitative Concept]
   760   C1280500:Effect [Qualitative Concept]
   760   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(42"

Phrase: ")."
Processing 00000000.tx.330: This contrasts with our observations that production of soluble synuclein oligomers under these conditions correlates with an inhibition of filament formation (Fig. 6, C and D). 

Phrase: "This contrasts with our observations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   726   C1979874:Contrast [Qualitative Concept]

Phrase: "that production of soluble synuclein oligomers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0033268:production [Occupational Activity]

Phrase: "under these conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "correlates with an inhibition of filament formation"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0010851:Filament [Cell Component]
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C0220781:formation [Biologic Function]
   748   C0439634:formation [Spatial Concept]
   748   C1522492:Formation [Functional Concept]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.331: At present, it is unclear as to the nature of this difference, as different detection methods were used to monitor the effectiveness of synuclein oligomerization. 

Phrase: "At present,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0150312:Present [Quantitative Concept]
  1000   C0449450:Present [Idea or Concept]

Phrase: "it"

Phrase: "is"

Phrase: "unclear as to the nature of this difference,"

Phrase: "as"

Phrase: "different detection methods"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0449335:detection methods [Intellectual Product]
   827   C0025663:Methods [Intellectual Product]
   827   C0025664:methods [Intellectual Product]
   827   C0449851:Methods [Functional Concept]
   793 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "monitor"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0030695:monitor [Health Care Activity]
  1000   C0150369:monitor [Health Care Activity]
  1000   C0181904:Monitor [Medical Device]
  1000   C0596972:Monitor [Medical Device]
  1000   C1521743:Monitor [Professional or Occupational Group]
  1000   C1704646:Monitor [Manufactured Object]

Phrase: "the effectiveness of synuclein oligomerization."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1280519:Effectiveness [Qualitative Concept]
Processing 00000000.tx.332: In contrast to the effects of copper, we did observe that relatively high concentrations of iron in the presence of hydrogen peroxide neither result in the significant production of synuclein oligomers nor prevent fibril formation (Fig. 6, C and D). 

Phrase: "In contrast to the effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1280500:effects [Qualitative Concept]
   966 E C2348382:Effect [Qualitative Concept]

Phrase: "of copper,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "we"

Phrase: "did"

Phrase: "observe"

Phrase: "that relatively high concentrations of iron"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "neither result in the significant production of synuclein oligomers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1274040:Result [Functional Concept]
   742   C1546471:Result [Idea or Concept]
   742   C2825142:Result [Finding]

Phrase: "nor"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "(Fig. 6,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "C"

Phrase: "and"

Phrase: "D)."
Processing 00000000.tx.333: This contrasts with the complete inhibition of fibril assembly with significantly lower concentrations of iron in the presence of DTT (Fig. 7A). 

Phrase: "This contrasts with the complete inhibition of fibril assembly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   708   C1979874:Contrast [Qualitative Concept]

Phrase: "with significantly lower concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0086045:Concentrations [Mental Process]
   793 E C1446561:Concentration [Quantitative Concept]
   743 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of DTT"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "(Fig. 7A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1571602:7a [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: ")."
Processing 00000000.tx.334: Conversely, copper is much less effective than iron in inducing synuclein oligomerization in the DTT system (see Fig. 1A; data not shown). 

Phrase: "Conversely,"

Phrase: "copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "is"

Phrase: "much less effective than iron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1280519:effective [Qualitative Concept]
   760   C1704419:Effective [Qualitative Concept]

Phrase: "in inducing synuclein oligomerization"

Phrase: "in the DTT system"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "; data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.335: Thus, it appears that under the different oxidizing systems, copper and iron affect synuclein oligomerization and filament assembly differently. 

Phrase: "Thus,"

Phrase: "it"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "that under the different oxidizing systems,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C1705242:Different [Qualitative Concept]
   719   C0449913:System [Functional Concept]
   719   C1553451:System [Manufactured Object]
   719   C1704459:System [Medical Device]

Phrase: "copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "iron"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C0376520:Iron [Inorganic Chemical]
  1000   C1166521:iron [Pharmacologic Substance]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "synuclein oligomerization"

Phrase: "and"

Phrase: "filament assembly differently."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1706853:Assembly [Activity]
   827   C1879748:Assembly [Manufactured Object]
Processing 00000000.tx.336: Whether this reflects distinct binding sites for the different metals (90) that result in differences in the site-specific generation of ROS (15, 69) is unclear. 

Phrase: "Whether"

Phrase: "this"

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "distinct binding sites for the different metals"
Meta Candidates (Total=10; Excluded=3; Pruned=0; Remaining=7)
   778   C0005456:Binding Sites [Receptor]
   771   C1513163:Metal Binding Site [Amino Acid Sequence]
   757   C1323274:metal binding [Molecular Function]
   748   C0205145:Sites [Spatial Concept]
   748   C0243122:binding [Functional Concept]
   748   C1145667:Binding [Activity]
   748   C1167622:Binding [Molecular Function]
   745 E C0682969:Binding Site [Amino Acid Sequence]
   714 E C1515974:Site [Body Location or Region]
   714 E C2825164:Site [Spatial Concept]

Phrase: "(90"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439083:>90 [Quantitative Concept]
  1000   C0439087:<90 [Quantitative Concept]

Phrase: ")"

Phrase: "that result in differences"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1274040:Result [Functional Concept]
   770   C1546471:Result [Idea or Concept]
   770   C2825142:Result [Finding]

Phrase: "in the site-specific generation"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   827   C0079411:Generation [Temporal Concept]
   827   C3146294:Generation [Activity]
   734   C0449604:site specific [Spatial Concept]
   734 E C1414672:Genesis [Gene or Genome]
   734 E C2984892:Genesis [Gene or Genome]

Phrase: "of ROS"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "(15,"

Phrase: "69"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450388:69 [Intellectual Product]

Phrase: ")"

Phrase: "is"

Phrase: "unclear."
Processing 00000000.tx.337: That different metals may target distinct regions of the synuclein molecule is supported by studies indicating that oligomerization of synuclein in the presence of copper and hydrogen peroxide generated dityrosine cross-links, whereas no dityrosine formation could be observed in the presence of iron (41). 

Phrase: "That different metals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0025552:Metals [Inorganic Chemical]
   777 E C2986473:Metallic [Qualitative Concept]

Phrase: "may"

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "distinct regions of the synuclein molecule"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C0017446:Region [Geographic Area]
   719   C0205147:Region [Spatial Concept]

Phrase: "is"

Phrase: "supported by studies"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C0947630:studies [Laboratory Procedure]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C0557651:Study [Manufactured Object]
   756 E C2603343:Study [Research Activity]

Phrase: "indicating"

Phrase: "that oligomerization of synuclein"

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of copper"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0009968:Copper [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C2347872:Copper+ [Element, Ion, or Isotope]
  1000   C2348263:Copper [Element, Ion, or Isotope]

Phrase: "and"

Phrase: "hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "dityrosine cross-links,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0332220:cross links [Functional Concept]
   884 E C0178576:Cross link [Natural Phenomenon or Process]
   827   C2828360:Cross [Conceptual Entity]
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]

Phrase: "whereas"

Phrase: "no dityrosine formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "could"

Phrase: "be"

Phrase: "observed in the presence of iron"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0302583:Iron [Biologically Active Substance,Element, Ion, or Isotope,Pharmacologic Substance]
   753   C0376520:Iron [Inorganic Chemical]
   753   C0392148:Presence [Therapeutic or Preventive Procedure]
   753   C1166521:iron [Pharmacologic Substance]
   753   C1441672:Observed [Functional Concept]

Phrase: "(41"

Phrase: ")."
Processing 00000000.tx.338: It must be emphasized that free radical-mediated oxidation of proteins can lead to a number of modifications of amino acid side chain residues, including the formation of reactive carbonyl groups (ketones and aldehydes) that render proteins susceptible to intra- and intermolecular cross-linking (91) (see below). 

Phrase: "It"

Phrase: "must"

Phrase: "be"

Phrase: "emphasized"

Phrase: "that free radical-mediated oxidation of proteins"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C1159301:protein oxidation [Molecular Function]
   748   C0030011:Oxidation [Molecular Function]

Phrase: "can"

Phrase: "lead to a number of modifications of amino acid side chain residues,"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   753   C0002520:Amino acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C2917660:Amino Acid [Pharmacologic Substance]
   751   C0546742:Acid number [Laboratory Procedure]
   736   C0001128:Acid [Chemical]
   736   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   736   C0202406:Acid [Laboratory Procedure]
   736   C0237753:*Number [Quantitative Concept]
   736   C0337112:Chain [Manufactured Object]
   736   C0441987:Side [Spatial Concept]
   736   C0449788:Number [Quantitative Concept]
   736   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   736   C1522538:Lead [Functional Concept]
   736   C1524075:Chain [Idea or Concept]
   736   C2348269:Lead [Element, Ion, or Isotope]
   736   C3275067:LEAD [Therapeutic or Preventive Procedure]
   703   C0392747:Modification [Functional Concept]
   703   C1554963:modification [Qualitative Concept]
   703   C1709915:Residue [Conceptual Entity]
   703   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the formation of reactive carbonyl groups"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1522492:Formation [Functional Concept]

Phrase: "(ketones"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022634:Ketones [Organic Chemical]

Phrase: "and"

Phrase: "aldehydes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001992:Aldehydes [Organic Chemical]

Phrase: ")"

Phrase: "that"

Phrase: "render"

Phrase: "proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "susceptible to intra-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0231204:Susceptible [Functional Concept]
   790   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "and"

Phrase: "intermolecular"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "(91"

Phrase: ")"

Phrase: "("

Phrase: "see below"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   833   C0042789:see [Organism Function]
   833   C1947903:See [Activity]

Phrase: ")."
Processing 00000000.tx.339: Thus, the covalent association of proteins under oxidizing conditions is not restricted to dityrosine formation. 

Phrase: "Thus,"

Phrase: "the covalent association of proteins"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "under oxidizing conditions"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   827   C0012634:condition [Disease or Syndrome]
   827   C0348080:Condition [Qualitative Concept]
   827   C1705253:Condition [Conceptual Entity]
   777 E C0009647:Conditioned [Mental Process]
   777 E C1701901:Conditional [Qualitative Concept]
   777 E C1963686:Conditional [Functional Concept]
   755 E C1519605:Conditionality [Conceptual Entity]

Phrase: "is"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "restricted to dityrosine formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0058505:dityrosine [Amino Acid, Peptide, or Protein]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C0443288:Restricted [Functional Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.340: Indeed, tyrosine-deficient synuclein retains the capacity to form oligomers under oxidizing conditions (42), and in the absence of peroxynitrite, we were unable to detect appreciable dityrosine formation under any of our oxidizing conditions (data not shown). 

Phrase: "Indeed,"

Phrase: "tyrosine-deficient synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "retains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333118:Retain [Functional Concept]

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "oligomers under oxidizing conditions"

Phrase: "(42"

Phrase: ")"

Phrase: ","

Phrase: "and in the absence of peroxynitrite,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0136157:Peroxynitrite [Biologically Active Substance,Inorganic Chemical]
   753   C0332197:absence [Quantitative Concept]
   753   C1515981:And [Idea or Concept]
   753   C1689985:Absence [Anatomical Abnormality]

Phrase: "we"

Phrase: "were"

Phrase: "unable to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1299582:Unable [Finding]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "appreciable dityrosine formation under any of our oxidizing conditions"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0220781:formation [Biologic Function]
   742   C0439634:formation [Spatial Concept]
   742   C1522492:Formation [Functional Concept]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.341: Rather, each of the treatments that generate synuclein cross-links in our system are likely to occur through modifications of one or more of the fifteen lysine residues present in the N-terminal two-thirds of synuclein. 

Phrase: "Rather,"

Phrase: "each of the treatments"
Meta Candidates (Total=7; Excluded=5; Pruned=0; Remaining=2)
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C1457900:Each [Quantitative Concept]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]

Phrase: "that"

Phrase: "generate"

Phrase: "synuclein cross-links in our system"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   790   C0332220:cross links [Functional Concept]
   773 E C0178576:Cross link [Natural Phenomenon or Process]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "occur through modifications of one"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0205447:One [Quantitative Concept]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]
   726   C0392747:Modification [Functional Concept]
   726   C1554963:modification [Qualitative Concept]

Phrase: "or"

Phrase: "more of the fifteen lysine residues"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0024337:Lysine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   753   C0205172:More [Functional Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "present in the N-terminal two-thirds of synuclein."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   742   C0150312:Present [Quantitative Concept]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205088:Terminal [Temporal Concept]
   742   C0205437:Third [Quantitative Concept]
   742   C0205448:Two [Quantitative Concept]
   742   C0449450:Present [Idea or Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.342: One of the main products of MCO of proteins is derivatization of lysine residues to aminoadipic semialdehyde (92), and tTGase (65, 66), lipid peroxide decomposition products (80), and the cross-linker DSP all have the capacity to introduce cross-links into proteins through lysine modifications. 

Phrase: "One of the main products of MCO of proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0205447:One [Quantitative Concept]

Phrase: "is"

Phrase: "derivatization of lysine residues"

Phrase: "to aminoadipic semialdehyde"

Phrase: "(92"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "tTGase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "(65,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450385:65 [Intellectual Product]

Phrase: "66"

Phrase: ")"

Phrase: ","

Phrase: "lipid peroxide decomposition products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C1514468:Products [Entity]
   779 E C1704444:Product [Quantitative Concept]

Phrase: "(80"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the cross-linker DSP"

Phrase: "all"

Phrase: "have"

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "introduce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1292748:introduce [Functional Concept]

Phrase: "cross-links into proteins"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C0332220:cross links [Functional Concept]
   816 E C0178576:Cross link [Natural Phenomenon or Process]
   786   C0065011:link protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C2828360:Cross [Conceptual Entity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "through lysine modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.343: In contrast, of the four tyrosine residues that may be susceptible to dityrosine formation, three are located in the unstructured C-terminal tail of synuclein. 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "of the four tyrosine residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   793   C1709915:Residue [Conceptual Entity]
   793   C1882936:RESIDUE [Phenomenon or Process]
   743 E C1609982:Residual [Qualitative Concept]

Phrase: "that"

Phrase: "may"

Phrase: "be"

Phrase: "susceptible to dityrosine formation,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "three"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "are"

Phrase: "located in the unstructured C-terminal tail of synuclein."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   764   C1707271:C-Terminal [Amino Acid Sequence]
   742   C0039259:Tail [Body Part, Organ, or Organ Component]
   742   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0205088:Terminal [Temporal Concept]
   742   C1705314:Terminal [Manufactured Object]
   742   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.344: Thus, the possibility remains that cross-linking via the N-terminal and central regions of synuclein abrogate fibril formation, whereas cross-linking via the C terminus of synuclein does not. 

Phrase: "Thus,"

Phrase: "the possibility"

Phrase: "remains"

Phrase: "that"

Phrase: "cross-linking via the N-terminal"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   790   C0332220:Cross-linking [Functional Concept]
   773 E C0178576:Cross link [Natural Phenomenon or Process]
   753   C0205088:Terminal [Temporal Concept]
   753   C1705314:Terminal [Manufactured Object]
   753   C1705315:Terminal [Spatial Concept]
   753   C2828360:Cross [Conceptual Entity]
   719   C1517892:Link [Intellectual Product]
   719   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "central regions of synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   816   C0454907:Central region [Geographic Area]
   737   C0017446:Region [Geographic Area]
   737   C0205147:Region [Spatial Concept]

Phrase: "abrogate"

Phrase: "fibril formation,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "whereas"

Phrase: "cross-linking via the C terminus of synuclein"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0332220:Cross-linking [Functional Concept]
   754 E C0178576:Cross link [Natural Phenomenon or Process]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C2828360:Cross [Conceptual Entity]
   711   C1517892:Link [Intellectual Product]
   711   C1704666:Link [Intellectual Product]

Phrase: "does"

Phrase: "not."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]
Processing 00000000.tx.345: A careful examination of the nature of these cross-links and amino acid side chain modification(s) generated under different oxidizing conditions is necessary before deciding on a mechanistic role for synuclein oxidation in oligomer formation and possible PD pathogenesis. 

Phrase: "A careful examination of the nature of these cross-links"

Phrase: "and"

Phrase: "amino acid side chain modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0392747:Modification [Functional Concept]
   804   C1554963:modification [Qualitative Concept]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "generated under different oxidizing conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C1705242:Different [Qualitative Concept]
   760   C3146294:Generated [Activity]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "is"

Phrase: "necessary before deciding"

Phrase: "on a mechanistic role"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0035820:Role [Social Behavior]
   861   C1705810:Role [Conceptual Entity]

Phrase: "for synuclein oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "in oligomer formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "possible PD pathogenesis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0543483:pathogenesis [Functional Concept]
   827   C0699748:Pathogenesis [Pathologic Function]
Processing 00000000.tx.346: Based on the available evidence and the results presented here, a potential model relating synuclein oxidation/oligomerization to fibril assembly can be envisioned (Fig. 8). 

Phrase: "Based on the available evidence"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0332120:Evidence [Functional Concept]
   760   C0470187:Available [Functional Concept]
   760   C1527178:Based [Functional Concept]
   760   C1705938:Based [Idea or Concept]
   726 E C0002055:base [Inorganic Chemical]
   726 E C0178499:Base [Chemical Viewed Functionally]
   726 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here,"

Phrase: "a potential model relating synuclein oxidation/oligomerization to fibril assembly"

Phrase: "can"

Phrase: "be"

Phrase: "envisioned"

Phrase: "(Fig. 8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.347: The normally unmodified synuclein monomer (1) is susceptible to oxidative modifications (2), especially during long term incubations in vitro. 

Phrase: "The normally unmodified synuclein monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "is"

Phrase: "susceptible to oxidative modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0231204:Susceptible [Functional Concept]
   770   C2827758:SUSCEPTIBLE [Laboratory or Test Result]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: ","

Phrase: "especially during long term incubations"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.348: These include oxidation of histidinyl residues to oxo-histidine and its degradation products and conversion of methionine to methionine sulfoxide (92). 

Phrase: "These"

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "oxidation of histidinyl residues"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0030011:Oxidation [Molecular Function]

Phrase: "to oxo-histidine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0019602:Histidine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "its degradation products"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1514468:Products [Entity]
   827 E C1704444:Product [Quantitative Concept]

Phrase: "and"

Phrase: "conversion of methionine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439836:Conversion [Functional Concept]

Phrase: "to methionine sulfoxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0066124:methionine sulfoxide [Amino Acid, Peptide, or Protein]
   861   C0025646:Methionine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0038770:sulfoxide [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C0038771:sulfoxide [Organic Chemical]
   861   C0851343:Sulfoxide [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(92"

Phrase: ")."
Processing 00000000.tx.349: Carbonyl groups, introduced principally by the MCO of specific amino acid side chains, include glutamic and aminoadipic semialdehydes resulting from oxidation of prolyl and lysyl residues, respectively (91, 92), and in the presence of polyunsaturated fatty acids can also be introduced by adduction of aldehydic lipid peroxide degradation products (e.g. malondialdehyde and 4-hydroxy-2-nonenal) that also target histidinyl and lysyl residues (80). 

Phrase: "Carbonyl groups,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0596259:carbonyl group [Inorganic Chemical]
   861   C0441833:Group [Idea or Concept]
   861   C0687744:group [Population Group]
   861   C1257890:Group [Population Group]
   861   C1552516:Group [Health Care Related Organization]
   861   C1552839:groups [Idea or Concept]
   861   C1705428:Group [Conceptual Entity]
   861   C1705429:Group [Population Group]

Phrase: "introduced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1292748:introduce [Functional Concept]

Phrase: "principally by the MCO"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025552:Metal [Inorganic Chemical]
   748   C0030011:Oxidation [Molecular Function]
   748   C3161035:Model [Intellectual Product]

Phrase: "of specific amino acid side chains,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0337112:chains [Manufactured Object]
   804   C0441987:Side [Spatial Concept]
   804   C1524075:Chains [Idea or Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "glutamic"

Phrase: "and"

Phrase: "aminoadipic semialdehydes"

Phrase: "resulting from oxidation of prolyl"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   760   C0030011:Oxidation [Molecular Function]
   760   C0678226:resulting [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "and"

Phrase: "lysyl residues,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "respectively"

Phrase: "(91,"

Phrase: "92"

Phrase: ")"

Phrase: ","

Phrase: "and in the presence of polyunsaturated fatty acids"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   800   C0032615:Polyunsaturated Fatty Acids [Biologically Active Substance,Lipid]
   770   C0015684:Fatty Acids [Lipid]
   744   C0001128:Acids [Chemical]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1515981:And [Idea or Concept]
   711 E C0202406:Acid [Laboratory Procedure]

Phrase: "can"

Phrase: "also"

Phrase: "be"

Phrase: "introduced by adduction of aldehydic lipid peroxide degradation products"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   764   C0023776:lipid peroxide [Lipid]
   762   C0023796:lipid degradation [Organism Function]
   742   C0023779:Lipid [Lipid]
   742   C0031180:Peroxide [Inorganic Chemical]
   742   C0231457:Adduction [Functional Concept]
   742   C0243125:degradation [Functional Concept]
   742   C0699900:Degradation [Organism Function]
   742   C1514468:Products [Entity]
   708   C1292748:introduce [Functional Concept]
   708 E C1704444:Product [Quantitative Concept]

Phrase: "("

Phrase: "e.g. malondialdehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024643:Malondialdehyde [Organic Chemical]

Phrase: "and"

Phrase: "4-hydroxy-2-nonenal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxy-2-nonenal [Organic Chemical,Pharmacologic Substance]

Phrase: ")"

Phrase: "that also"

Phrase: "target"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]

Phrase: "histidinyl"

Phrase: "and"

Phrase: "lysyl residues"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C1709915:Residue [Conceptual Entity]
   827   C1882936:RESIDUE [Phenomenon or Process]
   777 E C1609982:Residual [Qualitative Concept]

Phrase: "(80"

Phrase: ")."
Processing 00000000.tx.350: Indeed, purified recombinant synuclein can be cross-linked in the presence of both 4-hydroxy-2-nonenal and malondialdehyde (data not shown). 

Phrase: "Indeed,"

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "recombinant synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "can"

Phrase: "be"

Phrase: "cross-linked in the presence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0178576:Cross Linked [Natural Phenomenon or Process]
   806   C0332220:cross linked [Functional Concept]
   760   C0392148:Presence [Therapeutic or Preventive Procedure]
   760   C2828360:Cross [Conceptual Entity]
   726   C1517892:Link [Intellectual Product]
   726   C1704666:Link [Intellectual Product]

Phrase: "of both 4-hydroxy-2-nonenal"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0048297:4-hydroxy-2-nonenal [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "malondialdehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024643:Malondialdehyde [Organic Chemical]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.351: Modification(s) of the synuclein monomer that do not result in species capable of subsequent intra- or intermolecular cross-linking (e.g. by hydrogen peroxide or tetranitromethane) become incapable of assembling into filaments, in the absence of extrinsic modifiers (3) (73, 79, 93). 

Phrase: "Modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "of the synuclein monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "that"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "result in species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C1705920:Species [Conceptual Entity]
   790   C2825142:Result [Finding]

Phrase: "capable of subsequent intra-"

Phrase: "or"

Phrase: "intermolecular"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "("

Phrase: "e.g."

Phrase: "by hydrogen peroxide"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0020281:Hydrogen Peroxide [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   861   C0020275:Hydrogen [Element, Ion, or Isotope]
   861   C0031180:Peroxide [Inorganic Chemical]
   861   C0523702:HYDROGEN [Laboratory Procedure]
   861   C0885426:hydrogen [Inorganic Chemical]

Phrase: "or"

Phrase: "tetranitromethane"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039694:Tetranitromethane [Hazardous or Poisonous Substance,Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: ")"

Phrase: "become"

Phrase: "incapable of assembling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1550518:incapable [Idea or Concept]

Phrase: "into filaments,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "in the absence"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332197:absence [Quantitative Concept]
  1000   C1689985:Absence [Anatomical Abnormality]
   928 E C2699517:ABSENT [Finding]

Phrase: "of extrinsic modifiers"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205349:Modifier [Qualitative Concept]
   827   C1514623:Modifier [Conceptual Entity]
   827   C1516451:Modifier [Chemical Viewed Functionally]
   827   C3542952:Modifier [Intellectual Product]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "(73,"

Phrase: "79,"

Phrase: "93"

Phrase: ")."
Processing 00000000.tx.352: Modification(s) resulting in reactive carbonyl formation (e.g. MCO, lipid peroxidation) or through enzymatic processes (e.g. tTGase) are capable of generating intra- and intermolecular cross-links (4) that can progress from dimers up to large soluble synuclein conglomerates that may represent sheet-rich but non-amyloid synuclein protofibrils (5) that, when accumulated, inhibit filament formation. 

Phrase: "Modification"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392747:Modification [Functional Concept]
  1000   C1554963:modification [Qualitative Concept]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "resulting in reactive carbonyl formation"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
   806   C0332294:Resulting in [Functional Concept]
   760   C0205332:Reactive [Qualitative Concept]
   760   C0220781:formation [Biologic Function]
   760   C0439634:formation [Spatial Concept]
   760   C0678226:resulting [Functional Concept]
   760   C1522492:Formation [Functional Concept]
   726 E C1274040:Result [Functional Concept]
   726 E C1546471:Result [Idea or Concept]
   726 E C2825142:Result [Finding]

Phrase: "("

Phrase: "e.g. MCO,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0025552:Metal [Inorganic Chemical]
   812   C0030011:Oxidation [Molecular Function]
   741 E C2986473:Metallic [Qualitative Concept]

Phrase: "lipid peroxidation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023775:Lipid Peroxidation [Molecular Function]
   861   C0023779:Lipid [Lipid]
   861   C0178796:peroxidation [Phenomenon or Process]

Phrase: ")"

Phrase: "or through enzymatic processes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C1184743:Process [Body Part, Organ, or Organ Component]
   737   C1522240:Process [Phenomenon or Process]

Phrase: "("

Phrase: "e.g. tTGase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: ")"

Phrase: "are"

Phrase: "capable of generating intra-"

Phrase: "and"

Phrase: "intermolecular cross-links"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0332220:cross links [Functional Concept]
   884 E C0178576:Cross link [Natural Phenomenon or Process]
   827   C2828360:Cross [Conceptual Entity]
   793   C1517892:Link [Intellectual Product]
   793   C1704666:Link [Intellectual Product]

Phrase: "(4"

Phrase: ")"

Phrase: "that"

Phrase: "can"

Phrase: "progress from dimers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0596448:dimers [Chemical Viewed Structurally]
   790   C1272688:progress [Functional Concept]
   790   C1280477:Progress [Functional Concept]

Phrase: "up to large soluble synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "conglomerates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0680940:conglomerate [Organization]

Phrase: "that"

Phrase: "may"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "sheet-rich"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0699759:Rich [Qualitative Concept]

Phrase: "but"

Phrase: "non-amyloid synuclein protofibrils"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")"

Phrase: "that,"

Phrase: "when"

Phrase: "accumulated"

Phrase: ","

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "filament formation."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]
Processing 00000000.tx.353: Conversely, when oxidation/oligomerization is prevented, protofibrils do not accumulate, and the assembly of synuclein into amyloid filaments becomes more efficient (6). 

Phrase: "Conversely,"

Phrase: "when"

Phrase: "oxidation/oligomerization"

Phrase: "is"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: ","

Phrase: "protofibrils"

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "accumulate"

Phrase: ","

Phrase: "and"

Phrase: "the assembly of synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1706853:Assembly [Activity]
   770   C1879748:Assembly [Manufactured Object]

Phrase: "into amyloid filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0010851:Filament [Cell Component]
   777 E C1979891:Filamentous [Qualitative Concept]

Phrase: "becomes"

Phrase: "more efficient"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0442799:Efficient [Qualitative Concept]
   789 E C0013682:Efficiency [Quantitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.354: View larger version (18K): [in this window] [in a new window]  FIG. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(18K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  FIG."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0349966:Fig [Food]
  1000   C1337208:FIG [Food]
Processing 00000000.tx.355: 8. 

Phrase: "8."
Processing 00000000.tx.356: Model of synuclein oxidation/oligomerization as it relates to filament formation. 

Phrase: "Model of synuclein oxidation/oligomerization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C3161035:Model [Intellectual Product]

Phrase: "as"

Phrase: "it"

Phrase: "relates to filament formation."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0010851:Filament [Cell Component]
   770   C0163712:Relate [Organic Chemical]
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]
Processing 00000000.tx.357: The natively unfolded synuclein monomer (1) can undergo oxidative modifications (2) resulting in molecules refractory (3, stars) or sensitive (4, lightning bolts) to subsequent intra- and intermolecular cross-linking. 

Phrase: "The natively unfolded synuclein monomer"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0596973:Monomer [Chemical Viewed Structurally]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ")"

Phrase: "can"

Phrase: "undergo"

Phrase: "oxidative modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "(2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: ")"

Phrase: "resulting in molecules"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   882   C0332294:Resulting in [Functional Concept]
   790   C0567416:molecules [Substance]
   790   C0678226:resulting [Functional Concept]
   756 E C1274040:Result [Functional Concept]
   756 E C1546471:Result [Idea or Concept]
   756 E C2825142:Result [Finding]
   706 E C1521991:Molecular [Qualitative Concept]

Phrase: "refractory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205269:Refractory [Functional Concept]

Phrase: "(3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "stars"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1825825:STARS [Gene or Genome]
   928 E C0995242:Stella [Bacterium]
   928 E C1426084:Stella [Gene or Genome]
   928 E C2986872:Stella [Gene or Genome]

Phrase: ")"

Phrase: "or"

Phrase: "sensitive"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332324:Sensitive [Functional Concept]
  1000   C1550474:sensitive [Idea or Concept]

Phrase: "(4,"

Phrase: "lightning"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023701:Lightning [Natural Phenomenon or Process]

Phrase: "bolts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0336726:Bolt [Manufactured Object]
   966   C1706205:Bolt [Manufactured Object]

Phrase: ")"

Phrase: "to subsequent intra-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0347985:Intra [Temporal Concept]

Phrase: "and"

Phrase: "intermolecular"

Phrase: "cross-linking."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]
Processing 00000000.tx.358: Depending on the level of oxidation and extent of oligomerization, sheet-rich soluble oligomers form (4) that may progress to synuclein protofibrils (5). 

Phrase: "Depending on the level of oxidation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0030011:Oxidation [Molecular Function]
   753   C0441889:Level [Qualitative Concept]
   753   C0456079:Level [Classification]
   753   C1547707:Level [Geographic Area]
   753   C2946261:Level [Pharmacologic Substance]
   719   C0725813:depend [Medical Device]

Phrase: "and"

Phrase: "extent of oligomerization,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0439792:Extent [Spatial Concept]

Phrase: "sheet-rich soluble oligomers"

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "(4"

Phrase: ")"

Phrase: "that"

Phrase: "may"

Phrase: "progress"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1272688:progress [Functional Concept]
  1000   C1280477:Progress [Functional Concept]

Phrase: "to synuclein protofibrils"

Phrase: "(5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.359: Partially folded intermediates that may normally function as early intermediates during filament formation can enter the oxidative pathway when oxidation/oligomerization becomes extensive (6). 

Phrase: "Partially folded intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C0205103:Intermediate [Spatial Concept]
   793   C1550465:intermediate [Idea or Concept]
   793   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "that"

Phrase: "may"

Phrase: "normally"

Phrase: "function as early intermediates"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0031843:function [Physiologic Function]
   770   C0542341:Function [Functional Concept]
   770   C0700205:FUNCTION [Classification]
   770   C1279919:Early [Temporal Concept]
   770   C1705273:Function [Intellectual Product]
   737   C0205103:Intermediate [Spatial Concept]
   737   C1550465:intermediate [Idea or Concept]
   737   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "during filament formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "can"

Phrase: "enter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522196:ENTER [Functional Concept]

Phrase: "the oxidative pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "when"

Phrase: "oxidation/oligomerization"

Phrase: "becomes"

Phrase: "extensive"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205231:Extensive [Qualitative Concept]
   928 E C0439795:Extensiveness [Qualitative Concept]

Phrase: "(6"

Phrase: ")."
Processing 00000000.tx.360: At high levels of oxidation, the entire population of synuclein molecules are likely to be affected, rendering synuclein incapable of forming filaments, as well as becoming resistant to degradation by the proteasome. 

Phrase: "At high levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "the entire population of synuclein molecules"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0032659:Population [Quantitative Concept]
   753   C1257890:Population [Population Group]

Phrase: "are"

Phrase: "likely to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "be"

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: ","

Phrase: "rendering"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "incapable of forming filaments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1550518:incapable [Idea or Concept]

Phrase: "as well as"

Phrase: "becoming"

Phrase: "resistant to degradation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   882   C0332325:Resistant to [Functional Concept]
           Resistant
   790   C2827757:RESISTANT [Laboratory or Test Result]

Phrase: "by the proteasome."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.361: At low levels of oxidation, where protofibrils (or dityrosine cross-linked dimers) represent a small proportion of the available synuclein pool, reentry into the pathway leading to filaments may occur, with these structures possibly serving as nucleating centers (7). 

Phrase: "At low levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "of oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "where protofibrils"

Phrase: "("

Phrase: "or"

Phrase: "dityrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0058505:dityrosine [Amino Acid, Peptide, or Protein]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "dimers"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596448:dimers [Chemical Viewed Structurally]

Phrase: ")"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a small proportion of the available synuclein pool,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1709707:Proportion [Quantitative Concept]

Phrase: "reentry into the pathway"

Phrase: "leading to filaments"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756   C0010851:Filament [Cell Component]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   706 E C1979891:Filamentous [Qualitative Concept]

Phrase: "may"

Phrase: "occur"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1709305:Occur [Activity]
  1000   C2745955:OCCUR [Temporal Concept]

Phrase: ","

Phrase: "with these structures possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "serving as nucleating centers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0205099:centers [Spatial Concept]
   770   C1519269:Serving [Quantitative Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.362: In general, oxidation reduces the capacity to form filaments, whereas when oxidation is prevented fibril formation is enhanced (8).  

Phrase: "In general, oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "reduces"

Phrase: "the capacity to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1516240:Capacity [Quantitative Concept]

Phrase: "form"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0348078:Form [Qualitative Concept]
  1000   C0376315:Form [Manufactured Object]
  1000   C1522492:Form [Functional Concept]

Phrase: "filaments,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: "whereas"

Phrase: "when"

Phrase: "oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "prevented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "fibril formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0220781:formation [Biologic Function]
   861   C0439634:formation [Spatial Concept]
   861   C1522492:Formation [Functional Concept]

Phrase: "is"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "(8"

Phrase: ")."
Processing 00000000.tx.363: Fink and colleagues (94, 95) have suggested that synuclein undergoes a transition from the natively unfolded monomer into a more compact partially folded intermediate that ultimately leads to fibril formation. 

Phrase: "Fink"

Phrase: "and"

Phrase: "colleagues"

Phrase: "(94,"

Phrase: "95"

Phrase: ")"

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "undergoes"

Phrase: "a transition from the natively unfolded monomer"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0599156:Transition [Cell or Molecular Dysfunction]
   748   C2700061:Transition [Activity]

Phrase: "into a more compact partially"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205172:More [Functional Concept]
   827   C1333134:Compact [Finding]

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "intermediate"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "that ultimately"

Phrase: "leads to fibril formation."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   770   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   770   C0181586:leads [Medical Device]
   770   C0220781:formation [Biologic Function]
   770   C0225328:Fibril [Cell Component]
   770   C0439634:formation [Spatial Concept]
   770   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   770   C1522492:Formation [Functional Concept]
   770   C1522538:Lead [Functional Concept]
   770   C1948066:Fibril [Physical Object]
   770   C2348269:Lead [Element, Ion, or Isotope]
   770   C3275067:LEAD [Therapeutic or Preventive Procedure]
Processing 00000000.tx.364: For example, fully reversible structural changes are induced by brief incubations at elevated temperatures (95). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "fully reversible structural changes"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   812   C0392747:changes [Functional Concept]
   812   C0443172:changes [Quantitative Concept]
   812   C0678594:Structural [Spatial Concept]
   779 E C1705241:Change [Quantitative Concept]

Phrase: "are"

Phrase: "induced by brief incubations"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205263:Induced [Functional Concept]
   770   C1282927:brief [Qualitative Concept]
   770   C1879313:Brief [Temporal Concept]

Phrase: "at elevated temperatures"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   983   C0015967:elevated temperature [Finding]
   861   C0039476:Temperatures [Quantitative Concept]
   827 E C0005903:temperature [Organism Attribute]

Phrase: "(95"

Phrase: ")."
Processing 00000000.tx.365: Extended incubations (with heating), however, lead to the irreversible formation of cross-linked synuclein that was proposed to stabilize an intermediate in the fibril assembly pathway (88). 

Phrase: "Extended incubations"

Phrase: "("

Phrase: "with heating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018851:Heating [Environmental Effect of Humans]

Phrase: ")"

Phrase: ","

Phrase: "however,"

Phrase: "lead to the irreversible formation of"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   753   C0220781:formation [Biologic Function]
   753   C0439634:formation [Spatial Concept]
   753   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   753   C1522492:Formation [Functional Concept]
   753   C1522538:Lead [Functional Concept]
   753   C2348269:Lead [Element, Ion, or Isotope]
   753   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "that"

Phrase: "was"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "stabilize"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0184512:stabilize [Qualitative Concept]

Phrase: "an intermediate in the fibril assembly pathway"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0205103:Intermediate [Spatial Concept]
   748   C1550465:intermediate [Idea or Concept]
   748   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "(88"

Phrase: ")."
Processing 00000000.tx.366: Rather, we favor the idea that if cross-linking becomes extensive and involves a large fraction of the monomer population then these oligomers are removed from the pathway leading to filaments (7). 

Phrase: "Rather,"

Phrase: "we"

Phrase: "favor"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309049:FAVOR [Organic Chemical,Pharmacologic Substance,Vitamin]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "if"

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "becomes"

Phrase: "extensive"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205231:Extensive [Qualitative Concept]
   928 E C0439795:Extensiveness [Qualitative Concept]

Phrase: "and"

Phrase: "involves"

Phrase: "a large fraction of the monomer population then"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1264633:Fraction of [Quantitative Concept]
           Fraction
   744   C1554103:Fraction [Idea or Concept]

Phrase: "these oligomers"

Phrase: "are"

Phrase: "removed from the pathway"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0849355:Removed [Qualitative Concept]
   770   C1704259:Pathway [Molecular Function]
   770   C1705987:Pathway [Conceptual Entity]
   737 E C1883720:Remove [Activity]
   737 E C3244314:remove [Functional Concept]

Phrase: "leading to filaments"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0332152:Leading [Temporal Concept]
   790   C1522538:Leading [Functional Concept]
   756   C0010851:Filament [Cell Component]
   756 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   756 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   756 E C2348269:Lead [Element, Ion, or Isotope]
   756 E C3275067:LEAD [Therapeutic or Preventive Procedure]
   706 E C1979891:Filamentous [Qualitative Concept]

Phrase: "(7"

Phrase: ")."
Processing 00000000.tx.367: This two-pathway model (i.e. soluble oligomers versus filaments) is similar to that suggested by Fink and colleagues (96), although we have no information on the formation of a partially folded monomeric intermediate during synuclein oxidation/oligomerization, nor do we have evidence of whether the covalently associated synuclein oligomers generated under our oxidizing conditions can reenter the fibril assembly pathway in the presence of modifiers, such as Zn(II) (96) or low pH (79). 

Phrase: "This two-pathway model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3161035:Model [Intellectual Product]

Phrase: "(i.e. soluble oligomers"

Phrase: "versus"

Phrase: "filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   966   C0010851:Filament [Cell Component]
   916 E C1979891:Filamentous [Qualitative Concept]

Phrase: ")"

Phrase: "is"

Phrase: "similar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C2348205:Similar [Qualitative Concept]

Phrase: "suggested by Fink"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1705535:Suggest [Idea or Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(96"

Phrase: ")"

Phrase: ","

Phrase: "although"

Phrase: "we"

Phrase: "have"

Phrase: "no information on the formation of a partially"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1546437:No Information [Qualitative Concept]
   770   C1549058:No Information [Idea or Concept]
   744   C1533716:Information [Idea or Concept]

Phrase: "folded"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332462:Folded [Spatial Concept]
  1000   C1880834:FOLDED [Phenomenon or Process]

Phrase: "monomeric intermediate during synuclein oxidation/oligomerization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205103:Intermediate [Spatial Concept]
   753   C1550465:intermediate [Idea or Concept]
   753   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "nor"

Phrase: "do"

Phrase: "we"

Phrase: "have"

Phrase: "evidence of"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "whether"

Phrase: "the covalently associated synuclein oligomers"

Phrase: "generated under our oxidizing conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C3146294:Generated [Activity]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "can"

Phrase: "reenter"

Phrase: "the fibril assembly pathway in the presence of modifiers,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1704259:Pathway [Molecular Function]
   742   C1705987:Pathway [Conceptual Entity]

Phrase: "such as Zn"

Phrase: "(II"

Phrase: ")"

Phrase: "(96"

Phrase: ")"

Phrase: "or"

Phrase: "low pH"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0728725:Low pH [Finding]
   861   C0020283:[pH] [Quantitative Concept]
   861   C0205251:low [Qualitative Concept]
   861   C0450407:ph+ [Finding]
   861   C0450408:ph++ [Finding]
   861   C0450409:ph+++ [Finding]
   861   C1299352:Low [Qualitative Concept]
   861   C1550472:low [Idea or Concept]

Phrase: "(79"

Phrase: ")."
Processing 00000000.tx.368: Complicating the above model is the observed transient nature of the protofibrils described by Lansbury and colleagues (49, 89) and cross-linked dimers by Krishnan et al. 

Phrase: "Complicating"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231242:complicating [Functional Concept]
  1000   C1522701:Complicating [Functional Concept]

Phrase: "the above model"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3161035:Model [Intellectual Product]

Phrase: "is"

Phrase: "the observed transient nature of the protofibrils"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0349590:Nature [Idea or Concept]
   748   C1262865:Nature [Functional Concept]

Phrase: "described by Lansbury"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(49,"

Phrase: "89"

Phrase: ")"

Phrase: "and"

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "dimers by Krishnan et al."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596448:dimers [Chemical Viewed Structurally]
Processing 00000000.tx.369: (44). 

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.370: During incubations, these structures appear then disappear as filaments are produced. 

Phrase: "During incubations,"

Phrase: "these structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "appear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "disappear as filaments"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   756   C0010851:Filament [Cell Component]
   706 E C1979891:Filamentous [Qualitative Concept]

Phrase: "are"

Phrase: "produced."
Processing 00000000.tx.371: These results suggest that during the mildly oxidizing conditions encountered during long term incubations and in the absence of exogenous oxidizing species, low levels of synuclein oligomers may be generated that subsequently reenter the fibril pathway (8), possibly functioning as nucleating centers, as proposed by Krishnan et al. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that during the mildly oxidizing conditions"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0750532:MILDLY [Idea or Concept]
   753   C2945599:Mildly [Qualitative Concept]
   719   C0012634:condition [Disease or Syndrome]
   719   C0348080:Condition [Qualitative Concept]
   719   C1705253:Condition [Conceptual Entity]

Phrase: "encountered during long term incubations"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0443252:Long-term [Temporal Concept]
   760   C0205166:Long [Qualitative Concept]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C1706317:Long [Qualitative Concept]
   760   C2826302:TERM [Intellectual Product]
   726   C0545082:Encounter [Behavior]
   726   C1512346:encounter [Health Care Activity]
   726   C1947978:Encounter [Behavior]

Phrase: "and in the absence of exogenous oxidizing species,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0205101:Exogenous [Spatial Concept]
   744   C0205228:Exogenous [Functional Concept]
   744   C0332197:absence [Quantitative Concept]
   744   C1515981:And [Idea or Concept]
   744   C1689985:Absence [Anatomical Abnormality]
   744   C1705920:Species [Conceptual Entity]

Phrase: "low levels of synuclein oligomers"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   760   C0441889:Levels [Qualitative Concept]
   726 E C0456079:Level [Classification]
   726 E C1547707:Level [Geographic Area]
   726 E C2946261:Level [Pharmacologic Substance]

Phrase: "may"

Phrase: "be"

Phrase: "generated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3146294:Generated [Activity]

Phrase: "that subsequently"

Phrase: "reenter"

Phrase: "the fibril pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1704259:Pathway [Molecular Function]
   861   C1705987:Pathway [Conceptual Entity]

Phrase: "(8"

Phrase: ")"

Phrase: ","

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "functioning as nucleating centers,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   770   C0205099:centers [Spatial Concept]
   770   C0542341:functioning [Functional Concept]
   737 E C0031843:function [Physiologic Function]
   737 E C0700205:FUNCTION [Classification]
   737 E C1705273:Function [Intellectual Product]

Phrase: "as"

Phrase: "proposed by Krishnan et al."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1441414:PROPOSED [Idea or Concept]
   760   C1553874:Proposed [Qualitative Concept]
   760   C1578820:Proposed [Idea or Concept]
Processing 00000000.tx.372: (44). 

Phrase: "(44"

Phrase: ")."
Processing 00000000.tx.373: Indeed, our observation that purified synuclein oligomers become incorporated into synuclein filaments when supplied with a large excess of unmodified monomer supports the idea that when oxidation is limited, oligomers are capable of becoming assembled into filaments, acting neither as seeds nor poisons. 

Phrase: "Indeed,"

Phrase: "our observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that purified synuclein oligomers"

Phrase: "become"

Phrase: "incorporated into synuclein filaments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   737   C0010851:Filament [Cell Component]

Phrase: "when"

Phrase: "supplied with a large excess of unmodified monomer"
Meta Candidates (Total=9; Excluded=5; Pruned=0; Remaining=4)
   744   C0549177:Large [Quantitative Concept]
   744   C0596973:Monomer [Chemical Viewed Structurally]
   744   C1979886:Excess [Qualitative Concept]
   744   C1999230:Supplied [Activity]
   711 E C0243163:supply [Idea or Concept]
   711 E C0699914:supply [Quantitative Concept]
   711 E C1314650:SUPPLY, NOT OTHERWISE SPECIFIED [Medical Device]
   711 E C1561604:supply [Functional Concept]
   711 E C1875802:SUPPLY [Medical Device]

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the idea"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C1512612:Ideal [Qualitative Concept]

Phrase: "that"

Phrase: "when"

Phrase: "oxidation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030011:Oxidation [Molecular Function]

Phrase: "is"

Phrase: "limited"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0439801:Limited [Functional Concept]
  1000   C3542948:Limited [Intellectual Product]
   966 E C1549649:Limit [Idea or Concept]
   966 E C2349209:Limit [Conceptual Entity]

Phrase: ","

Phrase: "oligomers"

Phrase: "are"

Phrase: "capable of"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   761   C2698977:Capability [Qualitative Concept]

Phrase: "becoming"

Phrase: "assembled into filaments,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   756   C0010851:Filament [Cell Component]
   756   C1706853:Assemble [Activity]
   706 E C1979891:Filamentous [Qualitative Concept]

Phrase: "acting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "neither as seeds"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0036563:Seed [Plant]
   790   C1705192:Seed [Laboratory Procedure]
   790   C1882540:{Seed} [Quantitative Concept]
   790   C2346495:Seed [Conceptual Entity]
   790   C3274651:Neither [Qualitative Concept]
   734 E C1519232:Seminal [Clinical Attribute]

Phrase: "nor"

Phrase: "poisons."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0032346:Poisons [Hazardous or Poisonous Substance]
   966 E C1548769:Poison [Intellectual Product]
   966 E C1550590:poison [Idea or Concept]
   928 E C0600688:toxic [Injury or Poisoning]
   928 E C1407029:Toxic [Qualitative Concept]
   900 E C0040539:toxicity [Qualitative Concept]
Processing 00000000.tx.374: However, extensive oxidation, in which a significant proportion of the synuclein population becomes modified, irrespective of whether these modifications ultimately result in oligomerization, renders synuclein incompetent to assemble into fibrils. 

Phrase: "However,"

Phrase: "extensive oxidation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030011:Oxidation [Molecular Function]

Phrase: "in which"

Phrase: "a significant proportion of the synuclein population"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1709707:Proportion [Quantitative Concept]

Phrase: "becomes"

Phrase: "modified,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "irrespective of"

Phrase: "whether"

Phrase: "these modifications ultimately"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0392747:Modification [Functional Concept]
   827   C1554963:modification [Qualitative Concept]

Phrase: "result in oligomerization,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1274040:Result [Functional Concept]
   790   C1546471:Result [Idea or Concept]
   790   C2825142:Result [Finding]

Phrase: "renders"

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "incompetent to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0231190:Incompetent [Functional Concept]

Phrase: "assemble into fibrils."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0225328:fibrils [Cell Component]
   790   C1706853:Assemble [Activity]
   756 E C1948066:Fibril [Physical Object]
Processing 00000000.tx.375: Oxidized Synuclein Inhibits the 20 S ProteasomeAlthough it has not been determined whether the generation of synuclein oligomers within diseased tissue represents a cause or a consequence of the pathology, it is likely that their accumulation is reflected by insufficient degradation by cellular proteases. 

Phrase: "Oxidized Synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "Inhibits"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the 20 S ProteasomeAlthough"

Phrase: "it"

Phrase: "has"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "been"

Phrase: "determined"

Phrase: "whether"

Phrase: "the generation of synuclein oligomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0079411:Generation [Temporal Concept]
   760   C3146294:Generation [Activity]

Phrase: "within diseased tissue"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a cause"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0015127:cause [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "or"

Phrase: "a consequence of the pathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0686907:Consequence of [Functional Concept]
           Consequence

Phrase: "it"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "their accumulation"

Phrase: "is"

Phrase: "reflected by insufficient degradation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205412:Insufficient [Qualitative Concept]
   770   C0231180:Insufficient [Qualitative Concept]
   770   C0243125:degradation [Functional Concept]
   770   C0558058:reflected [Mental Process]
   770   C0699900:Degradation [Organism Function]

Phrase: "by cellular proteases."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0030940:Proteases [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0030946:proteases [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   861   C1947941:Proteases [Enzyme]
Processing 00000000.tx.376: The discovery of gene defects in familial PD linked to protein turnover by the proteasome (e.g. parkin, UCH-L1), as well as evidence for impairment of the ubiquitin-proteasome system in sporadic PD, has led to the proposal that dysregulation of protein turnover by the proteasome represents a major aspect in the pathogenesis of PD (3). 

Phrase: "The discovery of gene defects"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C2717881:Gene Discovery [Molecular Biology Research Technique]
   760   C1880355:Discovery [Activity]

Phrase: "in familial PD"

Phrase: "linked to protein turnover"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0597297:Protein Turnover [Molecular Function]
   819   C0065011:linked protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0031227:turnover [Quantitative Concept]
   770   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0243127:turnover [Functional Concept]
   770   C0443331:Turnover [Health Care Activity]
   737   C1517892:Link [Intellectual Product]
   737   C1704666:Link [Intellectual Product]

Phrase: "by the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "("

Phrase: "e.g. parkin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1418270:PARKIN [Gene or Genome]
  1000   C2983549:Parkin [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "UCH-L1"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C1421309:Uch-L1 [Gene or Genome]
  1000   C3539585:UCH-L1 [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C3541328:Uch-L1 [Gene or Genome]
   861   C0164005:UCH [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0441918:L1 [Finding]
   861   C1179698:L1 [Body Location or Region]
   861   C1416177:L1 [Gene or Genome]

Phrase: ")"

Phrase: ","

Phrase: "as well as"

Phrase: "evidence for impairment of the ubiquitin-proteasome system"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0332120:Evidence of [Functional Concept]
           Evidence

Phrase: "in sporadic PD,"

Phrase: "has"

Phrase: "led to the proposal"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   770   C1555306:proposal [Idea or Concept]
   770   C1708698:LED [Manufactured Object]
   770   C1948033:Proposal [Intellectual Product]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C1522538:Lead [Functional Concept]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "that dysregulation of protein turnover"

Phrase: "by the proteasome"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0208355:Proteasome [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1325620:proteasome [Cell Component]
  1000   C1752727:Proteasome [Molecular Function]

Phrase: "represents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "a major aspect in the pathogenesis of PD (3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1547011:Aspect [Quantitative Concept]
   742   C1879746:Aspect [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.377: Although the normal cellular mechanism for synuclein turnover has been debated (97), purified recombinant synuclein is efficiently degraded by isolated 20 S proteasomes without participation of the 19 S regulatory cap or the need for ubiquitinylation (81). 

Phrase: "Although"

Phrase: "the normal cellular mechanism for synuclein turnover"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441712:Mechanism [Functional Concept]
   748   C1706376:Mechanism [Manufactured Object]

Phrase: "has"

Phrase: "been"

Phrase: "debated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0870392:debate [Activity]

Phrase: "(97"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "purified"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1998793:Purified [Functional Concept]
   907 E C1947930:Cleanse [Activity]

Phrase: "recombinant synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "efficiently"

Phrase: "degraded by isolated 20 S proteasomes"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   753   C0205409:Isolated [Functional Concept]
   753   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   753   C1548221:Isolated [Idea or Concept]
   753   C1881707:DEGRADED [Phenomenon or Process]
   719 E C1325620:proteasome [Cell Component]
   719 E C1752727:Proteasome [Molecular Function]

Phrase: "without participation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0679823:Participation [Functional Concept]

Phrase: "of the 19 S regulatory cap"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0179586:Cap [Manufactured Object]
   812   C1657858:CAP [Medical Device]
   812   C1706092:Cap [Medical Device]

Phrase: "or"

Phrase: "the need for ubiquitinylation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027552:Need [Qualitative Concept]
   770   C0686904:need [Functional Concept]

Phrase: "(81"

Phrase: ")."
Processing 00000000.tx.378: Previously it has been reported that monomeric synuclein has little effect on the activity of purified erythrocyte 20 S proteasomes, except at high concentrations (54, 55). 

Phrase: "Previously"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "little effect on the activity of purified erythrocyte 20 S proteasomes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1280500:Effect [Qualitative Concept]
   738   C2348382:Effect [Qualitative Concept]

Phrase: "except"

Phrase: "at high concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.379: We found, however, using 20 S proteasomes purified from rat liver that at 1 M (representing a 20-fold molar excess over the 20 S core particle) monomeric synuclein inhibit the glutamyl-peptidase activity by 45%, whereas the trypsin-like and chymotrypsin-like activities are relatively unaffected. 

Phrase: "We"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: ","

Phrase: "however,"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "20 S proteasomes"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   793 E C1325620:proteasome [Cell Component]
   793 E C1752727:Proteasome [Molecular Function]

Phrase: "purified from rat liver"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C1882726:Rat Liver [Body Part, Organ, or Organ Component]
   770   C0023884:Liver [Body Part, Organ, or Organ Component]
   770   C0034693:Rat, NOS [Mammal]
   770   C0034721:Rat [Mammal]
   770   C0736268:LIVER [Body Part, Organ, or Organ Component]
   770   C1278929:Liver [Body Part, Organ, or Organ Component]
   770   C1998793:Purified [Functional Concept]
   770   C2346688:LIVER [Food]
   715 E C0205054:Hepatic [Body Location or Region]

Phrase: "that at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: "M ("

Phrase: "representing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "a 20-fold molar excess over the 20 S core particle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C1979886:Excess [Qualitative Concept]

Phrase: ")"

Phrase: "monomeric synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the glutamyl-peptidase activity by 45%,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C1150095:peptidase activity [Molecular Function]
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C1561536:*Activity [Idea or Concept]

Phrase: "whereas"

Phrase: "the trypsin-like"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]

Phrase: "and"

Phrase: "chymotrypsin-like activities"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   896   C1150252:chymotrypsin activity [Molecular Function]
   827   C0441655:Activities [Activity]
   793 E C0205177:Activity [Functional Concept]
   793 E C0439167:% activity [Quantitative Concept]
   793 E C1561536:*Activity [Idea or Concept]
   734   C1413809:chymotrypsin-like [Gene or Genome]

Phrase: "are"

Phrase: "relatively unaffected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2986417:Unaffected [Conceptual Entity]
Processing 00000000.tx.380: Whether the decrease in glutamyl-peptidase activity is through substrate competition or an allosteric effect mediated through binding of monomeric synuclein to non-catalytic site(s) on the 20 S particle (see Refs. 98 and 99), is unknown. 

Phrase: "Whether"

Phrase: "the decrease in glutamyl-peptidase activity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0392756:Decrease [Qualitative Concept]
   753   C0547047:Decrease [Quantitative Concept]

Phrase: "is through substrate competition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0679932:competition [Social Behavior]
   770   C1710236:Substrate [Manufactured Object]

Phrase: "or"

Phrase: "an allosteric effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1280500:Effect [Qualitative Concept]
   861   C2348382:Effect [Qualitative Concept]

Phrase: "mediated through binding of monomeric synuclein"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0086597:mediated [Social Behavior]
   753   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   753   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0243122:binding [Functional Concept]
   753   C1145667:Binding [Activity]
   753   C1167622:Binding [Molecular Function]

Phrase: "to non-catalytic site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0205681:Catalytic Site [Functional Concept]
   901   C0600499:catalytic site [Amino Acid Sequence]
   827   C0205145:Site [Spatial Concept]
   827   C1515974:Site [Body Location or Region]
   827   C2825164:Site [Spatial Concept]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "on the 20 S particle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597177:Particle [Chemical Viewed Structurally]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Refs. 98"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1425988:REF [Gene or Genome]

Phrase: "and"

Phrase: "99"

Phrase: ")"

Phrase: ","

Phrase: "is"

Phrase: "unknown."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439673:Unknown [Qualitative Concept]
Processing 00000000.tx.381: Similar mechanism(s) may play a role in the increase in trypsin-like activity observed with oxidized synuclein (see Table I). 

Phrase: "Similar mechanism"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0441712:Mechanism [Functional Concept]
   861   C1706376:Mechanism [Manufactured Object]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "may"

Phrase: "play"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0032214:Play [Daily or Recreational Activity]
  1000   C0600138:play [Finding]

Phrase: "a role in the increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in trypsin-like activity"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C1150284:trypsin activity [Molecular Function]
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]

Phrase: "observed with oxidized synuclein"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1441672:Observed [Functional Concept]
   737   C0030011:oxidize [Molecular Function]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.382: Previously, oligomeric and fibrillar forms of synuclein were shown to effectively inhibit the chymotrypsin-like activity of purified 20 S proteasomes, when assayed by proteolysis of small fluorogenic peptides (54, 55). 

Phrase: "Previously,"

Phrase: "oligomeric"

Phrase: "and"

Phrase: "fibrillar forms of synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0348078:forms [Qualitative Concept]
   770   C0376315:Forms [Manufactured Object]
   737 E C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to effectively"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "inhibit"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   944   C0018790:arrested [Disease or Syndrome]
   944   C0237477:Arrest [Temporal Concept]
   944   C0392351:arrest [Governmental or Regulatory Activity]
   944   C0521111:Retarded [Qualitative Concept]
   916 E C0311403:Inhibited [Qualitative Concept]
   916 E C3463820:Inhibiting [Activity]

Phrase: "the chymotrypsin-like activity of purified 20 S proteasomes,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   762   C1150252:chymotrypsin activity [Molecular Function]
   745   C1622946:proteasome activity [Molecular Function]
   742   C0205177:Activity [Functional Concept]
   742   C0439167:% activity [Quantitative Concept]
   742   C0441655:Activity [Activity]
   742   C1561536:*Activity [Idea or Concept]

Phrase: "when"

Phrase: "assayed by proteolysis of small fluorogenic peptides"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0030956:Peptides [Amino Acid, Peptide, or Protein]
   748   C0597304:Proteolysis [Molecular Function]
   748   C0700321:Small [Quantitative Concept]
   714   C0005507:Assay [Laboratory Procedure]
   714   C0243073:assay [Qualitative Concept]
   714   C1510438:Assay [Laboratory Procedure]

Phrase: "(54,"

Phrase: "55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.383: This was demonstrated to occur through a non-competitive mechanism and thus likely occurred through direct binding to the proteasomal subunits themselves (55). 

Phrase: "This"

Phrase: "was"

Phrase: "demonstrated"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur through a non-competitive mechanism"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0441712:Mechanism [Functional Concept]
   753   C0679932:competitive [Social Behavior]
   753   C1518422:Non [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]
   753   C1709305:Occur [Activity]
   753   C2745955:OCCUR [Temporal Concept]

Phrase: "and"

Phrase: "thus likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0332148:Likely [Qualitative Concept]
   861   C0750492:Likely [Idea or Concept]

Phrase: "occurred through direct binding"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   770   C0243122:binding [Functional Concept]
   770   C0439851:Direct [Qualitative Concept]
   770   C1145667:Binding [Activity]
   770   C1167622:Binding [Molecular Function]
   770   C1709305:Occurred [Activity]
   770   C1947931:Direct [Qualitative Concept]
   737 E C2745955:OCCUR [Temporal Concept]

Phrase: "to the proteasomal subunits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1711351:Subunit [Quantitative Concept]

Phrase: "themselves"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.384: By immunoblotting, we observed that oxidized synuclein is poorly degraded by 20 S proteasomes. 

Phrase: "By immunoblotting,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0020985:Immunoblotting [Laboratory Procedure]

Phrase: "we"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that oxidized synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "poorly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205169:Poorly [Qualitative Concept]

Phrase: "degraded by 20 S proteasomes."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   760   C0208355:proteasomes [Amino Acid, Peptide, or Protein,Enzyme]
   760   C1881707:DEGRADED [Phenomenon or Process]
   726 E C1325620:proteasome [Cell Component]
   726 E C1752727:Proteasome [Molecular Function]
Processing 00000000.tx.385: Yet, this appears not to be because of inhibition of the various proteasomal activities, because no additional effects are detected using fluorogenic peptides when compared with unmodified synuclein (see Table I). 

Phrase: "Yet,"

Phrase: "this"

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "be because of inhibition of the various proteasomal activities,"
Meta Candidates (Total=12; Excluded=3; Pruned=0; Remaining=9)
   742   C0021467:Inhibition [Mental Process]
   742   C0021469:Inhibition [Molecular Function]
   742   C0440102:Various [Indicator, Reagent, or Diagnostic Aid]
   742   C0441655:Activities [Activity]
   742   C1628982:% inhibition [Quantitative Concept]
   742   C2987476:Be [Conceptual Entity]
   742   C3463820:Inhibition [Activity]
   726   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   712   C1622946:proteasome activity [Molecular Function]
   708 E C0205177:Activity [Functional Concept]
   708 E C0439167:% activity [Quantitative Concept]
   708 E C1561536:*Activity [Idea or Concept]

Phrase: "because"

Phrase: "no additional effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "are"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "fluorogenic peptides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0030956:Peptides [Amino Acid, Peptide, or Protein]

Phrase: "when"

Phrase: "compared with unmodified synuclein"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1707455:Compared [Activity]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Table I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.386: Rather, this inhibition may be because of a failure of cross-linked synuclein to act as an efficient 20 S proteasomal substrate, for example, through structural alterations that occur during synuclein oxidation (cross-links, etc.). 

Phrase: "Rather,"

Phrase: "this inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "may"

Phrase: "be because of a failure of"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0231174:Failure [Functional Concept]
   753   C0680095:failure [Individual Behavior]
   753   C2987476:Be [Conceptual Entity]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "synuclein to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "act as an efficient 20 S proteasomal substrate,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0079613:ACT [Therapeutic or Preventive Procedure]
   744   C0442799:Efficient [Qualitative Concept]
   744   C1710236:Substrate [Manufactured Object]

Phrase: "for example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "through structural alterations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1515926:Alteration [Idea or Concept]

Phrase: "that"

Phrase: "occur during synuclein oxidation"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0030011:Oxidation [Molecular Function]
   770   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]

Phrase: "(cross-links,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:cross links [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "etc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548556:etc. [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.387: The failure to degrade the monomeric portion of synuclein within the oxidized sample may occur through steric inhibition by synuclein oligomers, thereby preventing access of monomers to the 20 S active site(s) or by the stable association of synuclein monomers with cross-liked species. 

Phrase: "The failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "degrade"

Phrase: "the monomeric portion of synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449719:Portion [Spatial Concept]

Phrase: "within the oxidized sample"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0370003:Sample [Substance]
   861   C2347026:Sample [Conceptual Entity]

Phrase: "may"

Phrase: "occur through steric inhibition"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C1709305:Occur [Activity]
   770   C2745955:OCCUR [Temporal Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "by synuclein oligomers,"

Phrase: "thereby"

Phrase: "preventing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "access of monomers"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0444454:Access [Spatial Concept]
   790   C1554204:access [Idea or Concept]

Phrase: "to the 20 S active site"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205681:Active Site [Functional Concept]
   812   C0205145:Site [Spatial Concept]
   812   C0205177:Active [Functional Concept]
   812   C1515974:Site [Body Location or Region]
   812   C2825164:Site [Spatial Concept]

Phrase: "(s"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1550101:Supernatant [Body Substance]

Phrase: ")"

Phrase: "or by the stable association of synuclein monomers"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   744   C0004083:Association [Mental Process]
   744   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0205360:Stable [Qualitative Concept]
   744   C0439849:Association [Qualitative Concept]
   744   C0596306:Association [Phenomenon or Process]
   744   C0596973:monomers [Chemical Viewed Structurally]
   744   C0699792:association [Social Behavior]
   744   C1547311:Stable [Intellectual Product]

Phrase: "with cross-liked species."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]
Processing 00000000.tx.388: Lindersson et al. 

Phrase: "Lindersson et al."
Processing 00000000.tx.389: (55) have shown that inhibition of the chymotrypsin-like activity of the proteasome required an amyloid-like structure of synuclein oligomers. 

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that inhibition of the chymotrypsin-like activity of the proteasome"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C1514526:Proteasome Inhibition [Cell Function,Molecular Function]
   739   C0021467:Inhibition [Mental Process]
   739   C0021469:Inhibition [Molecular Function]
   739   C1628982:% inhibition [Quantitative Concept]
   739   C3463820:Inhibition [Activity]

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "an amyloid-like structure of synuclein oligomers."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.390: Because the oligomers generated under our oxidizing conditions do not contain amyloid (see Fig. 3) and are not recognized by anti-oligomer antibodies (61) (data not shown), the inhibition we observe is likely mechanistically dissimilar to that reported previously (55). 

Phrase: "Because"

Phrase: "the oligomers"

Phrase: "generated under our oxidizing conditions"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C3146294:Generated [Activity]
   726   C0012634:condition [Disease or Syndrome]
   726   C0348080:Condition [Qualitative Concept]
   726   C1705253:Condition [Conceptual Entity]

Phrase: "do"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "contain"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contain [Functional Concept]
  1000   C2700400:Contain [Activity]

Phrase: "amyloid"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "("

Phrase: "see"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0042789:see [Organism Function]
  1000   C1947903:See [Activity]

Phrase: "Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "and"

Phrase: "are"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "recognized by anti-oligomer antibodies"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   797   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   781 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(61"

Phrase: ")"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "the inhibition"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0021467:Inhibition [Mental Process]
  1000   C0021469:Inhibition [Molecular Function]
  1000   C1628982:% inhibition [Quantitative Concept]
  1000   C3463820:Inhibition [Activity]
   928 E C0311403:Inhibited [Qualitative Concept]

Phrase: "we"

Phrase: "observe"

Phrase: "is"

Phrase: "likely mechanistically dissimilar to that"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0443202:Dissimilar [Qualitative Concept]

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "previously"

Phrase: "(55"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.391: Thus, discounting possible differences because of the source of proteasomes, various oligomeric forms of synuclein (amyloid/non-covalently associated versus non-amyloid/covalently cross-linked) can have different net effects on proteasomal activity and substrate turnover. 

Phrase: "Thus,"

Phrase: "discounting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1555671:discount [Intellectual Product]

Phrase: "possible differences because of the source of proteasomes,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   711   C1705241:*Difference [Quantitative Concept]
   711   C1705242:Difference [Qualitative Concept]

Phrase: "various oligomeric forms of synuclein"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   760   C0348078:forms [Qualitative Concept]
   760   C0376315:Forms [Manufactured Object]
   726 E C1522492:Form [Functional Concept]

Phrase: "(amyloid/non-covalently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1518422:Non [Functional Concept]

Phrase: "associated"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332281:Associated [Qualitative Concept]
   966 E C0750490:Associate [Idea or Concept]
   966 E C1706221:Associate [Professional or Occupational Group]

Phrase: "versus"

Phrase: "non-amyloid/covalently"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0011560:Amyloid [Pathologic Function]
   827   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1518422:Non [Functional Concept]

Phrase: "cross-linked"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0178576:Cross Linked [Natural Phenomenon or Process]
  1000   C0332220:cross linked [Functional Concept]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: ")"

Phrase: "can"

Phrase: "have"

Phrase: "different net effects on proteasomal activity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C1280500:effects [Qualitative Concept]
   719 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "substrate turnover."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0031227:turnover [Quantitative Concept]
   861   C0243127:turnover [Functional Concept]
   861   C0443331:Turnover [Health Care Activity]
Processing 00000000.tx.392: Nevertheless, our results suggest that failure to clear oxidatively modified synuclein assembled into higher molecular mass oligomers may ultimately result in a cascade of events leading to cell degeneration in PD and other synucleinopathies (5255). 

Phrase: "Nevertheless,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that failure to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0231174:Failure [Functional Concept]
   861   C0680095:failure [Individual Behavior]

Phrase: "clear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2963144:Clear [Qualitative Concept]

Phrase: "oxidatively"

Phrase: "modified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392747:Modified [Functional Concept]

Phrase: "synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "assembled into higher molecular mass oligomers"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   790   C3152252:Molecular Mass [Quantitative Concept]
           Mass
   753   C0577559:Mass [Finding]
   753   C1306372:*Mass [Quantitative Concept]
   753   C1521991:Molecular [Qualitative Concept]
   719   C0205250:High [Qualitative Concept]
   719   C1299351:High [Qualitative Concept]
   719   C1706853:Assemble [Activity]
   719   C2700149:HIGH [Intellectual Product]

Phrase: "may"

Phrase: "ultimately"

Phrase: "result in a cascade of events"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0441471:Events [Event]
   753   C1274040:Result [Functional Concept]
   753   C1546471:Result [Idea or Concept]
   753   C1707310:Cascade [Manufactured Object]
   753   C2825142:Result [Finding]
   753   C3541888:Events [Classification]

Phrase: "leading to cell degeneration"
Meta Candidates (Total=13; Excluded=4; Pruned=0; Remaining=9)
   833   C0333467:Cell degeneration [Pathologic Function]
   770   C0007634:Cell [Cell]
   770   C0011164:Degeneration [Pathologic Function]
   770   C0332152:Leading [Temporal Concept]
   770   C1269647:Cell [Cell]
   770   C1522538:Leading [Functional Concept]
   770   C1704653:Cell [Medical Device]
   770   C1880269:Degeneration [Functional Concept]
   770   C1948049:Cell [Spatial Concept]
   737 E C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
   737 E C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
   737 E C2348269:Lead [Element, Ion, or Isotope]
   737 E C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "in PD"

Phrase: "and"

Phrase: "other synucleinopathies"

Phrase: "(5255"

Phrase: ")."
Processing 00000000.tx.393: Determining the chemical nature of these modifications that lead to synuclein cross-linking and ultimately to synuclein deposition within insoluble aggregates (31, 3537) will be an important aspect of future PD research.  

Phrase: "Determining"

Phrase: "the chemical nature of these modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0349590:Nature [Idea or Concept]
   753   C1262865:Nature [Functional Concept]

Phrase: "that"

Phrase: "lead"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0023175:???lead [Element, Ion, or Isotope,Hazardous or Poisonous Substance]
  1000   C1442948:lead [Inorganic Chemical,Pharmacologic Substance]
  1000   C1522538:Lead [Functional Concept]
  1000   C2348269:Lead [Element, Ion, or Isotope]
  1000   C3275067:LEAD [Therapeutic or Preventive Procedure]

Phrase: "to synuclein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0165073:Synuclein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "cross-linking"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0332220:Cross-linking [Functional Concept]
   983 E C0178576:Cross link [Natural Phenomenon or Process]
   861   C2828360:Cross [Conceptual Entity]
   827   C1517892:Link [Intellectual Product]
   827   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "ultimately to synuclein deposition within insoluble aggregates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0333562:Deposition [Functional Concept]

Phrase: "(31,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450355:31 [Intellectual Product]

Phrase: "3537"

Phrase: ")"

Phrase: "will"

Phrase: "be"

Phrase: "an important aspect of future PD research."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1547011:Aspect [Quantitative Concept]
   748   C1879746:Aspect [Qualitative Concept]
Processing 00000000.tx.394: FOOTNOTES  * The costs of publication of this article were defrayed in part by the payment of page charges. 

Phrase: "FOOTNOTES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2825232:Footnote [Intellectual Product]

Phrase: "*"

Phrase: "The costs of publication of this article"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0010186:Costs [Quantitative Concept]
   748   C0220812:Costs [Quantitative Concept]

Phrase: "were"

Phrase: "defrayed in part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0449719:Part [Spatial Concept]
   790   C1709471:Part [Quantitative Concept]

Phrase: "by the payment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0220808:payment [Quantitative Concept]
  1000   C0680264:payment [Quantitative Concept]

Phrase: "of page charges."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0007961:Charges [Quantitative Concept]
   827 E C1706211:Charge [Organism Attribute]
Processing 00000000.tx.395: This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. 

Phrase: "This article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "must"

Phrase: "therefore"

Phrase: "be"

Phrase: "hereby"

Phrase: "marked"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0522501:Marked [Qualitative Concept]
  1000   C1706089:Marked [Qualitative Concept]

Phrase: """advertisement"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0949214:advertisement [Intellectual Product]

Phrase: "in accordance with 18 U.S.C."
Processing 00000000.tx.396: Section 1734 solely to indicate this fact. 

Phrase: "Section 1734 solely to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0205155:Section [Spatial Concept]
   812   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   812   C1522472:Section [Substance]
   812   C1552923:Section [Quantitative Concept]
   812   C1705191:Section [Physical Object]

Phrase: "indicate"

Phrase: "this fact."
Processing 00000000.tx.397: To whom correspondence should be addressed: 49 Convent Dr./Rm. 

Phrase: "To whom correspondence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282413:Correspondence [Intellectual Product]

Phrase: "should"

Phrase: "be"

Phrase: "addressed"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0376649:Address [Intellectual Product]
   966   C1442065:Address [Spatial Concept]

Phrase: ":"

Phrase: "49 Convent Dr./Rm."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2951520:RM [Body Location or Region]
Processing 00000000.tx.398: 4B67, Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892. 

Phrase: "4B67,"

Phrase: "Genetic Disease Research Branch,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C1253959:Branch [Body Part, Organ, or Organ Component]
   812   C1881507:Branch [Chemical Viewed Structurally]
   812   C2700383:Branch [Plant]
   812   C2826234:BRANCH [Intellectual Product]
   708   C0243064:Genetic Research [Research Activity]

Phrase: "National Human Genome Research Institute,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C1955973:National Human Genome Research Institute [Health Care Related Organization]
   840   C0017429:Genome, Human [Gene or Genome]
   840   C0035172:Research Institute [Organization]
   804   C0017428:Genome [Gene or Genome]
   804   C0021622:institute [Organization]
   804   C0035168:research [Research Activity]
   804   C0086418:Human [Human]
   804   C0242481:Research [Research Activity]
   804   C1272753:Institute [Idea or Concept]
   804   C2338314:Genome [Conceptual Entity]
   804   C3245503:national [Intellectual Product]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "Bethesda,"

Phrase: "MD 20892."
Processing 00000000.tx.399: Tel.: 

Phrase: "Tel."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0254343:TEL [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0796520:TEL [Gene or Genome]
  1000   C3272379:TEL [Intellectual Product]

Phrase: ":"
Processing 00000000.tx.400: 301-402-2038; 

Phrase: "301-402-2038"

Phrase: ";"
Processing 00000000.tx.401: Fax: 301-402-2170; 

Phrase: "Fax"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0085205:Fax [Manufactured Object]
  1000   C1549619:FAX [Conceptual Entity]
  1000   C1880669:Fax [Manufactured Object]

Phrase: ":"

Phrase: "301-402-2170"

Phrase: ";"
Processing 00000000.tx.402: E-mail: ncole{at}mail.nih.gov . 1 The abbreviations used are: PD, Parkinson's disease; 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "ncole{at}mail.nih.gov . 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0024492:Mail [Manufactured Object]
   799   C0027468:NIH [Health Care Related Organization]
   799   C1419208:GOV [Gene or Genome]
   799   C1538057:MAIL [Gene or Genome]
   799   C1547565:Mail [Idea or Concept]

Phrase: "The abbreviations"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0000723:Abbreviations [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "PD,"

Phrase: "Parkinson's disease"
Meta Candidates (Total=8; Excluded=3; Pruned=0; Remaining=5)
  1000   C0030567:Parkinson Disease [Disease or Syndrome]
  1000   C1521736:Parkinson's Disease [Functional Concept]
  1000   C2681933:PARKINSON DISEASE [Gene or Genome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
   761   C1021144:Parkinsonia [Plant]

Phrase: ";"
Processing 00000000.tx.403: MCO, metal catalyzed oxidation; 

Phrase: "MCO,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0025552:Metal [Inorganic Chemical]
   812   C0030011:Oxidation [Molecular Function]
   741 E C2986473:Metallic [Qualitative Concept]

Phrase: "metal catalyzed oxidation"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0025552:Metal [Inorganic Chemical]
   827   C0030011:Oxidation [Molecular Function]
   755 E C2986473:Metallic [Qualitative Concept]

Phrase: ";"
Processing 00000000.tx.404: ROS, reactive oxygen species; 

Phrase: "ROS,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: "reactive oxygen species"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0162772:Reactive Oxygen Species [Biologically Active Substance,Element, Ion, or Isotope]
   827   C0030054:Oxygen [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C0205332:Reactive [Qualitative Concept]
   827   C1705920:Species [Conceptual Entity]

Phrase: ";"
Processing 00000000.tx.405: DTT, dithiothreitol; 

Phrase: "DTT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: "dithiothreitol"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012789:Dithiothreitol [Carbohydrate,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.406: DSP, dithiobis(succinimidyl propionate); 

Phrase: "DSP,"

Phrase: "dithiobis(succinimidyl propionate)"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0058494:dithiobis((succinimidyl)propionate) [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   827   C0033474:propionate [Organic Chemical]
   827   C0392214:Propionate [Lipid]

Phrase: ";"
Processing 00000000.tx.407: bis-ANS, 44'-dianilino-11'-binaphthyl-55'-disulfonic acid; 

Phrase: "bis-ANS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0048876:bis-ANS [Organic Chemical,Pharmacologic Substance]
   861   C0004388:ANS [Body System]

Phrase: "44'-dianilino-11'-binaphthyl-55'-disulfonic acid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0001128:Acid [Chemical]
   795   C0202406:Acid [Laboratory Procedure]

Phrase: ";"
Processing 00000000.tx.408: tTGase, tissue transglutaminase; 

Phrase: "tTGase,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: "tissue transglutaminase"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0529334:tissue transglutaminase [Amino Acid, Peptide, or Protein,Enzyme,Immunologic Factor]
  1000   C1420714:TRANSGLUTAMINASE, TISSUE [Gene or Genome]
  1000   C2256568:tissue transglutaminase [Molecular Function]
   861   C0033679:Transglutaminase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0040300:Tissue [Tissue]
   861   C1547928:Tissue [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.409: tricine, N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine; 

Phrase: "tricine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0077068:tricine [Organic Chemical]

Phrase: "N-[2-hydroxy-1,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441922:N+ [Intellectual Product]
   812   C0700307:Hydroxy [Inorganic Chemical]
   812   C1553036:[n] [Quantitative Concept]

Phrase: "1-bis("
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0556985:BIS [Temporal Concept]
   861   C2247301:BIS [Molecular Function]
   861   C3540495:BIS [Intellectual Product]

Phrase: "hydroxymethyl"

Phrase: ")"

Phrase: "ethyl"

Phrase: "]glycine"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C0522461:Glycine [Plant]

Phrase: ";"
Processing 00000000.tx.410: PBS, phosphate-buffered saline. 

Phrase: "PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "phosphate-buffered saline."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   884   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   827   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   827   C0031701:phosphate [Organophosphorus Compound]
   827   C0036082:Saline [Substance]
   827   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.411: 2 The terms "protofibril" and "protofilament" have been used to represent distinct on-pathway intermediates that form during protein filament assembly, often containing filament-like (100, 101) or curved (74, 102, 103) morphologies. 

Phrase: "2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0740116:+2 [Quantitative Concept]
  1000   C2827735:2+ [Quantitative Concept]
  1000   C2981700:2+ [Classification]

Phrase: "The terms ""protofibril"""

Phrase: "and """

Phrase: "protofilament"""
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1179914:Protofilament [Cell Component]

Phrase: "have"

Phrase: "been"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "distinct on-pathway"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1704259:Pathway [Molecular Function]
   827   C1705987:Pathway [Conceptual Entity]

Phrase: "intermediates"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205103:Intermediate [Spatial Concept]
  1000   C1550465:intermediate [Idea or Concept]
  1000   C2827755:INTERMEDIATE [Laboratory or Test Result]

Phrase: "that form during protein filament assembly,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "filament-"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0010851:Filament [Cell Component]
   928 E C1979891:Filamentous [Qualitative Concept]

Phrase: "like"

Phrase: "(100,"

Phrase: "101"

Phrase: ")"

Phrase: "or"

Phrase: "curved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205134:Curved [Spatial Concept]

Phrase: "(74,"

Phrase: "102,"

Phrase: "103"

Phrase: ")"

Phrase: "morphologies."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0332437:Morphology [Qualitative Concept]
   966   C0543482:morphology [Spatial Concept]
   966   C0700329:Morphology, NOS [Finding]
   966   C0700619:Morphology [Biomedical Occupation or Discipline]
Processing 00000000.tx.412: To avoid confusion, we will use the term synuclein protofibril to represent non-fibrillar, non-fluorogenic (or weakly fluorogenic) synuclein oligomers that elute in the void volume from Superdex 200 or Superose 6 gel filtration columns, as originally described by Lansbury and colleagues (74, 104).  

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "confusion,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0009676:Confusion [Mental or Behavioral Dysfunction]
  1000   C1963086:Confusion [Finding]
   928 E C1547301:Confused [Intellectual Product]

Phrase: "we"

Phrase: "will"

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the term synuclein protofibril to"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "non-fibrillar, non-fluorogenic"

Phrase: "("

Phrase: "or"

Phrase: "weakly fluorogenic"

Phrase: ")"

Phrase: "synuclein oligomers"

Phrase: "that"

Phrase: "elute in the void volume"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0042034:void [Organism Function]
   760   C0449468:*Volume [Quantitative Concept]
   760   C1552835:void [Idea or Concept]
   760   C1690016:% volume [Qualitative Concept]
   760   C1705102:Volume [Intellectual Product]
   760   C2700258:Volume [Laboratory Procedure]

Phrase: "from Superdex 200"

Phrase: "or"

Phrase: "Superose 6 gel filtration columns,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1185738:Column [Body Part, Organ, or Organ Component]
   771   C1706132:Column [Idea or Concept]

Phrase: "as"

Phrase: "originally"

Phrase: "described by Lansbury"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "colleagues"

Phrase: "(74,"

Phrase: "104"

Phrase: ")."
Processing 00000000.tx.413: ACKNOWLEDGMENTS  We thank Dr. 

Phrase: "ACKNOWLEDGMENTS"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.414: Tracey Rouault (Cell Biology and Metabolism Branch, NICHD, National Institutes of Health) for suggesting the use of DTT in the synuclein oxidation experiments, Drs. 

Phrase: "Tracey Rouault"

Phrase: "(Cell Biology"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0010819:Cell Biology [Biomedical Occupation or Discipline]
   861   C0005532:Biology [Biomedical Occupation or Discipline]
   789 E C0205460:Biologic [Qualitative Concept]
   789 E C2979985:BIOLOGIC [Biologically Active Substance,Pharmacologic Substance]

Phrase: "and"

Phrase: "Metabolism Branch,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1253959:Branch [Body Part, Organ, or Organ Component]
   861   C1881507:Branch [Chemical Viewed Structurally]
   861   C2700383:Branch [Plant]
   861   C2826234:BRANCH [Intellectual Product]

Phrase: "NICHD,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1513896:NICHD [Health Care Related Organization]
  1000   C2982885:NICHD [Intellectual Product]

Phrase: "National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: ")"

Phrase: "for"

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the use of DTT"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "in the synuclein oxidation experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0681814:Experiments [Research Activity]
   793 E C1706386:Experiment [Conceptual Entity]
   743 E C1517586:Experimental [Qualitative Concept]

Phrase: "Drs."
Processing 00000000.tx.415: Paul Smith and the late Alec Eidsath (ORS/DBEPS, National Institutes of Health) for help with the Thioflavin T measurements, Dr. 

Phrase: "Paul Smith"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0554249:Smith [Professional or Occupational Group]

Phrase: "and"

Phrase: "the late Alec Eidsath"

Phrase: "(ORS/DBEPS,"

Phrase: "National Institutes of Health"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: ")"

Phrase: "for"

Phrase: "help with the Thioflavin T measurements,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0076466:Thioflavin T [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C0018896:Help [Social Behavior]
   753   C0242485:measurements [Functional Concept]
   753   C0950261:thioflavine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   753   C1552861:help [Idea or Concept]

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.416: Brian Andrews and the NINDS, National Institutes of Health electron microscopy facility for help with the electron microscopy, and Dr. 

Phrase: "Brian Andrews"

Phrase: "and"

Phrase: "the NINDS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2350584:NINDS [Health Care Related Organization]

Phrase: "National Institutes of Health electron microscopy facility for"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C1512192:Electron Microscopy Facility [Health Care Related Organization,Manufactured Object]
   767   C0018704:HEALTH FACILITY [Health Care Related Organization,Manufactured Object]
   744   C1547538:Facility [Idea or Concept]

Phrase: "help with the electron microscopy,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   806   C0026019:Electron Microscopy [Laboratory Procedure]
   806   C2984656:ELECTRON MICROSCOPY [Functional Concept]
   760   C0013852:Electron [Quantitative Concept]
   760   C0018896:Help [Social Behavior]
   760   C0026018:Microscopy [Laboratory Procedure]
   760   C1552861:help [Idea or Concept]
   760   C3463986:Electron [Bird]

Phrase: "and"

Phrase: "Dr."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031831:DR [Professional or Occupational Group]
  1000   C1707664:DR [Biomedical or Dental Material]
  1000   C2348314:Dr. [Conceptual Entity]
  1000   C3540849:DR [Idea or Concept]
Processing 00000000.tx.417: Paul Wingfield, Protein Expression Laboratory/NIAMS, National Institutes of Health, for the CD analysis.  

Phrase: "Paul Wingfield,"

Phrase: "Protein Expression Laboratory/NIAMS,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1955976:NIAMS [Health Care Related Organization]

Phrase: "National Institutes of Health,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027468:National Institutes of Health [Health Care Related Organization]
           national institute health
   812   C0018684:Health [Idea or Concept]
   812   C0021622:Institutes [Organization]
   812   C3245503:national [Intellectual Product]
   779 E C1272753:Institute [Idea or Concept]
   712 E C0031206:healthiness [Finding]

Phrase: "for the CD analysis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0002778:Analysis [Laboratory Procedure]
   861   C0936012:Analysis [Research Activity]
   861   C1524024:analysis [Functional Concept]
Processing 00000000.tx.418: REFERENCES TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION REFERENCES  Jenner, P., and Olanow, C. 

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "TOP ABSTRACT INTRODUCTION EXPERIMENTAL PROCEDURES RESULTS DISCUSSION"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   795   C0557061:Discussion [Therapeutic or Preventive Procedure]
   795   C2584313:Discussion [Social Behavior]

Phrase: "REFERENCES"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Jenner,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Olanow,"

Phrase: "C."
Processing 00000000.tx.419: W. 

Phrase: "W."
Processing 00000000.tx.420: (1998) Ann. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.421: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.422: 44, (suppl.) 

Phrase: "44,"

Phrase: "(suppl."

Phrase: ")"
Processing 00000000.tx.423: 72-84[CrossRef] Giasson, B. 

Phrase: "72-84"

Phrase: "[CrossRef"

Phrase: "] Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.424: I., Duda, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Duda,"

Phrase: "J."
Processing 00000000.tx.425: E., Murray, I. 

Phrase: "E.,"

Phrase: "Murray,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.426: V., Chen, Q., Souza, J. 

Phrase: "V., Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0999213:Chen [Bird]

Phrase: "Q.,"

Phrase: "Souza,"

Phrase: "J."
Processing 00000000.tx.427: M., Hurtig, H. 

Phrase: "M."

Phrase: ","

Phrase: "Hurtig,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.428: I., Ischiropoulos, H., Trojanowski, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ischiropoulos,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.429: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.430: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.431: (2000) Science 290, 985-989[Abstract/Free FullText] Jenner, P. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Science 290,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "985-989"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jenner,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.432: (2003) Ann. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.433: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.434: 53, Suppl. 

Phrase: "53,"

Phrase: "Suppl."
Processing 00000000.tx.435: 3, 26-36[CrossRef] Dawson, T. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "26-36"

Phrase: "[CrossRef"

Phrase: "] Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.436: M., and Dawson, V. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Dawson,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551910:Dawson [Language]

Phrase: "V."
Processing 00000000.tx.437: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.438: (2003) Science 302, 819-822[Abstract/Free FullText] Kowall, N. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 302,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "819-822"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kowall,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.439: W., Hantraye, P., Brouillet, E., Beal, M. 

Phrase: "W., Hantraye,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Brouillet,"

Phrase: "E.,"

Phrase: "Beal,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.440: F., McKee, A. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "McKee,"

Phrase: "A."
Processing 00000000.tx.441: C., and Ferrante, R. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Ferrante,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.442: J. 

Phrase: "J."
Processing 00000000.tx.443: (2000) Neuroreport 11, 211-213[Medline] [OrderarticleviaInfotrieve] Vila, M., and Przedborski, S. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neuroreport 11,"

Phrase: "211-213"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Vila,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1061396:Vila [Eukaryote]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Przedborski,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.444: (2003) Nat. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.445: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.446: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.447: 4, 365-375[CrossRef][Medline] [OrderarticleviaInfotrieve] Thiruchelvam, M., Brockel, B. 

Phrase: "4,"

Phrase: "365-375"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Thiruchelvam,"

Phrase: "M."

Phrase: ","

Phrase: "Brockel,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.448: J., Richfield, E. 

Phrase: "J.,"

Phrase: "Richfield,"

Phrase: "E."
Processing 00000000.tx.449: K., Baggs, R. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Baggs,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.450: B., and Cory-Slechta, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Cory-Slechta,"

Phrase: "D."
Processing 00000000.tx.451: A. 

Phrase: "A."
Processing 00000000.tx.452: (2000) Brain Res. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Brain Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.453: 873, 225-234[CrossRef][Medline] [OrderarticleviaInfotrieve] Manning-Bog, A. 

Phrase: "873,"

Phrase: "225-234"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Manning-Bog,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1706414:Bog [Natural Phenomenon or Process]

Phrase: "A."
Processing 00000000.tx.454: B., McCormack, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "McCormack,"

Phrase: "A."
Processing 00000000.tx.455: L., Li, J., Uversky, V. 

Phrase: "L., Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Uversky,"

Phrase: "V."
Processing 00000000.tx.456: N., Fink, A. 

Phrase: "N., Fink,"

Phrase: "A."
Processing 00000000.tx.457: L., and Di Monte, D. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Di Monte,"

Phrase: "D."
Processing 00000000.tx.458: A. 

Phrase: "A."
Processing 00000000.tx.459: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.460: Biol. 

Phrase: "Biol."
Processing 00000000.tx.461: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.462: 277, 1641-1644[Abstract/Free FullText] Betarbet, R., Sherer, T. 

Phrase: "277,"

Phrase: "1641-1644"

Phrase: "[Abstract/Free FullText"

Phrase: "] Betarbet,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Sherer,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.463: B., MacKenzie, G., Garcia-Osuna, M., Panov, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "MacKenzie,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Garcia-Osuna,"

Phrase: "M."

Phrase: ","

Phrase: "Panov,"

Phrase: "A."
Processing 00000000.tx.464: V., and Greenamyre, J. 

Phrase: "V.,"

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J."
Processing 00000000.tx.465: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.466: (2000) Nat. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.467: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.468: 3, 1301-1306[CrossRef][Medline] [OrderarticleviaInfotrieve] Sherer, T. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "1301-1306"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Sherer,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.469: B., Kim, J. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.470: H., Betarbet, R., and Greenamyre, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Betarbet,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Greenamyre,"

Phrase: "J."
Processing 00000000.tx.471: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.472: (2003) Exp. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.473: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.474: 179, 9-16[CrossRef][Medline] [OrderarticleviaInfotrieve] Netto, L. 

Phrase: "179,"

Phrase: "9-16"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Netto,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.475: E., and Stadtman, E. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "E."
Processing 00000000.tx.476: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.477: (1996) Arch. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.478: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.479: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.480: 333, 233-242[CrossRef][Medline] [OrderarticleviaInfotrieve] Berlett, B. 

Phrase: "333,"

Phrase: "233-242"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Berlett,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.481: S., and Stadtman, E. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "E."
Processing 00000000.tx.482: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.483: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.484: Biol. 

Phrase: "Biol."
Processing 00000000.tx.485: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.486: 272, 20313-20316[Free FullText] Minotti, G., and Aust, S. 

Phrase: "272,"

Phrase: "20313-20316"

Phrase: "[Free FullText"

Phrase: "] Minotti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Aust,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.487: D. 

Phrase: "D."
Processing 00000000.tx.488: (1992) Lipids 27, 219-226[Medline] [OrderarticleviaInfotrieve] Welch, K. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Lipids 27,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "219-226"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "]"

Phrase: "Welch"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043114:Welsh [Population Group]

Phrase: ","

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.489: D., Davis, T. 

Phrase: "D."

Phrase: ","

Phrase: "Davis,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.490: Z., Van Eden, M. 

Phrase: "Z.,"

Phrase: "Van Eden,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.491: E., and Aust, S. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Aust,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.492: D. 

Phrase: "D."
Processing 00000000.tx.493: (2002) Free Radic. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.494: Biol. 

Phrase: "Biol."
Processing 00000000.tx.495: Med. 

Phrase: "Med."
Processing 00000000.tx.496: 32, 577-583[CrossRef][Medline] [OrderarticleviaInfotrieve] Halliwell, B., and Gutteridge, J. 

Phrase: "32,"

Phrase: "577-583"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Halliwell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Gutteridge,"

Phrase: "J."
Processing 00000000.tx.497: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.498: (1986) Arch. 

Phrase: "(1986"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.499: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.500: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.501: 246, 501-514[CrossRef][Medline] [OrderarticleviaInfotrieve] Halliwell, B., and Gutteridge, J. 

Phrase: "246,"

Phrase: "501-514"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Halliwell,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Gutteridge,"

Phrase: "J."
Processing 00000000.tx.502: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.503: (1992) FEBS Lett. 

Phrase: "(1992"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.504: 307, 108-112[CrossRef][Medline] [OrderarticleviaInfotrieve] Girotti, A. 

Phrase: "307,"

Phrase: "108-112"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Girotti,"

Phrase: "A."
Processing 00000000.tx.505: W. 

Phrase: "W."
Processing 00000000.tx.506: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.507: Free Radic. 

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.508: Biol. 

Phrase: "Biol."
Processing 00000000.tx.509: Med. 

Phrase: "Med."
Processing 00000000.tx.510: 1, 87-95[CrossRef][Medline] [OrderarticleviaInfotrieve] Minotti, G., and Aust, S. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "87-95"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Minotti,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Aust,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.511: D. 

Phrase: "D."
Processing 00000000.tx.512: (1987) Chem. 

Phrase: "(1987"

Phrase: ")"

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.513: Phys. 

Phrase: "Phys."
Processing 00000000.tx.514: Lipids 44, 191-208[CrossRef][Medline] [OrderarticleviaInfotrieve] Stokes, A. 

Phrase: "Lipids 44,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023779:Lipids [Lipid]

Phrase: "191-208"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stokes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1551086:Stokes [Quantitative Concept]

Phrase: "A."
Processing 00000000.tx.515: H., Hastings, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Hastings,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.516: G., and Vrana, K. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Vrana,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.517: E. 

Phrase: "E."
Processing 00000000.tx.518: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.519: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.520: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.521: 55, 659-665[CrossRef][Medline] [OrderarticleviaInfotrieve] Davidson, W. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "659-665"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Davidson,"

Phrase: "W."
Processing 00000000.tx.522: S., Jonas, A., Clayton, D. 

Phrase: "S."

Phrase: ","

Phrase: "Jonas,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1652689:Jonas [Eukaryote]

Phrase: "A.,"

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.523: F., and George, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.524: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.525: (1998) J. 

Phrase: "(1998"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.526: Biol. 

Phrase: "Biol."
Processing 00000000.tx.527: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.528: 273, 9443-9449[Abstract/Free FullText] Giasson, B. 

Phrase: "273,"

Phrase: "9443-9449"

Phrase: "[Abstract/Free FullText"

Phrase: "] Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.529: I., Murray, I. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Murray,"

Phrase: "I."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
Processing 00000000.tx.530: V., Trojanowski, J. 

Phrase: "V., Trojanowski,"

Phrase: "J."
Processing 00000000.tx.531: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.532: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.533: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.534: Biol. 

Phrase: "Biol."
Processing 00000000.tx.535: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.536: 276, 2380-2386[Abstract/Free FullText] Crowther, R. 

Phrase: "276,"

Phrase: "2380-2386"

Phrase: "[Abstract/Free FullText"

Phrase: "] Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.537: A., Jakes, R., Spillantini, M. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.538: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.539: (1998) FEBS Lett. 

Phrase: "(1998"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.540: 436, 309-312[CrossRef][Medline] [OrderarticleviaInfotrieve] Kim, T. 

Phrase: "436,"

Phrase: "309-312"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.541: D., Paik, S. 

Phrase: "D."

Phrase: ","

Phrase: "Paik,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.542: R., and Yang, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "C."
Processing 00000000.tx.543: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.544: (2002) Biochemistry 41, 13782-13790[CrossRef][Medline] [OrderarticleviaInfotrieve] Park, S. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochemistry 41,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "13782-13790"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.545: M., Jung, H. 

Phrase: "M."

Phrase: ","

Phrase: "Jung,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.546: Y., Kim, T. 

Phrase: "Y.,"

Phrase: "Kim,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.547: D., Park, J. 

Phrase: "D."

Phrase: ","

Phrase: "Park,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0562547:Park [Manufactured Object]
  1000   C3160718:PARK [Disease or Syndrome]

Phrase: "J."
Processing 00000000.tx.548: H., Yang, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Yang,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "C."
Processing 00000000.tx.549: H., and Kim, J. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.550: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.551: Biol. 

Phrase: "Biol."
Processing 00000000.tx.552: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.553: 277, 28512-28520[Abstract/Free FullText] Polymeropoulos, M. 

Phrase: "277,"

Phrase: "28512-28520"

Phrase: "[Abstract/Free FullText"

Phrase: "] Polymeropoulos,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.554: H., Lavedan, C., Leroy, E., Ide, S. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Lavedan,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Leroy,"

Phrase: "E.,"

Phrase: "Ide,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0328104:Ide [Fish]
  1000   C1415875:IDE [Gene or Genome]
  1000   C2826366:IDE [Idea or Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.555: E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., Stenroos, E. 

Phrase: "E.,"

Phrase: "Dehejia,"

Phrase: "A.,"

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Pike,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Root,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0040452:Root [Body Part, Organ, or Organ Component]
  1000   C0242726:Root [Plant]
  1000   C1318154:Root [Body Part, Organ, or Organ Component]
  1000   C1705917:Root [Idea or Concept]

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Rubenstein,"

Phrase: "J.,"

Phrase: "Boyer,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Stenroos,"

Phrase: "E."
Processing 00000000.tx.556: S., Chandrasekharappa, S., Athanassiadou, A., Papapetropoulos, T., Johnson, W. 

Phrase: "S."

Phrase: ","

Phrase: "Chandrasekharappa,"

Phrase: "S."

Phrase: ","

Phrase: "Athanassiadou,"

Phrase: "A.,"

Phrase: "Papapetropoulos,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Johnson,"

Phrase: "W."
Processing 00000000.tx.557: G., Lazzarini, A. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Lazzarini,"

Phrase: "A."
Processing 00000000.tx.558: M., Duvoisin, R. 

Phrase: "M."

Phrase: ","

Phrase: "Duvoisin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.559: C., Di Iorio, G., Golbe, L. 

Phrase: "C., Di Iorio,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Golbe,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.560: I., and Nussbaum, R. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.561: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.562: (1997) Science 276, 2045-2047[Abstract/Free FullText] Kruger, R., Kuhn, W., Muller, T., Woitalla, D., Graeber, M., Kosel, S., Przuntek, H., Epplen, J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Science 276,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "2045-2047"

Phrase: "[Abstract/Free FullText"

Phrase: "] Kruger,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Kuhn,"

Phrase: "W.,"

Phrase: "Muller,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Woitalla,"

Phrase: "D."

Phrase: ","

Phrase: "Graeber,"

Phrase: "M."

Phrase: ","

Phrase: "Kosel,"

Phrase: "S."

Phrase: ","

Phrase: "Przuntek,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Epplen,"

Phrase: "J."
Processing 00000000.tx.563: T., Schols, L., and Riess, O. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Schols,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Riess,"

Phrase: "O."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]
Processing 00000000.tx.564: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.565: Genet. 

Phrase: "Genet."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0325074:Genet [Mammal]
Processing 00000000.tx.566: 18, 106-108[CrossRef][Medline] [OrderarticleviaInfotrieve] Singleton, A. 

Phrase: "18,"

Phrase: "106-108"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A."
Processing 00000000.tx.567: B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., Lincoln, S., Crawley, A., Hanson, M., Maraganore, D., Adler, C., Cookson, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Johnson,"

Phrase: "J.,"

Phrase: "Singleton,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0481462:singleton [Finding]
  1000   C1313913:Singleton [Family Group]

Phrase: "A.,"

Phrase: "Hague,"

Phrase: "S."

Phrase: ","

Phrase: "Kachergus,"

Phrase: "J.,"

Phrase: "Hulihan,"

Phrase: "M."

Phrase: ","

Phrase: "Peuralinna,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Dutra,"

Phrase: "A.,"

Phrase: "Nussbaum,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Lincoln,"

Phrase: "S."

Phrase: ","

Phrase: "Crawley,"

Phrase: "A.,"

Phrase: "Hanson,"

Phrase: "M."

Phrase: ","

Phrase: "Maraganore,"

Phrase: "D."

Phrase: ","

Phrase: "Adler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Cookson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.568: R., Muenter, M., Baptista, M., Miller, D., Blancato, J., Hardy, J., and Gwinn-Hardy, K. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Muenter,"

Phrase: "M."

Phrase: ","

Phrase: "Baptista,"

Phrase: "M."

Phrase: ","

Phrase: "Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "D."

Phrase: ","

Phrase: "Blancato,"

Phrase: "J.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Gwinn-Hardy,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.569: (2003) Science 302, 841[Free FullText] Zarranz, J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 302,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "841"

Phrase: "[Free FullText"

Phrase: "] Zarranz,"

Phrase: "J."
Processing 00000000.tx.570: J., Alegre, J., Gomez-Esteban, J. 

Phrase: "J.,"

Phrase: "Alegre,"

Phrase: "J.,"

Phrase: "Gomez-Esteban,"

Phrase: "J."
Processing 00000000.tx.571: C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atares, B., Llorens, V., Gomez Tortosa, E., del Ser, T., Munoz, D. 

Phrase: "C., Lezcano,"

Phrase: "E.,"

Phrase: "Ros,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ampuero,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Vidal,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hoenicka,"

Phrase: "J.,"

Phrase: "Rodriguez,"

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Atares,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Llorens,"

Phrase: "V.,"

Phrase: "Gomez Tortosa,"

Phrase: "E.,"

Phrase: "del Ser,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Munoz,"

Phrase: "D."
Processing 00000000.tx.572: G., and de Yebenes, J. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "de Yebenes,"

Phrase: "J."
Processing 00000000.tx.573: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.574: (2004) Ann. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.575: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.576: 55, 164-173[CrossRef][Medline] [OrderarticleviaInfotrieve] Spillantini, M. 

Phrase: "55,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450382:55 [Intellectual Product]

Phrase: "164-173"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.577: G., Schmidt, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Schmidt,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.578: L., Lee, V. 

Phrase: "L., Lee,"

Phrase: "V."
Processing 00000000.tx.579: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.580: Q., Jakes, R., and Goedert, M. 

Phrase: "Q., Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.581: (1997) Nature 388, 839-840[CrossRef][Medline] [OrderarticleviaInfotrieve] Spillantini, M. 

Phrase: "(1997"

Phrase: ")"

Phrase: "Nature 388,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: "839-840"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.582: G., Crowther, R. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Crowther,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.583: A., Jakes, R., Hasegawa, M., and Goedert, M. 

Phrase: "A.,"

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hasegawa,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.584: (1998) Proc. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.585: Natl. 

Phrase: "Natl."
Processing 00000000.tx.586: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.587: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.588: U. 

Phrase: "U."
Processing 00000000.tx.589: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.590: A. 

Phrase: "A."
Processing 00000000.tx.591: 95, 6469-6473[Abstract/Free FullText] Baba, M., Nakajo, S., Tu, P. 

Phrase: "95,"

Phrase: "6469-6473"

Phrase: "[Abstract/Free FullText"

Phrase: "] Baba,"

Phrase: "M."

Phrase: ","

Phrase: "Nakajo,"

Phrase: "S."

Phrase: ","

Phrase: "Tu,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1532464:TU [Quantitative Concept]
  1000   C2700314:TU [Fish]

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.592: H., Tomita, T., Nakaya, K., Lee, V. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Tomita,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Nakaya,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.593: M., Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.594: Q., and Iwatsubo, T. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Iwatsubo,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.595: (1998) Am. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.596: J. 

Phrase: "J."
Processing 00000000.tx.597: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.598: 152, 879-884[Abstract] Conway, K. 

Phrase: "152,"

Phrase: "879-884"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.599: A., Harper, J. 

Phrase: "A.,"

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.600: D., and Lansbury, P. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.601: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.602: (1998) Nat. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Nat."
Processing 00000000.tx.603: Med. 

Phrase: "Med."
Processing 00000000.tx.604: 4, 1318-1320[CrossRef][Medline] [OrderarticleviaInfotrieve] Narhi, L., Wood, S. 

Phrase: "4,"

Phrase: "1318-1320"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Narhi,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.605: J., Steavenson, S., Jiang, Y., Wu, G. 

Phrase: "J.,"

Phrase: "Steavenson,"

Phrase: "S."

Phrase: ","

Phrase: "Jiang,"

Phrase: "Y.,"

Phrase: "Wu,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1431628:wu [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.606: M., Anafi, D., Kaufman, S. 

Phrase: "M."

Phrase: ","

Phrase: "Anafi,"

Phrase: "D."

Phrase: ","

Phrase: "Kaufman,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.607: A., Martin, F., Sitney, K., Denis, P., Louis, J. 

Phrase: "A.,"

Phrase: "Martin,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Sitney,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Denis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332319:denis [Qualitative Concept]

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.608: C., Wypych, J., Biere, A. 

Phrase: "C., Wypych,"

Phrase: "J.,"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.609: L., and Citron, M. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
  1000   C1135895:citron [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.610: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.611: Biol. 

Phrase: "Biol."
Processing 00000000.tx.612: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.613: 274, 9843-9846[Abstract/Free FullText] Giasson, B. 

Phrase: "274,"

Phrase: "9843-9846"

Phrase: "[Abstract/Free FullText"

Phrase: "] Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.614: I., Uryu, K., Trojanowski, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Uryu,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.615: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.616: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.617: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.618: Biol. 

Phrase: "Biol."
Processing 00000000.tx.619: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.620: 274, 7619-7622[Abstract/Free FullText] Dickson, D. 

Phrase: "274,"

Phrase: "7619-7622"

Phrase: "[Abstract/Free FullText"

Phrase: "] Dickson,"

Phrase: "D."
Processing 00000000.tx.621: W., Liu, W., Hardy, J., Farrer, M., Mehta, N., Uitti, R., Mark, M., Zimmerman, T., Golbe, L., Sage, J., Sima, A., D'Amato, C., Albin, R., Gilman, S., and Yen, S. 

Phrase: "W., Liu,"

Phrase: "W.,"

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Mehta,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Uitti,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Mark,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0522501:mark [Qualitative Concept]
   928 E C1706089:Marked [Qualitative Concept]

Phrase: "M."

Phrase: ","

Phrase: "Zimmerman,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Golbe,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Sage,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1122976:Sage [Food]
  1000   C3265310:sage [Organic Chemical,Pharmacologic Substance]

Phrase: "J.,"

Phrase: "Sima,"

Phrase: "A.,"

Phrase: "D'"

Phrase: "Amato,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Albin,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Gilman,"

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Yen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555429:Yen [Quantitative Concept]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.622: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.623: (1999) Am. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Am."
Processing 00000000.tx.624: J. 

Phrase: "J."
Processing 00000000.tx.625: Pathol. 

Phrase: "Pathol."
Processing 00000000.tx.626: 155, 1241-1251[Abstract/Free FullText] Campbell, B. 

Phrase: "155,"

Phrase: "1241-1251"

Phrase: "[Abstract/Free FullText"

Phrase: "] Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.627: C., Li, Q. 

Phrase: "C., Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Q."
Processing 00000000.tx.628: X., Culvenor, J. 

Phrase: "X.,"

Phrase: "Culvenor,"

Phrase: "J."
Processing 00000000.tx.629: G., Jakala, P., Cappai, R., Beyreuther, K., Masters, C. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jakala,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Cappai,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.630: L., and McLean, C. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "McLean,"

Phrase: "C."
Processing 00000000.tx.631: A. 

Phrase: "A."
Processing 00000000.tx.632: (2000) Neurobiol. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Neurobiol."
Processing 00000000.tx.633: Dis. 

Phrase: "Dis."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0451119:DIS [Intellectual Product]
  1000   C1444662:DIS [Finding]
Processing 00000000.tx.634: 7, 192-200[CrossRef][Medline] [OrderarticleviaInfotrieve] Campbell, B. 

Phrase: "7,"

Phrase: "192-200"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Campbell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331936:Campbell [Health Care Related Organization]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.635: C., McLean, C. 

Phrase: "C., McLean,"

Phrase: "C."
Processing 00000000.tx.636: A., Culvenor, J. 

Phrase: "A.,"

Phrase: "Culvenor,"

Phrase: "J."
Processing 00000000.tx.637: G., Gai, W. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Gai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517505:GAI [Research Activity]

Phrase: "W."
Processing 00000000.tx.638: P., Blumbergs, P. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Blumbergs,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.639: C., Jakala, P., Beyreuther, K., Masters, C. 

Phrase: "C., Jakala,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Beyreuther,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Masters,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0444649:Master [Qualitative Concept]

Phrase: "C."
Processing 00000000.tx.640: L., and Li, Q. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "Q."
Processing 00000000.tx.641: X. 

Phrase: "X."
Processing 00000000.tx.642: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.643: Neurochem. 

Phrase: "Neurochem."
Processing 00000000.tx.644: 76, 87-96[CrossRef][Medline] [OrderarticleviaInfotrieve] Duda, J. 

Phrase: "76,"

Phrase: "87-96"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Duda,"

Phrase: "J."
Processing 00000000.tx.645: E., Giasson, B. 

Phrase: "E.,"

Phrase: "Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.646: I., Gur, T. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Gur,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0062006:Gur [Biologically Active Substance,Pharmacologic Substance]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.647: L., Montine, T. 

Phrase: "L., Montine,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.648: J., Robertson, D., Biaggioni, I., Hurtig, H. 

Phrase: "J.,"

Phrase: "Robertson,"

Phrase: "D."

Phrase: ","

Phrase: "Biaggioni,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Hurtig,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.649: I., Stern, M. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Stern,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.650: B., Gollomp, S. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Gollomp,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.651: M., Grossman, M., Lee, V. 

Phrase: "M."

Phrase: ","

Phrase: "Grossman,"

Phrase: "M."

Phrase: ","

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.652: M., and Trojanowski, J. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.653: Q. 

Phrase: "Q."
Processing 00000000.tx.654: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.655: Neuropathol. 

Phrase: "Neuropathol."
Processing 00000000.tx.656: Exp. 

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.657: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.658: 59, 830-841[Medline] [OrderarticleviaInfotrieve] Hashimoto, M., Hsu, L. 

Phrase: "59,"

Phrase: "830-841"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Hashimoto,"

Phrase: "M."

Phrase: ","

Phrase: "Hsu,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.659: J., Xia, Y., Takeda, A., Sisk, A., Sundsmo, M., and Masliah, E. 

Phrase: "J.,"

Phrase: "Xia,"

Phrase: "Y.,"

Phrase: "Takeda,"

Phrase: "A.,"

Phrase: "Sisk,"

Phrase: "A.,"

Phrase: "Sundsmo,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Masliah,"

Phrase: "E."
Processing 00000000.tx.660: (1999) Neuroreport 10, 717-721[Medline] [OrderarticleviaInfotrieve] Ostrerova-Golts, N., Petrucelli, L., Hardy, J., Lee, J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Neuroreport 10,"

Phrase: "717-721"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ostrerova-Golts,"

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.661: M., Farer, M., and Wolozin, B. 

Phrase: "M."

Phrase: ","

Phrase: "Farer,"

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.662: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.663: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.664: 20, 6048-6054[Abstract/Free FullText] Paik, S. 

Phrase: "20,"

Phrase: "6048-6054"

Phrase: "[Abstract/Free FullText"

Phrase: "] Paik,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.665: R., Shin, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.666: J., and Lee, J. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.667: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.668: (2000) Arch. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.669: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.670: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.671: 378, 269-277[CrossRef][Medline] [OrderarticleviaInfotrieve] Norris, E. 

Phrase: "378,"

Phrase: "269-277"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Norris,"

Phrase: "E."
Processing 00000000.tx.672: H., Giasson, B. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.673: I., Ischiropoulos, H., and Lee, V. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ischiropoulos,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.674: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.675: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.676: Biol. 

Phrase: "Biol."
Processing 00000000.tx.677: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.678: 278, 27230-27240[Abstract/Free FullText] Souza, J. 

Phrase: "278,"

Phrase: "27230-27240"

Phrase: "[Abstract/Free FullText"

Phrase: "] Souza,"

Phrase: "J."
Processing 00000000.tx.679: M., Giasson, B. 

Phrase: "M."

Phrase: ","

Phrase: "Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.680: I., Chen, Q., Lee, V. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Chen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0999213:Chen [Bird]

Phrase: "Q.,"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.681: M., and Ischiropoulos, H. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Ischiropoulos,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.682: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.683: Biol. 

Phrase: "Biol."
Processing 00000000.tx.684: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.685: 275, 18344-18349[Abstract/Free FullText] Krishnan, S., Chi, E. 

Phrase: "275,"

Phrase: "18344-18349"

Phrase: "[Abstract/Free FullText"

Phrase: "] Krishnan,"

Phrase: "S."

Phrase: ","

Phrase: "Chi,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1720589:Chi [Intellectual Product]

Phrase: "E."
Processing 00000000.tx.686: Y., Wood, S. 

Phrase: "Y.,"

Phrase: "Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.687: J., Kendrick, B. 

Phrase: "J.,"

Phrase: "Kendrick,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1564557:Kendrick [Antibiotic,Organic Chemical]

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.688: S., Li, C., Garzon-Rodriguez, W., Wypych, J., Randolph, T. 

Phrase: "S."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Garzon-Rodriguez,"

Phrase: "W.,"

Phrase: "Wypych,"

Phrase: "J.,"

Phrase: "Randolph,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.689: W., Narhi, L. 

Phrase: "W., Narhi,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.690: O., Biere, A. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.691: L., Citron, M., and Carpenter, J. 

Phrase: "L., Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Carpenter,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336362:Carpenter [Professional or Occupational Group]

Phrase: "J."
Processing 00000000.tx.692: F. 

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.693: (2003) Biochemistry 42, 829-837[CrossRef][Medline] [OrderarticleviaInfotrieve] Perrin, R. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "829-837"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Perrin,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.694: J., Woods, W. 

Phrase: "J.,"

Phrase: "Woods,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0043217:Woods [Substance]
  1000   C0442548:Woods [Geographic Area]
   928 E C0144237:Sylvan [Organic Chemical]

Phrase: "W."
Processing 00000000.tx.695: S., Clayton, D. 

Phrase: "S."

Phrase: ","

Phrase: "Clayton,"

Phrase: "D."
Processing 00000000.tx.696: F., and George, J. 

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "George,"

Phrase: "J."
Processing 00000000.tx.697: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.698: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.699: Biol. 

Phrase: "Biol."
Processing 00000000.tx.700: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.701: 276, 41958-41962[Abstract/Free FullText] Sharon, R., Bar-Joseph, I., Frosch, M. 

Phrase: "276,"

Phrase: "41958-41962"

Phrase: "[Abstract/Free FullText"

Phrase: "] Sharon,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Bar-Joseph,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Frosch,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.702: P., Walsh, D. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Walsh,"

Phrase: "D."
Processing 00000000.tx.703: M., Hamilton, J. 

Phrase: "M."

Phrase: ","

Phrase: "Hamilton,"

Phrase: "J."
Processing 00000000.tx.704: A., and Selkoe, D. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Selkoe,"

Phrase: "D."
Processing 00000000.tx.705: J. 

Phrase: "J."
Processing 00000000.tx.706: (2003) Neuron 37, 583-595[CrossRef][Medline] [OrderarticleviaInfotrieve] Jensen, P. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Neuron 37,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "583-595"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.707: H., Sorensen, E. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Sorensen,"

Phrase: "E."
Processing 00000000.tx.708: S., Petersen, T. 

Phrase: "S."

Phrase: ","

Phrase: "Petersen,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.709: E., Gliemann, J., and Rasmussen, L. 

Phrase: "E.,"

Phrase: "Gliemann,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Rasmussen,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.710: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.711: (1995) Biochem. 

Phrase: "(1995"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.712: J. 

Phrase: "J."
Processing 00000000.tx.713: 310, 91-94[Medline] [OrderarticleviaInfotrieve] Junn, E., Ronchetti, R. 

Phrase: "310,"

Phrase: "91-94"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Junn,"

Phrase: "E.,"

Phrase: "Ronchetti,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.714: D., Quezado, M. 

Phrase: "D."

Phrase: ","

Phrase: "Quezado,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.715: M., Kim, S. 

Phrase: "M."

Phrase: ","

Phrase: "Kim,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.716: Y., and Mouradian, M. 

Phrase: "Y.,"

Phrase: "and"

Phrase: "Mouradian,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.717: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.718: (2003) Proc. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.719: Natl. 

Phrase: "Natl."
Processing 00000000.tx.720: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.721: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.722: U. 

Phrase: "U."
Processing 00000000.tx.723: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.724: A. 

Phrase: "A."
Processing 00000000.tx.725: 100, 2047-2052[Abstract/Free FullText] Conway, K. 

Phrase: "100,"

Phrase: "2047-2052"

Phrase: "[Abstract/Free FullText"

Phrase: "] Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.726: A., Lee, S. 

Phrase: "A.,"

Phrase: "Lee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.727: J., Rochet, J. 

Phrase: "J.,"

Phrase: "Rochet,"

Phrase: "J."
Processing 00000000.tx.728: C., Ding, T. 

Phrase: "C., Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419419:DING [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.729: T., Harper, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.730: D., Williamson, R. 

Phrase: "D."

Phrase: ","

Phrase: "Williamson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.731: E., and Lansbury, P. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.732: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.733: (2000) Ann. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.734: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.735: Y. 

Phrase: "Y."
Processing 00000000.tx.736: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.737: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.738: 920, 42-45[Free FullText] Volles, M. 

Phrase: "920,"

Phrase: "42-45"

Phrase: "[Free FullText"

Phrase: "] Volles,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.739: J., Lee, S. 

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.740: J., Rochet, J. 

Phrase: "J.,"

Phrase: "Rochet,"

Phrase: "J."
Processing 00000000.tx.741: C., Shtilerman, M. 

Phrase: "C., Shtilerman,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.742: D., Ding, T. 

Phrase: "D."

Phrase: ","

Phrase: "Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1419419:DING [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.743: T., Kessler, J. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Kessler,"

Phrase: "J."
Processing 00000000.tx.744: C., and Lansbury, P. 

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.745: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.746: (2001) Biochemistry 40, 7812-7819[CrossRef][Medline] [OrderarticleviaInfotrieve] Volles, M. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Biochemistry 40,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0005477:Biochemistry [Occupation or Discipline]
   861   C0439509:/40 [Temporal Concept]

Phrase: "7812-7819"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Volles,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.747: J., and Lansbury, P. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.748: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.749: (2003) Biochemistry 42, 7871-7878[CrossRef][Medline] [OrderarticleviaInfotrieve] Stefanis, L., Larsen, K. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biochemistry 42,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "7871-7878"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stefanis,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Larsen,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.750: E., Rideout, H. 

Phrase: "E.,"

Phrase: "Rideout,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.751: J., Sulzer, D., and Greene, L. 

Phrase: "J.,"

Phrase: "Sulzer,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Greene,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.752: A. 

Phrase: "A."
Processing 00000000.tx.753: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.754: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.755: 21, 9549-9560[Abstract/Free FullText] Petrucelli, L., O'Farrell, C., Lockhart, P. 

Phrase: "21,"

Phrase: "9549-9560"

Phrase: "[Abstract/Free FullText"

Phrase: "] Petrucelli,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "O'Farrell,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439114:O NOS [Intellectual Product]

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lockhart,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.756: J., Baptista, M., Kehoe, K., Vink, L., Choi, P., Wolozin, B., Farrer, M., Hardy, J., and Cookson, M. 

Phrase: "J.,"

Phrase: "Baptista,"

Phrase: "M."

Phrase: ","

Phrase: "Kehoe,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Vink,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Choi,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Wolozin,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Farrer,"

Phrase: "M."

Phrase: ","

Phrase: "Hardy,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Cookson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.757: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.758: (2002) Neuron 36, 1007-1019[Medline] [OrderarticleviaInfotrieve] Snyder, H., Mensah, K., Theisler, C., Lee, J., Matouschek, A., and Wolozin, B. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Neuron 36,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: "1007-1019"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450318:1019 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Snyder,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Mensah,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Theisler,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Lee,"

Phrase: "J.,"

Phrase: "Matouschek,"

Phrase: "A.,"

Phrase: "and"

Phrase: "Wolozin,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.759: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.760: Biol. 

Phrase: "Biol."
Processing 00000000.tx.761: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.762: 278, 11753-11759[Abstract/Free FullText] Lindersson, E., Beedholm, R., Hojrup, P., Moos, T., Gai, W., Hendil, K. 

Phrase: "278,"

Phrase: "11753-11759"

Phrase: "[Abstract/Free FullText"

Phrase: "] Lindersson,"

Phrase: "E.,"

Phrase: "Beedholm,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hojrup,"

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "Moos,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234884:moos [Individual Behavior]

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gai,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1517505:GAI [Research Activity]

Phrase: "W.,"

Phrase: "Hendil,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.763: B., and Jensen, P. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Jensen,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.764: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.765: (2004) J. 

Phrase: "(2004"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.766: Biol. 

Phrase: "Biol."
Processing 00000000.tx.767: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.768: 279, 12924-12934[Abstract/Free FullText] McNaught, K. 

Phrase: "279,"

Phrase: "12924-12934"

Phrase: "[Abstract/Free FullText"

Phrase: "] McNaught,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.769: S., and Olanow, C. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Olanow,"

Phrase: "C."
Processing 00000000.tx.770: W. 

Phrase: "W."
Processing 00000000.tx.771: (2003) Ann. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Ann."
Processing 00000000.tx.772: Neurol. 

Phrase: "Neurol."
Processing 00000000.tx.773: 53, Suppl. 

Phrase: "53,"

Phrase: "Suppl."
Processing 00000000.tx.774: 3, 73-84[Medline] [OrderarticleviaInfotrieve] Kim, K., Rhee, S. 

Phrase: "3,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: "73-84"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kim,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Rhee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.775: G., and Stadtman, E. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "E."
Processing 00000000.tx.776: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.777: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.778: Biol. 

Phrase: "Biol."
Processing 00000000.tx.779: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.780: 260, 15394-15397[Abstract/Free FullText] Jakes, R., Spillantini, M. 

Phrase: "260,"

Phrase: "15394-15397"

Phrase: "[Abstract/Free FullText"

Phrase: "] Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.781: G., and Goedert, M. 

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "and"

Phrase: "Goedert,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.782: (1994) FEBS Lett. 

Phrase: "(1994"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.783: 345, 27-32[CrossRef][Medline] [OrderarticleviaInfotrieve] Cole, N. 

Phrase: "345,"

Phrase: "27-32"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Cole,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.784: B., Murphy, D. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Murphy,"

Phrase: "D."
Processing 00000000.tx.785: D., Grider, T., Rueter, S., Brasaemle, D., and Nussbaum, R. 

Phrase: "D."

Phrase: ","

Phrase: "Grider,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Rueter,"

Phrase: "S."

Phrase: ","

Phrase: "Brasaemle,"

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Nussbaum,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.786: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.787: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.788: Biol. 

Phrase: "Biol."
Processing 00000000.tx.789: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.790: 277, 6344-6352[Abstract/Free FullText] Giasson, B. 

Phrase: "277,"

Phrase: "6344-6352"

Phrase: "[Abstract/Free FullText"

Phrase: "] Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.791: I., Jakes, R., Goedert, M., Duda, J. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Jakes,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Goedert,"

Phrase: "M."

Phrase: ","

Phrase: "Duda,"

Phrase: "J."
Processing 00000000.tx.792: E., Leight, S., Trojanowski, J. 

Phrase: "E.,"

Phrase: "Leight,"

Phrase: "S."

Phrase: ","

Phrase: "Trojanowski,"

Phrase: "J."
Processing 00000000.tx.793: Q., and Lee, V. 

Phrase: "Q.,"

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.794: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.795: (2000) J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.796: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.797: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.798: 59, 528-533[CrossRef][Medline] [OrderarticleviaInfotrieve] Kayed, R., Head, E., Thompson, J. 

Phrase: "59,"

Phrase: "528-533"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kayed,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Head,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0018670:Head [Body Location or Region]
  1000   C1281590:Head [Body Part, Organ, or Organ Component]
  1000   C1706305:Head [Manufactured Object]
   944 E C0205096:Cephalic [Spatial Concept]

Phrase: "E.,"

Phrase: "Thompson,"

Phrase: "J."
Processing 00000000.tx.799: L., McIntire, T. 

Phrase: "L., McIntire,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.800: M., Milton, S. 

Phrase: "M."

Phrase: ","

Phrase: "Milton,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.801: C., Cotman, C. 

Phrase: "C., Cotman,"

Phrase: "C."
Processing 00000000.tx.802: W., and Glabe, C. 

Phrase: "W.,"

Phrase: "and"

Phrase: "Glabe,"

Phrase: "C."
Processing 00000000.tx.803: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.804: (2003) Science 300, 486-489[Abstract/Free FullText] Wood, S. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Science 300,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "486-489"

Phrase: "[Abstract/Free FullText"

Phrase: "] Wood,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0043217:Wood [Substance]
   944 E C0144237:Sylvan [Organic Chemical]
   916 E C0442548:Woods [Geographic Area]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.805: J., Wypych, J., Steavenson, S., Louis, J. 

Phrase: "J.,"

Phrase: "Wypych,"

Phrase: "J.,"

Phrase: "Steavenson,"

Phrase: "S."

Phrase: ","

Phrase: "Louis,"

Phrase: "J."
Processing 00000000.tx.806: C., Citron, M., and Biere, A. 

Phrase: "C., Citron,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0759909:CITRON [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1135895:citron [Plant]

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Biere,"

Phrase: "A."
Processing 00000000.tx.807: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.808: (1999) J. 

Phrase: "(1999"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.809: Biol. 

Phrase: "Biol."
Processing 00000000.tx.810: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.811: 274, 19509-19512[Abstract/Free FullText] Friguet, B., Szweda, L. 

Phrase: "274,"

Phrase: "19509-19512"

Phrase: "[Abstract/Free FullText"

Phrase: "] Friguet,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Szweda,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.812: I., and Stadtman, E. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "E."
Processing 00000000.tx.813: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.814: (1994) Arch. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.815: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.816: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.817: 311, 168-173[CrossRef][Medline] [OrderarticleviaInfotrieve] Conconi, M., Petropoulos, I., Emod, I., Turlin, E., Biville, F., and Friguet, B. 

Phrase: "311,"

Phrase: "168-173"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Conconi,"

Phrase: "M."

Phrase: ","

Phrase: "Petropoulos,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Emod,"

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Turlin,"

Phrase: "E.,"

Phrase: "Biville,"

Phrase: "F.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "Friguet,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.818: (1998) Biochem. 

Phrase: "(1998"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.819: J. 

Phrase: "J."
Processing 00000000.tx.820: 333, 407-415[Medline] [OrderarticleviaInfotrieve] Birckbichler, P. 

Phrase: "333,"

Phrase: "407-415"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Birckbichler,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.821: J., Orr, G. 

Phrase: "J.,"

Phrase: "Orr,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.822: R., Patterson, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Patterson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.823: K., Jr., Conway, E., and Carter, H. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Jr.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]

Phrase: "Conway,"

Phrase: "E.,"

Phrase: "and"

Phrase: "Carter,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.824: A. 

Phrase: "A."
Processing 00000000.tx.825: (1981) Proc. 

Phrase: "(1981"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.826: Natl. 

Phrase: "Natl."
Processing 00000000.tx.827: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.828: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.829: U. 

Phrase: "U."
Processing 00000000.tx.830: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.831: A. 

Phrase: "A."
Processing 00000000.tx.832: 78, 5005-5008[Abstract] Greenberg, C. 

Phrase: "78,"

Phrase: "5005-5008"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Greenberg,"

Phrase: "C."
Processing 00000000.tx.833: S., Birckbichler, P. 

Phrase: "S."

Phrase: ","

Phrase: "Birckbichler,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.834: J., and Rice, R. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Rice,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0035567:Rice [Food]
  1000   C1140671:rice [Plant]
  1000   C1509547:RICE [Organic Chemical,Pharmacologic Substance]
  1000   C3484401:RICE [Pharmacologic Substance]

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.835: H. 

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.836: (1991) FASEB J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "FASEB J."
Processing 00000000.tx.837: 5, 3071-3077[Abstract/Free FullText] Armstrong, D., Hiramitsu, T., Gutteridge, J., and Nilsson, S. 

Phrase: "5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "3071-3077"

Phrase: "[Abstract/Free FullText"

Phrase: "] Armstrong,"

Phrase: "D."

Phrase: ","

Phrase: "Hiramitsu,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Gutteridge,"

Phrase: "J.,"

Phrase: "and"

Phrase: "Nilsson,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.838: E. 

Phrase: "E."
Processing 00000000.tx.839: (1982) Exp. 

Phrase: "(1982"

Phrase: ")"

Phrase: "Exp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1417055:EXP [Gene or Genome]
Processing 00000000.tx.840: Eye Res. 

Phrase: "Eye Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C2347379:RES [Finding]
Processing 00000000.tx.841: 35, 157-171[Medline] [OrderarticleviaInfotrieve] Miller, D. 

Phrase: "35,"

Phrase: "157-171"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Miller,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0402830:Miller [Professional or Occupational Group]

Phrase: "D."
Processing 00000000.tx.842: M., Buettner, G. 

Phrase: "M."

Phrase: ","

Phrase: "Buettner,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.843: R., and Aust, S. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Aust,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.844: D. 

Phrase: "D."
Processing 00000000.tx.845: (1990) Free Radic. 

Phrase: "(1990"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.846: Biol. 

Phrase: "Biol."
Processing 00000000.tx.847: Med. 

Phrase: "Med."
Processing 00000000.tx.848: 8, 95-108[CrossRef][Medline] [OrderarticleviaInfotrieve] Stadtman, E. 

Phrase: "8,"

Phrase: "95-108"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stadtman,"

Phrase: "E."
Processing 00000000.tx.849: R., and Oliver, C. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Oliver,"

Phrase: "C."
Processing 00000000.tx.850: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.851: (1991) J. 

Phrase: "(1991"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.852: Biol. 

Phrase: "Biol."
Processing 00000000.tx.853: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.854: 266, 2005-2008[Free FullText] Held, K. 

Phrase: "266,"

Phrase: "2005-2008"

Phrase: "[Free FullText"

Phrase: "] Held, K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.855: D., Sylvester, F. 

Phrase: "D."

Phrase: ","

Phrase: "Sylvester,"

Phrase: "F."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]
Processing 00000000.tx.856: C., Hopcia, K. 

Phrase: "C., Hopcia,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.857: L., and Biaglow, J. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Biaglow,"

Phrase: "J."
Processing 00000000.tx.858: E. 

Phrase: "E."
Processing 00000000.tx.859: (1996) Radiat. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Radiat."
Processing 00000000.tx.860: Res. 

Phrase: "Res."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347379:RES [Finding]
Processing 00000000.tx.861: 145, 542-553[Medline] [OrderarticleviaInfotrieve] Aust, S. 

Phrase: "145,"

Phrase: "542-553"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Aust,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.862: D., Morehouse, L. 

Phrase: "D."

Phrase: ","

Phrase: "Morehouse,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.863: A., and Thomas, C. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Thomas,"

Phrase: "C."
Processing 00000000.tx.864: E. 

Phrase: "E."
Processing 00000000.tx.865: (1985) J. 

Phrase: "(1985"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.866: Free Radic. 

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.867: Biol. 

Phrase: "Biol."
Processing 00000000.tx.868: Med. 

Phrase: "Med."
Processing 00000000.tx.869: 1, 3-25[CrossRef][Medline] [OrderarticleviaInfotrieve] Conway, K. 

Phrase: "1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: "3-25"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439086:<3 [Quantitative Concept]
   861   C2827736:3+ [Quantitative Concept]
   861   C2981702:3+ [Classification]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.870: A., Rochet, J. 

Phrase: "A.,"

Phrase: "Rochet,"

Phrase: "J."
Processing 00000000.tx.871: C., Bieganski, R. 

Phrase: "C., Bieganski,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.872: M., and Lansbury, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.873: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.874: (2001) Science 294, 1346-1349[Abstract/Free FullText] Uversky, V. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Science 294,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: "1346-1349"

Phrase: "[Abstract/Free FullText"

Phrase: "] Uversky,"

Phrase: "V."
Processing 00000000.tx.875: N., Yamin, G., Souillac, P. 

Phrase: "N., Yamin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Souillac,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.876: O., Goers, J., Glaser, C. 

Phrase: "O.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439114:O NOS [Intellectual Product]

Phrase: "Goers,"

Phrase: "J.,"

Phrase: "Glaser,"

Phrase: "C."
Processing 00000000.tx.877: B., and Fink, A. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.878: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.879: (2002) FEBS Lett. 

Phrase: "(2002"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.880: 517, 239-244[CrossRef][Medline] [OrderarticleviaInfotrieve] Lashuel, H. 

Phrase: "517,"

Phrase: "239-244"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Lashuel,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.881: A., Petre, B. 

Phrase: "A.,"

Phrase: "Petre,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.882: M., Wall, J., Simon, M., Nowak, R. 

Phrase: "M."

Phrase: ","

Phrase: "Wall,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0677535:Wall [Manufactured Object]

Phrase: "J.,"

Phrase: "Simon,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443058:Simon [Intellectual Product]

Phrase: "M."

Phrase: ","

Phrase: "Nowak,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.883: J., Walz, T., and Lansbury, P. 

Phrase: "J.,"

Phrase: "Walz,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.884: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.885: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.886: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.887: Biol. 

Phrase: "Biol."
Processing 00000000.tx.888: 322, 1089-1102[CrossRef][Medline] [OrderarticleviaInfotrieve] Weinreb, P. 

Phrase: "322,"

Phrase: "1089-1102"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Weinreb,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.889: H., Zhen, W., Poon, A. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Zhen,"

Phrase: "W.,"

Phrase: "Poon,"

Phrase: "A."
Processing 00000000.tx.890: W., Conway, K. 

Phrase: "W., Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.891: A., and Lansbury, P. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.892: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.893: (1996) Biochemistry 35, 13709-13715[CrossRef][Medline] [OrderarticleviaInfotrieve] Adler, A. 

Phrase: "(1996"

Phrase: ")"

Phrase: "Biochemistry 35,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "13709-13715"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Adler,"

Phrase: "A."
Processing 00000000.tx.894: J., Greenfield, N. 

Phrase: "J.,"

Phrase: "Greenfield,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.895: J., and Fasman, G. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Fasman,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.896: D. 

Phrase: "D."
Processing 00000000.tx.897: (1973) Methods Enzymol. 

Phrase: "(1973"

Phrase: ")"

Phrase: "Methods Enzymol."
Processing 00000000.tx.898: 27, 675-735[Medline] [OrderarticleviaInfotrieve] Conway, K. 

Phrase: "27,"

Phrase: "675-735"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.899: A., Harper, J. 

Phrase: "A.,"

Phrase: "Harper,"

Phrase: "J."
Processing 00000000.tx.900: D., and Lansbury, P. 

Phrase: "D."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.901: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.902: (2000) Biochemistry 39, 2552-2563[CrossRef][Medline] [OrderarticleviaInfotrieve] Jarrett, J. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Biochemistry 39,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "2552-2563"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Jarrett,"

Phrase: "J."
Processing 00000000.tx.903: T., and Lansbury, P. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.904: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.905: (1993) Cell 73, 1055-1058[CrossRef][Medline] [OrderarticleviaInfotrieve] Yamin, G., Uversky, V. 

Phrase: "(1993"

Phrase: ")"

Phrase: "Cell 73,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1055-1058"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Yamin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Uversky,"

Phrase: "V."
Processing 00000000.tx.906: N., and Fink, A. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.907: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.908: (2003) FEBS Lett. 

Phrase: "(2003"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.909: 542, 147-152[CrossRef][Medline] [OrderarticleviaInfotrieve] Esterbauer, H., Schaur, R. 

Phrase: "542,"

Phrase: "147-152"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Esterbauer,"

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Schaur,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.910: J., and Zollner, H. 

Phrase: "J.,"

Phrase: "and"

Phrase: "Zollner,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.911: (1991) Free Radic. 

Phrase: "(1991"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.912: Biol. 

Phrase: "Biol."
Processing 00000000.tx.913: Med. 

Phrase: "Med."
Processing 00000000.tx.914: 11, 81-128[CrossRef][Medline] [OrderarticleviaInfotrieve] Tofaris, G. 

Phrase: "11,"

Phrase: "81-128"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Tofaris,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.915: K., Layfield, R., and Spillantini, M. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Layfield,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Spillantini,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.916: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.917: (2001) FEBS Lett. 

Phrase: "(2001"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.918: 509, 22-26[CrossRef][Medline] [OrderarticleviaInfotrieve] Winterbourn, C. 

Phrase: "509,"

Phrase: "22-26"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Winterbourn,"

Phrase: "C."
Processing 00000000.tx.919: C. 

Phrase: "C."
Processing 00000000.tx.920: (1979) Biochem. 

Phrase: "(1979"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.921: J. 

Phrase: "J."
Processing 00000000.tx.922: 182, 625-628[Medline] [OrderarticleviaInfotrieve] Kehrer, J. 

Phrase: "182,"

Phrase: "625-628"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Kehrer,"

Phrase: "J."
Processing 00000000.tx.923: P., and Lund, L. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Lund,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.924: G. 

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.925: (1994) Free Radic. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.926: Biol. 

Phrase: "Biol."
Processing 00000000.tx.927: Med. 

Phrase: "Med."
Processing 00000000.tx.928: 17, 65-75[CrossRef][Medline] [OrderarticleviaInfotrieve] Spear, N., and Aust, S. 

Phrase: "17,"

Phrase: "65-75"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450385:65 [Intellectual Product]

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Spear,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336708:Spear [Manufactured Object]

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Aust,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.929: D. 

Phrase: "D."
Processing 00000000.tx.930: (1994) Arch. 

Phrase: "(1994"

Phrase: ")"

Phrase: "Arch."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0230467:arch [Body Location or Region]
  1000   C0741204:ARCH [Body Space or Junction]
Processing 00000000.tx.931: Biochem. 

Phrase: "Biochem."
Processing 00000000.tx.932: Biophys. 

Phrase: "Biophys."
Processing 00000000.tx.933: 312, 198-202[CrossRef][Medline] [OrderarticleviaInfotrieve] Requena, J. 

Phrase: "312,"

Phrase: "198-202"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Requena,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1225174:Requena [Eukaryote]

Phrase: "J."
Processing 00000000.tx.934: R., and Levine, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Levine,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.935: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.936: (2001) Free Radic. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Free Radic."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328660:Radic [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.937: Biol. 

Phrase: "Biol."
Processing 00000000.tx.938: Med. 

Phrase: "Med."
Processing 00000000.tx.939: 30, 141-147[CrossRef][Medline] [OrderarticleviaInfotrieve] Woodmansee, A. 

Phrase: "30,"

Phrase: "141-147"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Woodmansee,"

Phrase: "A."
Processing 00000000.tx.940: N., and Imlay, J. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Imlay,"

Phrase: "J."
Processing 00000000.tx.941: A. 

Phrase: "A."
Processing 00000000.tx.942: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.943: Biol. 

Phrase: "Biol."
Processing 00000000.tx.944: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.945: 277, 34055-34066[Abstract/Free FullText] Hoyer, W., Antony, T., Cherny, D., Heim, G., Jovin, T. 

Phrase: "277,"

Phrase: "34055-34066"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hoyer,"

Phrase: "W.,"

Phrase: "Antony,"

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Cherny,"

Phrase: "D."

Phrase: ","

Phrase: "Heim,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Jovin,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.946: M., and Subramaniam, V. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Subramaniam,"

Phrase: "V."
Processing 00000000.tx.947: (2002) J. 

Phrase: "(2002"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.948: Mol. 

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.949: Biol. 

Phrase: "Biol."
Processing 00000000.tx.950: 322, 383-393[CrossRef][Medline] [OrderarticleviaInfotrieve] Uversky, V. 

Phrase: "322,"

Phrase: "383-393"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Uversky,"

Phrase: "V."
Processing 00000000.tx.951: N., Lee, H. 

Phrase: "N., Lee,"

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.952: J., Li, J., Fink, A. 

Phrase: "J.,"

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.953: L., and Lee, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Lee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.954: J. 

Phrase: "J."
Processing 00000000.tx.955: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.956: Biol. 

Phrase: "Biol."
Processing 00000000.tx.957: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.958: 276, 43495-43498[Abstract/Free FullText] Caughey, B., and Lansbury, P. 

Phrase: "276,"

Phrase: "43495-43498"

Phrase: "[Abstract/Free FullText"

Phrase: "] Caughey,"

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.959: T. 

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.960: (2003) Annu. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Annu."
Processing 00000000.tx.961: Rev. 

Phrase: "Rev."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347961:Rev. [Professional or Occupational Group]
Processing 00000000.tx.962: Neurosci. 

Phrase: "Neurosci."
Processing 00000000.tx.963: 26, 267-298[CrossRef][Medline] [OrderarticleviaInfotrieve] Paik, S. 

Phrase: "26,"

Phrase: "267-298"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Paik,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.964: R., Shin, H. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Shin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0230444:Shin [Body Location or Region]

Phrase: "H."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.965: J., Lee, J. 

Phrase: "J.,"

Phrase: "Lee,"

Phrase: "J."
Processing 00000000.tx.966: H., Chang, C. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "Chang,"

Phrase: "C."
Processing 00000000.tx.967: S., and Kim, J. 

Phrase: "S."

Phrase: ","

Phrase: "and"

Phrase: "Kim,"

Phrase: "J."
Processing 00000000.tx.968: (1999) Biochem. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochem."
Processing 00000000.tx.969: J. 

Phrase: "J."
Processing 00000000.tx.970: 340, 821-828[CrossRef][Medline] [OrderarticleviaInfotrieve] Stadtman, E. 

Phrase: "340,"

Phrase: "821-828"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Stadtman,"

Phrase: "E."
Processing 00000000.tx.971: R., and Levine, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "and"

Phrase: "Levine,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.972: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.973: (2003) Amino Acids (Vienna) 25, 207-218[CrossRef] Requena, J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Amino Acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(Vienna"

Phrase: ")"

Phrase: "25,"

Phrase: "207-218"

Phrase: "[CrossRef"

Phrase: "] Requena,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1225174:Requena [Eukaryote]

Phrase: "J."
Processing 00000000.tx.974: R., Levine, R. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Levine,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.975: L., and Stadtman, E. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Stadtman,"

Phrase: "E."
Processing 00000000.tx.976: R. 

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.977: (2003) Amino Acids (Vienna) 25, 221-226[CrossRef] Yamin, G., Glaser, C. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Amino Acids"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0002520:Amino Acids [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   966 E C2917660:Amino Acid [Pharmacologic Substance]
   861   C0001128:Acids [Chemical]
   827 E C0202406:Acid [Laboratory Procedure]

Phrase: "(Vienna"

Phrase: ")"

Phrase: "25,"

Phrase: "221-226"

Phrase: "[CrossRef"

Phrase: "] Yamin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Glaser,"

Phrase: "C."
Processing 00000000.tx.978: B., Uversky, V. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Uversky,"

Phrase: "V."
Processing 00000000.tx.979: N., and Fink, A. 

Phrase: "N.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]

Phrase: "and"

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.980: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.981: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.982: Biol. 

Phrase: "Biol."
Processing 00000000.tx.983: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.984: 278, 27630-27635[Abstract/Free FullText] Uversky, V. 

Phrase: "278,"

Phrase: "27630-27635"

Phrase: "[Abstract/Free FullText"

Phrase: "] Uversky,"

Phrase: "V."
Processing 00000000.tx.985: N. 

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.986: (2003) J. 

Phrase: "(2003"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.987: Biomol. 

Phrase: "Biomol."
Processing 00000000.tx.988: Struct. 

Phrase: "Struct."
Processing 00000000.tx.989: Dyn. 

Phrase: "Dyn."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600130:dyn [Quantitative Concept]
Processing 00000000.tx.990: 21, 211-234[Medline] [OrderarticleviaInfotrieve] Uversky, V. 

Phrase: "21,"

Phrase: "211-234"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Uversky,"

Phrase: "V."
Processing 00000000.tx.991: N., Li, J., and Fink, A. 

Phrase: "N., Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "and"

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.992: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.993: (2001) J. 

Phrase: "(2001"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.994: Biol. 

Phrase: "Biol."
Processing 00000000.tx.995: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.996: 276, 10737-10744[Abstract/Free FullText] Hokenson, M. 

Phrase: "276,"

Phrase: "10737-10744"

Phrase: "[Abstract/Free FullText"

Phrase: "] Hokenson,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.997: J., Uversky, V. 

Phrase: "J.,"

Phrase: "Uversky,"

Phrase: "V."
Processing 00000000.tx.998: N., Goers, J., Yamin, G., Munishkina, L. 

Phrase: "N., Goers,"

Phrase: "J.,"

Phrase: "Yamin,"

Phrase: "G.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "Munishkina,"

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.999: A., and Fink, A. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.1000: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.1001: (2004) Biochemistry 43, 4621-4633[CrossRef][Medline] [OrderarticleviaInfotrieve] Giasson, B. 

Phrase: "(2004"

Phrase: ")"

Phrase: "Biochemistry 43,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "4621-4633"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Giasson,"

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.1002: I., and Lee, V. 

Phrase: "I.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0021966:I- [Inorganic Chemical]
  1000   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "and"

Phrase: "Lee,"

Phrase: "V."
Processing 00000000.tx.1003: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1004: (2003) Cell 114, 1-8[Medline] [OrderarticleviaInfotrieve] Myung, J., Kim, K. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Cell 114,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "1-8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C2827734:1+ [Quantitative Concept]
   861   C2981698:1+ [Classification]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Myung,"

Phrase: "J.,"

Phrase: "Kim,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.1005: B., Lindsten, K., Dantuma, N. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Lindsten,"

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Dantuma,"

Phrase: "N."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441922:N+ [Intellectual Product]
  1000   C1553036:[n] [Quantitative Concept]
Processing 00000000.tx.1006: P., and Crews, C. 

Phrase: "P.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]

Phrase: "and"

Phrase: "Crews,"

Phrase: "C."
Processing 00000000.tx.1007: M. 

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1008: (2001) Mol. 

Phrase: "(2001"

Phrase: ")"

Phrase: "Mol."
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
  1000   C0027960:Mole [Neoplastic Process]
  1000   C0324740:Mole [Mammal]
  1000   C0439189:Mole [Quantitative Concept]
  1000   C1456781:mole [Neoplastic Process]
  1000   C1824986:mol [Gene or Genome]
   916 E C0026367:Molar [Body Part, Organ, or Organ Component]
   900 E C0027962:moles [Neoplastic Process]
Processing 00000000.tx.1009: Cell 7, 411-420[Medline] [OrderarticleviaInfotrieve] Ferrington, D. 

Phrase: "Cell 7,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: "411-420"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Ferrington,"

Phrase: "D."
Processing 00000000.tx.1010: A., and Kapphaha, R. 

Phrase: "A.,"

Phrase: "and"

Phrase: "Kapphaha,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.1011: J. 

Phrase: "J."
Processing 00000000.tx.1012: (2004) FEBS Lett. 

Phrase: "(2004"

Phrase: ")"

Phrase: "FEBS Lett."
Processing 00000000.tx.1013: 578, 217-223[CrossRef][Medline] [OrderarticleviaInfotrieve] Khurana, R., Ionescu-Zanetti, C., Pope, M., Li, J., Nielson, L., Ramirez-Alvarado, M., Regan, L., Fink, A. 

Phrase: "578,"

Phrase: "217-223"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Khurana,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Ionescu-Zanetti,"

Phrase: "C.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "Pope,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0044577:POPE [Lipid]

Phrase: "M."

Phrase: ","

Phrase: "Li,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3495095:Li+ [Element, Ion, or Isotope]

Phrase: "J.,"

Phrase: "Nielson,"

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Ramirez-Alvarado,"

Phrase: "M."

Phrase: ","

Phrase: "Regan,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0740201:regan [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "Fink,"

Phrase: "A."
Processing 00000000.tx.1014: L., and Carter, S. 

Phrase: "L.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]

Phrase: "and"

Phrase: "Carter,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.1015: A. 

Phrase: "A."
Processing 00000000.tx.1016: (2003) Biophys. 

Phrase: "(2003"

Phrase: ")"

Phrase: "Biophys."
Processing 00000000.tx.1017: J. 

Phrase: "J."
Processing 00000000.tx.1018: 85, 1135-1144[Abstract/Free FullText] Nichols, M. 

Phrase: "85,"

Phrase: "1135-1144"

Phrase: "[Abstract/Free FullText"

Phrase: "] Nichols,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1019: R., Moss, M. 

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Moss,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0282635:Moss [Plant]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1020: A., Reed, D. 

Phrase: "A.,"

Phrase: "Reed,"

Phrase: "D."
Processing 00000000.tx.1021: K., Lin, W. 

Phrase: "K.,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]

Phrase: "Lin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0861352:LIN [Neoplastic Process]

Phrase: "W."
Processing 00000000.tx.1022: L., Mukhopadhyay, R., Hoh, J. 

Phrase: "L., Mukhopadhyay,"

Phrase: "R.,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]

Phrase: "Hoh,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555091:Hoh [Population Group]

Phrase: "J."
Processing 00000000.tx.1023: H., and Rosenberry, T. 

Phrase: "H.,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "and"

Phrase: "Rosenberry,"

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.1024: L. 

Phrase: "L."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439394:l's [Quantitative Concept]
  1000   C1706495:L- [Intellectual Product]
  1000   C3642217:/L [Quantitative Concept]
Processing 00000000.tx.1025: (2002) Biochemistry 41, 6115-6127[CrossRef][Medline] [OrderarticleviaInfotrieve] Walsh, D. 

Phrase: "(2002"

Phrase: ")"

Phrase: "Biochemistry 41,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "6115-6127"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Walsh,"

Phrase: "D."
Processing 00000000.tx.1026: M., Lomakin, A., Benedek, G. 

Phrase: "M."

Phrase: ","

Phrase: "Lomakin,"

Phrase: "A.,"

Phrase: "Benedek,"

Phrase: "G."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]
Processing 00000000.tx.1027: B., Condron, M. 

Phrase: "B.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "Condron,"

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.1028: M., and Teplow, D. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Teplow,"

Phrase: "D."
Processing 00000000.tx.1029: B. 

Phrase: "B."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]
Processing 00000000.tx.1030: (1997) J. 

Phrase: "(1997"

Phrase: ")"

Phrase: "J."
Processing 00000000.tx.1031: Biol. 

Phrase: "Biol."
Processing 00000000.tx.1032: Chem. 

Phrase: "Chem."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0201682:CHEM [Laboratory Procedure]
Processing 00000000.tx.1033: 272, 22364-22372[Abstract/Free FullText] Harper, J. 

Phrase: "272,"

Phrase: "22364-22372"

Phrase: "[Abstract/Free FullText"

Phrase: "] Harper,"

Phrase: "J."
Processing 00000000.tx.1034: D., Wong, S. 

Phrase: "D."

Phrase: ","

Phrase: "Wong,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.1035: S., Lieber, C. 

Phrase: "S."

Phrase: ","

Phrase: "Lieber,"

Phrase: "C."
Processing 00000000.tx.1036: M., and Lansbury, P. 

Phrase: "M."

Phrase: ","

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.1037: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.1038: (1999) Biochemistry 38, 8972-8980[CrossRef][Medline] [OrderarticleviaInfotrieve] Conway, K. 

Phrase: "(1999"

Phrase: ")"

Phrase: "Biochemistry 38,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005477:Biochemistry [Occupation or Discipline]

Phrase: "8972-8980"

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "[OrderarticleviaInfotrieve"

Phrase: "] Conway,"

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.1039: A., Lee, S. 

Phrase: "A.,"

Phrase: "Lee,"

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.1040: J., Rochet, J. 

Phrase: "J.,"

Phrase: "Rochet,"

Phrase: "J."
Processing 00000000.tx.1041: C., Ding, T. 

Phrase: "C., Ding,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1419419:DING [Gene or Genome]

Phrase: "T."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]
Processing 00000000.tx.1042: T., Williamson, R. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Williamson,"

Phrase: "R."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205090:R- [Spatial Concept]
  1000   C0684010:R. [Professional or Occupational Group]
  1000   C2603358:R' [Clinical Attribute]
Processing 00000000.tx.1043: E., and Lansbury, P. 

Phrase: "E.,"

Phrase: "and"

Phrase: "Lansbury,"

Phrase: "P."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C2603361:P' [Clinical Attribute]
Processing 00000000.tx.1044: T., Jr. 

Phrase: "T.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603360:T' [Clinical Attribute]

Phrase: "Jr."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1708595:Jr [Idea or Concept]
  1000   C3280986:JR [Disease or Syndrome]
Processing 00000000.tx.1045: (2000) Proc. 

Phrase: "(2000"

Phrase: ")"

Phrase: "Proc."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1418943:PROC [Gene or Genome]
Processing 00000000.tx.1046: Natl. 

Phrase: "Natl."
Processing 00000000.tx.1047: Acad. 

Phrase: "Acad."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0268596:ACAD [Disease or Syndrome]
  1000   C2700624:ACAD [Cell Function]
Processing 00000000.tx.1048: Sci. 

Phrase: "Sci."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3642273:SCI [Professional or Occupational Group]
Processing 00000000.tx.1049: U. 

Phrase: "U."
Processing 00000000.tx.1050: S. 

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.1051: A. 

Phrase: "A."
Processing 00000000.tx.1052: 97, 571-576[Abstract/Free FullText]

Phrase: "97,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439073:97 [Intellectual Product]
  1000   C0439082:>97 [Quantitative Concept]

Phrase: "571-576"

Phrase: "[Abstract/Free FullText"

Phrase: "]"

